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Abstract 
 
 
The Ajudazols A and B are secondary metabolites, isolated in 2004, that exhibit anti-fungal and 
cytotoxic activity.  
 
 
 
The primary objective of the work presented in this thesis was to expand and develop our 
novel isobenzofuran oxidative rearrangement methodology for generation of isochromanones, 
and to apply this methodology towards the total synthesis of the ajudazols.  
 
 
 
An efficient, high yielding, regio- and diastereoselective oxidative rearrangement sequence has 
been developed, allowing for the generation of elaborately-functionalised isochromanone 
structures, from transient isobenzofuran intermediates. 
 
 
 
A flexible route to the synthesis of the ajudazol B eastern section was achieved, and this 
research culminated in the synthesis of ent-8-epi-ajudazol B.  
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1 Introduction 
1.1 Total Synthesis of Natural Products 
“The synthesis of a complicated molecule is, however, a very difficult task; every group, every 
atom must be placed in its proper position and this should be taken in its most literal sense. It 
is sometimes said that organic synthesis is at the same time an exact science and a fine art.” 
A. Fredga (Nobel Prize Committee, 1965)1 
Total synthesis is regarded as the complete chemical synthesis of a complex organic molecule, 
constructed from smaller fragments, without the aid of biological processes. The birth of total 
synthesis can ultimately be traced back to Wöhler’s synthesis of urea in 1828. Although 
rendered somewhat trivial by today’s standards, this milestone event served as the gateway 
for future endeavours in total synthesis.2 
There are various motives for one to undertake the total synthesis of a natural product. 
Embarking on the challenge of a total synthesis is often undertaken to showcase recently 
developed chemical methodology, with total synthesis providing the ultimate testing ground 
for new methodology and synthetic strategies. Conversely, total synthesis can be justified as a 
stimulus for the development of new chemical reactivity, thereby adding to the toolkit of the 
organic chemist. Total synthesis is also often pursued for the purpose of checking the 
correctness of a newly isolated compound. Furthermore, if a compound is of practical 
importance, in particular, having notable biological activity, obtaining the substance by 
synthetic methods may offer a cost advantage over isolation method and may provide a more 
accessible route to the natural product, especially if it has a low abundance in nature.1,2 
The early 20th century saw efforts towards the synthesis of the naturally occurring antimalarial 
agent, quinine (1), which prompted research into the synthesis of heteroaromatic systems and 
led to the discovery of the unique properties of quinoline and piperidine rings (Figure 1). In 
more recent times, the structure of quinine has served as the foundation for new classes of 
antimalarials. Similarly, efforts towards the synthesis of steroids, for example, progesterone 
(2), led to a greater understanding of how to synthesise and cleave carbon-carbon bonds. The 
ability to synthesise partial and fully-steroidal frameworks in meaningful quantities allowed for 
the development of new drugs, notably the birth control pill, used by millions of women 
worldwide.2  
 
Figure 1  Milestones in Total Synthesis 
In the 1950s the highly sensitive β-lactam of penicillin (3) acted as a driver for John Sheehan as 
he developed carbodiimide reagents for the synthesis of peptide bonds.3 This methodology 
revolutionised the field of peptide synthesis, and to this day it receives widespread use. This 
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breakthrough allowed for the first total synthesis of penicillin and opened the door for the 
synthesis of antibiotic derivatives with biological activity superior to the parental natural 
product.2 
The work of Corey in the 1960s and 1970s into the synthesis of many of the eicosanoid family 
of natural products, such as prostaglandin F2α (4), resulted in the development of the first 
catalysts capable of effecting asymmetric Diels-Alder reactions. This work also inspired the 
now ubiquitous silyl-based protecting groups, together with the catalytic asymmetric 
reduction of ketones (Corey-Bakshi-Shibata reduction): inventions that have become the bread 
and butter of the modern day synthetic chemist.2 
The latter part of the 20th century saw researchers pushing the boundaries of total synthesis. 
Notably, the prolific work of Nicolaou has highlighted the feasibility of synthesising highly 
complex natural products, for example, the brevetoxins A and B (5) and taxol (6) (Figure 2).4 
Taxol was discovered in 1962 and has become an important drug for cancer treatment but 
unfortunately it is harvested in insufficient quantities from a scarce resource, the pacific yew 
tree. Due to its limited availability, taxol is incredibly expensive and therefore a synthetic route 
to this densely functionalised polycyclic natural product has generated great interest from the 
chemical community. The first successful total synthesis of a popular molecule is a huge 
honour and achievement, a philosophy no better exemplified than by the taxol case. The total 
synthesis of taxol was hotly contested, with no less than 30 competing research groups by 
1992. A close finish in 1994 saw the Holton group narrowly beat the efforts of K.C.Nicolaou.5,6 
With other masters in total synthesis, including Mukaiyama7 and Danishefsky8 publishing their 
respective total synthesis, together with the fact that there are still numerous research groups 
actively working on taxol, it is great testament to the significance of this natural product.9 
 
Figure 2  Highly Complex Natural Product Targets 
Regardless of the motives to embark on a total synthesis, they all serve as a vehicle for 
discovery, perhaps unparalleled, in the realm of chemical synthesis; every natural product 
isolated from the vast chemical diversity in nature provides a unique challenge and numerous 
research opportunities that originate from the unique three-dimensional architecture and 
associated biological activity.1,2  
Modern day total synthesis concerns the selection of structurally challenging and preferably, 
biologically significant, target molecules. Powerful tools have allowed for the isolation and 
structural elucidation of novel natural products, thereby rendering nature a seemingly limitless 
source of chemical targets for total synthesis.1,2 
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The total synthesis of complex natural products is increasingly perceived as an artform, an 
issue first addressed by Hendrickson in 1975 when he described the concept of an “ideal” 
synthesis as one which “…creates a complex molecule… in a sequence of only construction 
reactions involving no intermediary refunctionalisations, and leading directly to the target, not 
only its skeleton but also its correctly placed functionality.” 
Hendrickson’s concept of an ideal synthesis epitomises the desire to design a total synthesis 
with high atom efficiency, minimal synthetic steps and good redox-economy, ensures that the 
role of the synthetic chemist is akin to that of an inventor.10 
1.2 Ajudazol A and B 
Ajudazols A (7) and B (8) are biologically active metabolites isolated from the Chondromyces 
crocatus strain of myxobacteria (Figure 3).11 Myxobacteria lives preferentially in areas of high 
microbial life and organic matter, typically temperate topsoil, animal dung, rotting plant 
material and tree bark. Myxobacteria are present in all climatic regions but are particularly 
prevalent in warm, semi-arid climatic regions, for example, Egypt and northern India.12  
 
Figure 3  The Ajudazols 
The Chondromyces crocatus strain of myxobacteria is renowned for exhibiting high cytotoxic 
and antifungal activities. This activity has been ascribed to several structurally diverse groups 
of secondary metabolites, which are simultaneously produced by Chondromyces crocatus. 
Chondromyces crocatus strains have long been recognised as an important source of 
biologically active natural products notably, the crocacins A-D and the chondramides A-D 
(Figure 4).  Crocacin A, the most abundant member of the crocacin family of N-acyl dipeptides, 
effectively inhibits the growth of yeasts and fungi. Chondromides A-D are new cyclo-
depsipeptides that exhibit high cytostatic activity against mammalian cell lines.13,14
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Figure 4  Notable Secondary Metabolites Isolated From Chondromyces Crocatus 
Ajudazols A and B were isolated in 2003 as a result of screening of myxobacteria for new 
biologically active compounds. Advanced analysis of crude extracts of Chondromyces crocatus 
cultures led to the discovery of the ajudazols, together with the isolation of new β-amino 
styrenes, the chondrochlorens.11 
The antifungal activity of the ajudazols has been partly assessed. Ajudazol A, the major 
metabolite, showed only minor activity against a few fungi and Gram-positive bacteria. 
However ajudazol B inhibited the growth of several important fungi: Botrytis cinerea, 
Trichoderma koningii, Giberella fujikuroi and Ustilago maydis.13 It also exhibited weak activity 
against several Gram-positive bacteria. Botrytis cinerea is a fungus that causes grey rot which, 
although welcomed in the wine industry, can have a severe effect on many plant species. 
Furthermore, Ustilago maydis (corn smut) causes smut disease on maize and, if untreated, can 
ruin entire harvests.  
The ajudazols have been identified as inhibitors of the bacterial mitochondrial electron 
transport chain at low nanomolar concentrations; the ajudazols showed inhibition of 
nicotinamide adenine dinucleotide oxidation in submitochondrial particles with an IC50 of 13.0 
ng/mL (22.0 nM) for ajudazol A. Ajudazol B was marginally more potent at 10.9 ng/mL (18.4 
nM). 
Structurally, the ajudazols showcase a number of highly unusual features. The most notable 
feature is the isochroman-1-one core: a fused phenol-lactone bicyclic unit (Figure 5). The bi-
cycle possesses hydroxyl functionality at the C8 position and an alkyl chain extending out from 
the C9 position. 
Introduction 
 
15 
 
 
Figure 5  The Structure of the Ajudazols 
Other than the isochromanone core, the ajudazols boast an extended side chain containing a 
2,5-substituted oxazole (C12-C14), a Z,Z-diene (C17-C20) and an E-olefin (C23-C24), together 
with a (E)-3-methoxy-N-methylbut-2-enamide moiety, previously unprecedented in natural 
product synthesis. The ajudazols A and B differ only at the C15 position: ajudazol A has an exo-
methylene olefin whereas ajudazol B bears a fully saturated methyl group, the stereochemistry 
of which is unassigned.  
Extensive NMR studies have been carried out to assign the stereochemistry of ajudazols A and 
B. The C8, C9 and C10 protons have a trans-stereochemical relationship with one another and 
this relative stereochemical configuration of the isochromanone core unit, together with the 
Z,Z,E-triene, were assigned on the basis of NOESY and 1H–1H coupling constant analysis; 
however, the stereochemistry of the C15 methyl group of ajudazol B could not be assigned. 
Likewise, the absolute stereochemistry of the ajudazols remains to be determined.11 
1.3 4-Hydroxyisochromanones 
The 4-hydroxyisochromanone motif is a biologically relevant building block that is present in a 
number of biologically active compounds including the ajudazols A (7) & B (8), 4-
hydroxymellein (17), (4R)-hydroxyochratoxin A (18),15 acetoxy-geranyloxymellein (19),16 
thailandolide B (20),17 bergenin (21),18 and the Helminthosporium monoceras antifungal 
metabolite monocerin (22) (Figure 6).19  
 
Figure 6  Hydroxyisochromanone Containing Natural products 
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Synthetically, 4-hydroxyisochromanones have been approached via four distinct methods, 
with one approach coming from within our research group (vide infra) and two novel 
approaches appearing within the past year. The recent interest towards the synthesis of 4-
hydroxyisochromanones from within the chemical community highlights their importance, due 
to their presence in structurally interesting natural products, coupled with their biological and 
pharmacological potential. 
1.3.1 Danishefsky’s Approach to 4-Hydroxyisochromanones 
In 2000, Danishefsky reported an approach for the synthesis of 4-hydroxyisochromanones, 
utilizing ortho-quinone dimethides in intermolecular hetero-Diels-Alder cycloadditions 
(Scheme 1).20 Under thermal conditions, 1,2-trans-benzyloxycyclobutane 23 undergoes facile 
ring opening to generate ortho-quinone dimethide 24,  an intermediate that can then function 
as a diene in Diels-Alder reactions. Diene 23 reacts with ethanal to generate the hetero-Diels-
Alder intermediate 25, which is oxidized in situ to afford 4-silyloxyisochromanone 26 in 
excellent yield under mild reaction conditions. 
 
Scheme 1 4-Hydroxyisochromanones from 1,2-Trans-Benzyloxycyclobutanes 
This ground-breaking methodology constituted the first completely stereodefined [4+2] 
intermolecular Diels-Alder cycloaddition of dienes with unactivated aldehydes, in the absence 
of catalytic activation.21  
1.3.2 Yeung’s Approach to 4-Hydroxyisochromanones 
In late 2011, Yeung reported an enantioselective approach towards 4-hydroxyisochromanone 
synthesis through the bromocyclisation of styrene-type carboxylic acids.21 The synthetic route 
allows for the synthesis of various 4-functionalised-isochromanone derivatives, accessible from 
a common late-stage intermediate (Scheme 2).  
Mechanistically, the styrene-type carboxylic acid 27 undergoes an enantioselective 
bromocyclisation, using NBS as stoichiometric oxidant, in the presence of the chiral amino-
thiocarbamate catalyst 28, to generate the bromonium species 29. The 4-
bromoisochromanone product 30, the result of 6-endo cyclisation, is formed in strong 
preference to the phthalide (5-exo) species 31. In general, high yields, together with excellent 
levels of enantioselectivity are achieved (Scheme 2). 
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Scheme 2 Yeung’s Bromocyclisation Route to 4-Bromoisochromanones 
Yeung then showed that the 4-bromoisochromanone moiety 32 could be used to access 
various isochromanone building blocks (Scheme 3). Radical debromination of 4-
bromoisochromanone 32, allowed access to the deshydroxyisochromanone 33. Alternatively 
the bromide could be displaced by nucleophilic acetate displacement to generate the 
oxygenated core 34, while azide displacement allowed entry to the nitrogen substituted core 
35. Inversion of stereochemistry of the 4-bromo-isochromanone ensured that the oxygen and 
nitrogen analogues 34 and 35, displayed syn stereochemistry (C3-C4).21  
 
Scheme 3 4-Bromoisochromanone Functionalisation 
1.3.3 Fujita’s Approach to 4-Hydroxyisochromanones 
A month after Yeung’s report, Fujita  reported methodology for the asymmetric synthesis of 4-
hydroxyisochromanones ortho-alkenylbenzoate substrates.22 The stereoselective 
oxylactonisation of ortho-alkenylbenzoate 36 proceeds in the presence of the chiral 
hypervalent iodine oxidant 37, to afford, almost exclusively, the 6-endo cyclisation product 38 
in good yield and enantioselectivity (Scheme 4). 
 
Scheme 4 Fujita’s Oxylactonisation Route to 4-Hydroxyisochromanones  
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Based on the syn selectivities observed, mechanistically, it was proposed that the 
(diacetoxyiodo)arene is activated by the Lewis acid, followed by asymmetric electrophilic 
addition of the activated iodine(III) reagent 37 to the alkene substrate 36. From intermediate 
39, two consecutive nucleophilic displacements lead to the 4-acetoxyisochromanone product 
38. Mechanistically, two possible pathways may exist. The initial nucleophilic displacement of 
39 may occur via Path A where the acetate counterion acts as a nucleophile at the benzylic 
position, where the building positive charge can be delocalised, to generate intermediate 40. 
The ensuing participation of the internal carboxylate leads to the departure of the aryliodonio 
group and this second nucleophilic displacement with inversion generates the 4-
acetoxyisochromanone product 38. Fuijta believed that reaction pathway B is unlikely because 
substrates of type 41 gave similar regioselectivity independent of the nucleophilicity of the 
internal carboxylate. If the reaction proceeded via 41, the stereochemical purity of product 38 
would have decreased, owing to facile elimination of the aryliodonio group at the benzyl 
position of intermediate 39 in an SN1 fashion (Scheme 5). 
22,23 
 
Scheme 5 Mechanism for Fujita’s Oxylactonisation Route to 4-Hydroxyisochromanones 
Fujita applied this methodology towards the synthesis of 4-hydroxyisochromanone polyketide 
derivatives. Hydroxymellein (17) was accessed via the asymmetric oxylactonisation of ortho-
alkenylbenzoate 42, via hydrolysis of the acetylated intermediate 43 (Scheme 6).  
 
Scheme 6 Fujita’s Synthesis of Hydroxymellein 
The antipodal enantiomer of monocerin ent-(22) was generated from ortho-alkenylbenzoate 
45 via hypervalent iodine oxylactonisation, with the silyloxy tether acting as an internal 
nucleophile to afford the tricyclic product in good yield and excellent enantiocontrol (Scheme 
7).22 
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Scheme 7 Fujita’s Synthesis of Monocerin ent-(22) 
1.4 Biosynthesis of the Ajudazols 
Polyketides are a large class of secondary metabolites that are found in bacteria, plants, fungi 
and animals. Type I polyketide synthases (PKSs) are large, covalently bound multienzyme 
complexes which are responsible for the biosynthesis of a plethora of polyketide natural 
products. Biosynthetically, polyketide formation occurs by the catalytic action of PKS 
multienzymes in a highly co-ordinated assembly-line, wherein each catalytic step is 
attributable to a specific domain. The organisation of modules within a specific domain, 
together with the catalytic activities present in each module ultimately determines the 
structure of the polyketide chain. Thus, polyketides are generated in a fashion analogous to 
fatty acid biosynthesis.24 
In modular PKSs, the polyketide chain is assembled by the stepwise condensation of activated 
carboxylic acid-derived units. The growth of the polyketide carbon chain is initiated by the 
condensation of a starter unit with an extender unit. The starter and extender units are 
present in the host as CoA thioesters. The starter units are derived from acetyl-CoA or 
propionyl-CoA, while malonyl-CoA and methylmalonyl-CoA are the typical extender units; 
however, various acetyl-CoA derivatives that are activated by carboxylation at the α-position 
may also be used. The CoA-bound starter group is loaded onto the acyl carrier protein (ACP) 
domain of the PKS starter module, a process catalysed by the acyltranferase (AT) domain. The 
starter group is then transferred to the ketosynthase (KS) domain of the current module, 
whilst the extender group is loaded onto the ACP domain. Decarboxylation of the ACP-bound 
elongation group then promotes a Claisen condensation with the KS-bound starter group, 
under CO2 evolution, to furnish a free KS domain and the ACP-bound elongated chain (Scheme 
8).24   
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Scheme 8  Polyketide Biosynthesis 
The fate of the resultant elongated diketide depends on whether post-ketosynthase 
modifications are present in the module. Functional ketoreductase (KR), dehydratase (DH) or 
enoylreductase (ER) can act to promote one or more of the sequential reactions of 
ketoreduction, dehydration and enoylreduction, to generate compounds containing a hydroxyl 
group, unsaturated double bond or fully reduced carbon. Therefore the variety of extender 
units available, together with multiple post-KS modifications available, provides great potential 
to introduce structural diversity, with asymmetric reduction introducing chirality. Following 
post-KS modification, the elongated chain is transferred to the KS domain of subsequent 
modules, allowing for further chain elongation as it passes through each domain of the 
assembly line (Scheme 8).  
The growing polyketide chain can pass through numerous elongation and functionalisation 
stages in a pre-determined order, as determined by the PKS multienzyme. Once complete, the 
polyketide chain enters the termination stage. The thioesterase (TE) domain releases the 
completed polyketide from the PKS multienzyme via either hydrolysis or cyclisation 
(alcoholysis or aminolysis) (Scheme 8).  
As far as the ajudazols are concerned, the gene cluster in Chondromyces crocatus Cm c5 that is 
responsible for their biosynthesis, was identified by Buntin and co-workers.25 Although the 
shared backbone of both ajudazols could be predicted to arise from a mixed system of type I 
PKS and non-ribosomal polyketide synthase (NRPS), the origins of the isochromanone unit and 
the exo-methylene of ajudazol B are not clear, as neither of these units are obvious products 
of classical assembly-line biosynthesis. 
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Scheme 9 Biosynthesis of the Ajudazols 
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Biosynthetically, ajudazol formation requires the growing chain to pass through a total of 13 
modules, with various PKS and NRPKS domains introducing the necessary functionality, until 
the termination stage is reached. Importantly, the biosynthetic machinery does not 
incorporate a terminal cyclase, but a variant thioesterase (TE) domain.   Upon reaching the end 
of the PKS-NRPS assembly line, the elongated ajudazol chain is transacylated onto the serine 
active site of the terminal TE domain (Scheme 9).25 
Two mechanisms have been postulated for TE catalysed chain release and isochromanone ring 
formation. Mechanism A involves TE catalysed lactonisation between the C9Hydroxyl group 
and the acyl terminus to generate the 10-membered lactone 48, with chain release from the 
protein. Subsequent intramolecular aldol condensation and aromatisation affords the 
isochromanone ring of deshydroxyajudazol B (49). Alternatively, for mechanism B, 
aromatisation occurs whilst the chain is still bound to TE, to generate intermediate 50, 
followed by TE catalysed lactonisation and chain release, to generate the lactone ring of 
deshydroxyajudazol B (49) (Scheme 10). 
Scheme 10 Thioesterase Catalysed Chain Release in Ajudazol Biosynthesis 
Biosynthetically, ajudazols A and B share a common PKS-NRPS assembly line, followed by TE 
catalysed isochromanone generation and chain release, resulting in the common metabolite, 
deshydroxyajudazol B (49). Following release from the protein cluster, deshydroxyajudazol B 
(49) undergoes several post-PKS modifications in order to generate the hydroxyl functionality 
at C8 and the C15 exo-methylene of ajudazol A. The enzymes ajuI and ajuJ, are responsible for 
these late stage post PKS modifications. AjuI is responsible for C15 dehydrogenation while ajuJ 
is responsible for C8Hydroxylation. Again, two possible pathways have been proposed. If 
deshydroxyajudazol B (49) acts first with ajuJ, the product, ajudazol B (8), is no longer a 
substrate for ajuI. However, if deshydroxyajudazol B (49) acts first as a substrate for AjuI then 
the resulting deshydroxyajudazol A (51) can then react with ajuJ to generate ajudazol A (7). 
The fact that ajudazol A is the major metabolite isolated from Chondromyces crocatus, would 
suggest that ajuI is the more efficient enzyme, and hence, the second route is the preferred 
pathway (Scheme 11).25,26 
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 Scheme 11 Post-PKS Modifications in Ajudazol Biosynthesis 
1.5 Approaches Towards the Total Synthesis of the Ajudazols 
The combination of unusual structural features, coupled with their biological activity makes 
the ajudazols highly attractive synthetic targets. As such, they have received notable interest 
from the chemical community. To date, a complete total synthesis of either ajudazol A or B is 
yet to be reported; however, two research groups besides our own have published their 
respective approaches and progress towards the total synthesis of the ajudazols.27-29 
1.5.1 Taylor’s Synthesis of Ajudazol Eastern Section 52 
In 2004, Taylor reported his approach to the synthesis of the C12-C29 fragment of ajudazol A 
52, showcasing a one-pot double acetylene carbocupration to efficiently generate the internal 
Z,Z-diene (Figure 7).29  
 
Figure 7  Taylors Ajudazol A Eastern Section 52 
Taylor’s retrosynthetic approach towards ajudazol A relied on the key Stille disconnection to 
generate the 2-stannyl-oxazole 53 and vinyl bromide 54, comprising the eastern side-chain 
unit (Scheme 12). This convergent route, involving the introduction of the eastern side-chain 
15, as a late stage intermediate, was specifically devised to circumvent any potential side 
reactions that could occur between the oxazole or isochromanone portions of the molecule 
and reactive intermediates that would be required to otherwise construct the polyene side 
chain. Retrosynthetic analysis of the side-chain 54 suggested an amide coupling with 3-
methoxybutenoic acid 56 as the final step, preceded by an amination and E-selective Wittig 
olefination to suggest the polyene-aldehyde 55 as a suitable precursor. Aldehyde 55 would be 
accessible from alcohol 57 which, in turn, could be constructed via the key double acetylene 
Introduction 
 
24 
 
carbo-cupration reaction of propoxylithium cuprate 58, followed by trapping with 2,3-
dibromopropene. 
 
Scheme 12 Taylor’s Retrosynthesis of Ajudazol A 
Taylor’s synthesis commenced with the stereocontrolled double acetylene carbocupration of 
the readily available THP-protected 3-iodopropanol 59, to generate the Z,Z-dienyl cuprate 
intermediate 60 (Scheme 13). This was quenched with 2,3-dibromopropene to afford the 
desired diene 61 in 54% yield and excellent Z,Z-selectivity (>95%). The highly efficient double 
acetylene carbocupration is a variant of the Normant reaction: the nucleophilic addition of 
organocuprate reagents to acetylene or terminal alkynes to yield alkenyl copper compounds.30 
Taylor had previously utilized this double acetylene carbocupration methodology in his 
syntheses of navel orangeworm pheromone and leukotriene B4 analogues.
31 
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Scheme 13  Taylor’s Synthesis of Polyene Eastern Fragment 66 
The THP-protected diene 61 was deprotected and the resulting alcohol 57 was oxidized to the 
corresponding aldehyde 55, under Dess-Martin conditions. Wittig olefination yielded the 
desired E-configured α,β-unsaturated ester 62 in excellent yield. Ester reduction followed by 
THP protection of the resulting alcohol occured in 85% yield. Vinyl bromide 63 was then 
converted to the corresponding vinyl iodide 65 in 75% yield, via lithium-halogen exchange with 
tBuLi and iodine.  This halogen interconversion was necessary because their studies revealed 
that the vinyl bromide species 54 was insufficiently reactive as a Stille coupling partner. 
Compound 64 was then deprotected and the resulting alcohol was converted to the 
corresponding bromide which was displaced with methylamine to generate the desired allylic 
amine 65. Peptide coupling with 3-methoxybutenoic acid 56 afforded amide 66 in excellent 
yield (Scheme 13). 3-Methoxybutenoic acid 56 was synthesized from methyl acetoacetate in 
two steps following literature procedure (Scheme 14).32 
 
Scheme 14 Synthesis of 3-Methoxybutenoic Acid 56 
The key and final step to Taylor’s synthesis of the C12-C29 eastern fragment of ajudazol A 52 
involved the convergent Stille cross-coupling between vinyl iodide 66 and stannyl oxazole 67. 
Unfortunately, polyene 66 proved to be unstable under high temperatures (>100 oC). After 
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extensive optimisation, the C12-C29 fragment 52 was best achieved using PdCl2(PPh3)2 in DMF. 
The relatively low reaction temperature was vital in order to avoid any substantial product 
degradation (Scheme 15). 
 
Scheme 15 Stille Coupling to Access C12-C29 Ajudazol A Fragment 52 
1.5.2 Rizzacasa’s Synthesis of Ajudazol A & B C9-C29 Eastern Fragments 
Rizzacasa reported his approach to the synthesis of the C9-C29 fragment of both ajudazols A 
68 and B 69 in 2007. The ajudazol fragment generated by the Rizzacasa group differs from 
Taylor’s only by way of an additional alkoxy tether at the oxazole C4 position (Figure 8).27  
 
Figure 8  Rizzacasa’s C9-C29 Eastern Fragments of Ajudazol A & B  
Rizzacasa envisaged a convergent approach in which both ajudazol A and B model systems 
could arise from common late stage intermediates. For Ajudazol A, the key Sonogashira 
reaction between alkyne fragment 70 and vinyl iodide 72 would generate the C18-C19 bond of 
the ajudazol A C9-C29 fragment 68, in a convergent manner. Partial hydrogenation would then 
yield the desired Z,Z-diene functionality  in a stereoselective fashion, followed by dehydration 
to generate the C15-olefin and complete the synthesis of the ajudazol A C9-C29 fragment 68. It 
was envisioned that the ajudazol B system 69 would be accessed via the coupling of the same 
late-stage fragment 72 with either enantiomer of the chiral acetylene 71R or 71S, followed by 
stereoselective enyne reduction to generate either enantiomer of the ajudazol B C9-C29 
fragment 69a and 69b (Scheme 16).   
The vinyl iodide fragment 72 could be accessed via the amide coupling between 3-
methoxybutenoic acid 56 and amine 76. Oxazole units 70 and 71R/S would be obtained by the 
cyclodehydration of the amide generated from condensation of amine 73 and either acid 74 
(for C9-C29 ajudazol A fragment 68) or enantiopure acids 75R and 75S (for C9-C19 ajudazol B 
diastereoisomers 69a and 69b) (Scheme 16). 
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Scheme 16 Rizzacasa’s Retrosynthesis of C9-C29 Ajudazol A & B Fragments 
Rizzacasa’s synthesis of the C9-C29 fragments of ajudazol A 68 and B 69 commenced with the 
known alcohol 77, which was oxidized to the corresponding aldehyde and subjected to E-
selective Wittig olefination to generate diene 78. Ester reduction, followed by bromination of 
the resulting alcohol and displacement with methylamine, afforded the secondary amine 76. 
Amide coupling with 3-methoxybutenoic acid 56 generated the key vinyl iodide 72 (Scheme 
17). 
 
Scheme 17 Synthesis of Vinyl Iodide 72 
The synthesis of the ajudazol B acetylene fragment rac-71 began from the known racemic 
alcohol 79, which was converted into amine 73 in a 3-step sequence in excellent yield. Amine 
73 then underwent peptide coupling with the racemic carboxylic acid 80 to afford amide 81 as 
a mixture of diastereoisomers. Silyl deprotection followed by oxidation of the subsequent 
alcohol 82, afforded the aldehyde intermediate, which upon cyclodehydration, generated the 
racemic oxazole rac-71, in excellent yield (Scheme 18). 
 
Scheme 18 Synthesis of the Ajudazol B Acetylene Fragment rac-71 
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On the other hand, the synthesis of the oxazole unit 70, present in ajudazol B C9-C29 fragment 
69, commenced with the alkylation of dimethyl malonate with propargyl bromide, followed by 
reduction to the corresponding diol 83 in low overall yield. The diol 83 was mono-protected 
and the resultant alcohol was oxidised to afford racemic acid 84 in good yield. Subsequent 
peptide coupling with amine 73 generated amide 85. Regioselective deprotection followed by 
oxidation of the newly obtained alcohol, afforded the aldehyde intermediate that underwent 
cyclodehydration to generate the racemic oxazole 86 in high yield. Deprotection afforded 
primary alcohol 70 (Scheme 19).  
 
Scheme 19 Synthesis of the Ajudazol A Acetylene Fragment 70 
Having synthesized the common vinyl iodide side chain 72, together with the oxazole-alkyne 
unit rac-71, Rizzacasa sought to attempt the crucial C18-C19 coupling reaction. Sonogashira 
cross-coupling between acetylene rac-71 and vinyl iodide 72 proceeded in good yield to 
generate enyne 87. Subsequent stereoselective partial hydrogenation using P-2 nickel catalysis 
afforded the racemic ajudazol B C9-C29 fragment rac-69 in 55% yield (Scheme 20).  
 
Scheme 20 Synthesis of C9-C29 Ajudazol B Fragment rac-69 
Rizzacasa also demonstrated that this route could be modified to allow for the 
enantioselective synthesis of ajudazol B. Both enantiomers of acid 75 were synthesized and 
used to generate both enantiomers of oxazole-aldehyde 71. This enantioselective approach 
would allow for either enantiomer of the ajudazol B C9-C29 fragment to be synthesized, 
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33merely by selecting the appropriate acid coupling partner. However, despite this, no 
enantioselective synthesis of the ajudazol B C9-C19 fragment 69 was reported.  
On the other hand, Sonogashira coupling between acetylene 70 and vinyl iodide 72 proceeded 
in good yield to generate enyne 88. Partial hydrogenation of the enyne unit followed by 
dehydration yielded the ajudazol A C9-C19 fragment 68 (Scheme 21). 
 
Scheme 21 Synthesis of C9-C29 Ajudazol A Fragment 68 
1.5.3 Rizzacasa’s Synthesis of 8-Deshydroxyajudazol B 49 
In 2011, Rizzacasa reported the synthesis of the 15R-isomer of deshydroxyajudazol B 49, a 
compound that is believed to be a putative intermediate in the biosynthesis of both ajudazol A 
and B (Scheme 11). The route took advantage of an intramolecular Diels-Alder reaction to 
generate the deshydroxyisochromanone unit, cyclodehydration chemistry to generate the 
oxazole and the previously reported Sonogashira/reduction protocol to synthesize the polyene 
side chain.28 
Retrosynthetic analysis of the deshydroxyajudazol B 49 utilizes the Sonogashira coupling 
between terminal acetylene 89 and vinyl iodide 72, followed by partial reduction, to secure 
the Z,Z-diene. It was predicted that the 2,4-substituted oxazole of 89 could be accessed via 
cyclodehydration of a β-formylamide, which in turn could be accessed from terminal olefin 90 
and either enantiomer of carboxylic acid 75, thereby allowing for the synthesis of both C15 
stereoisomers of deshydroxyajudazol B 49, in an efficient manner. It was envisioned that 
deshydroxyisochromanone 90 could be accessed via an intramolecular Diels-Alder reaction of 
the tethered dienyne 91 followed by subsequent aromatization, bromide-oxygen exchange, 
and Wittig extension (Scheme 22). 
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Scheme 22 Retrosynthetic Analysis of 8-Deshydroxyajudazol B  
Synthesis of the intramolecular Diels-Alder precursor 91 began with the known enantiopure 
aldehyde 92, which underwent Wittig olefination to yield diene 94, as a 3:1 mixture of isomers, 
with the E,Z-diene being favoured. Silyl deprotection, followed by transesterification with 
methyl propynoate, generated ester 95. Bromination of the acetylene moiety afforded the 
dienyne intramolecular Diels-Alder precursor 91 (Scheme 23). 
 
Scheme 23 Synthesis of Intramolecular Diels-Alder Precursor 91 
The intramolecular Diels-Alder reaction of dienyne 91, followed by oxidation of the Diels-Alder 
product, generated isochromanone 96 in 49% yield. Br-O exchange was achieved via a Miyaura 
borylation/oxidation sequence, generating phenol 97, which was protected as PMB ether 98. 
Hydroboration/oxidation of the terminal olefin 98 proved troublesome and required rhodium 
catalysis to obtain the terminal alcohol 99. Oxidation followed by Wittig methylenation 
generated olefin 90 (Scheme 24).  
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Scheme 24 Synthesis of Terminal Olefin 90 
Upjohn dihydroxylation of olefin 90 afforded diol 100 as a mixture of diastereoisomers. 
Chemoselective esterification of diol 100 with enantiomerically pure 75R yielded ester 101.  
Mitsunobu conditions successfully generated the azide 102. A one-pot azide reduction, 
followed by an O,N-acyl shift yielded β-hydroxyamide 103. Finally, oxidation and 
cyclodehydration generated the 15R-deshydroxyajudazol B western section 89 (Scheme 25). 
 
Scheme 25 Synthesis of Terminal Acetylene 89 
Sonogashira coupling between acetylene 89 and vinyl iodide 72 generated enyne 105, 
generating the key C18-C19 bond. Partial hydrogenation, previously optimized on the earlier 
studies towards the ajudazol eastern fragment synthesis, was implemented on enyne 105 to 
afford the 15R-isomer of deshydroxyajudazol B 49 in 34% yield (Scheme 26). 
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Scheme 26 Rizzacasa’s End-Game Route to 15R-Deshydroxyajudazol B 49 
1.5.4 Preliminary Work within the Marquez Group 
Until the most recent letter published by Rizzacasa, all synthetic efforts towards the synthesis 
of the ajudazols focussed on the oxazole-linked polyene eastern side-chain. On the contrary, 
research efforts within the Marquez group focussed on the synthesis of the western section of 
the ajudazols, with particular emphasis on the isochromanone core. In the Marquez approach, 
it was envisioned that the isochromanone functionality could be accessed via a modified 
Achmatowicz rearrangement, utilising the high reactivity of isobenzofurans (IBFs) as synthetic 
intermediates. 
Retrosynthetically, it was hypothesised that isochromanone 106 could be accessed via 
oxidation and chemoselective reduction of keto-lactol 107, which in turn could be generated 
via an Achmatowicz-type rearrangement of α-hydroxyisobenzofuran 108. It was hypothesised 
that α-hydroxy-IBF 108 could be obtained by the lithiation and alkylation of IBF intermediate 
109, which could be generated from phthalan precursor 110 (Scheme 27).33 
 
Scheme 27 Retrosynthetic Analysis of Isochromanones via IBF Intermediates 
1.5.4.1 The Achmatowicz Rearrangement 
The Achmatowicz rearrangement, first reported in 1971, involves the generation of α,β-
unsaturated pyranones via the oxidative treatment of α-hydroxyfurans.35 In the original 
publication, furfuryl alcohol 111 was treated with bromine in methanol to give the 
dihydrofuran derivative 112, that in acidic conditions, underwent acetal cleavage to give the 
dicarbonyl species 113, that immediately cyclised to afford the hydroxypyranone 114. Alcohol 
protection, followed by ketone reduction, afforded the dihydropyran intermediate 116, from 
which a variety of monosaccharides were synthesized (Scheme 28). 
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Scheme 28 Original Achmatowicz Rearrangement of Furfuryl Alcohol 111 
The accepted mechanism for the Achmatowicz rearrangement involves hydroxyl directed 
allylic epoxidation of furfuryl alcohol 117, followed by ring opening to generate the transient 
1,4-dicarbonyl species 120 via an initial zwitterionic intermediate 119. Nucleophilic attack of 
the free hydroxyl onto the aldehyde functionality then generates the lactol product 121, 
favouring the α-anomeric product (Scheme 29).  
 
Scheme 29 Mechanism of the Achmatowicz Rearrangement 
Various one-pot conditions for the generation of α,β-unsaturated pyranones from furfuryl 
alcohols have been developed since the original Achmatowicz report: NBS/H2O,
36,37 
peroxyacids, (in particular, mCPBA)38-41 and VO(acac)2/
tBuOOH has proved popular for this 
transformation. 
The Achmatowicz rearrangement initially found widespread use in organic synthesis in the 
field of carbohydrate chemistry; 32,42,35  however, more recently it has been utilised in natural 
product synthesis for the generation of substituted pyran rings. The Achmatowicz 
rearrangement was implemented as the key step in the synthesis of (+)-mycoepoxydiene (124) 
by Tadano,43 where VO(acac)2/
tBuOOH was used to effectively generate the pyranone product 
123 as a 2:1 mixture of anomers (Scheme 30). 
 
Scheme 30 Utility of Achmatowicz Rearrangement in the Synthesis of (+)-Mycoepoxydiene (124) 
1.5.4.2 Isobenzofurans 
IBFs are highly reactive 10π heteroaromatic compounds that readily polymerise at room 
temperature. The extreme reactivity of IBF is in contrast to the stable benzofuran which differs 
only in the placement of the heteroatom (Figure 9).44 
 
Introduction 
 
34 
 
 
Figure 9  Benzofuran and Isobenzofuran 
A number of theoretical studies have been published to account for the instability of IBF.45-49 
The accumulation of these studies concluded that the resonance stabilisation and aromaticity 
in IBF is confined to the 5-membered heteroaromatic ring with two continuous, but virtually 
non-interacting π-systems. Hence, the extreme reactivity is believed to be attributable to the 
adjacent diene moiety. This structural feature allows synchronous disruption of the π-system 
in the 5-membered heterocyclic ring and formation of the more stable benzene ring during 
dienophile addition, resulting in the observed hyper-reactivity.46 Therefore, due to the high 
instability of IBFs, they have been synthesized as transient intermediates and reacted in situ. 
IBFs have been used in both inter- and intramolecular Diels-Alder cycloadditions. For example, 
IBF 125 reacts with alkyne 126 to generate oxabicyclo adduct 127. Similarly, IBF 125a also 
reacts with olefin 128, followed by acid treatment, to generate naphthalene 129 (Scheme 
31).44 
 
Scheme 31  Utility of Isobenzofurans in Diels-Alder Chemistry 
Deprotonation of IBF and related systems has been reported in which the lithiated species can 
be intercepted by a variety of electrophiles.50 Sequential lithiation and alkylation can be 
achieved to generate alkyl- and 1,3-dialkyl-IBF derivatives. However such derivatives have only 
ever been generated in situ and consequently, have only been used in Diels-Alder 
chemistry.44,49 Therefore, at the time when the Marquez group sought to access 
isochromanones from IBFs, their synthetic utility was restricted, almost exclusively, to Diels-
Alder chemistry. 
1.5.4.3 Marquez’ Synthesis of Ajudazol Western Section 
Preliminary work on the ajudazols within the Marquez group focussed on the development of 
an efficient approach to isochroman-1-one 136, starting from simple phthalide 130.33 In the 
initial approach, phthalide 130 was efficiently converted to phthalan 131, which upon 
treatment with 2 equivalents of LDA, proceeded to generate the putative IBF anion 132. 
Mechanistically, the first equivalent of base promotes the elimination of methanol to induce 
aromatization, before the second equivalent of base directly deprotonates the IBF 
intermediate. The highly reactive IBF anion 132 was trapped with a variety of simple aldehydes 
to afford the corresponding alcohol 133. Oxidative treatment of the crude α-hydroxy-IBF 133 
then generated the keto-lactols 134a-g, believed to be through a mechanism analogous to that 
of the Achmatowicz rearrangement. Lactol oxidation then afforded the desired keto-lactones 
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135a-g. A variety of keto-lactone species were generated in excellent yield (Scheme 32, Table 
1). 
 
Scheme 32 Isobenzofuran Alkylation and Oxidative Rearrangement Sequence  
Table 1  Isobenzofuran Alkylation and Oxidative Rearrangement Sequence 
Entry Aldehyde Keto-lactone  Yield / % 
1 MeCHO 135a 94 
2 chexCH2CHO 135b 67 
3 EtCHO 135c 84 
4 BuCHO 135d 72 
5 iBuCHO 135e 82 
6 iPrCHO 135f 85 
7 chexCHO 135g 57 
8 PhCHO 135h 67 
    
Chemoselective reduction of keto-lactones 135a-g under Luche conditions generated the 
desired isochroman-1-one species 136a-g (Scheme 33, Table 2). 
 
Scheme 33 Keto-Lactone Reduction to Afford Isochromanones
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Table 2  Keto-Lactone Reduction to Afford Isochromanones 
Entry R group Isochromanone  Yield / % 136 : 137 
1 Me a 90 50 : 50 
2 chexCH2 b 58 50 : 50 
3 Et c 56 60 : 40 
4 Bu d 80 75 : 25 
5 iBu e 56 90 : 10 
6 iPr f 96 100 : 0 
7 chex g 82 100 : 0 
8 Ph h 48 100 : 0 
     
This approach was used to efficiently generate a number of isochroman-1-ones in excellent 
yields. The syn-stereochemistry observed during the Luche reduction step was attributable to 
the nature of the alkyl side chain. For sterically bulky side chains for example, isopropyl, 
cyclohexyl and phenyl groups (Table 2, entries 6-8), complete facial selectivity in the reduction 
was observed to exclusively obtain the C8-C9 syn-products 136f-h.  
The entire 5-step protocol could be carried out in the space of 48h and allowed for the 
synthesis of isochromanones from phthalan precursors, with complete diastereoselectivity and 
in high yields. Furthermore, isolation of any of the intermediate species was unnecessary 
which avoided the need for unnecessary purification. The methodology radically expanded the 
use and scope of IBFs as useful synthetic intermediates.  
In order to investigate the compatibility of the newly developed α-hydroxy-IBF oxidative 
rearrangement with more complex aldehyde systems and test its applicability in natural 
product synthesis, the synthesis of a model system of ajudazol A was undertaken.  
Retrosynthetically, it was envisioned that the ajudazol western section model system 138 
could be accessed via stereochemical inversion of isochromanone 139, which in turn could be 
accessed by the oxidative rearrangement of IBF anion 132 with aldehyde 141. The known 
formyl-oxazole 142 would provide easy access to aldehyde 141. 
 
Scheme 34 Retrosynthetic Analysis of Ajudazol A Model System 138 
Formyl oxazole 142 was accessed via a 4-step sequence, starting from serine methyl ester 143. 
Conversion to the oxazolidine 144, followed by aromatization, afforded oxazole 145. DIBAL 
reduction to the alcohol followed by Swern oxidation generated aldehyde 142. E-selective 
Wittig olefination then produced acrylate 146, which upon a reduction, hydrogenation and 
Swern oxidation sequence, yielded the racemic oxazole-aldehyde 141 (Scheme 35).33  
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Scheme 35 Synthesis of Oxazole-Aldehyde 141 
With the functionalised aldehyde 141 in hand, the oxidative rearrangement sequence was 
undertaken. The IBF anion 132, generated from treatment of phthalan 131 with LDA, was 
trapped with aldehyde 141, affording the transient α-hydroxy-IBF intermediate, which was 
subjected to the oxidative rearrangement conditions to generate the keto-lactol intermediate 
147. Oxidative rearrangement and Jones oxidation of the keto-lactol intermediate gave the 
desired keto-lactones 148 and 149 as a 3:2 mixture of diastereoisomers. Luche reduction of 
the diastereoisomeric mixture afforded the isochromanones 139 and 150 with complete facial 
selectivity. The major diastereoisomer 139, possessing a syn,anti-C8-C10 stereochemical 
relationship, was separable by crystallization. Isochromanone 139 was subjected to Mitsunobu 
conditions to yield the benzoate ester 151, in which the C8 stereochemistry has been inverted 
to match that of the ajudazols (Scheme 36).33  
 
Scheme 36 Synthesis of the Ajudazol Western Section Model System 
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1.6 Summary and Outlook 
The ajudazols, secondary metabolites isolated from the myxobacterial Chondromyces crocatus, 
exhibit interesting biological activity and possess interesting structural features. As such, the 
chemical community has taken an interest in the total synthesis of Ajudazols A (7) and B (8), 
with Taylor (2004) and Rizzacasa (2007) reporting their respective approaches to the oxazole-
linked polyene eastern section sections of the ajudazols 52, 68 and 69. More recently, in 2011, 
Rizzacasa reported his approach towards the 15R-deshydroxyajudazol metabolite 49. Recent 
work within the Marquez group has focussed on the synthesis of the isochromanone 
containing ajudazol western section 151. As such, a novel oxidative rearrangement sequence 
for the efficient synthesis of isochromanone units has been developed, utilising putative 
isobenzofurans as reactive intermediates. 
 
 2 Retrosynthetic Analysis of the Ajudazols 
The main aim of this project was to complete the total synthesis of ajudazols A (7) and B (8), 
utilising the IBF oxidative rearrangement methodology for the synthesis of isochromanones, 
recently developed within the Marquez group.33  
Upon embarking on this project in late 2008, at least two other research groups, those of 
Taylor and Rizzacasa, were known to be actively pursuing the ajudazols as synthetic targets, 
having respectively reported their partial syntheses of ajudazols A and B.29,27,3427  
2.1 Ajudazol A  
Retrosynthetically, ajudazol A was envisioned as originating from a convergent, late-stage 
coupling between the oxazole-linked isochromanone western section 152 and the polyene 
eastern section 153 (Scheme 37). The strategic coupling was based on the C-H activation of 
unfunctionalised oxazole 152a with vinyl fragment 153a.29 Alternatively, the key C14-C15 bond 
was also thought as originating through the more conventional palladium catalysed cross-
coupling between western section 152b and eastern sections 153b or 153c (or their reverse 
coupling counterparts). The oxazole-linked hydroxyisochroman-1-one unit 152, in turn, would 
be obtained via the coupling of IBF anion 154 and aldehyde 155, followed by an IBF oxidative 
rearrangement sequence. IBF anion 154 could be generated from phthalan precursor 156, 
while oxazole-aldehyde 155 would originate from oxazole-ester 157. 
 
Scheme 37 Retrosynthetic Analysis of Ajudazol A 
Upon pursuing the total synthesis of related natural products, it is often advantageous to 
utilise a late stage intermediate from which more than one synthetic target can be generated. 
Unfortunately, in the case of the ajudazols, it is unlikely that ajudazol B could be accessed via a 
late stage reduction of the C15 olefin of ajudazol A, which would have to be both stereo- and 
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chemoselective, due to the presence of numerous other olefin functionalities. Therefore, any 
proposed retrosynthesis of ajudazol B would require that the saturated C15 methyl group be 
installed early on in the synthesis and therefore, the approach taken to each of the respective 
eastern sections would differ. 
2.2 Ajudazol B 
Thus, ajudazol B was thought as being accessed via the late-stage Stille cross-coupling between 
vinyl-iodide 158 and vinyl-stannane 159 (Scheme 38). Stannane 159 could be generated from 
vinyl iodide 72, which in turn could be obtained via the amide condensation between 3-
methoxybutenoic acid 56 and simple allylic amine 76.27 The isochromanone-containing vinyl 
iodide intermediate 158 was envisioned as originating from ether 160. Isochromanone 
fragment 160 being the product of the IBF oxidative rearrangement sequence, originating from 
IBF anion 154 and either aldehyde 161 or 162. Utilising aldehyde 161 would provide 15R-
diastereoisomer of ajudazol B, whilst aldehyde 162 would provide the 15S-diastereoisomer of 
ajudazol B.  
 
Scheme 38 Retrosynthetic Analysis of Ajudazol B 
 3 Regiochemistry of the IBF Oxidative Rearrangement 
In order to achieve the ultimate goal of completing the total synthesis of ajudazols A and B, it 
was necessary to adapt the IBF oxidative rearrangement methodology, so to be able to 
incorporate the aromatic substitution pattern present in the isochromanone aromatic 
framework of the ajudazols. 
Prior to the start of this work, all of the IBF anion alkylations and oxidative rearrangements 
previously undertaken within the Marquez group utilised unsubstituted phthalan precursors. 
Regioselectivity of the alkylation step was not an issue as deprotonation of unsubstituted IBF 
at either C1 or C3 resulted in the generation of equivalent IBF anions 132 (Scheme 39).33 
 
Scheme 39 IBF Anion Generation 
This would no longer be the case when substituted IBFs are used. For instance, while 
treatment of C7-substituted phthalan 163 with LDA would generate the key IBF intermediate 
164, the second equivalent of LDA could potentially deprotonate at either C1 or C3, resulting 
in the generation of regioisomeric IBF anions 165 and 166 (Scheme 40).  
 
Scheme 40 Generation of Non-Equivalent IBF Anions 
It was postulated that if a suitable C4 substituted IBF unit 164 could be generated, then it 
would be possible to use the chemical nature of the C4 group to influence the second 
deprotonation step.  A regioselective deprotonation would allow for the selective formation of 
either the C5 or C8-substituted isochromanone 167 or 168 (Scheme 41). The ability to control 
the regiochemistry of the deprotonation step was crucial if the 4-hydroxy-isochromanone 
substitution pattern present in the ajudazols was to be accessed using this methodology. 
 
Scheme 41 Regioselective Approach Towards Isochromanone Synthesis 
3.1 Investigation of Methoxy Substituent 
Initial studies on the influence that a C4-IBF substituent may have on the regiochemistry of IBF 
anion alkylation, and hence, the regiochemical outcome of the isochromanone product of the 
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subsequent oxidative rearrangement, were focussed on the alkylation and oxidative 
rearrangement sequence of 4-methoxy-IBF (164 when R = MeO). The methoxy group was 
chosen due to its likely ability to withtand the reaction conditions whilst simultaneously 
allowing the assessment of the reliability and flexibility of the oxidative rearrangement 
sequence in the presence of a potentially competing highly activated olefin. 
The synthesis of 7-methoxyphthalide 172 began with commercially available o-anisic acid 169, 
which was converted into benzamide 170 in excellent yield. Directed ortho-formylation using 
Snieckus’ conditions yielded the benzaldehyde 171, which upon reduction, followed by acid 
catalysed cyclisation, generated 7-methoxyphthalide 172 in good yield.51 The robust, high 
yielding route was attractive as it was reproducible on a multi-gram scale (>20 g) and required 
minimal purification (Scheme 42). 
 
 
Scheme 42 7-Methoxyphthalan Synthesis 75 
Initial attempts to reduce 7-methoxyphthalide 172 using DIBAL, followed by methylation, 
generated 7-methoxyphthalan 175 in a modest 40% yield, with significant amounts of by-
product 176. The problem of over-reduction of phthalide 172 to diol 174 was observed and 
methylation of intermediates 173 and 174 with NaH/MeI resulted in the formation of the 
desired phthalan 175, together with the undesired bis-methoxy ether 176, in an inseparable 
6:1 ratio. Attempts to suppress the over-reduction by the carefully controlled addition of 
DIBAL, together with a reduction in the quantity of the reducing agent from 1.05 to 0.97 
equivalents, increased the yield of the phthalan product to 48% (Scheme 43). However, due to 
the still unavoidable presence of the bis-methoxy ether by-product 176, alternative reaction 
conditions were desired. 
 
 
Scheme 43 Synthesis of 7-Methoxyphthalan 175 
In our modified approach, the lactol methylation was attempted using  tosic acid in methanol, 
which resulted in a much improved yield of 75%, under mild conditions and avoided the use of 
toxic MeI.52,53 Furthermore, the chemoselective methylation conditions allowed for a 
drastically easier purification (Scheme 44).  
 
Scheme 44 Improved Synthesis of 7-Methoxyphthalan 175 
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With the 7-methoxyphthalan 175 to hand, the regiochemistry of the IBF anion alkylation was 
investigated. This was achieved by undertaking the entire IBF oxidative rearrangement 
sequence, as reported previously within the Marquez group, to afford the isochromanone 
products(s). Due to the instabilities of the α-hydroxy-IBF, keto-lactol and keto-lactone 
intermediates, the regiochemical outcome of the IBF anion alkylation would be identified from 
the isochromanone products obtained. The decision to use isobutyraldehyde as the alkylating 
species emanated from the fact that the isopropyl group had previously shown complete 
diastereocontrol in the Luche reduction step and therefore, would simplify characterization of 
the isochromanone products. 
 
 
Scheme 45 IBF Oxidative Rearrangement Sequence with Methoxy Substituent 
Treatment of 7-methoxyphthalan 175 with LDA resulted in the formation of the corresponding 
IBF anions 177 and 178 before trapping with isobutyraldehyde, to access the putative α-
hydroxy-IBF intermediate 179. Oxidative rearrangement using mCPBA to generate keto-lactol 
180, followed by Jones oxidation yielded the crude keto-lactone 181, which upon Luche 
reduction gave the isochromanone species in 54% and as a 1:2 mixture of the two 
regioisomers 182 and 183 (Scheme 45). The product ratio was determined to be 1:2 via 1H 
NMR analysis of the crude mixture. Fortunately, the two regiosiomers could be separated and 
X-ray crystallographic studies revealed their regiochemistry (Figure 10). The major 
isochromanone 183, the C8-methoxy substituted isochromanone, is the result of alkylation 
occuring at the C1 position of IBF 178. This initial moderate selectivity is likely due to the steric 
hindrance provided by the methoxy group which forces IBF anion formation on the opposite 
side of the molecule. X-ray crystallographic structures also confirmed that, as expected, the 
use of isobutyraldehyde as an alkylating agent resulted in complete diastereocontrol during 
the Luche reduction, yielding the syn-isochromanone products 182 and 183 as single 
diastereoisomers. 
 
Figure 10 X-ray Crystallographic Structures of Isochromanones rac-182 and rac-183 
3.2 Steric Control 
This promising initial result made us hopeful that complete regiocontrol could be achieved 
through the use of large, sterically demanding groups. In order to test this hypothesis, 7-
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hydroxyphthalide 184Had to be generated as a platform from which an array of 7-substituted 
compounds could easily be accessed. Initially, it was envisioned that 7-hydroxyphthalide 184 
could be easily accessed via the demethylation of 7-methoxyphthalide 172, which had been 
synthesized with ease. Initial attempts of deprotection using BBr3 afforded the desired 
product, but in a poor yield of 25%, together with large amounts of benzoic acid by-product 
185.54 Interestingly, when the demethylation of 7-methoxyphthalide 172 was attempted using 
iodocyclohexane in DMF, the desired phenol 184 was obtained in good yield.55 It has been 
postulated that iodocyclohexane in DMF acts as a mild form of HI. In this case, it not only 
increased the yield of the desired product, but it also suppressed formation of benzoic acid 
185. 
 
Scheme 46 Synthesis of 7-Methoxyphthalide and Functionalisation 
In an attempt to introduce a large, bulky and stable group at C7, 7-hydroxyphthalide 184 was 
protected as the TIPS-ether 186.56 Unfortunately however, reduction of 7-TIPS-phthalide 186 
proved unsuccessful, yielding only the over-reduced diol 187. Unfortunately, despite extensive 
experimentation: modifying the reaction solvent (DCM, Et2O, THF), temperature (-100
 oC, –78 
oC, -20oC) and reducing the equivalents of DIBAL, the over-reduction was unable to be 
suppressed.  
An alternative approach for the synthesis of 7-TIPS-phthalan 190 was then attempted. It was 
envisioned that 7-hydroxyphthalide 184 could undergo DIBAL reduction to give the lactol 188, 
which followed by acid-catalysed methylation, would give phthalan 189. TIPS protection of 
phenol 189 would then yield the desired silyl-ether 190 (Scheme 47). Unfortunately, 7-
hydroxyphthalide 184 failed to undergo reduction to the lactol 188. When the reduction was 
performed with DIBAL, a bright yellow precipitate, believed to be a chelate, resulted instead. 
 
Scheme 47 Alternative Approach to the Synthesis of Phthalan 190 
As an alternative approach to the conversion of phthalides to phthalans, the conditions used 
by Meerwein for the synthesis of ethoxyphthalans, were trialled.57,58 Meerwein reported that 
treatment of phthalide 130 with triethoxy fluoroborate generated oxonium salt 191 that could 
then be reduced to the ethoxyphthalan 192 with NaBH4 (Scheme 48). However, in our hands, 
Meerwein’s conditions were found to be irreproducible, and thus it was decided to continue 
with the well-established DIBAL/TsOH/MeOH protocol for the conversion of phthalides to 
phthalans. 
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Scheme 48 Meerwein’s Phthalan Synthesis 
As a result of the inability to access 7-TIPS pthalan 190, the next logical step was to synthesize 
other C7-substituted phthalides stable enough to undergo DIBAL reduction with minimal over-
reduction to the diol by-product, yet be bulky enough to influence the regiochemical outcome 
of the IBF anion alkylation. Hence, it was decided to investigate 7-benzyloxyphthalan 194 as a 
suitable substrate. Alkylation of 7-hydroxyphthalide 184 cleanly generated 7-
benzyloxyphthalide 193, which upon DIBAL reduction and methylation, yielded phthalan 194 in 
good overall yield (Scheme 49).59 
 
Scheme 49 IBF Oxidative Rearrangement Sequence with Benzyloxy Substituent 
Subjecting 7-benzyloxyphthalan 194 to our oxidative rearrangement sequence afforded two 
regioisomeric isochromanone products, 195 and 196, in excellent overall yield and in a 1:4 
ratio (Scheme 49). X-ray crystallographic analysis of the major product 196 confirmed its 
identity as the sterically directed regioisomer (Figure 11). The change from a methoxy to 
benzloxy group increased the regioselectivity in the IBF anion alkylation from 1:2 to 1:4. This 
small change is consistent with the similar size of the two groups.  
 
Figure 11 X-ray Crystallographic Structure of Isochromanones rac-196 
Encouraged by this result, it was hoped that the use of a TBS group would further increase the 
regioselectivity of IBF anion alkylation. 7-TBS-phthalan 198 was synthesised from 7-
hydroxyphthalide 184 and subjected to our oxidative rearrangement sequence (Scheme 50).
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Scheme 50 IBF Oxidative Rearrangement Sequence with Silyloxy Substituent 
Excitingly, isochromanone 199 was obtained as a single regioisomeric product, together with 
the TBS-deprotected isochromanone 200, in good overall yield (Scheme 50). It was reasoned 
that the TBS cleavage was likely to have taken place during the Jones oxidation stage of the 
rearrangement sequence. The unwanted deprotection made it clear that the reaction 
conditions had to be optimised if the rearrangement sequence was to accommodate, and be 
able to handle, sensitive substrates. 
 
3.3 Optimisation of the Keto-Lactol Oxidation and Keto-Lactone 
Reduction Conditions 
Hypervalent periodinane reagents such as IBX and DMP are known for their mildness and 
selectivity.60 We hypothesised that IBX and DMP might be able to selectively oxidise the keto-
lactol 201 to the keto-lactone 135f whilst avoiding loss of sensitive functionalities, should they 
be present. Unfortunately both IBX and DMP failed to react with the keto-lactol 201 at 
ambient temperature. Although disappointing, this was not surprising considering that all 
previous reported instances of lactol oxidation with periodinane reagents have required 
refluxing conditions in order to achieve reaction completion.61 However, efficient lactol 
oxidations at room temperature in the presence of acetal and TBS ether groups had been 
reported using PCC, PDC and TPAP/NMO.62,63 Replacing the Jones oxidation step in our 
sequence with PCC, PDC or TEMPO/BAIB promoted oxidation of the keto-lactol 201 to the 
keto-lactone 135f (Scheme 51, Table 3). Rewardingly, the TEMPO oxidation conditions 
provided a high yielding alternative to the Jones oxidation and eliminated the need for heavy 
metal-based, toxic reagents.  
 
 
Scheme 51 Optimisation of Oxidation and Reduction Conditions
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Table 3  Oxidation of Keto-Lactol 201 to Keto-Lactone 135f 
Entry Oxidant Reaction Time Yield / % 
1 2.5 M Jones 45 min 96 
2 TEMPO, BAIB 6H 84 
3 PCC 24H 82 
4 PDC 24H 80 
5 PDC, Py.TFA 12H 80 
    
Having found a mild, non-toxic, viable alternative to the Jones oxidation, we decided to focus 
on the reduction step of our rearrangement sequence. It was desirable to achieve the keto-
lactone reduction under non-Luche conditions so that, again, sensitive functionalities could be 
tolerated, and our synthetic sequence simplified. To our satisfaction, reduction of the keto-
lactone 135f was successfully carried out under standard NaBH4 conditions to afford the syn-
isochromanone 136f in 89% yield, exceeding the 82% yield obtained under Luche conditions 
(Scheme 51).  
Having developed a set of optimised conditions, 7-TBS-phthalan 198 was subjected to the IBF 
alkylation and oxidative rearrangement sequence. Rewardingly 7-TBS-phthalan 198 was 
converted to the desired isochroman-1-one 199 in an improved overall yield of 60%, once 
again, with complete regiocontrol and with no desilylated product 200 observed (Scheme 52). 
 
Scheme 52 Synthesis of Isochromanone rac-199 Under Optimised Conditions 
3.4 Chelation Control 
After successfully demonstrating that IBF anion alkylation can be controlled to give exclusively 
the sterically directed product, we then set out to investigate whether this regiocontrol could 
be reversed. It was postulated that by having a chelating functional group in the C4-position of 
the IBF intermediate, addition of the second equivalent of base to generate the IBF anion 202 
could be directed to the C3-position (i.e. on the same side of the IBF framework). In a process 
analogous to ortho-lithiation, it was hypothesised that the presence of heteroatoms, namely 
nitrogen or oxygen, could form a stabilised chelate with the IBF anion and metal ion of the 
organometallic base. This chelate would in turn allow for the generation of regioisomeric 
isochroman-1-one 204 (Scheme 53). 
 
Scheme 53  Chelation Controlled IBF Anion Alkylation and Rearrangement 
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It was envisioned that by incorporating functionality akin to the already well established 
chelating groups implemented in directed ortho-metallation chemistry, chelation controlled 
IBF anion alkylation could be achievable.51 Groups with the ability to promote chelation; MOM, 
MEM, MTM and N,N-diethylcarbamate were seen as attractive functionalities that could be 
attached to the phthalan precursors and used in the oxidative rearrangement sequence, in 
order to investigate whether chelation controlled IBF anion alkylation is achievable.  
The first chelating group that was investigated was the MOM group. The 7-MOM-phthalan 206 
was readily synthesized via simple alkylation of 7-hydroxyphthalide 184 with MOM-Br followed 
by reduction and methylation, in reasonable yields. The oxidative rearrangement sequence 
was carried out on phthalan 206 using LDA and isobutyraldehyde, followed by mCPBA 
promoted rearrangement, TEMPO oxidation and NaBH4 reduction. The two regioisomeric 
isochroman-1-ones 207 and 208 were obtained in a 1:2 ratio in favour of the sterically directed 
product 208, and in good overall yield (Scheme 54). The structure of regiosiomer 208 was 
subsequently confirmed by X-ray crystallographic analysis (Figure 12).   
 
 Scheme 54 IBF Oxidative Rearrangement Sequence with MOM Substituent 
  
Figure 12 X-ray Crystallographic Structure of Isochromanone rac-208 
Although disappointing, the results are consistent with a lack of chelation and suggest a slight 
steric bias akin to that observed with the methoxy group. Our initial set-back prompted us to 
suggest that chelation control would be achieved by modification of the deprotonation 
conditions (Scheme 55, Table 4).  
 
Scheme 55 Alternative Conditions to Access Chelation Controlled IBF Anion Alkylation 
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Table 4  Alternative Conditions for IBF Anion Generation 
Entry R Deprotonation Conditions 210 : 211 Yield / % 
1 Me MeLi (2.1eq), iPr2NH (0.1eq), 0 
oC 1:2 54 
2 Me MeLi (2.1eq), iPr2NH (2.1eq), 0 
oC 1:2 58 
3 Me MeLi (2.1eq), Me2NH (0.1eq), 0 
oC 1:1.3 52 
4 Me MeLi (2.1eq), 2,2,6,6-TMP (0.1eq), 0 oC  1:1.1 47 
5 Me MeLi (2.1eq), 0 oC 1:1 18 
6 Me sBuLi (2.1eq), TMEDA (2.1eq), 0 oC 1:3 36 
7 Me MeMgBr (2.1 eq), 0 oC - - 
8 Me LiHMDS (2.1 eq), 0 oC - - 
9 Me NaHMDS (2.1 eq), 0 oC - - 
10 MOM MeLi (2.1eq), iPr2NH (0.1eq), 0 
oC 1:2 48 
11 MOM MeLi (2.1eq), 2,2,6,6-TMP (0.1eq), 0 oC 1:1.2 54 
12 MOM sBuLi (2.1eq), TMEDA (2.1eq), 0 oC 1:3 66 
13 Me MeLi (2.1eq), iPr2NH (2.1eq), r.t. 1:2 21 
14 MOM MeLi (2.1eq), iPr2NH (2.1eq), 45 
oC. - - 
 
Disappointingly, the effect of varying the choice of base failed to have a profound effect on 
regiochemistry of the IBF anion alkylation. The regiochemical outcome was independent of 
whether stoichiometric or catalytic LDA was used (Table 4, entries 1 and 2). The use of a 
lithium-amine base appears crucial to promote IBF anion formation, as MeMgBr, NaHMDS and 
LiHMDS failed to generate the IBF anion (entries 7-9). MeLi in the absence of a secondary 
amine, reacted slowly and incompletely to generate isochromanone products in poor yield 
with no regiochemical bias (entry 5). sBuLi in combination with TMEDA, the optimal conditions 
for directed ortho-metalation chemistry, afforded isochromanones in good yield, however still 
promoting steric control (entries 6 and 12). The use of lithum dimethylamine or lithium-
2,2,6,6-tetramethylpiperidine generated an almost equal amount of both regioisomers (entries 
3, 4, 10 and 11). Although this could be viewed optimistically as an inverse in terms of 
chelation control, it could also be seen as an erosion of overall selectivity.  
At this stage it was hypothesised whether the steric bias achieved to this point was a result of 
kinetic control. For the IBF anion formation and subsequent alkylation, deprotonation has 
been performed at 0 oC before cooling to –78 oC, followed by addition of aldehyde. It would 
not be unreasonable to envisage that at low temperature, under kinetic control, sterics would 
predominate and trapping with aldehyde at low temperature would lock the regiochemistry to 
generate sterically directed isochromanone 211. Alternatively, should the phthalan-base 
reaction mixture be allowed to warm, and assuming the second deprotonation to generate the 
IBF anion 213 is reversible, equilibration between the steric and chelation controlled anions 
213 and 214 could occur, of which subsequent oxidative rearrangement could afford the 
chelation-directed isochromanone product 210 (Scheme 56).  
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Scheme 56 Kinetic Versus Thermodynamic Control 
However, the difficulty in investigating kinetic vs thermodynamic control with this particular 
reaction is the great instability of the IBF intermediates which needs the reaction to be kept at 
suppressed temperatures to avoid polymerisation and degradation. This severely limits the 
temperature to which the IBF anion can be warmed before degradation becomes the 
prevalent pathway. When the IBF anion generation reaction was warmed to room 
temperature, no change in the isochromanone product ratios were observed. However, as a 
consequence of warming to room temperature, drastically reduced product yields were 
obtained (Table 4, entry 13). Furthermore, heating to 45 oC resulted in complete degradation 
(entry 14). Faced with such instability, it was decided that temperature control was not a 
viable way to alter the regiochemical outcome of the reaction. 
At this point, due to time constraints, it was decided to stop our investigation into chelation 
control, although interesting and potentially very useful.   
3.5 IBF Oxidative Rearrangement with Regioisomeric Phthalan 
Precursors 
It has been demonstrated that complete regiocontrol can be achieved in the IBF oxidative 
rearrangement sequence through the use of C7 phthalan substituents. It was hypothesised 
that isochromanone 199, previously accessed from 7-TBS phthalan 198, could be synthesized 
under analogous oxidative rearrangement conditions starting from the regioisomeric 4-TBS 
phthalan 215. Obtaining the identical isochroman-1-one product 199 from either the 7- or 4-
TBS-phthalan precursor would prove that the reaction proceded via the common IBF 
intermediate 216. (Scheme 57). 
 
Scheme 57 Rearrangement with Regiosiomeric Phthalan Precursors 
The chemical literature is sparsely populated with approaches to the synthesis of 4-
hydroxyphthalide 217. The single example was reported by O’Doherty, who takes advantage of 
a one-step procedure in which 3-hydroxybenzoic acid is condensed with formaldehyde in the 
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presence of sulfuric and hydrochloric acid.64 Unfortunately, in our hands, O’Doherty’s 
procedure gave an inseparable mixture of products (Scheme 58).  
 
Scheme 58 O’Doherty’s Synthesis of 4-Hydroxyphthalide 217 
The lack of success with the O’Doherty protocol meant that an approach to 4-TBS-phthalan 
215, analogous to our 7-TBS phthalan synthesis, was carried out. Thus, commercially available 
3-hydroxybenzoic acid was converted to the 3-methoxybenzoic acid 219 in high yield via a two-
step dimethylation/hydrolysis procedure (Scheme 59). Acid 219 was converted into the 
benzamide 221, proceeding via the acid chloride, in good overall yield. Alternatively, 
benzamide 221 was also obtained through reversal of the methylation and amidation steps, 
proceeding via the 3-hydroxybenzamide intermediate 220. Benzamide 221 was ortho-
formylated using Snieckus’s conditions in satisfactory yield to afford  benzaldehyde 222.51 
Reduction, followed by lactonisation of the resulting alcohol, generated 4-methoxyphthalide 
223 in good yield. The entire process was reproducible on a multi-gram scale. Demethylation 
of methyl ether 223 with iodocyclohexane in DMF afforded 4-hydroxyphthalide 217, which 
was reprotected as the TBS-ether 224. Reduction and methylation afforded the desired 4-TBS-
phthalan 215 in excellent yield (Scheme 59). 
 
Scheme 59 Synthesis of 4-TBS Phthalan 215  
The alkylation and oxidative rearrangement sequence was carried out with 4-TBSO-phthalan 
215 using our standard conditions, to afford exclusively the sterically directed isochroman-1-
one 199 in 45% yield (Scheme 60).  
 
Scheme 60 Rearrangement with Regiosiomeric Phthalan Precursors 
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This demonstrated that the rearrangement does in fact proceed via identical IBF anion 
intermediates, regardless of whether the 7-TBS-phthalan 198 or 4-TBS-phthalan 215, is used. 
Mechanistically, the hindered C3 position of 4-TBS-phthalan 215 is first deprotonated by the 
first equivalent of LDA to generate IBF 225, while the second equivalent of LDA deprotonates 
exclusively at the C1 position, at the expense of the hindered C3 position (Scheme 61). 
Therefore this methodology allows for the use of either C4 or C7-substituted phthalans to 
access 8-hydroxyisochromanones. 
 
Scheme 61 Generation of IBF Anion 216 
3.6 Summary and Outlook 
In summary, the IBF oxidative rearrangement sequence for the diastereoselective synthesis of 
anti-isochromanones has been extended by achieving complete regiocontrol to access C8 
oxygenated isochromanones in excellent yield. The 7-substituted phthalan precursors were 
synthesised efficiently in high yield from o-anisic acid. The reaction conditions for the oxidative 
rearrangement sequence were optimised to accommodate acid sensitive functionalities. It was 
demonstrated that C8 oxygenated isochromanones could be generated from regiosiomeric 4-
substituted phthalan precursors, showing that both pathways proceed via a common IBF anion 
intermediate. Chelation-controlled IBF anion alkylation to access C5-substituted 
isochromanones, as yet, could not be achieved and requires further investigation. 
 4 The Ajudazol Western Section  
4.1 Ajudazol Isochromanone Moiety  
After demonstrating that complete regiocontrol can be achieved in the IBF oxidative 
rearrangement, we sought to implement this methodology to generate a simple model system 
of the ajudazol isochromanone moiety. We were keen to evaluate the oxidative 
rearrangement’s ability to tolerate the additional methyl substituent on the aromatic ring. 
Retrosynthetically, the ajudazol isochromanone fragment 226 was envisioned as originating 
via the sterically directed IBF alkylation and oxidative rearrangement sequence of 
functionalised phthalan 227. In turn, phthalan 227 would be accessible from hydroxyphthalide 
228 (Scheme 62).  
 
Scheme 62  Retrosynthetic Ananlysis of Ajudazol Isochromanone Moiety 226 
To date there have been two examples where 7-hydroxy-6-methylphthalide 228Has been 
synthesised. McNab reported the synthesis of phthalide 228; however, it involved low yielding, 
unattractive pyrolysis chemistry.65 Toney published a highly regioselective, moderate yielding, 
one-pot synthesis of phthalide 228 from 3-hydroxy-4-methylbenzylalcohol 230 in an acid-
catalysed Friedel-Crafts acylation reaction.66 Mechanistically, the formation of phthalide 228 
involves ortho-formylation followed by hemiacetal formation and oxidation (Scheme 63).  
 
Scheme 63 Toney’s SnCl4 Catalysed Friedel-Crafts Acylation to Afford Phthalide 228 
Following Toney’s procedure, borane reduction of benzoic acid 229 was performed 
successfully to yield alcohol 230 in good yield. However, the key Friedel-Crafts reaction failed 
to afford any of the desired 7-hydroxy-6-methylphthalide 228. All that was recovered from the 
reaction was benzaldehyde 236 in 6% yield (Scheme 64). This was a side-product that was 
reported in Toney’s original publication; however, its abundance was not reported. The failure 
of the Friedel-Crafts reaction coupled with the low yield reported in the original publication, 
meant that an alternative route to access 7-hydroxy-6-methylphthalide 228Had to be found. 
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Scheme 64 Repetition of Toney’s Synthesis of 7-hydroxy-6-methylphthalide 228 
Thus, it was decided to attempt to access 7-hydroxy-6-methylphthalide 228 via a synthetic 
route analogous to our already well-established protocol for the synthesis of 4- and 7-
hydroxyphthalides. 
In our new approach, commercially available benzoic acid 237 was converted to the acid 
chloride 238 and then treated with diethylamine to afford the desired benzamide 239, 
together with significant amounts of the dimeric species 240 (Scheme 65). This result was 
unexpected because previously, in the synthesis of 4-TBS-phthalan 215 (Scheme 59), 3-
hydroxybenzoic acid underwent smooth amidation with no by-product formation. In this case, 
on steric grounds, one would expect acid 237 to disfavour dimerization due to the increased 
steric bulk around the phenol functionality, as opposed to the more accessible phenol 
functionality in 3-hydroxybenzoic acid, which proceeded without dimerisation. However, it is 
possible that dimerisation may have occurred due to the increased nucleophilic character of 
the phenol group due to activation by the ortho-methyl group.  
 
Scheme 65 Synthesis of Benzamide 239 
It was decided that the dimerization problem could be easily avoided through methylation of 
the phenol functionality prior to amidation. Hence, benzoic acid 237 was converted to 2-
methoxy-3-methylbenzoic acid 241 in excellent yield, followed by clean conversion to the 
benzamide 242. Ortho-formylation of amide 242 afforded benzaldehyde 243, which upon 
reduction and lactonisation, yielded phthalide 244 in excellent yield. Demethylation of methyl 
ether 244 gave phenol 245, which was protected as the TBS ether 246, before being converted 
into the phthalan 227 in high yield (Scheme 66). The entire synthetic route to phthalan 247 
was robust and was easily scaled up to provide over 30 g of the target compound. 
 
Scheme 66 Synthesis of Phthalan 227 
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The IBF oxidative rearrangement sequence was carried out with functionalised phthalan 227, 
using our optimised conditions, to generate isochromanone 226 in good yield over the entire 
protocol and as a single regioisomer (Scheme 67). This result demonstrated that functionalised 
phthalan 227 is well-tolerated in the oxidative rearrangement sequence and should be 
applicable towards the total synthesis of the ajudazols. 
 
Scheme 67 Synthesis of Ajudazol Isochromanone Moiety 226 
4.2 Ajudazol Western Section Model System  
Having demonstrated that the oxidative rearrangement sequence can be used to efficiently 
access the isochromanone moieties present in the ajudazols, with complete regio- and 
diastereocontrol, we sought to generate the oxazole-linked isochromanone moiety 247, based 
on the IBF alkylation and oxidative rearrangement with IBF anion 132 and aldehyde 248 
(Scheme 68). 
 
Scheme 68 Retrosynthetic Analysis of Ajudazol Western Section Model System 
It was hypothesised that the unsubstituted oxazole C2 position may have a profound effect on 
the IBF alkylation and rearrangement due to its relatively acidic nature (pKa 20-25), and 
therefore, we were eager to test whether it could be tolerated in the oxidative rearrangement 
sequence.67 The decision for using a C2 unsubstituted oxazole emanated from the hope that 
direct C-H activation chemistry could be implemented to provide a convergent, late-stage 
coupling in the total synthesis of the ajudazols (Scheme 37). 
The synthesis of oxazole-linked aldehyde 248 commenced with the cyclodehydration between 
ethyl isocyanoacetate, formic acid and CDI to generate oxazole-ester 157. Reeves claimed a 
64% yield for the partial reduction of ethyl oxazole-4-carboxylate 157 to aldehyde 250; 
however, like most partial DIBAL reductions reported in the literature, we found the conditions 
irreproducible.68 In our hands, DIBAL reduction of ester 157 afforded alcohol 249 in excellent 
yield. Frustratingly, oxidation of alcohol 249 to aldehyde 250 proved troublesome, with Swern 
conditions resulting in only a 35% yield. Furthermore, aldehyde 250 proved to be both 
thermally unstable and volatile. On the other hand, Wittig olefination of aldehyde 250 
afforded exclusively the desired E-olefin 251 in 54% yield (Scheme 69). 
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Scheme 69 Synthesis of Ester 251 
However, due to the unacceptably poor yielding oxidation and olefination steps, an alternative 
method for the synthesis of ester 251 was sought. Taylor’s tandem oxidation Wittig olefination 
methodology for the one-pot oxidation and olefination of allylic and benzylic alcohols was 
implemented.69 Gratifyingly, alcohol 249 readily reacted with MnO2 in the presence of 
stabilised ylid, to afford E-olefin 251 in excellent yield and with complete E-selectivity (Scheme 
70). Ester 251 was then reduced to the allylic alcohol 252 in excellent yield, followed by 
hydrogenation using Pd/C, to afford the desired alcohol 253. Alternatively, alcohol 253 was 
also accessed by a reversal of the reduction and hydrogenation steps, with no overall drop in 
yield. Oxidation of alcohol 253 to the racemic aldehyde 248 was achieved with TEMPO in high 
yield (Scheme 70). 
 
Scheme 70 Synthesis of Aldehyde 248 
With racemic aldehyde 248 in hand, the oxidative rearrangement was then carried out using 
the unfunctionalised phthalan 131 in the first instance. Rewardingly, a 2:3 mixture of two 
diastereoisomeric isochromanones, 255 and 256, were obtained in good overall yield (Scheme 
71). The identity of both diastereoisomers was corroborated by X-ray crystallographic analysis, 
which confirmed the relative C8-C9 stereochemistry of the major diastereoisomer 256 as 
syn,anti (Figure 13).  
 
Scheme 71 IBF Oxidative Rearrangement Sequence with Aldehyde 248 
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Figure 13  X-ray Crystal Structures of Isochromanones rac-255 and rac-256 
The Felkin-Anh model can be used to explain the stereochemical outcome of nucleophilic 
additions to aldehydes. The model predicts that the two lowest energy, non-eclipsing, 
conformations result from the largest group (RL = CH2-oxazole) on the α-stereocentre, being 
orientated perpendicular to the carbonyl. As the nucleophile (IBF anion) will attack the 
aldehyde at 107o along the Bürgi-Dunitz trajectory, then the lowest energy conformation arises 
when the nucleophile “passes” over the small group (Rs = H), conformation A, as opposed to 
the medium group (RM = CH3), conformation B. Conformation A encounters less steric 
hindrance and is expected to be the favoured Felkin addition product 255, over the anti-Felkin 
product 256 (Figure 14). 
 
Figure 14 Felkin-Anh Model 
However, in the addition to aldehyde 248 in the synthesis of the syn,syn and syn,anti 
diastereoisomers 255 and 256, both diastereoisomers were obtained in near-equal 
proportions, with a marginal bias (3:2) for the anti-Felkin product 256 in this case. It is 
hypothesized that the marginal preference for the anti-Felkin product is because the 
substituents RS and RM (H and Me respectively) are not sufficiently size differentiated for there 
to be full steric control over the addition. 
Gratifyingly, the syn,anti-diastereoisomer 256 underwent Mitsunobu inversion with 4-
nitrobenzoic acid to afford the para-nitrobenzoate ester 257 in reasonable yield (Scheme 72). 
However, purification of the Mitsunobu product proved troublesome due to the presence of 
phosphine and azodicarboxylate by-products and impurities. Forcing conditions (reflux in 
toluene) were necessary to invert the hindered benzylic 2o alcohol 256. Chemoselective 
cleavage of the para-nitrobenzoate group was achieved in the presence of the lactone 
functionality under extremely mild conditions, using NaN3 in MeOH, to afford isochromanone 
247 in good yield (Scheme 72). The C8-C10 anti,anti stereochemistry of isochromanone 247 
reflecting that of the ajudazols was confirmed via NMR analysis, and was further corroborated 
via X-ray crystallographic analysis (Figure 15). 
 
Scheme 72 Stereochemical Inversion to Access Western Section Model System rac-247 
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Figure 15 X-Ray Crystallographic Structure of Western Section Model System rac-247 
4.3 Synthesis of Ajudazol Western Section  
Having demonstrated that the oxidative rearrangement sequence can be used to efficiently 
access the western section model system 247, the synthesis of a true western section was 
then undertaken. Our synthesis of western section 258 would be based on oxidative 
rearrangement sequence between the functionalised phthalan precursor 227 and enantiopure 
aldehyde 259a or b (Scheme 73). 
 
 
Scheme 73 Retrosynthetic Analysis of Ajudazol Western Section 258 
 The main challenge of this target was to access and use the enantiopure oxazole-linked 
aldehydes 259a and 259b, having to this stage, only carried out the oxidative rearrangement 
with racemic aldehydes. Furthermore, since only the relative stereochemistry of the ajudazols 
is known, it would be desirable to access both aldehydes 259a and 259b in enantio-enriched 
form. Pfaltz has show that olefins of type 260 can be asymmetrically reduced under iridium 
catalysis to afford alcohol 262 with complete enatioselectivity (Scheme 74).70 
 
 
Scheme 74 Pfaltz’s Asymmetric Iridium Catalysed Hydrogenation 
Although Pfaltz’s chemistry could hopefully be applied to oxazole-linked allylic alcohol 252, 
from which both aldehydes 259a and 259b could be accessed in enantio-enriched form, the 
time and resources that optimising such a step would require, could not be justified at this 
stage in the project (Scheme 75).  
 
Scheme 75 Asymmetric Hydrogenation Route Towards Aldehydes 259a and 259b 
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Therefore, as part of our first generation synthesis, enantiopure aldehydes 259a and 259b 
were accessed via chiral separation of the racemic alcohol 253, followed by TEMPO oxidation, 
in good yields (Scheme 76). At this stage, the stereochemical identity of aldehydes 259a and 
259b was arbitrarily assigned. 
  
Scheme 76 Synthesis of Enantiopure Aldehydes 259a and 259b 
With the enantiopure aldehydes to hand, the IBF oxidative rearrangement protocol was 
carried out with functionalised phthalan 227 and R-aldehyde 259a, to generate the syn,syn and 
syn,anti-isochromanones  265 and 258, in 59% overall yield (Scheme 77).  
 
Scheme 77 IBF Oxidative Rearrangement Sequence with Enantiopure Aldehyde 259a 
Fortunately, an X-ray crystal structure of the major syn,anti-diastereoisomer 258 was 
obtained, which allowed for the absolute stereochemistry of our western section to be 
elucidated, and hence, the absolute stereochemistry of aldehydes 259a and 259b.  
 
Figure 16 X-Ray Crystallographic Structure of Ajudazol Western Section 258 
4.4 Accessing Anti-Isochromanones 
4.4.1 Keto-Lactone Reduction 
One of the major limitations of the current route towards accessing anti-isochromanones was 
the need to invert the stereochemistry of syn-isochromanones, the direct products of the IBF 
oxidative rearrangement  sequence. The ability to directly access anti-isochromanones via the 
reduction of the keto-lactone intermediates would be far more efficient as it would avoid the 
need for the troublesome, poor yielding Mitsunobu inversion/hydrolysis steps. 
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For the reduction of the conformationally locked 4-tert-butylcyclohexanone, the reducing 
agent can potentially attack from either the axial or equatorial position, to afford either the 
cis-266 or trans-diastereoisomer 267 (Figure 17). Equatorial attack is favoured for sterically 
large nucleophiles because it minimises unfavourable 1,3-diaxial interactions. L-Selectride 
reduces 4-tert-butylcyclohexanone to afford the cis-product 266 in a 19:1 ratio.  
 
Figure 17 Reduction of 4-Tert-Butylcyclohexanone 
However, for smaller nucleophiles there is a reversal in selectivity as axial attack is favoured, 
even though this is a more sterically restricted approach than the equatorial trajectory, to 
afford predominately the trans-product 267 (Scheme 17). LiAlH4 reduction of 4-tert-
butylcyclohexanone generates, almost exclusively, the trans-diastereoisomer 267, in a 9:1 
ratio. Various theories have been put forward to try to explain the preference for axial attack 
of unhindered cyclohexanones by small nucleophiles. Felkin proposed that the preference for 
axial attack was due to greater torsional strain in the transition state for equatorial attack. On 
the cyclohexanone substrate, the C2 and C6 C-H bonds almost eclipse the carbonyl and this 
torsional strain is relieved by axial attack, but equatorial attack increases it somewhat because 
the oxygen must move through a fully eclipsed arrangement.71,72 Anh further expressed the 
importance of an electronic effect in which flattening of the carbonyl bond resulted in the C2 
and C6 C-H bonds becoming almost anti-periplanar with the incoming axial nucleophile. This 
would allow delocalisation of electron density from the approaching axial nucleophile to the 
σ* orbital of the vicinal C-H bonds.73,74 
The keto-lactones of type 135f, generated via the IBF oxidative rearrangement sequence, are 
more complex than simple cyclohexanones as they incorporate an aromatic ring, lactone unit 
and an iPr group α-to the ketone carbonyl. The keto-lactone 135f is believed to adopt a 
pseudo-half chair conformation (Figure 18). Due to this additional complexity, together with 
the added degree of steric bulk on either side of the ketone carbonyl, it was perhaps 
unsurprising that complete selectivity to generate the syn-isochromanone 136f was achieved 
under Luche conditions and with NaBH4 (Table 5, entries 1 and 2), the result of equatorial 
attack at the sterically hindered ketone carbonyl. Increasing the reaction temperature from –
78 oC to room temperature failed to alter the selectivity. Similarly Na(CN)BH3/ZnI2 exclusively 
gave syn-product 136f  in a modest 52% yield (entry 3). Because the small reducing agent 
(NaBH4), attacked exclusively from the equatorial position, then it would have been very 
unlikely that a bulky reducing agent would do anything else. L-selectride failed to react with 
keto-lactone 135f, presumably due to the clash of a hindered ketone environment and a 
sterically bulky nucleophile (entry 4).  
The Ajudazol Western Section 
61 
 
 
Figure 18 Reduction of Keto-Lactone 135f 
It was hypothesised that the anti-isochromanone 137f, with the hydroxyl group in the 
equatorial position, would be more thermodynamically stable than the syn-isochromanone 
136f, where such hydroxyl is axial. It was hoped that by utilising reversible reaction conditions, 
equilibration could yield the anti-isochromanone 137f. The reversible Meerwein-Ponndorf-
Verley reduction failed to show any evidence of the anti-diastereoisomer 137f (entry 5).75 A 
Sm(OiPr)3 variant of the Meerwein-Ponndorf-Verley reduction also exclusively afforded the 
syn-isochromanone 136f in reasonable yield (entry 6).76 It is believed that the energy barrier to 
reach the anti-isochromanone 137f was too high. 
Table 5  Reduction of Keto-Lactone 135f 
Entry Reaction conditions 136f:137f Yield / % 
1 NaBH4, CeCl3, MeOH, DCM, –78 
oC 100:0 82 
2 NaBH4, MeOH, –78 
oC 100:0 89 
3 Na(CN)BH3, ZnI2, DCE, reflux, 16H 100:0 52 
4 L-selectride, THF, 0 oC - - 
5 Me2AlCl, 
iPrOH, Tolune, reflux, 50 h 100:0 71 (85% brsm) 
6 Sm(OiPr)3, 
iPrOH, Tolune, RT, 50 h 100:0 64% 
7 BH3, THF, –78 
oC 12:1 40% 
8 9-BBN, THF, 0 oC - - 
9 Alpine borane, THF, 0 oC - - 
10 
11 
(R)-CBS, BH3, THF, 0 
oC 
(S)-CBS, BH3, THF, 0 
oC 
12:1 
12:1 
45% 
45% 
 
Borane reductions were then investigated. The use of BH3/THF showed glimpses of the anti-
product 137f, albeit in a very low 1:12 ratio of 137f:136f, and in low yield (entry 7). Varying the 
reaction temperature (–78oC, 0 oC, RT) failed to improve either the selectivity or yield. 9-BBN 
failed to react with keto-lactone 135f, as did alpine borane (entries 8 and 9). The use of CBS 
with BH3, failed to show any improvements on the selectivity achieved with BH3 alone (entry 
10).77 
4.4.2 Reduction of α-Anomeric Intermediates  
Due to the inability to generate the anti-isochromanone 137f via the direct reduction of keto-
lactone 135f, an alternative strategy was investigated. Through O’Doherty's efforts towards 
the diastereoselective synthesis of sugar molecules, he has shown that pyranones can be 
diastereoselectively reduced to furnish allylic alcohols with 1,2-anti stereoselectivity (Scheme 
78).78-80 The Achmatowicz rearrangement of furfuryl alcohol 268, promoted by NBS/H2O, 
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yielded hemiacetal 269 as an equilibrating mixture of diastereoisomers. However, O’Doherty 
took advantage of the difference in reactivities of axial and equatorial anomeric alcohols to 
selectively protect the axial anomer. Benzoylation afforded pyranone 271 in >20:1 
diastereoselectivity. Luche reduction of pyranone 271 proceeded with complete 
diastereocontrol to afford allylic alcohol 272. Benzoylated pyranone 271 was believed to adopt 
a half-chair conformation, with the steric bulk of the axial benzoyl group hindering attack of 
NaBH4 from the equatorial trajectory of the carbonyl, forcing it to attack via the axial trajectory 
on the top face, resulting in the generation of the trans,trans-diastereosiomer 272. O’Doherty 
then deprotected anomeric benzoyl-lactol 272 with NH3/MeOH, and re-oxidised with MnO2 to 
afford lactone 273 (Scheme 78).78 
 
Scheme 78 O’Doherty’s Route to 5,6-Anti-Pyranones 
Phillips then used O’Doherty's approach in efforts towards the synthesis of halichondrins. 
Allylic alcohol 274 was generated with complete diastereocontrol from α-benzoylated 
pyranone 273.81 After olefin metathesis and cyclisation to generate pyropyran 277, Phillips 
employed a Grieco oxidation to convert benzoyl alcohol 277 to lactone 278 in a single step, an 
improvement to O’Doherty’s troublesome two-step procedure (Scheme 79).81,82 
 
Scheme 79 Phillips’ Route to 5,6-Anti-Pyranones 
It was hoped that O’Doherty’s α-anomer benzoylation/reduction approach could be 
incorporated into the oxidative rearrangement sequence to allow access to anti-
isochromanones. Retrosynthetically, the highly sought after anti-isochromanone 137f could be 
accessed via Grieco oxidation of benzoyl acetal 279, which in turn could originate from the 
diastereoselective reduction of ketone 280.78,81 Ketone 280 could be generated via the 
diastereoselective benzoylation of lactol 134f, the initial product from the IBF oxidative 
rearrangement sequence (Scheme 80).  
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Scheme 80 Retrosynthetic Analysis of Anti-Isochromanones Via O’Doherty Approach 
Benzoylation of keto-lactol intermediate 134f, according to O’Doherty’s conditions, failed to 
provide the benzolyated product 280 as a single diastereoisomer. Instead, a poor 2:1 ratio in 
favor of the α-benzoylated species 280 resulted. Varying the reaction temperature failed to 
improve the product ratios. The diastereoisomers could be separated after careful 
chromatography to afford α-benzoylated lactol 280, in modest yield. However, Luche 
reduction of 280 failed to give a single diastereoisomeric product and instead an inseparable 
3:2 mixture in favour of the syn-product 282 was observed (Scheme 81). It was apparent that 
the axial trajectory was still too inaccessible even with the axial-benzoyl group which would 
have been acting against equatorial attack. 
 
Scheme 81 α-Anomer Benzoylation/Reduction Route to Anti-Isochromanoes 
For the unfunctionalised keto-lactol 134f, a dynamic equilibrium of anomers existed, which 
was evident in 1H NMR; however, for the TBS protected phenolic species 283, only the α-
anomer was observed (Scheme 82). It was hoped that this conformational anchor would allow 
for complete axial benzoylation, unlike the situation for unfunctionalised lactol 134f. However, 
this was not the case, with similar ratios of unseparable benzoylated species 284 and 285 
being observed. 
 
Scheme 82 α-Anomer Benzoylation/Reduction Route Using Keto-Lactol 283 
 Due to these shortcomings, together with the inability to obtain diastereocontrol in the 
reduction of the α-diastereosiomer 285, this route towards the synthesis of anti-
isochromanones was abandoned.  
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4.5 Summary and Outlook 
In summary, the functionalised phthalan 227 was efficiently generated in excellent yield and 
multi-gram scale from 3-methylsalicylic acid and was implemented in the IBF oxidative 
rearrangement sequence to generate the ajudazol isochromanone moiety 226. The C2 
unsubstituted oxazole-linked aldehyde 248, efficiently generated from ethylisocyanoacetate, 
was used to synthesise the western section model system 256, for which the C8-
stereochemistry could be inverted, generating the anti,anti-isochromanone 247, akin to that 
observed in the ajudazols. Furthermore, the true ajudazol C1-C14 western section framework 
258 was accessed via the IBF oxidative rearrangement sequence between functionalised 
phthalan 227 and enantiopure aldehyde 259a. Methods to access anti-isochromanones, via 
methods other than the inversion of syn-isochromanones, proved unsuccessful. 
 
 5 Ajudazol C14-C15 Bond Construction 
5.1 Oxazole C-H Activation 
Over recent years, the preparation of (hetero)-biaryl, (hetero)-aryl alkenyl units has been 
dominated by transition metal-catalysed processes, whereby an organometallic species is 
cross-coupled with a (hetero)aromatic halide. Such chemistry, namely Suzuki, Stille and Negishi 
cross-coupling, has become fundamental to the pharmaceutical industry to allow rapid access 
to bioactive (hetero)biaryl species.83 Such transformations can be typically achieved in 
excellent yields, with good selectivity and functional group tolerance. However, the major 
drawback to such chemistry is the need to pre-functionalise one of the coupling partners, 
which can be time-consuming and atom-inefficient. There are few heteroaryl halides and 
metallated coupling partners commercially available and their synthesis can often be difficult, 
often further compounded with stability issues.84 Furthermore, the need to dispose of 
stoichiometric by-products is a major concern to industry.85  
Therefore, unsurprisingly, there has been considerable interest in transition metal-catalysed 
direct C-C (sp2-sp2) bond formation, in which one of the coupling partners, typically the 
organometallic component, is replaced by a simple unactivated (hetero)aromatic 286, which 
upon transition metal catalysed coupling with halide 287, generates (hetero)biaryl species 288 
(Scheme 83). A streamlined synthesis would provide major time and atom economies once the 
need to prepare a suitably activated coupling partner has been eliminated. Direct C-H 
activation, as a replacement for conventional transition metal cross-coupling chemistry, would 
provide environmental benefits, with less waste, in particular, toxic by-products.85 
 
Scheme 83 Direct C-H Arylation 
Palladium catalysed direct C-H activation has received the most widespread attention; 
however other second-row transition metals: rhodium, ruthenium, copper and nickel have also 
been shown to participate in such processes. The ligands used in C-H activation processes 
depend on the nature of the aryl-halide component 287. Although the more reactive 
(hetero)aryl iodides have been used predominately, bromides and chlorides have been shown 
to participate in direct C-H arylation processes. However, to obtain satisfactory conversions 
and yields, they have been used in conjunction with more sterically bulky and electron rich 
phosphine ligands. Direct C-H activation reactions usually require the presence of a base, 
although the exact role of the base can remain unclear. A wide variety of bases have been 
reported, and typically the inorganic bases K2CO3, Cs2CO3,KOAc, 
tBuOK and CsOPiv are 
employed. Typically, polar, aprotic solvents have been used most frequently for direct C-H 
activation processes.85 
Direct C-H activation chemistry is believed to occur via several possible mechanisms, strongly 
dependent on the substrates, catalytic systems and bases. For 1,3-azoles in particular, direct 
arylation is proposed to occur via oxidative addition of the transition metal into the aryl halide 
followed by, predominately, one of two C-C bond forming pathways: electrophilic aromatic 
substitution (SEAr) or concerted metallation-deprotonation (CMD) (Scheme 84).
85-87 
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Scheme 84  SEAr and CMD Direct Pathways for Direct C5 Arylation of Oxazole 
It was initially believed that electron rich 1,3-azoles reacted via an SEAr mechanism, whereby 
electropalladation of the azole onto the PdII intermediate 289 occurred, which, followed by re-
aromatisation from the Wheland intermediate 290 and reductive elimination, afforded the 
hetero(biaryl) species 291.85 However, Fagnou has shown that π-excessive heteroaromatics, 
commonly proposed to react via electrophilic aromatic substitution pathways (SEAr), can 
operate via the CMD pathway, whereby the acetate/pivalate serves as a soluble proton 
transfer agent to facilitate metal insertion into the C-H bond, via a six-membered transition 
state 292 (Scheme 84).86 
In the case of azoles, and more particularly oxazoles, ab initio calculations have revealed that 
the HOMO, indicating the most electron rich site, resides on C2 and C5 carbons of the oxazole 
ring.88 Arylation should then occur at these two positions. It is believed that the C5 direct 
activation of oxazoles proceeds via SEAr and/or CMD mechanistic pathways; however, the 
exact nature of the mechanism for C2 direct arylation of oxazoles has received considerably 
more debate. Together with support of SEAr and CMD mechanistic pathways for the direct C2 
arylation of oxazoles, anionic cross-coupling mechanisms have also been mooted. 
Initially Miura rationalised that the C2 selectivity observed in a Pd(0)/Cu(I) system was 
suspected to arise from a proton-metal exchange of the most acidic position (C2>C5>C4), 
leading to the C2-oxazolylcopper species  296, which acts as a transmetallating agent, reacting 
with Pd(II) species 299 to generate intermediate 300, followed by reductive elimination to 
afford aryl-oxazole 298 (Scheme 85, Route B).89 Daugulis reported the first rationalised route 
for the direct C2 arylation of azoles, including oxazoles, using a strong base under Cu(I) 
catalysis.90 The C2-oxazolylcopper species 296 was believed to undergo a subsequent oxidative 
addition step with aryl iodide, before reductive elimination of the Cu(III) species 297, to afford 
the arylated-oxazole 298 (Route A). 
 
Ajudazol C14-C15 Bond Construction 
67 
 
 
Scheme 85 Catalytic Cycles for Cu(I) and Pd(0)/Cu(I)-Catalysed Direct Arylation of Oxazoles 
However Bellina and Rossi argued that the formation of C2-oxazolylcopper species 296 
remained unclear.91 They proposed that copper coordination to the oxazole could induce C2 
deprotonation by a mild base, to generate C2-deprotonated species 293. They stressed that 
the subsequent transmetallation step may be further complicated by the well-known 
equilibrium of the 2-metallated oxazole 293 and its ring opened tautomer 294 (Scheme 85). 
Furthermore, under copper-free palladium(0) catalysis, Zhuralev and co-workers have 
disclosed mechanistic studies on the C2 phenylation of the related benzoxazole system, 
believed to take place via an anionic mechanism, proceeding via a ring-opened species akin to 
294.92  
5.1.1 Direct C2 Alkenylation of Oxazoles 
Having demonstrated that the ajudazol C1-C14 framework can be generated, the ability to 
directly activate and react the oxazole C2 position in a late-stage coupling would be highly 
desirable as it would allow for a highly efficient and convergent synthesis of ajudazol A, from 
the oxazole-containing western section 152a and eastern section vinyl halide 153a (Scheme 
86). 
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Scheme 86 Direct C-H Activation Route Towards Ajudazol A 
Although there were emerging methods for the C2 or C5-selective direct arylation of oxazoles, 
very few reports for C2-alkenylation were reported. Moreover, of these, most were only 
applicable to activated oxazoles, such as oxazole-ethyl ester 157, where C-H alkenylation with 
vinyl bromide 301, under palladium catalysis, to generate alkenylated species 302 (Scheme 
87).93 Although there have been reports of regioselective C2 or C5 direct C-H arylation of 
oxazoles, most examples had one of the reactive positions (C2 or C5) blocked off. 
 
Scheme 87  Hoarau’s Direct C2 Alkenylation of Oxazle Ethyl Ester 
However, encouragingly, the work of Piguel showed that unsubstituted 1,3-oxazole could be 
alkenylated exclusively at the C2 position in 58% yield, under copper catalysis, to generate 
alkenyl oxazole 303.94 In a closely related publication, Piguel showed that the same 
transformation could be realised under palladium catalysis (Scheme 88).95  
 
Scheme 88 Piguel’s Direct C2 Alkenylation of Oxazle 
Pleasingly, applying Piguel’s conditions to the oxazole model system 304 resulted in C2 
selective C-H alkenylation, under both palladium and copper mediated conditions, to generate 
the desired sp2-sp2 coupled product 305 (Scheme 89).94,95 
 
Scheme 89 Direct C-H Alkenylation of Oxazole 304 
Unfortunately, to our disappointment, the reaction conditions used to generate alkene 305 
could not be applied successfully to the oxazole-containing western section 258.  Modification 
of the C-H activation conditions proved fruitless with isochromanone ring degradation being 
the predominant pathway, rather than generation of alkenyl oxazole 306. It’s believed that this 
degradation is due to the strong base and high temperatures used. Attempts to improve the 
coupling conditions by using K2CO3 in dioxane at 70 
oC proved unsuccessful and resulted in 
complete substrate degradation. Although various other catalytic conditions reported in the 
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literature may have been successfully applied to oxazole 304, the inability of the 
isochromanone unit to withtand even mild base at elevated temperatures meant that C-H 
activation chemistry would not be applicable towards the total synthesis of ajudazol A.87  
5.2 Oxazole C2 Stille Coupling 
Faced with the failure of C-H activation chemistry to achieve the desired C14-C15 coupling, 
conventional cross-coupling reactions were considered. Suzuki, Negishi and Heck couplings, 
however, were ruled out due to their dependency of base, usually in combination with 
elevated reaction conditions, which we believe would result in isochromanone decomposition. 
However, it was possible a Stille reaction could be suitable for achieving the C14-C15 coupling 
as Stille reactions proceed under neutral conditions, and importantly, in the absence of base. 
However, a Stille coupling would require the oxazole C2 position to be activated as either the 
trialkylstannane 307 or halide 308. The C2 functionality would have to be installed prior to the 
IBF oxidative rearrangement sequence as any conditions requiring strong base to deprotonate 
on the oxazole ring to introduce the necessary functionality would result in isochromanone 
ring degradation. Initial studies on the Stille strategy focussed on the introduction of a 
trialkylstannane prior to the oxidative rearrangement sequence. A successful rearrangement 
would then provide us with an advanced intermediate (307 or 308) which could be used in 
cross-coupling with  vinyl halide 153a or vinyl stannane 153b, akin to that employed by Taylor 
in his ajudazol A eastern section (Scheme 90). 
 
Scheme  90 Late-Stage Stille Route Towards Ajudazol A 
The synthesis of stannane 310 began with oxazole 253 which was protected as the TBS ether 
309. Deprotonation of 309 with nBuLi, followed by treatment with Bu3SnCl, failed to yield any 
of the desired stannane 310 (Scheme 91, Table 6, entry 1). Replacing LDA with nBuLi as base 
failed to improve matters (entry 3). Trapping the oxazole anion with TMSCl failed to generate 
the silyl oxazole 311 (entry 5). There was concern that the lack of success might be due to 
competing deprotonation at the C5 position. However, quenching with D2O yielded exclusively 
the C2 deuterated species 312, showing that complete C2 deprotonation did indeed take place 
(entry 6).  
 
Scheme 91 Oxazole C2 Functionalisation 
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Table 6  Oxazole C2 Functionalisation 
Entry Deprotonation Conditions Electrophile E Yield 
1 nBuLi, THF, –78 
oC Bu3SnCl SnBu3 - 
2 tBuLi, THF, –78 
oC Bu3SnCl SnBu3 - 
3 LDA, THF, –78 
oC Bu3SnCl SnBu3 - 
4 nBuLi, THF, 0 
oC Bu3SnCl SnBu3 - 
5 nBuLi, THF, –78 
oC TMSCl TMS - 
6 nBuLi, THF, –78 
oC D2O D 83% 
 
The lack of reactivity is believed to be attributable to the well known phenomenon of 
electrocyclic ring opening of C2 lithio-oxazoles. Studies have shown that the C2-lithiated 
oxazole 314 is in equilibrium with the acyclic lithium enolate tautomer 315.96,97 This 
equilibrium, together with the choice of electrophile, has been shown to dictate the product 
distribution between C2-functionalised oxazole 318 and acyclic side-products. NMR studies by 
Hughes and co-workers showed that the acyclic species tend to predominate; however, 
transmetallation with ZnCl2Has been shown to shift the equilibrium from the acyclic species to 
predominately cyclic 2-zincated oxazole species.98 
Vedejs and co-workers reported a practical solution to the problem of electrocyclic ring-
opening of 2-lithiooxazoles.99 Vedejs discovered that the ring-opening pathway could be 
suppressed via Lewis Acid complexation, in particular, with BH3. Mechanistically, complexation 
of the oxazole 313 with BH3, prior to organolithium addition, suppressed C2 ring-opening by 
locking the oxazole nitrogen lone pair in place (316), preventing it from participating in ring-
opening, avoiding generation of the acyclic isonitrile species 315.  Complexation also enhanced 
the acidity of the C2 position and ensured that only the C2 substituted product 318 was 
obtained (Scheme 92).  
 
Scheme 92 Vedejs’ Oxazole C2 Functionalisation Via BH3 Complexation 
Following Vedejs’ complexation protocol, the 2-stannyl oxazole 310, chloride 319 and 
trimethylsilane 311 were all successfully generated in good yields (Scheme 93 and Table 7, 
entries 1,2 and 8). 100,99 Attempts to introduce further halides (entries 4-7), and sterically 
bulkier silanes (entry 9) proved fruitless.  
 
Scheme 93 Oxazole C2 Functionalisation Via BH3 Complexation 
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Table 7  Oxazole C2 Functionalisation Via BH3 Complexation 
Entry Electrophile E Yield / % 
1 Bu3SnCl SnBu3 71 
2 C2Cl6 Cl 87 
3 NCS Cl - 
4 NBS Br - 
5 Br2 Br - 
6 NIS I - 
7 I2 I - 
8 TMSCl TMS 81 
9 TIPSCl TIPS - 
 
However, attempts at functionalising the C2 oxazole position of western section model system 
258, using this methodology resulted only in substrate degradation (Scheme 94). This was 
disappointing as the ability to directly functionalise the western section 258 would have been 
very desirable as it would have meant that oxazole functionalisation would have taken place at 
a later-stage intermediate, and thus minimising the number of functional group and protecting 
group manipulations required. 
 
Scheme 94 Attempted Functionalisation of Western Section 258 
The failure to stannylate isochromanone 258 meant that the pre-functionalised oxazole 321 
would have to be carried through the IBF oxidative rearrangement sequence, in order to 
access stannyl oxazole western section 307 (Scheme 95). However, attempts to convert 2-
stannyl oxazole 310 to the aldehyde 321 failed due to the inability to desilylate 310 without 
competing protodestannylation, under TBAF, CSA/MeOH or even HF.Py conditions.101  
 
Scheme 95 Revised Retrosynthetic Analysis of Stannylated Western Section 307 
Attempts to bypass the need to access aldehyde 321 by undertaking the C14-C15 Stille 
coupling prior to the oxidative rearrangement was trialled on the system with stannyl-oxazole 
310 and 2-bromopropene. However, the instability of stannyl-oxazole 310, coupled with its 
poor reactivity meant that the Stille coupling to generate vinyl-oxazole 324 failed (Scheme 96). 
Ultimately, the inability to utilise 2-stannyl oxazoles towards the synthesis of ajudazol A forced 
this route to be abandoned.  
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Scheme 96 Attempted Stille Coupling of Stannyl-Oxazole 310 
However, despite our initial Stille setbacks, it was postulated that a 2-chloro-oxazole unit (the 
only halo-oxazole that could be generated using Vedejs procedure (Scheme 93, Table 7),  could 
be used in a reverse Stille coupling between western section 308a (X=Cl) and vinyl stannane 
eastern section 153b (Scheme 90). In order to test whether such a coupling would be feasible, 
a simple model Stille coupling was investigated. 2-Bromopropene was thus stannylated under 
Barbier conditions, with sonication, to access the 2-stannylpropene coupling partner 323 in 
excellent yield (Scheme 97).102 
 
Scheme 97   Stille Cross-Coupling with Chloro-Oxazole 319 
Table 8  Stille Cross-Coupling Conditions 
Heat Source Temp / oC Time / h Catalyst Yield / % 
Thermal 60 72 Pd(PPh3)2Cl2 (8%) 10 (25) 
MW 75 48 Pd(PPh3)2Cl2 (8 %) 17 (47) 
MW 120 12 Pd(PPh3)2Cl2 (8 %) 80 
MW 120 12 Pd(PPh3)4 (8 %) 86 
MW 120 6 Pd(PPh3)4, TFP (20 %) 78 (87) 
MW 120 2 Pd2(dba)3 (8 %) - 
MW 120 12 Pd(PPh3)2Cl2 (8 %), CuI (20 
%) 
70 
MW 80 24 Pd2(dba)3 (1.5%), P
tBu3 
(6%) & CsF (220%) in THF 
8 (22) 
 
N.B Stille reactions carried out in anhydrous, degassed DMF (0.1M) with 1.10 eq of stannane 323, unless stated 
otherwise. Yields in parenthesis are based on recovered starting material. All reactions performed on scale 
specified in general procedure. 
Initially the Stille coupling was trialled at 60 oC with convential heating, in the presence of 
Pd(PPh3)2Cl2 catalyst in DMF (Table 8, entry 1). However, these conditions yielded only 10% of 
the desired cross-coupled product 324 after 72h. Switching to microwave irradiation at  75 oC 
failed to improve the product yield. It was not until temperatures in excess of 120 oC were 
used that complete conversion to the alkenyl-oxazole product 324 was observed, in good yield 
with  Pd(PPh3)2Cl2 (entry 3). The yields were marginally improved by using Pd(PPh3)4 as the 
catalyst (entry 4). Unfortunately, all other catalyst combinations failed to allow the reaction to 
proceed at lower temperatures, not even Fu’s conditions that have been reported for the 
successful coupling of aryl-chlorides at ambient temperatures (entry 8).103 
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In conclusion, although 2-chloro oxazole 319Has been shown to successfully undergo Stille 
cross-coupling in excellent yield, the high temperatures necessary for reaction (120 oC), would 
not be tolerated by an eastern section coupling partner bearing the thermally unstable Z,Z-
diene moiety. 
5.3 Nucleophilic Aromatic Substitution of 2-Halo Oxazoles 
Faced with the limitations of the Stille coupling approach, it was hypothesised that 2-chloro 
oxazole 319 could participate in nucleophilic aromatic substitution chemistry (SNAr).
100 This 
method could potentially provide an alternative late-stage coupling method, utilising the same 
chloro-oxazole western section 308a (X=Cl) and vinyl-halide eastern section 153a coupling 
partners to the previously investigated Stille route (Scheme 90).  
Yamanaka demonstrated that 2-chloro and 2-mesyl oxazoles 325 could readily undergo 
displacement with carbanions of active methylene compounds, generating alkylated oxazoles 
326.104 Vedejs utilised this chemistry to synthesize bis-oxazole 330 in a one-pot procedure 
from 2-chloro-oxazole 327 (Scheme 98).100 The TosMIC anion and chloro-oxazole 327 
participate in an SNAr reaction and the resultant substituted oxazole 328 is treated with 
glyoxylic acid monohydrate and K2CO3 to generate bis-oxazole 330, via fragmentation of the 
oxazoline intermediate 329. 
 
Scheme 98 Nucleophilic Aromatic Substitution of Chloro-Oxazoles 
Although there were no specific reports of SNAr chemistry of 2-halo oxazoles with vinylic 
nucleophiles, we were hopeful of its feasibility. To test this hypothesis, propenylmagnesium 
bromide 331, generated in situ from 2-bromopropene and magnesium turnings, was trialled as 
a nucleophile in an SNAr reaction with 2-chloro-oxazole 319. The reaction showed promise, 
with a yield of 31% (62% based on recovered starting material). In an attempt to push the 
reaction to completion, a further three-fold excess of nucleophile was added. This 
modification resulted in complete consumption of starting material; however, none of the 
desired vinyl oxazole 324 was obtained. Instead, dimeric species 332 was isolated in high yield 
(Scheme 99).  
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Scheme 99 Nucleophilic Aromatic Substitution of Chloro Oxazole 319 
Mechanistically, it would appear that the reaction undergoes the desired SNAr process and 
then undergoes 1,4-addition with excess Grignard reagent to yield 333. The resulting 
intermediate 333 then acts as a nucleophile to undergo a second SNAr reaction with 2-chloro 
oxazole 319, to generate dimeric species 332 (Scheme 100).  
 
Scheme 100 Proposed Mechanism for Generation of Dimeric Species 332 
Although disappointing, these results are consistent with recent reports by Lam which 
demonstrate the reactivity of 2-alkenyl oxazoles as they have been shown to be ideal 
substrates for asymmetric conjugate addition reactions. 105 The use of 2-lithiopropene as the 
nucleophile resulted only in unreacted starting material. Although the use of a 2-fluoro oxazole 
substrate may increase the rate of reaction, it would be unlikely to completely suppress the 
undesirable dimerisation. 
5.4 2-Silyl Oxazoles as Oxazolyl Anion Equivalents 
Pedrini has shown that 2-silyl-oxazoles can behave as stable 2-oxazolyl anion equivalents 
toward various carbon electrophiles, including aldehydes and acid chlorides, to yield the 
corresponding C2-substituted-oxazoles. In Pedrini’s work, 2-TMS-oxazole 334 was converted to 
the corresponding 2-acyl-oxazole 335, in modest to good yields, and provides an alternative to 
the lithiation of oxazoles and all the problems associated with it (Scheme 101).106  
 
Scheme 101 Silyl-Oxazole Acylation 
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It was hoped that 2-acyl oxazoles could be methylenated to generate the C15 methylene 
functionality of ajudazol A. However, Pedrini’s 2-sily oxazole acylation methodology was not 
reproducible with 2-TMS-oxazole 311, with only protodesilylation taking place, rather than 
acylation to generate oxazole 336 (Scheme 102).  
 
Scheme 102 Attempted Acylation of Silyl-Oxazole 311 
5.5 Summary and Outlook 
In order to access the key C14-C15 oxazole-olefin bond of ajudazol A, various methods to 
investigate oxazole C2 alkenylation were investigated. C-H activation chemistry was used to 
alkenylate the simple model oxazole 304; however, the harsh, basic reaction conditions could 
not be tolerated by isochromanone-containing systems. After much investigation, model 
oxazole 309 was functionalised as the 2-chloro oxazole 319, which was shown to undergo Stille 
alkenylation, to access vinyl oxazole 324 in excellent yield. Unfortunately, the high 
temperatures necessary for the coupling would not be tolerated by an eastern section 
coupling partner bearing the thermally unstable Z,Z-diene moiety. Alternative methods to 
access 2-alkenyl oxazoles from 2-chloro oxazoles were investigated: SNAr chemistry was 
utilised to generate alkenyl oxazole 324; however the reaction was capricious, whilst the 
investigation of using silyl-oxazoles as oxazolyl anion equivalents, proved fruitless. 
 
 
 
 6 Studies Towards the Synthesis of Ajudazol A 
6.1 Revised Stille Route Towards Ajudazol A 
Due to the unsuitability of the SNAr and 2-silyl oxazole approaches towards the ajudazol C14-
C15 coupling, efforts were diverted back towards the Stille coupling of 2-chloro oxazoles. It 
was researched that a Stille approach might still be successful in a total synthesis of ajudazol A, 
provided that the unstable Z,Z-diene functionality is only introduced after the Stille cross-
coupling has been achieved. Hence, in our revised retrosynthetic analysis, ajudazol A was 
envisioned as originating from the stereospecific reduction of bis-alkyne 337, generated via 
the Stille cross-coupling between 2-chloro oxazole 308a and vinyl stannane 153b (Scheme 
103). It was hoped that the bis-alkyne unit would be thermally robust enough to survive the 
elevated temperatures required for the Stille cross-coupling. The vinyl stannane eastern 
fragment 153b could be obtained from the amide condensation of 3-methoxybutenoic acid 56 
and amine 340. Amine 340 could be accessed via double alkylation of bis-TMS-diyne 341. The 
2-chloro-oxazole-linked isochromanone unit 308a, on the other hand, could be obtained via 
coupling of IBF anion 338 and aldehyde 339, followed by oxidative rearrangement and 
Mitsunobu inversion. IBF anion 338 could be generated from phthalan precursor 227, while 
oxazole-aldehyde 339 would originate from oxazole-ester 157. 
 
Scheme 103 Revised Retrosynthetic Analysis of Ajudazol A 
Although this new approach had the potential to provide a very efficient synthesis of ajudazol 
A, there were a number of potential pit-falls as well. The main one involved the potential for 
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the 2-chloro oxazole unit to participate in nucleophilic aromatic substitution, together with 
potential transmetallation issues, under the IBF alkylation conditions. 
Hence, to test whether the chloro-oxazole moiety could tolerate such conditions, an ajudazol 
western section, comprising a 2-chloro oxazole-linked isochromanone 345, was synthesised 
(Scheme 104). Our synthesis began with 2-chloro oxazole 319 which was desilylated, and the 
resultant alcohol 342 was oxidised to aldehyde 343 in good yield. Aldehyde 343 was then 
subjected to the IBF oxidative rearrangement sequence with simple phthalan 131. Gratifyingly, 
the sequence proceeded to generate the syn,syn and syn,anti isochromanone products 344 
and 345 respectively, in good overall yield. More importantly, the 2-chloro oxazole 
functionality remained intact after the entire sequence (Scheme 104). 
 
Scheme 104 Synthesis of Chloro Oxazole-Containing Western Section Model 345 
Furthermore, the key Stille coupling between chloro oxazole 345 and vinyl stannane 323 
provided the desired C14-C15 linked species 346 in excellent yield (Scheme 105). Moreover, 
the isochromanone ring was stable under the Stille reaction conditions.  
 
Scheme 105 Stille Coupling of Ajudazol Western Section System 345 
6.1.1 Bis-alkyne Synthesis and Functionalisation 
Faced with such encouraging preliminary results, a more representative test of the late-stage 
Stille coupling, in which a bis-alkyne unit was present within the vinyl-stannane coupling 
partner, was developed.   
In natural product synthesis unsymmetrical diynes are frequently constructed linearly, often 
starting from a terminal alkyne.107 Seeking a more direct approach to the synthesis of eastern 
section 153b, we looked at literature reports in which sequential alkylation of 1,4- bis-TMS-
diyne 341Had been used en route to the synthesis of diacetylinic fatty acids.108 In this 
procedure, bis-TMS-diyne 341 was mono-desilylated, alkylated and the second silyl group 
cleaved, to generate the mono-alkylated bis-alkyne 347, in reasonable yield. A second 
alkylation then proceeded in moderate yield to afford the internal diyne 348 (Scheme 106). 
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Scheme 106 Correia’s Route to Diynes  
 Therefore, based on this approach, eastern section model system 349 could potentially be 
accessed via stannylation of the vinyl bromide-linked diyne 350. In turn, diyne 350 could 
potentially be generated via the sequential alkylation of bis-TMS-diyne 341 with alkyl halide 
352 and 2,3-dibromopropene respectively (Scheme 107). 
 
Scheme 107 Retrosynthetic Analysis of Eastern Section Model 349 
Unfortunately, following Correia’s procedure, although the mono-alkylation of bis-TMS-diyne 
341, to generate diyne 347 could be reproduced in slightly improved yields, severe difficulties 
in purification meant that an alternative method for the synthesis of alkylated bis-alkynes was 
required (Scheme 108). 
 
Scheme 108 Attempted Synthesis of Bis-Alkynes via Correia’s Procedure 
Our alternative route towards the synthesis of mono-alkylated diyne 351 commenced with the 
bromination of TIPS-acetylene to generate bromo-acetylene 353 in quantitative yield (Scheme 
109).109 Bromo-acetylene 353 participated in a copper-catalyzed Cadiot-Chodkiewicz coupling 
to yield the bis-alkyne 354 in excellent yield and in a very short reaction time.110 TIPS-acetylene 
deprotection, followed by protection of the resultant alcohol 355, generated the terminal bis-
alkyne 356 in very high yield over 4 steps.  
 
Scheme 109 Cadiot-Chodkiewicz Route Towards Bis-Alkyne 356 
Having generated the desired diyne core, the next step was to alkylate diyne 356 with 2,3-
dibromopropene, in order to generate vinyl bromide 357, from which the vinyl-stannane 
eastern section model system 349 could potentially be accessed (Scheme 107). Unfortunately, 
despite extensive literature precedent for the allylation of terminal alkynes under copper 
catalysis, reaction of diyne 356 with 2,3-dibromopropene failed to proceed to completion 
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(Scheme 110).111-113 The most successful conditions using Cu(I)-catalysed phase transfer 
conditions gave only 50% conversion, with more forcing conditions leading to product 
degradation. Moreover, the allylated product 357 could not be separated from the unreacted 
terminal alkyne 356. Similar conversion problems were encountered when direct 
deprotonation and transmetallation to generate the copper-acetylide intermediate were 
attempted. 
 
Scheme 110 Attempted Allylation of Terminal Diyne 356 
Faced with such a low conversion step, combined with the purification issues, a new approach 
was sought in which the bis-alkyne 349 could be accessed via the convergent coupling of two 
asymmetric acetylene units, 358 and 359 (Scheme 111). 
 
Scheme 111 Revised Retrosynthetic Analysis of Eastern Section Model 349 
TMS-acetylene underwent efficient allylation with 2,3-dibromopropene to afford vinyl 
bromide 360 in excellent yield (Scheme 112). Metallation and stannylation, under Barbier 
conditions, provided vinyl stannane 361, which upon desilylation under mild conditions, 
generated terminal alkyne 362.114,102 The second alkyne coupling partner 363 was readily 
accessible from 4-pentyn-1-ol, through silyl protection, followed by alkyne bromination.  
 
Scheme 112 Synthesis of Cadiot-Chodkiewicz Coupling partners 
Cadiot-Chodkiewicz coupling between acetylene 362 and silyl-protected bromo-pentynol 363 
afforded bis-alkyne 365 in good yield (Scheme 113, Route A). However, the symmetrical diyne 
side-product 366, the result of the homo-coupling of bromo-acetylene 363, was obtained in 
significant amounts and therefore purification of bis-alkyne 365 proved difficult. 
Unfortunately, the inability to brominate alkyne 362 with AgNO3/NBS or Br2/KOH, meant that 
the analagous coupling, but with reverse coupling partners, could not be attempted.   
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Despite this initial setback, we decided to persist and modify the nature of the coupling 
partners. Cadiot-Chodkiewicz chemistry has been shown to work best when the acetylene and 
1-haloacetylene units are dissimilar, for example, alkyl vs. aryl or functionalised vs. 
unfunctionalised.115 Gratifyingly, Cadiot-Chodkiewicz coupling between acetylene 362 and 
bromo-acetylene 364, provided diyne 367 in excellent yield and with drastically suppressed 
homo-coupling (Scheme 113, Route B). Silylation provided the desired diyne 365 in excellent 
yield. 
 
Scheme 113 Cadiot-Chodkiewicz Routes Towards Diyne 365  
With the diyne-linked vinyl stannane 365 in hand, the more elaborate Stille coupling with 2-
chloro-oxazole 319 was attempted. Gratifyingly, the Stille coupling proceeded under 
microwave irradiation to generate the ene-diyne unit 368 in good yield (Scheme 114). Having 
achieved the synthesis of the eastern section framework, ene-diyne 368 was used as a model 
system to test whether the stereoselective reduction to generate Z,Z-diene 369 could be 
achieved. There was literature evidence showing the stereoselective reduction of diynes to 
Z,Z-dienes. However, despite extensive experimentation under a variety of conditions, no such 
conditions were able to afford Z,Z-diene 369. Hydroboration-protonolysis (dicyclohexylborate 
then HCl),116 Lindlar hydrogenation (5% Pd/CaCO3/Pb, quinoline, H2),
117 transfer hydrogenation 
(HCO2H-NEt3, [Pd2(dba)3]-P
tBu3, THF)
118 and Strykers’ reagent ([(Ph3P)CuH]6, C6H6) failed.
119 
Finally, the P2-Nickel conditions employed by Rizzacasa also failed to give the desired Z,Z-diene 
369.27,28 In general, the only observable products appeared to be those of over-reduction of 
diyne to alkane and/or reduction of the C15 exo-alkene (Scheme 114). 
 
Scheme 114 Synthesis and Attempted Reduction of Ene-Diyne 368 
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6.1.2 Double Stille Route Towards Ajudazol A 
Due to this setback, an alternative approach towards the synthesis of the key Z,Z-diene of 
ajudazol A was devised. In our newly modified retrosynthesis, it was proposed that the Z,Z-
diene functionality, as in previous approaches, would be introduced as the last step of the 
synthesis and would be accessed via the late stage Stille coupling between the western section 
vinyl iodide 370 and the eastern section vinyl stannane 159.120 Stannane 159 would originate 
from vinyl iodide 72. The western coupling partner 370 was envisioned to be generated from 
protected alcohol 371, which in turn could be accessed from the Stille coupling between vinyl 
stannane 373 and chloro-oxazole 372 (Scheme 115). 
 
Scheme 115 Retrosynthetic Analysis of Ajudazol A via Double Stille Approach 
To test the feasibility of the latest proposed route, the simple chloro-oxazole 319 was used as 
a model for the ajudazol western section 372. Our synthesis began with bromobutenol, which 
was protected as the PMB ether 375 (Scheme 116). Treatment of bromide 375, under the 
Barbier stannylation conditions previously employed to synthesise stannanes 323 and 361 
(Schemes 97 and 112), failed in this instance.102 However, metallation using tBuLi and anion 
trapping with Bu3SnCl afforded vinyl stannane 376 in excellent yield.
121 The use of Me3SnCl in 
place of Bu3SnCl afforded stannane 377 in comparable yield. The model Stille coupling 
between stannane 376 with chloro-oxazole 319 proceeded smoothly to provide vinyl oxazole 
378. Using trimethyl stannane 377 in the Stille coupling in place of tributyl stannane 376 
resulted in a slight improvement in yield; however it allowed for a considerably more straight-
forward purification, despite having similar reaction conditions. 
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Scheme 116 Synthetic Route Towards Vinyl Iodide 381 
Deprotection of PMB ether 378 gave alcohol 379, which it was hoped could be oxidised to the 
corresponding aldehyde 380 en route to accessing the Z-vinyl iodide 381, via Stork-Zhao 
olefination chemistry.122 Unfortunately, aldehyde 380 could not be isolated in pure form as it 
readily underwent alkene isomerisation to generate the thermodynamically stable enal 382, in 
which the double bond is in full conjugation with both the carbonyl and oxazole ring. 
Modification of the oxidation conditions (Dess-Martin, Tempo/BAIB, Swern) failed to suppress 
the alkene isomerisation.  
In an attempt to bypass the isomerisation issues, the stannane cross-coupling partner was 
modified. In our modified approach, Stille coupling between chloro oxazole 319 and vinyl 
stannane 361 generated the desired alkenyl oxazole 384 (Scheme 117). TMS removal 
proceeded cleanly to provide acetylene 385; however, isomerisation was evident at prolonged 
reaction times. Furthermore, complete conversion of TMS acetylene to enyne by-product 386 
occurred by merely increasing the reaction temperature from 25 to 35 oC.  
 
Scheme 117 Revised Synthetic Route Towards Vinyl Iodide 381 
These results demonstrated the inherent instability of the ajudazol C15 olefin and this factor 
could well have been a reason for the reported instability of ajudazol A (7) upon 
characterisation.11  
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6.2 Summary and Outlook 
The chloro oxazole-linked western section 345 was shown to successfully undergo Stille 
alkenylation and was very tolerant of the sensitive isochromanone functionality, 
demonstrating that this methodology could be applicable in the total synthesis of ajudazol A. 
The model diyne of ajudazol A, 368, was accessed using the Stille alkenylation and a Cadiot-
Chodkiewicz coupling to efficiently generate the bis-alkyne functionality.  Efforts towards the 
total synthesis of ajudazol A were thwarted by the inability to chemoselectively reduce the 
model diyne 368 in the presence of the C15 olefin functionality, and were further hampered by 
the tendancy of the C15-olefin to undergo isomerisation. Therefore, as a result, all further 
efforts were directed towards the total synthesis of ajudazol B, where the C15 position is fully 
saturated (Figure 3). 
 
 
 7 Synthesis of the C9-C29 Section of Ajudazol B 
Upon focussing our attention exclusively towards ajudazol B (8), it was noted that the ajudazol 
A vinyl-oxazole model 346 could potentially be further manipulated to resemble the ajudazol B 
system. Thus, olefin hydrogenation of alkene 346 proceeded in excellent yield, before 
Mitsunobu inversion and cleavage of the para-nitrobenzoate intermediate afforded the 
desired anti,anti-isochromanone species 388 (Scheme 118). It is noteworthy that Mitsunobu 
inversion did not proceed on either the chloro-oxazole 345 or vinyl olefin 346. 
 
Scheme 118 Synthesis of Anti,anti-Ajudazol B Model Western Section 388 
7.1 Late-Stage Stille Route Towards Ajudazol B 
Although efforts to access ajudazol A (7) via the double Stille route were ultimately 
abandoned, it was believed that an analogous strategy could be successfully applied towards 
the synthesis of ajudazol B (8), where it was expected that the aliphatic C15 position would be 
chemically inert, unlike the ajudazol A counterpart. 
 
Scheme 119 Retrosynthetic Analysis of Ajudazol B 
Retrosyntetically, ajudazol B (8a) was thought as being accessed via the late-stage Stille 
coupling between vinyl iodide 158a and vinyl stannane 159. The western vinyl iodide 158a, 
generated from protected alcohol 389a, in turn could be obtained from the alkylation and 
oxidative rearrangement sequence between IBF anion 338 and enantiopure aldehyde 161. This 
route would differ from our previous strategies towards the ajudazols as the C15-C17 
framework would already be installed prior to the oxidative rearrangement sequence, thereby 
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bypassing the need for functionalisation and cross-coupling at the oxazole C2 position. It is 
noteworthy that the C15 stereochemistry of ajudazol B is unknown, and therefore by carrying 
out the oxidative rearrangement with the alternative C15 aldehyde diastereoisomer 182, the 
corresponding ajudazol B C15-epimer (8b) could potentially be accessed. It was hoped that this 
flexible approach would be able to provide access to both possible ajudazol B 
diastereoisomers and help to deduce the absolute stereochemistry of ajudazol B. 
7.2 Stille Approach Towards the Synthesis of the Ajudazol B C9-
C29 Unit 390 
Initially, to test the feasibility of the Stille route towards the synthesis of ajudazol B, a model 
system of the key Stille coupling was developed. Ajudazol B C9-C29 unit 390 would be 
accessed via Stille coupling between vinyl iodide 391 and vinyl stannane 159 (Scheme 120). 
 
Scheme 120 Key Stille Disconnection of Ajudazol B C9-C29 Unit 
Our synthesis of the ajudazol B C9-C29 fragment 390 began with vinyl oxazole 379, which was 
hydrogenated and then oxidised to afford aldehyde 392 (Scheme 121). The fact that aldehyde 
392 was obtained as a racemic mixture of diastereoisomers was not deemed to be a hindrance 
as the diastereoisomers appeared indistinguishable on both flash chromatography and 1H/13C 
NMR. Moreover, in the true ajudazol B synthesis, the C10 and C15 stereochemistries would be 
set early in the synthesis rather than being generated via olefin hydrogenation. Stork-Zhao 
olefination of aldehyde 392 afforded Z-vinyl iodide 391 in good yield and as a single double 
bond isomer.123 
 
Scheme 121          Synthesis of Z-Vinyl Iodide 391 
Synthesis of the Z-vinyl stannane coupling partner 396 commenced with commercially 
available 4-pentyn-1-ol, which was efficiently converted into iodoalkyne 393 in good yield. 
Diimide reduction of iodoalkyne 393 gave exclusively the Z-vinyl iodide 77 in satisfactory yield. 
Oxidation was optimised using PCC, and the resulting aldehyde intermediate underwent Wittig 
olefination to yield the E-conjugated ester 78, in excellent yield over the two steps. DIBAL 
reduction generated the allylic alcohol 394 which was then used to generate the allylic 
bromide 395. Treatment of allylic bromide 395 with methylamine afforded the corresponding 
secondary amine intermediate which was then coupled with acid 56 to afford amide 72 
(Scheme 122).27,29,32 
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Scheme 122 Synthesis of Vinyl Stannane 396 
Unfortunately, the desired conversion of Z-vinyl iodide 72 into a suitable Z-vinyl stannane 159 
proved troublesome. Treatment with tBuLi followed by Bu3SnCl or Me3SnCl failed to generate 
the required stannane, with only unreacted starting material or the terminal olefin by-product 
being observed. After much optimisation, trimethylstannane 396 was obtained, albeit in 29% 
yield via transmetallation with (Me3Sn)2 under Pd catalysis (Scheme 122).
124 The low yield 
being partially due to the isolation of the stannane 396 from the unreacted starting material. 
Increasing the temperature either under conventional or microwave heating failed to achieve 
complete conversion. Moreover, the more active catalyst systems reported for vinyl stannane 
synthesis: Pd(TFP)2 and Pd(PAs3)2 failed to improve the reaction yield.
125  
Nevertheless, having achieved the synthesis of the vinyl stannane unit 396, the key Stille cross-
coupling was attempted. Gratifyingly, the desired coupling between Z-vinyl iodide 391 and Z-
vinyl stannane 396 proceeded cleanly to afford the Z,Z-diene 390 (Scheme 123). Importantly, 
the reaction took place at 60 oC, ensuring that the integrity of the thermally unstable Z,Z-diene 
was not compromised. More active catalyst systems failed to allow the reaction to proceed at 
lower temperatures. 
 
Scheme 123 Stille Coupling to Afford Ajudazol B C9-C29 Unit 390 
Although the synthesis of model system 390 demonstrated the viability of the Stille route 
towards the total synthesis of ajudazol B (8), the modest yield obtained, combined with the 
failure to optimise the conditions for the generation of Z-vinylstannane 396 meant that 
alternative routes for the synthesis of the Z,Z-diene unit of ajudazol B had to be sought.  
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7.3 Enyne Reduction Route for the Synthesis of the Ajudazol B 
C9-C29 Unit 390 
It was envisioned that ajudazol B C9-C29 unit 390 could be accessed via the chemoselective 
reduction of enyne 397 (Scheme 124). It was postulated that this reduction would be an 
improvement on the previously attempted reduction of ajudazol A model diyne 368 (Scheme 
114) as the C15 olefin would no longer be an issue. Enyne 397 was thought as being accessed 
via a late-stage Sonogashira coupling between vinyl iodide 391 and acetylene 398. 
 
Scheme 124 Sonogashira/Reduction Route Towards the Ajudazol C9-C29 Unit 390 
The synthesis of acetylene 399 began with 4-pentyn-1-ol, which was converted to the TMS-
acetylene 399 in excellent yield (Scheme 125). Oxidation of alcohol 399, followed by Wittig 
olefination, yielded the E-conjugated ester 400, in very high yield over the two steps. DIBAL 
reduction generated the allylic alcohol 401, which upon bromination, followed by amination, 
generated the secondary amine 402. Amide condensation with acid 56 provided access to 
amide 403, while desilylation provided the terminal acetylene 398 in excellent yield.  
 
Scheme 125 Synthesis of Eastern Acetylene Unit 398 
The Sonogashira coupling between vinyl iodide 391 and acetylene 398 proceeded in high yield 
to generate enyne 397 (Scheme 126). With the enyne 397 in hand, the key reduction was 
attempted. Pleasingly, the reduction proceeded cleanly to afford the desired Z,Z-diene 390, 
together with an over-reduced side-product in a 3:2 mixture. The side-product corresponded 
to either a C17-C18 or C19-C20 bond over-reduction. Despite careful monitoring of the 
reaction, suppression of side-product formation could not be achieved. Despite this, the 
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ajudazol B C9-C29 unit 390 was obtained in a reasonable yield of 55% after careful 
chromatographic purification. 
 
Scheme 126 Sonogashira Coupling and Reduction to Afford Ajudazol B C9-C29 Unit 390 
7.4 Reverse Enyne Reduction Route for the Synthesis of the 
Ajudazol B C9-C29 Unit 390 
Having demonstrated that the enyne reduction route could be applicable towards the 
synthesis of ajudazol B, a final complementary route for accessing the key Z,Z-diene 390 was 
investigated. It was hypothesised that the Z,Z-diene 390 could also be accessible via the 
stereoselective reduction of enyne 404, which would be the reverse enyne to 397 (Scheme 
127). Reverse enyne 404 was thought as originating from the acetylene western section 405 
and vinyl iodide eastern section 72. 
 
Scheme 127 Reverse Sonogashira/Reduction Route Towards Z,Z-diene 390 
The synthesis of alkyne 405 began with aldehyde 392, which was successfully converted to 
terminal acetylene 405 via an Ohira-Bestmann reaction (Scheme 128). Gratifyingly, acetylene 
405 participated in the Sonogashira coupling with vinyl iodide 72 to afford the reverse enyne 
404 in excellent yield.34 Encouragingly, the P2-Ni enyne reduction proceeded in analogous 
fashion to the previously observed reduction, affording Z,Z-diene 390, with a similar 
proportion of over-reduction product. 
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Scheme 128  Sonogashira and Reverse Sonogashira Routes Towards Z,Z-Diene 390 
7.5 Summary and Outlook 
Upon focussing exclusively on the total synthesis of ajudazol B (8), various end-game 
approaches were developed to achieve the key C17-C20 Z,Z-diene functionality, from a single 
late-stage intermediate. The ajudazol B eastern section 390 was synthesised via the Stille 
coupling between Z-vinyl olefin 391 and Z-vinyl stannane 396. Alternatively, acetylene 398 and 
Z-vinyl olefin 391 participated in a high yielding Sonogashira coupling to generate enyne 397, 
which was chemoselectively reduced to provide the ajudazol B C9-C29 unit 390. Finally, Z-vinyl 
olefin 72 was utilised in a reverse Sonogashira/reduction sequence with acetylene 405 to 
access the ajudazol B eastern section 390. In turn, these synthetic strategies would then be 
applied towards the total synthesis of ajudazol B (8). 
 
 
 8 Towards the Synthesis of Ajudazol B 
Due to the fact that only the C8-C10 relative stereochemistry of the ajudazols is known, for our 
first generation synthesis of ajudazol B, the absolute stereochemistry will be arbitrarily set. 
Commencing from the R-Roche ester (Scheme 132) would allow us to access the ajudazol B 
isomers 8a and 8b, which have the absolute stereochemistry that has been presented so far 
within this thesis. Therefore, upon completion of the synthesis of the C15-epimers of ajudazol 
B (8a and 8b), an analagous synthesis, commencing from S-Roche ester, would generate the 
final two ajudazol B isomers (8c and 8d). It was hoped that by synthesising all four possible 
ajudazol B isomers (8a-8d) could the absolute stereochemistry of the natural product be 
assigned (Scheme 129).11 
 
Scheme 129 Four Possible Ajudazol B Isomers 
Having developed the end-game methodology required for the synthesis of ajudazol B (8), a 
flexible approach to the synthesis of ajudazol B was designed. Based on recent results, 
ajudazol B was envisioned as being accessed via the late-stage Stille coupling between vinyl 
iodide 158a/b and vinyl stannane 396. Alternatively, vinyl iodide 158a/b could undergo 
Sonogashira couping with acetylene 398, followed by chemoselective reduction, to generate 
ajudazol B (8a/b). As a third option, the western acetylene section 406a/b could undergo 
Sonogashira coupling with the vinyl iodide eastern section 72, followed by enyne reduction, to 
provide access to ajudazol B (8a/b). The late stage western section intermediates, 158a/b and 
406a/b, could be accessed from protected alcohol 407a/b, the species that could be generated 
from the alkylation and oxidative rearrangement between IBF anion 338 and either one of the 
diastereoisomeric aldehydes 408a or 408b (Scheme 130).  
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Scheme 130 Retrosynthetic Analysis of Ajudazol B 
8.1 Synthesis of Aldehydes 408a and 408b 
The three possible eastern section coupling partners, vinyl stannane 396, vinyl iodide 72 and 
acetylene 398, have been synthesised, together with the functionalised phthalan precursor to 
IBF anion 338. Hence, attention was focussed on the synthesis of the C9-C17 aldehydes 408a 
and 408b.  
 
Scheme 131 Retrosynthetic Analysis of Oxazole Aldehydes 408a and 408b 
Retrosynthetically, diastereoisomeric aldehydes 408a and 408b could be accessed via the 
cyclodehydration of β-formyl amides 409a/b, which could be generated via the amide 
condensation between secondary amine 410 and enantiopure acids 411a or 411b (Scheme 
131).  
Our synthesis began with R-Roche ester which was TBS protected and then reduced to yield 
alcohol 412b in quantitative yield.126-128 Iodination of alcohol 412b afforded alkyl iodide 413 in 
excellent yield.129 Negishi coupling of iodide 413 with vinyl bromide afforded terminal olefin 
414 in good yield.128,130 This four step sequence to generate olefin 414 was efficient and high 
yielding; however, on scale-up, the yield of the Negishi coupling step suffered significantly. 
Therefore, on larger scales, it became more efficient to generate olefin 414 via an alternative 
synthetic sequence. Thus, alcohol 412b was oxidised to aldehyde 415,131,132 which upon 
homologation to give aldehyde 416,133 followed by a second Wittig olefination, generated 
terminal alkene 414 in good overall yield (Scheme 132). 132,134 
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Scheme 132 Synthesis of Terminal Olefin 414 
The terminal olefin 414 was then dihydroxylated to afford diol 417 in quantitative yield.135 
Regioselective silylation of the primary alcohol 417, followed by mesylation of the remaining 
secondary alcohol, generated mesylate 418 in quantitative yield. The mesylate 418 was 
displaced with NaN3, and the resulting azide intermediate was reduced to give the secondary 
amine 410 in high yield over two steps. It must be noted that although the dihydroxylation 
step afforded diol 417 as a 3:2 mixture of diastereoisomers, carrying forward the 
diastereoisomeric mixture was not problematic as the diastereoisomers coalesced into a single 
spot during flash chromatography. In this situation, asymmetric dihydroxylation would have 
been wasteful as the chiral centre was to be lost during the oxazole cyclodehydration step, 
becoming an sp2 centre (Scheme 131).136 
 
Scheme 133 Synthesis of Secondary Amine 410 
With the secondary amine 410 in hand, the synthesis of chiral acids 408a and 408b was 
embarked upon. In our initial approach, the enantiopure acid 411a was accessed, starting from 
alcohol intermediate 412a. Mesylation of alcohol 412a, followed by displacement with KCN 
afforded nitrile 419a in excellent yield.137 DIBAL reduction to the aldehyde, followed by NaBH4 
reduction, afforded alcohol 420a. Protecting group interconversion then generated alcohol 
421a. A number of different conditions were attempted to achieve the transformation of 
alcohol 421a into acid 411a. The one-step oxidation of alcohol 421a with PDC/DMF afforded 
acid 411a in a reasonable yield of 69%; however the reaction was sluggish and troublesome to 
purify.138 Unfortunately, other one-step oxidations such as TPAP/NMO/MeCN/H2O and 
TEMPO/NaOCl failed to give efficient conversion.139,140 Thus, two-step oxidation procedures 
were explored. Oxidation of alcohol 421a to the corresponding aldehyde intermediate was 
best performed under Dess-Martin conditions, as TEMPO/BAIB, TPAP/NMO and Swern 
oxidation conditions gave inferior results. Pinnick oxidation of the aldehyde intermediate then 
afforded the enantiopure acid 411a in excellent yield and with no detectable epimerisation of 
the α-stereocentre (vide infra). The S-enantiomer, 411b was obtained in identical yield and 
purity, starting from the corresponding S-alcohol 412b (Scheme 134). 
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Scheme 134 Synthesis of Enantiopure Acids 411a and 411b 
Faced with such a long-winded synthesis of such a simple fragment, an improved synthesis was 
sought. Our second generation synthesis of enantiomerically pure acid 411a began with (+)-
pseudoephedrine (422a), which was propionylated in excellent yield to afford amide 423a.141 
Meanwhile, alkyl iodide 426 was generated from ethylene glycol in a two step 
benzylation/iodination procedure in excellent yield.142  Pseudoephedrine amide then 
underwent diastereoselective enolate alkylation with alkyl iodide 426 in excellent yield and 
>99% de (vide infra).143,144 Amide hydrolysis was achieved through N - O acyl transfer, followed 
by borane complexation and ester saponification to afford the enantiopure acid 411a in 
superb overall yield (Scheme 135).143 The mild hydrolysis conditions ensured that the 
stereochemical integrity of the α-stereocentre was maintained (vide infra). The S-enantiomer 
411b was obtained in identical yield and purity, starting from (-)-pseudoephedrine (422b). 
 
 
 
Scheme 135 Second Generation Synthesis of Enantiopure Acids 411a and 411b 
With amine 410 and the enantiomerically pure acids 411a and 411b in hand, the synthesis of 
the oxazole-aldehydes 408a and 408b was undertaken. Condensation of amine 410 and acid 
411a, followed by desilylation, afforded β-hydroxyamide 409a in high yield.145 The oxidation of 
β-hydroxyamide 409a to the β-formylamide intermediate proved sluggish and was best 
performed under Swern conditions. Cyclodehydration of the β-formylamide intermediate 
under Wipf’s conditions, generated oxazole 427a, in good yield.146,34 Desilylation to oxazole 
428a, followed by oxidation of the resulting alcohol 428a provided aldehyde 408a in excellent 
yield (Scheme 136). Commencing with the S-acid 411b provided the diastereoisomeric 
aldehyde 408b in identical yield and purity to aldehyde 408a.  
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Scheme 136 Synthesis of Oxazole-Aldehyde 408a 
Inspection of the NMR spectra of both β-hydroxyamide intermediates 409a and 409b showed 
that no epimerisation had occurred over the entire synthetic route (Schemes 132-136) as there 
was zero evidence of cross-over products. The NMR analysis showed that the asymmetric 
alkylation of pseudoephedrine amides 423a and 423b occurred with complete 
diastereocontrol.  
 
 
 
 
 
 
 
 
Figure 19 NMR Analysis of β-Hydroxyamide Intermediates 409a and 409b 
  
8.2 Oxidative Rearrangement Sequence Towards Ajudazol B 
With the aldehydes 408a and 408b in hand, the crucial oxidative rearrangement sequence to 
generate the ajudazol B western section, was trialled. Disappointingly, the oxidative 
rearrangement sequence between functionalised phthalan 227 and oxazole-aldehyde 408a, 
under our standard conditions afforded the expected isochromanones 430a and 407a, in a 
very poor yield of 14% (Scheme 137).  
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Scheme 137 Oxidative Rearrangement Sequence of Phthalan 227 and Aldehyde 408a 
However, it was evident that significant levels of unreacted aldehyde 408a were still present 
after quenching, which seriously hindered purification. NMR analysis of the alkylated IBF 
intermediate showed a 2:1 mixture of unreacted aldehyde 408a to alkylated IBF intermediate 
429a. It was evident that the initial ratios of unreacted aldehyde 408a to IBF intermediate 
429a were far from optimal and this had a detrimental effect on the purification. While 
keeping in mind that aldehyde 408a was the more valuable substrate, efforts to improve the 
alkylation step were undertaken. Initial attempts to increase the yield by means of extended 
reaction times and carefully elevated reaction temperatures, failed to improve the degree of 
alkylation. Furthermore, it appeared that these two factors may have contributed to 
degradation of the transient IBF intermediate 429a. Interestingly, the use of HMPA and 
TMEDA additives, designed to enhance the nucleophilicy of IBF anion 338, resulted in 
complete suppression of the alkylation.  
Complete consumption of aldehyde 408a was achieved however, by using 2.0 equivalents of 
phthalan 227 relative to aldehyde 408a. This modification afforded the syn,syn and syn,anti-
isochromanones 430a and 407a, in a much improved yield over the entire sequence (Scheme 
138). The C15 epimer 407b was obtained, starting from aldehyde 408b, in analogous yield and 
in a similar diastereoisomeric ratio. 
 
Scheme 138 Improved Oxidative Rearrangement Conditions to Access Isochromanone 407a 
Having obtained the complete western section framework 407a, it was hoped that a C9 
Mitsunobu inversion, followed by homogation, could provide access to the late-stage aldehyde 
intermediate 431a. Aldehyde 431a, in turn, could provide access to either vinyl-iodide 158a or 
acetylene 406a in a single step. From these key intermediates, potentially either of the three 
end-game couplings that had been developed could be employed to generate the ajudazol B 
diastereoisomer (8b) (Scheme 139).   
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Scheme 139 End-game Routes Towards Ajudazol B 
 
8.3 Towards Late-Stage Aldehyde 431 
The first step in the proposed synthesis of aldehyde 431a from the syn,anti-isochromanone 
407a involved Mitsunobu inversion of the C9Hydroxyl group to access the anti,anti-C9-C11 
stereochemistry of the ajudazols. Significant difficulties were associated with the harsh 
Mitsunobu conditions employed previously, which resulted in complex mixtures, from which 
the desired products could only be isolated after careful purification. Therefore, alternative 
Mitsunobu conditions were sought.  
Para-nitrobenzoic acid has been shown to be the nucleophile of choice for Mitsunobu 
reactions on hindered secondary positions (i.e. as in the case of our isochromanone 
substrates).147 This factor, combined with our previous results showing the ability to 
chemoselectively cleave the para-nitrobenzoate moiety in the presence of the lactone ring of 
isochromanones, meant that varying the choice of nucleophile was not a desirable option in 
this case.148 Furthermore, the apparent difficulty experienced during the Mitsunobu inversions 
on isochromanone substrates was the problem of purification. Numerous azodicarboxylate 
reagents have been recently developed to aid purification.  
Methyl polyethylene glycol (MPEG)-supported DEAD and PPh3Has been shown to greatly aid 
purification as the reaction side-products can be easily removed by simple filtration (Figure 
20).149 Unfortunately, MPEG-DEAD and MPEG-PPh3 failed to react even with simple 
isochromanones. Further experimentation using para-nitrobenzoic acid in combination with 
polystyrene bound reagents: PS-DEAD/PPh3, DEAD/PS-PPh3 and PS-DEAD/PS-PPh3, either in 
THF or toluene, at room temperature or reflux, failed to improve the success of the 
transformation. Use of the Lipshutz DCAD reagent, which had been shown to aid purification 
as the hydrazine by-product (DCAD-H2) is insoluble in DCM, failed to react with isochromanone 
136f (Figure 20).150 
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Figure 20 Recently Developed Mitsunobu Reagents 
Whitten reported a solution to the often tedious separation of reaction product from 
Mitsunobu byproducts.151 Whitten used a combination of a basic triarylphosphine (2-PyPPh2 
432), together with the acid labile azodicarboxylate (DTBAD 434). This meant that a simple acid 
workup of the reaction crude mixture would remove the phosphine derived species 432 and 
433, while DTBAD 434 and DTBAD-H2 435 degraded into gaseous isobutene, CO2 and N2/N2H2 
respectively, thus alleviating the need for column chromatography (Figure 21).151  
 
Figure 21 Whitten’s DTBAD/2-PyPPh2 Mitsunobu Work-Up Procedure  
Gratifyingly, the combination of DTBAD/2-PyPPh2/para-nitrobenzoic acid in THF reacted with 
the simple isochromanone 136f to afford para-nitrobenzoate 437, albeit in a moderate 51% 
yield (Scheme 138). Importantly, the reaction achieved complete consumption of the starting 
material at room temperature. However, closer inspection of the reaction mixture showed the 
presence of by-product 436, in a significant yield of 25%. We believe that side-product 436 is 
the result of β-elimination occurring during the Mitsunobu reaction. 
 
Scheme 140 Mitsunobu Reactions of Isochromanones Using DTBAD/2-PyPPh2 
Mechanistically, the first step of the Mitsunobu reaction is irreversible formation of the 
betaine intermediate 438 (Scheme 141).  Betaine 438 then deprotonates the para-
nitrobenzoic acid to generate the ionic species 439, which upon reaction with the alcohol 
substrate 136f forms the key alkoxyphosphonium salt 440 and DTBAD-H2Hydrazine 435. 
Alkoxyphosphonium 440 can then either undergo SN2 inversion to generate the desired anti-
adduct 437, or an alternative E2 reaction to yield  by-product 436. Elimination must proceed 
via intermediate 440 and not from the para-nitrobenzoate product 437, as once inversion has 
taken place, it is no longer possible to achieve the anti-periplanar arrangement necessary for 
elimination (Scheme 141).  
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Scheme 141 Mitsunobu Mechanism to Generate Anti-Adduct 437 and Side-Product 436 
Hence, it would appear that the basicity of betaine intermediate 438 may have been 
responsible for the undesired β-elimination. Unfortunately, attempts to suppress the 
elimination by careful addition of DTBAD, failed to improve the product to by-product ratio. 
Evidence to support our mechanistic hypothesis was provided by close monitoring of the 
course of the reaction, as it was evident that by-product 436 formed long before starting 
material consumption. Furthermore, pre-forming betaine 438 prior to the addition of alcohol 
136f also failed to suppress β-elimination and merely resulted in incomplete consumption of 
starting material.  
Closer inspection of previous Mitsunobu reactions with DIAD/PPh3 also showed evidence of β-
elimination products. We believe that the β-elimination pathway is able to compete with the 
traditional Mitsunobu inversion due to the increase in aromatisation, and hence stability, 
which results upon elimination. Therefore, it was deemed unlikely that this side-reaction could 
be completely suppressed. 
Nevertheless, having worked out an improved Mitsunobu procedure for the key inversion, a 
more realistic model system was employed. Mitsunobu reaction of silyl phenol 199, under 
DTBAD/2-PyPPh2/para-nitrobenzoate conditions afforded the para-nitrobenzoate, together 
with by-product. Substantial silyl cleavage was observed during the reaction, and therefore 
HF.Py was used in a second step to access the fully deprotected product 442 and side-product 
441 (Scheme 142). Interestingly, the Mitsunobu reaction of protecting-group-free phenol 200 
proceeded to give products 442 and 441 with minimal drop off in yield. Para-nitrobenzoate 
cleavage to afford anti-isochromanone 443 was achieved using either NaN3/MeOH or TBAF. 
148 
Reprotection of the phenol proved troublesome, as isochromanone 443 failed to react with 
TBSCl/imid/DMF; however, the slightly more forcing conditions of TBSOTf/2,6-lutidine/DCM 
generated the protected phenol 444 in excellent yield (Scheme 142). 
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Scheme 142 Mitsunobu Reaction with Phenolic Isochromanones 
Isochromanone 226, more representative of the isochromanone moiety present in the 
ajudazols, was subjected to our improved Mitsunobu conditions, to yield the desired para-
nitrobenzoate 446, together with side-product 445, in a 2:1 mixture. Disappointingly, the more 
hindered 7-hydroxy-8-methyl isochromanone 446 could not be reprotected. Attempts to 
reprotect phenol 446 as the TMS ether using TMSCl/imid/DMF or TMSCl/(Me3Si)2NH/pyridine 
proved fruitless as the resultant products were too labile (Scheme 143).  
 
Scheme 143 Mitsunobu Reaction With Functionalised Isochromanone 226 
More forcing conditions for re-protection using stronger bases resulted in substrate 
degradation. However, it was observed that treatment of simple isochromanones with KH or 
even K2CO3 over prolonged reaction times, resulted in a 5-exo-trig cyclisation to generate 
phthalide 448 (Scheme 144). 
 
Scheme 144 Isochromanone Ring Degradation 
Faced with all of the protecting group stability issues, it was decided that a protecting group-
free synthesis would be necessary. Thus, isochromanone 407a was subjected to the DTBAD/2-
PyPPh2 Mitsunobu conditions followed by desilylation, to afford the unwanted elimination 
product 449 as the major product, together with the Mitsunobu adduct 450, in modest yields 
(Scheme 145). Unfortunately, efforts to separate Mitsunobu product 450 from the elimination 
product 449 proved fruitless, and resulted in partial product degradation. Hence, it was 
decided that in order to access ajudazol B, the Mitsunobu step would have to be undertaken 
later in the synthesis.  
 
Scheme 145 Mitsunobu Inversion of Isochromanone 407a 
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Nevertheless, the elimination product 449 that could be isolated, was debenzylated and the 
resultant alcohol was oxidised to aldehyde 451 in 65% overall yield. The oxidation proceeded 
surprisingly slowly with DMP and TPAP/NMO: mild oxidation conditions that have become 
synonymous with application in complex natural product synthesis.152,153 Aldehyde 451 would 
not provide access to ajudazol B without considerable difficulty and optimisation for which 
there was certainly not enough material; however, such a system would provide a model for 
which to trial the late stage coupling between eastern and western sections. Due to the 
apparent instabilities of the ajudazol B late-stage intermediates, it was decided that the 
Sonogashira/enyne reduction route (akin to Scheme 139, Route C), proceeding via acetylene 
406, would provide the mildest conditions. Therefore, although it was hopeful that the reverse 
Sonogashira/enyne reduction (Route B) and the Stille route (Route A) could work, when faced 
with the prospect of a very limited quantity of material, route C was investigated initially, as 
the preferred option. Thus, Ohira-Bestmann homologation provided access to acetylene 452, 
which was used in the Sonogashira coupling with the eastern section vinyl iodide 72, to 
generate enyne 453. Finally, P2-Ni reduction of enyne 453 generated the desired Z,Z-diene 
454, together with the over-reduced side-product 455 (Scheme 146). In accessing Z,Z-diene 
454, it gave us confidence that the this end-game strategy, proceeding via a western section 
aldehyde species, followed by Sonogashira coupling and chemoselective reduction, should 
allow us to access ajudazol B. However, obtaining the anti-isochromanone 450 in large enough 
quantity and purity remained a significant drawback. 
 
Scheme 146 Sonogashira/Reduction Route to Z,Z-diene 454 
8.4 Ajudazol B End-Game Strategy 
Our final effort towards the synthesis of ajudazol B involved attempting to firstly access the 
C8-epi-ajudazol B isomer 456 via the reduction of enyne 457, generated from acetylene 458, 
and then attempt to invert the C9Hydroxyl stereochemistry as the final step of the synthesis 
(Scheme 147).  Although it was more risky to attempt the audacious inversion as the final step 
with the entire ajudazol B skeleton in place, notably the Z,Z-diene, all other options had been 
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exhausted. N.B. Due to minimal quantity of the  western section 407a (which would be used to 
access the ajudazol B isomer (8a), the first generation synthesis was attempted with western 
section 408b, to provide access to ajudazol B isomer (8b). 
 
Scheme 147 Final Retrosynthetic Analysis of Ajudazol B 
The syn,anti-isochromanone 407b was debenzylated and the resultant alcohol intermediate 
was oxidised to generate aldehyde 459 (Scheme 148). Parikh-Doering conditions proved 
optimal to afford chemoselective oxidation in the presence of the benzylic alcohol 
functionality.154 Aldehyde 459 was subjected to Ohira-Bestmann conditions to afford the 
desired acetylene 458. However, together with the welcomed phenol desilylation, the K2CO3 
necessary to generate the active Ohira-Bestman species, generated noticeable levels of the 5-
membered cyclisation side-product 460. Unfortunately, the undesired cyclisation was 
unavoidable as it proceeded at such a rate that side-product formation was evident long 
before complete consumption of starting material. After optimisation, acetylene could be 
isolated in a modest 55% yield, based on a 2:1 ratio of product 458:side-product 460 (Table 9). 
Extreme care was necessary during flash chromatography as the acidity of the silica was also 
enough to promote cyclisation to the 5-membered side-product 460 (Scheme 148). 
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Scheme 148 Synthesis of Late-Stage Acetylene 458 
Table 9  Ohira-Bestmann Conditions 
Equiv. of K2CO3 Ratio of acetylene 458: side-product 460 Yield of 458 isolated /% 
5.0 1:4 17 
3.0 2:1 55 
 
Due to its instability, acetylene 458 was immediately coupled with eastern section vinyl iodide 
72, under Sonogashira conditions, to afford enyne 457 in good yield. Enyne 457 was then 
reduced under P-2 Ni conditions, with the crude product mixture showing that epi-ajudazol B 
456 was present in a 2:1 ratio, together with the over-reduced species 461. HPLC 
chromatography provided C8-epi-ajudazol B 456 in 53%, and allowed isolation of the over-
reduced species 461, in 25% from enyne 457 (Scheme 149).  
Scheme  149 Synthesis of Epi-Ajudazol B 456 
The C8-epi-ajudazol B isomer 456 represents the first example of the synthesis of the entire 
ajudazol C1-C29 framework, albeit with the opposite stereochemistry at C8, with respect to 
the desired ajudazol B isomer (8b). Unfortunately, all attempts to invert the C8 
stereochemistry of 456 failed. Although the Mitsunobu inversion of free phenol 200 
proceeded in a similar yield to the analogous protected substrate 199 (Scheme 142), such 
conditions failed to react with the more elaborate C8-epi-ajudazol B isomer 456. Addition of 
excess reagents or increasing the reaction temperature only led to degradation of starting 
material (Scheme 150). 
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Scheme 150 Attempted Mitsunobu Inversion of C8-Epi-Ajudazol B Analogue 456 
8.5 Summary and Outlook 
The enantiopure aldehydes 408a and 408b, necessary to access both C15-epimers of Ajudazol 
B, were accessed via a convergent route, from Roche ester and pseudoephedrine precursors. 
The ajudazol B western section framework 407a/b was accessed via the IBF oxidative 
rearrangement sequence from phthalan 227 and aldehydes 408a and 408b. Ultimately, after 
much investigation, ajudazol B could not be accessed, inherently due to instabilities of the 
isochromanone ring.  
Although we were unable to complete the total synthesis of ajudazol B, we managed to deliver 
the total synthesis of the C8-epimer of ajudazol B 456, via a convergent synthetic route. C8-
Epi-ajudazol B analogue 456 represents the first example of the synthesis of the entire 
ajudazol C1-C29 framework.  
 
 9 Conclusion 
The initial objective of the work presented in this thesis was to expand and develop the 
isobenzofuran oxidative rearrangement methodology, recently developed within the Marquez 
group for generation of isochromanones, and to apply this methodology towards the total 
synthesis of the ajudazols.33 
Our IBF alkylation and oxidative rearrangement sequence has been developed to efficiently 
generate C8-substituted isochromanones, of type 199, with complete regio- and 
diastereocontrol, in excellent yield and requiring minimal purification. C8-substituted 
isochromanone 199 can be accessed from either the C7 or C4-substituted phthalan precursor 
198 or 215 (Scheme 151).155 
 
Scheme 151 Regiocontrolled IBF Oxidative Rearrangement Sequence 
The oxazole-linked aldehyde 248 was compatible with the IBF alkylation and oxidative 
rearrangement conditions to generate isochromanone 256, en route to the anti,anti-adduct 
247, the C8-C10 stereochemistry matching that of the ajudazols. The functionalised phthalan 
227 and enantiopure aldehyde 259a were utilised in the IBF oxidative rearrangement 
sequence to successfully access the ajudazol C1-C14 western section framework 258 (Scheme 
152).156 
 
 
After applying our methodology towards the ajudazol western section, attention was focussed 
on achieving a coupling that would allow us to bring together the eastern and western 
ajudazol sections in a convergent manner. In order to access the key C14-C15 bond of ajudazol 
A, various methods to investigate oxazole C2 alkenylation were investigated, including C-H 
activation and SNAr chemistry, and although said chemistry worked on model systems, it was 
not tolerated by isochromanone systems. However, Stille coupling, utilising 2-chloro oxazoles, 
was very tolerant of the sensitive isochromanone functionality. The chloro-oxazole containing 
western section 345 was shown to undergo Stille alkenylation to generate alkenyl oxazole 346, 
en route to the anti,anti-adduct 388 (Scheme 153). 
Scheme 152 Synthesis of the Ajudazol Western Systems 258 
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 Scheme 153 Stille Route Towards Ajudazol C14-C15 Bond Synthesis 
Ultimately, efforts towards the total synthesis of ajudazol A were thwarted by the inability to 
chemoselectively reduce the model diyne 368 in the presence of the C15 olefin functionality, 
and were further hampered by the tendancy of the C15-olefin to undergo isomerisation 
(Scheme 154). 
 
Scheme 154 Attempt to Access the Z,Z-Diene of Ajudazol A 
Upon focussing our efforts exclusively on the total synthesis of ajudazol B (8), various end-
game approaches were developed to achieve the key C17-C20 Z,Z-diene functionality, from a 
single late-stage intermediate 392. Stille coupling, Sonogashira coupling/chemoselective 
reduction and reverse-Sonogashira/reduction methodologies were utilised in the synthesis of 
the ajudazol B eastern section 390 (Scheme 155). This would allow for a flexible synthesis of 
ajudazol B. 
 
Scheme 155 Accessing the Ajudazol B Eastern Section 390 
The enantiopure aldehydes 408a and 408b, necessary to access the C15-epimers of Ajudazol B, 
were accessed via a convergent route, from Roche ester and pseudoephedrine precursors. The 
ajudazol B western section framework 407a/b was accessed via the IBF oxidative 
rearrangement sequence from phthalan 227 and aldehydes 408a and 408b. Ultimately, after 
much investigation, ajudazol B could not be accessed, inherently due to instabilities of the 
isochromanone ring. 
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Although we were unable to complete the total synthesis of ajudazol B, we managed to deliver 
the total synthesis of ent-C8-epimer of ajudazol B 456 (refer to addendum), via a convergent 
synthetic route, utilising our novel IBF oxidative rearrangement sequence to efficiently 
generate the isochromanone-containing western section. Ent-C8-epi-ajudazol B 456 represents 
the first example of the synthesis of the entire ajudazol C1-C29 framework (Scheme 156).  
Scheme 156  Synthesis of C8-Epi-Ajudazol B Isomer 456 
We believe that the work carried out during the course of this project will provide a 
meaningful contribution to both the field of synthetic chemistry and the art of total synthesis. 
 
 
 10 Future Work 
Should there have been more time during the course of this doctorate research, there are a 
few areas of research that we would have liked to dedicate some time to. Time spent 
researching these areas would lead to a more complete research project. 
10.1 Chelation Controlled Route to 5-Substituted 
Isochromanones 
The IBF alkylation and oxidative rearrangement with MOM-substituted phthalan 206 gave the 
8-substituted isochromanone 208 as the major product (Scheme 157). Attempts to optimise 
reaction conditions to favour chelation control, failed to overturn the selectivity.   It is 
hypothesized that by using chelating groups that have heteroatoms fixed at different positions 
away from the aromatic framework, this may help to create more optimal chelation conditions 
between the heteroatom, metal ion and proximal anion 456. MEM, SEM, MTM and BOM 
ethers, or the diethylcarbamate, may help to access the chelation controlled C5-substituted 
isochromanones 465.51 
   
Scheme 157 Accessing 5-Substituted Isochromanones Via Chelation Control 
The ability to achieve both steric and chelation controlled IBF anion alkylation would enhance 
our methodology, whereby simply altering the nature of phenol protecting group on the 
phthalan precursor 163, would allow for the selective synthesis of either 5 or 8-substituted 
isochromanone products 167 or 186 (Scheme 158). 
 
Scheme 158 Accessing Either 5- or 8-Substituted Isochromanones  
10.2 Enhancing Anti-Felkin IBF Anion Alkylation 
During the course of this project, the IBF anion alkylation with aldehydes possessing an α-
stereocenter, resulted in a 3:2 ratio of isochromanone products, with a marginal bias in favour 
of the syn,anti-product. The syn,anti product appeared to be the result of anti-Felkin addition. 
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Therefore, the synthetic route towards syn,anti-isochromanones and thus, anti,anti-
isochromanones could be greatly improved if the anti-Felkin selectivity could be enhanced. 
Designer Lewis acid ligands have proven to be versatile reagents for the control of regio-, 
sterio- and chemoselective transformations. One such example is the sterically hindered 
aluminium aryloxide ligand, MAD (methylaluminium bis(2,6-di-tert-butyl-4-methylphenoxide)), 
developed by Yamamoto.157 The high oxophilicity of monomeric MAD results in the formation 
of stable Lewis acid complexes with the carbonyl oxygen (467). This complexion leads to steric 
protection of the initially less hindered substrate positions and has been used to enhance 
selectivities in nucleophiic addition reactions, often reversing the regio- or stereospecificity of 
reactions, to generate the anti-Felkin product 469 (Figure 19).158,159  
 
Figure 19 Felkin and Anti-Felkin Newman Projections 
Yamamoto showed that complexation of a range of substituted cyclohexanones, for example 
470, with MAD, inverts the facial selectivity of attacking nucleophiles by shielding the favoured 
equatorial side. This results in the almost exclusive formation of the axial substituted alcohol 
473 (99:1). In the absence of MAD, the equatorial substituted alcohol 472 (79:21) 
predominates (Scheme 159).157 
 
Scheme 159 Effect of MAD on Nucleophilic Addition to 
t
Bu-Cyclohexanone 
Furthermore Yamamoto also demonstrated that complexation of the chiral α-aldehyde 474 
with MAD reversed the selectivity of alkylation where no chelation control is possible. The 
MAD ligand coordinated to the least hindered face of the aldehyde followed by addition of the 
ethyl Grignard, which subsequently attacks the face opposite to the bulky MAD ligand, 
favouring the anti-Felkin product 476 in a ratio of 75:25. Meanwhile alkylation without 
preceeding complexation results in a 13:87 ratio in favour of the Felkin product 457 (Scheme 
160).157 
 
Scheme 160 Effect of MAD on Nucleophilic Addition to Acyclic Aldehydes 
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This selectivity is incredibly encouraging and the Yamamoto MAD protocol could possibly be 
implemented for use in the IBF alkylation step. In theory this could enhance the anti-Felkin 
selectivity and therefore increase the efficiency in the synthesis of the ajudazol western 
section 479 (Figure 20). 
 
Figure 20 Using MAD to Enhance of Selectivity of IBF Anion Alkylation
 11 Addendum 
Since the submission of this thesis in September 2012, Menche and co-workers have fully 
assigned the absolute stereochemistry of the ajudazols A (7b) and B (8c), based exclusively on 
gene cluster analysis, and reported the first total synthesis of ajudazol B (8c) (Figure 21).158 
 
 Figure 21 Menche's Full Stereochemical determination of the Ajudazols
 12 Experimental 
 
12.1 Apparatus 
Solvents were evaporated under reduced pressure at 40 C using a Buchi Rotavapor unless 
otherwise stated. IR spectra were recorded as thin films on NaCl plates using a JASCO FT/IR410 
Fourier Transform spectrometer or using a Shimadzu FTIR-8400 spectrometer (thin-layer). 
Only significant absorptions (max) are reported in wavenumbers (cm
-1). High resolution mass 
spectra were recorded on a JEOL JMS-700 spectrometer by EI, CI and FAB mass spectrometry, 
operating at a resolution of 15000 full width at half height. Melting points were recorded with 
an Electrothermal IA 9100 apparatus. 
Hydrogen magnetic resonance spectra (1H NMR) and carbon magnetic resonance spectra (13C 
NMR) were respectively recorded at 400 or 500 MHz and 100 or 125 MHz using a Bruker DPX 
Avance 400 or 500 instrument. Chemical shifts () are reported in parts per million (ppm) and 
are referenced to the residual solvent peak.  The order of citation in parentheses is (1) number 
of equivalent nuclei (by integration), (2) multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, sext = sextet, sept = septet, m = multiplet, br. = broad), (3) and 
coupling constant (J) quoted in Hertz to the nearest 0.1. DEPT Q, 135, DEPT 90 and two-
dimensional (COSY, HQC) NMR spectroscopy were used, where appropriate, to assist the 
assignment of signals in the 1H and 13C NMR spectra.  
 
12.2 Chromatography 
Flash chromatography was performed using silica gel (Fluorochem Silica Gel 60, 40-63 micron) 
as the stationary phase. TLC was performed on aluminium sheets pre-coated with silica (Merck 
Silica Gel 60 F254) unless otherwise stated where aluminium oxide plates were used.  The plates 
were visualised by the quenching of UV fluorescence (max254nm) and/or by staining with 
either anisaldehyde, potassium permanganate, cerium ammonium molybdate or 
phosphomolybdic acid hydrate solution, followed by heating. 
12.3 Solvents, Reagents and Reaction Conditions 
All reactions were performed in oven-dried glassware under an inert argon atmosphere unless 
otherwise stated. THF, Et2O, and DCM were purified through a Pure Solv 400-5MD solvent 
purification system (Innovative Technology, Inc). All reagents were used as received, unless 
otherwise stated.  
12.4 Experimental Details 
General Procedures 1-2: The Synthesis of Isochroman-1-ones from Phthalan 
Precursors 
Experimental 
 
112 
 
All of the IBF oxidative rearrangement sequences carried out here in this thesis were done so 
according to the following general procedures, unless explicitly stated otherwise. In the 
following general procedures the keto-lactone species 135f has been purified and fully 
characterised; however, all intermediates were typically taken on crude through the entire 
sequence from phthalan precursor to isochromanone product. The general procedures have 
been exemplified for the synthesis of isochromanone 136f 
 
General Procedure 1: The Synthesis of Keto-Lactones from Phthalan 
Precursors 
 3-Isopropylisochroman-1,4-dione 135f 
 
A 0 oC solution of phthalan 131 (1.88 g, 12.6 mmol) in anhydrous THF (75 mL), was treated 
with iPr2NH (176 µL, 1.25 mmol) and stirred for 10 min. MeLi (1.6 M in Et2O, 16.5 mL, 26.4 
mmol) was then added slowly, and the solution was stirred for 30 min. The reaction mixture 
was cooled to –78 oC, and freshly distilled isobutyraldehyde (1.37 mL, 15.1 mmol) was added. 
The resulting solution was then stirred for a further 90 min at –78 oC (until TLC analysis on 
alumina plates showed reaction was complete) before being quenched with water at 0 oC. The 
mixture was extracted with Et2O (3 × 100 mL) and the combined organic extracts were washed 
with water (50 mL), brine (50 mL), and dried over Na2SO4. The solvent was removed under 
reduced pressure at RT to afford the desired α-hydroxy-IBF intermediate 133f which was used 
in the next step without further purification.  
The crude α-hydroxy-IBF 133f was dissolved in anhydrous DCM (50 mL) and cooled to 0 oC. The 
resulting solution was then treated with mCPBA, (77%, 3.09 g, 13.8 mmol) and the reaction 
was stirred at 0 oC for 2h (until completion by TLC analysis on alumina plates). The reaction 
was quenched with sat’d NaHCO3 solution (60 mL), extracted with DCM (3 × 100 mL), and the 
combined organic extracts were dried over Na2SO4. The solvent was then removed under 
reduced pressure at RT to afford the crude keto-lactol 135f (2.43 g, 11.80 mmol, 94% from 
phthalan 131) as a yellow oil, which was taken on as crude immediately to the next step 
without further purification.  
Oxidation Method 1A: Jones Reagent 
Freshly prepared keto lactol 134f (1.68 g, 8.2 mmol) was dissolved in acetone (40 mL) and 
treated with freshly made 2.5 M Jones reagent at RT. The resulting red / brown solution was 
then stirred for 45 min (until complete consumption of starting material indicated by TLC 
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analysis on alumina plates). The reaction was quenched with water (100 mL), and the aqueous 
layer extracted with DCM (3 × 150 mL). The combined organic extracts were washed 
sequentially with water (3 × 30 mL), brine (50 mL), dried over Na2SO4 and the solvent 
evaporated under reduced pressure.  The crude residue was purified by flash column 
chromatography, elution with 100% DCM, to afford the desired keto-lactone 135f, (1.60 g, 
7.82 mmol, 96% from keto-lactol 135f) as a yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 0.89 (3H, d, 
J = 6.8, CH3), 1.12 (3H, d, J = 7.0, CH3), 2.43-2.51 (1H, m, CH(CH3)2), 4.91 (1H, d, J = 3.6, CH(
iPr)), 
7.78-7.86 (2H, m, ArH), 8.04 (1H, dd, J = 7.6, 1.2, ArH), 8.25 (1H, d, J = 7.3, ArH). 13C NMR 
(CDCl3, 100 MHz) δ: 16.3 (CH3), 18.9 (CH3), 33.4 (CH(CH3)2), 88.8 (CH(
iPr)), 125.7 (CArH), 128.1 
(CArCO), 130.6 (CArH), 132.0 (CArCO2), 134.6(C
ArH), 135.6 (CArH), 162.0 (CO2), 192.5 (CO). m/z  
[FAB+, NOBA] 205 [M+H]+ (100%), HRMS found [M+H]+ 205.0866, C12H13O3  requires 205.0865. 
υmax /cm
-1 (film): 2969, 2935, 2877, 1731, 1698, 1599. 
Oxidation Method 1B: TEMPO and BAIB  
The freshly prepared keto-lactol 135f (480 mg, 2.33 mmol) was dissolved in anhydrous DCM 
(12 mL) and sequentially treated with BAIB (2.40 g, 7.45 mmol) and TEMPO (73 mg, 0.47 
mmol) under argon. The reaction mixture was stirred at RT for 45 min until reaction 
completion as indicated by TLC analysis.  The reaction was then diluted with DCM (100 mL) 
and washed with sat’d aq. Na2S2O3 solution (2 × 30 mL), water (2 × 30 mL) and brine (30 mL). 
The organic layer was dried over Na2SO4 and then concentrated under reduced pressure. The 
crude residue was purified by flash column chromatography, elution with 0-25% 
Et2O:petroleum ether) to afford the desired keto-lactone 135f (399 mg, 1.96 mmol, 84%) as a 
yellow oil.  
General Procedure 2: The synthesis of Isochroman-1-ones from Keto-
Lactones 
4-Hydroxy-3-isopropylisochroman-1-one 136f 
 
Reduction Method 2A: Luche Conditions 
A –78 oC solution of the freshly prepared keto-lactone 135f (300 mg, 1.47 mmol) in anhydrous 
DCM (7.4 mL) was treated with a 0.4 M solution of CeCl3 in anhydrous MeOH (725 mg, (2.94 
mmol) of CeCl3 in 7.4 mL MeOH) and the resulting suspension was stirred for 10 min. NaBH4 
(84 mg, 2.21 mmol) was then added, and the reaction mixture was stirred at –78 oC for 30 min 
(until completion as indicated by TLC analysis on alumina plates). The reaction solution was 
quenched with water (10 mL) and 10% aq. citric acid solution (4 mL). The biphasic mixture was 
then stirred at RT for 20 min before being extracted with DCM (3 × 100 mL). The combined 
organic extracts were washed with water (3 × 20 mL), brine (20 mL), dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography, elution with 0-40% Et2O:petroleum ether, to yield the desired 
isochromanone 136f (247 mg, 1.20 mmol, 82%) as a colourless crystalline solid. 1H NMR (CDCl3, 
400 MHz) δ: 1.07 (3H, d, J = 6.8, CH3), 1.15 (3H, d, J = 6.6, CH3), 2.28-2.37 (1H, m, CH(CH3)2), 
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2.84 (1H, d, J = 7.6, OH), 3.95 (1H, dd, J = 9.8, 1.6, CH(O2C)), 4.72 (1H, d, J = 6.6, CH(OH)), 7.43-
7.48 (2H, m, ArH), 7.62 (1H, dt, J = 7.5, 1.2, ArH), 8.01 (1H, d, J = 8.0, ArH). 13C NMR (CDCl3, 100 
MHz) δ: 18.2 (CH3), 19.3 (CH3), 28.6 (CH(CH3)2), 65.0 (CH(OH)), 86.7 (CH(O2C)), 124.2 (C
ArCO2), 
128.1 (CArH), 129.8 (CArH), 130.2 (CArH), 134.3 (CArH), 140.4 (CArCH(OH)), 165.4 (CO2). m/z  [CI
+, 
isobutane] 207 [M+H]+ (100%), HRMS found [M+H]+ 207.1022, C12H15O3  requires 207.1021. 
υmax /cm
-1 (film): 3415, 2964, 2931, 2875, 1703, 1605. MP: 114-115 oC. The data observed is in 
accordance with literature values.33 
Reduction Method 2B: NaBH4  
A –78 oC solution of the freshly obtained keto-lactone 135f (181 mg, 0.89 mmol) in anhydrous 
MeOH (4 mL) was treated with NaBH4 (41 mg, 1.09 mmol), and the resulting reaction mixture 
was stirred at –78 oC for 30 min (until completion as indicated by TLC analysis on alumina 
plates). The reaction mixture was then warmed to 0 oC and quenched with water (7 mL) and 
10 % aq. citric acid solution (2 mL), and the biphasic solution was stirred at RT for 20 min 
before being extracted with DCM (3 × 70 mL). The combined organic extracts were washed 
with water (3 × 15 mL), brine (15 mL), dried over Na2SO4 and concentrated under reduced 
pressure. The crude residue was purified by flash column chromatography, elution with 0-50% 
Et2O:petroleum ether, to give isochromanone 136f (162 mg, 0.79 mmol, 89%) as a colourless 
crystalline solid.  
N,N-Diethyl-2-methoxybenzamide 170 
 
Neat SOCl2 (86.8 ml, 1.19 mol) was added to o-anisic acid 169 (12.7 g, 83.2 mmol) and stirred 
under argon. DMF (213 µL, 2.75 mmol) was then added dropwise, after which vigorous 
effervescence occurred. The solution was stirred for 1h after which time no further 
effervescence was visible. The excess SOCl2 was removed under reduced pressure by 
azeotroping with toluene (3 × 100 mL). The colourless oily residue obtained was dissolved in 
anhydrous THF (95 mL), cooled to 0 oC and treated by the slow addition of Me2NH (31.8 ml, 
308 mmol).  The mixture was then stirred for 15 min before being concentrated under reduced 
pressure. The crude residue was dissolved in DCM (400 mL), and washed with water (3 × 70 
mL) and brine (3 × 70 mL) before being concentrated under reduced pressure to afford a the 
desired benzamide 170 (17.1 g, 82.4 mmol, 99%) as a brown oil. 1H NMR (CDCl3, 400 MHz) δ: 
1.02 (3H, t, J = 7.4, CH3CH2N), 1.23 (3H, t, J = 7.4, CH3CH2N), 3.13 (2H, q, J = 6.6, NCH2CH3), 3.57 
(2H, br s, NCH2CH3), 3.81 (3H, s, OCH3), 6.89 (1H, d, J =  8.7, ArH), 6.95 (1H, t, J = 7.4, ArH), 7.18 
(1H, d, J = 7.1, ArH), 7.31 (1H, t, J = 8.1, ArH). 13C NMR (CDCl3, 100 MHz) δ: 12.8 (CH3CH2N), 
13.9(CH3CH2N), 38.8 (NCH2CH3), 42.7 (NCH2CH3), 55.4 (OCH3), 110.9 (C
ArH), 120.6 (CArH), 126.9 
(CArCON, 127.3 (CArH), 129.8, 155.1 (CArOCH3), 168.7 (CON). m/z  [Cl
+, isobutane] 208 [M+H]+ 
(100%), HRMS found [M+H]+ 208.1340, C12H18NO2 requires 208.1338. υmax /cm
-1 (film): 3063, 
2973, 2935, 2875, 2838, 1634, 1601, 1584. The data observed is in accordance with literature 
values.51 
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N,N-Diethyl-2-formyl-6-methoxybenzamide 171 
 
An oven dried flask was charged with THF (150 mL) and cooled to –78 oC under an atmosphere 
of argon. Freshly distilled TMEDA (16.0 mL, 107.1 mmol) and sBuLi (1.4 M in hexanes, 76.5 mL, 
107 mmol) were added successively and the resulting solution was stirred for 5 min. 
benzamide 170 (17.1 g, 82.4 mmol) in anhydrous THF (150 ml) was then added dropwise and 
the reaction mixture was stirred for 1h. DMF (7.65 mL, 98.9 mmol) was then also added 
dropwise and the reaction was stirred at –78 oC for a further 5 min before being allowed to 
rise to RT over 16h. The reaction mixture was then concentrated under reduced pressure to 
give a crude oil which was cooled to 0 oC and acidified to pH 4-5 by the addition of aqueous 6 
M HCl. The aqueous solution was extracted with EtOAc (5 × 100 mL) and the combined organic 
layers washed with water (3 × 40 mL) and brine (3 × 40 mL).  The organic layer was separated, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford the desired 
benzaldehyde 171 (17.3 g, 73.7 mmol, 89%) as a brown oil which was taken on without need 
for further purification. 1H NMR (CDCl3, 400 MHz) δ: 1.01 (3H, t, J = 7.1, CH3CH2N), 1.29 (3H, t, J 
= 7.1, CH3CH2N), 3.10 (2H, q, J = 7.2, NCH2CH3), 3.49-3.58 (1H, m, NCH2CH3), 3.68-3.77 (1H, m, 
NCH2CH3), 3.86 (3H, s, OCH3), 7.12 (1H, dd, J = 8.1, 1.9, ArH), 7.46 (1H, t, J = 7.8, ArH), 7.52 (1H, 
dd, J = 7.7, 1.0, ArH), 9.99 (1H, s, ArCHO). 13C NMR (CDCl3, 100 MHz) δ: 11.6 (CH3CH2N), 12.7 
(CH3CH2N), 38.0 (NCH2CH3), 41.8 (NCH2CH3), 55.0 (OCH3), 115.4 (C
ArH), 120.2 (CArH), 128.1 
(CArCON), 128.9 (CArH), 132.7 (CArCO), 154.7 (CArOCH3), 164.8 (CON), 189.6 (ArCHO). m/z  [Cl
+, 
isobutane] 236[M+H]+ (100%), HRMS found [M+H]+ 236.1282, C13H18NO3 requires 236.1287. 
υmax /cm
-1 (film): 2967, 2934, 2873, 2844, 2748, 1704, 1631, 1593, 1579. The data observed is 
in accordance with literature values.51 
7-Methoxyphthalide 172 
 
The crude benzaldehyde 171 (17.3 g, 73.7 mmol) was dissolved in anhydrous MeOH (400 mL) 
and the solution was cooled to 0 oC. NaBH4 (4.43 g, 147 mmol) was then added slowly and the 
reaction mixture was stirred at RT for 3h under an argon atmosphere.  The solution was then 
acidified to pH 4-5 by the addition of aqueous 6 M HCl at 0 oC. The reaction mixture was then 
heated at reflux for 16h after which, a white precipitate had formed. The solvent was removed 
under reduced pressure, and the resultant solid was dissolved in DCM (400 mL) and washed 
with water (3 × 50 mL) and brine (3 × 50 mL).  The organic phase was dried over anhydrous 
Na2SO4 and concentrated under reduced pressure to give a crude residue which was purified 
by recrystallization from EtOAc:hexane (1:1) to afford the desired phthalide 172 (8.87 g, 54.0 
mmol, 74%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 3.99 (3H, s, CH3CH2N), 5.23 (2H, s, 
ArCH2O2C), 6.92 (1H, d, J = 8.2, ArH), 7.00 (1H, d, J = 7.5, ArH), 7.61 (1H, t, J = 8.0, ArH).
13C NMR 
(CDCl3, 100 MHz) δ: 56.0 (OCH3), 68.7 (ArCH2O), 110.6 (C
ArH), 113.3 (CArCO2), 113.7 (C
ArH), 
136.3 (CArH), 149.4 (CArCH2O2C), 158.8 (C
ArOCH3), 169.1 (CO2), m/z  [Cl
+, isobutane] 165 [M+H]+ 
(100%), HRMS found [M+H]+ 165.0555, C9H9O3  requires 165.0552. υmax /cm
-1 (film): 2930, 
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2907, 2874, 1747, 1604. MP: 108-109 oC. The data observed is in accordance with literature 
values.51 
1,7-Dimethoxy-1,3-dihydroisobenzofuran 175 
 
A –78 oC solution of phthalide 172 (5.05 g, 30.8 mmol) in anhydrous DCM (370 mL) was treated 
by the dropwise addition of DIBAL via syringe pump (1 M in hexanes, 30.0 mL, 30.0 mmol over 
2h. The reaction mixture was then stirred until completion, indicated via TLC analysis, and was 
then diluted with Et2O (300 mL).  The reaction was quenched at –78 
oC by the successive 
addition of water (1.50 mL), 15% aq. NaOH solution (1.50 mL) and water (3.75 mL). The 
resultant slurry was stirred for 30 min, before being treated with anhydrous Na2SO4.  The 
newly formed suspension was stirred for a further 30 min and then the solids were removed 
by filtration.  The clear solution was evaporated under reduced pressure to afford the crude 
lactol intermediate 173, as colourless oil, and was used immediately without further 
purification.  
Method B: NaH and MeI 
The crude lactol intermediate was dissolved in anhydrous THF (150 mL) and was cannulated to 
a solution of NaH (60% dispersion in oil, 1.54g, 38.49 mmol) in THF (150 mL) at –78oC and 
stirred for 1Hr. MeI (filtered through basic alumina) was added (9.60 mL, 154 mmol) to the 
reaction mixture and the resulting solution was stirred for 12h. Once the reaction was 
complete according to TLC analysis, water (100 mL) was added and the mixture diluted with 
Et2O (400 mL). The combined organic extracts were washed with water (2 × 50 mL), brine (2 × 
50 mL) and dried over anhydrous Na2SO4. Purification by flash column chromatography, 
elution with 0-13% Et2O:petroleum ether, afforded the desired desired phthalan 175 (2.67 g, 
14.81 mmol, 48%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 3.47 (3H, s, CH3OCH), 3.86 
(3H, s, CH3OAr), 4.97 (1H, d, J = 12.7, CH2), 5.20 (1H, d, J = 12.7, CH2), 6.24 (1H, s, CHOCH3) 6.78 
(1H, d, J = 8.1, ArH), 6.83 (1H, d, J = 7.4, ArH), 7.32 (1H, t, J = 7.8, ArH). m/z  [EI+] 180 [M]+ 
(100%), HRMS found [M]+ 180.0790 C10H12O3  requires 180.0786. υmax /cm
-1 (film): 2932, 2897, 
2837, 1615, 1601. The data observed is in accordance with literature values.159 
Methylation Method B: TsOH in MeOH 
The crude lactol intermediate 173 was dissolved in anhydrous MeOH (50 mL) in the presence 
of 4 Å molecular sieves. TsOH.H2O (293 mg, 1.54 mmol) was then added, and the resultant 
solution was stirred at RT for 30 min. The solution was neutralized to pH 7 by the addition of 
sat’d aqueous NaHCO3 solution before the 4 Å  molecular sieves were removed by filtration. 
The resultant solution was extacted with Et2O (3 × 100 mL) and the combined organic extracts 
were washed with water (2 × 40 mL), aqueous aqueous NaHCO3 solution (40 mL) and brine (50 
mL) before being dried over anhydrous Na2SO4.  The solvent was removed under reduced 
pressure and the crude residue was purified by flash column chromatography, elution with 0-
13% Et2O:petroleum ether, to afford the desired phthalan 175 (3.79 g, 23.1 mmol, 75%) as a 
colourless oil.  
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(±)-(3R,4R)-4-Hydroxy-3-isopropyl-5-methoxyisochroman-1-one 182 
 
Using general procedure 1A, a solution phthalan 175 (897 mg, 4.98 mmol) in anhydrous THF 
(27 mL) was treated with iPr2NH (70 µL, 0.50 mmol), MeLi (1.6 M in Et2O, 6.53 mL, 10.5 mmol) 
and isobutyraldehyde (542 µL, 5.97 mmol) to generate the α-hydroxyisobenzofuran 
intermediate. The oxidative rearrangement was performed using mCPBA (77%, 945 mg, 5.48 
mmol) in anhydrous DCM (27 mL) to afford the keto-lactol intermediate. Oxidation was 
performed as a solution in acetone (27 mL) with 2.5 M Jones reagent to afford the keto-
lactone unit which was taken on crude. Using general procedure 2B, reduction was performed 
at –78 oC in anhydrous MeOH (25 mL) with NaBH4 (283 mg, 7.47 mmol). The crude products 
were purified by flash column chromatography, elution with 0-75% Et2O:petroleum ether, to 
afford 5-methoxyisochromanone 182 (221 mg, 0.94 mmol, 18% from phthalan 175) as a white 
solid. 1H NMR (CDCl3, 400 MHz) δ: 1.12 (3H, d, J = 6.6, CH3), 1.20 (3H, d, J = 6.6, CH3), 1.89 (1H, 
s, OH)), 2.3-2.42 (1H, m, CH(CH3)2), 3.92-3.94 (4H, m, CH3OAr, CH(O2C)), 5.13 (1H, s, CH(OH)), 
7.15 (1H, d, J = 8.2, ArH), 7.45 (1H, t, J = 8.0, ArH), 7.73 (1H, d, J = 7.7, ArH). 13C NMR (CDCl3, 
100 MHz) δ: 18.3 (CH3), 19.4 (CH3), 28.7 (CH(CH3)2), 55.9 (CH3OAr), 59.1 (CH(OH)), 86.5 
(CH(O2C)), 115.5 (C
ArH), 121.9 (CArH), 125.5 (CArCO2), 128.8 (C
ArC(OH)), 130.4 (CArH), 155.9 
(CArOCH3), 165.0 (CO2). m/z  [EI
+] 236 [M]+ (100%), HRMS found [M]+ 236.1052 C13H16O4  
requires 236.1049. υmax /cm
-1 (film): 3390, 2965, 2875, 2840, 1702, 1593. MP: 147-149 oC. 
 (±)-(3R,4R)-4-Hydroxy-3-isopropyl-5-methoxyisochroman-1-one 183 
 
Further elution with 0-75% Et2O:petroleum ether afforded 8-methoxyisochromanone 182  
(425 mg, 1.80 mmol, 36% from phthalan 175) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 
1.06 (3H, d, J = 6.7, CH3), 1.15 (3H, d, J = 6.5, CH3), 2.26-2.32 (1H, m, CH(CH3)2), 2.36 (1H, d, J = 
7.4, OH)), 3.87 (1H, d, J = 7.9, CH(O2C)), 3.91 (3H, s, CH3OAr), 4.69 (1H, d, J = 7.2, CH(OH)), 6.98-
7.01 (2H, m, ArH), 7.52 (1H, t, J = 7.9, ArH). 13C NMR (CDCl3, 100 MHz) δ: 18.1 (CH3), 19.4 (CH3), 
28.4 (CH(CH3)2), 56.2 (CH3OAr), 66.0 (CH(OH)), 85.6 (CH(O2C)), 112.6 (C
ArC(OH)), 112.9 (CArH), 
119.7 (CArH),135.2 (CArH), 143.0 (CArCO2),161.0 (C
ArOCH3), 162.3 (CO2). m/z  [EI
+] 236 [M]+ 
(100%), HRMS found [M]+ 236.1046 C13H16O4  requires 236.1049. υmax /cm
-1 (film): 3468, 2962, 
2926, 2874, 1702, 1598. MP: 208-209 oC. 
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7-Hydroxyphthalide 184 
 
Iodocyclohexane (69.0 mL, 534 mmol) was added to a solution of phthalide 172 (8.80 g, 53.6 
mmol) in anhydrous DMF (82 mL), and the resultant solution was heated at reflux for 5 days. 
The solution was diluted with water (100 mL) and extracted with EtOAc (3 × 150 mL). The 
combined organic extacts were then washed with sat’d aq. Na2S2O3 solution (3 x 150 mL), 
brine (3 x 50 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography, elution with 0-20% EtOAc:petroleum ether) 
afforded the 7-hydroxyphthalide 184 (7.13 g, 47.5 mmol, 65%) as a white solid. Alternatively 
the pure product could be obtained by triturating a solution of the crude residue with 
DCM:petroleum ether, in comparable yield. 1H NMR (CDCl3, 400 MHz) δ: 5.33 (2H, s, CH2), 6.94 
(1H, dd, J = 8.3, 0.6, ArH), 6.97 (1H, dd, J =7.6, 0.5, ArH), 7.57 (1H, app. t, J = 7.8, ArH), 7.74 (1H, 
br. s, ArOH). 13C NMR (CDCl3, 100 MHz) δ: 70.7 (ArCH2O), 110.9 (C
ArCO2), 113.4 (C
ArH), 115.3 
(CArH), 137.0 (CArH), 146.8 (CArCH2O2C), 156.6 (C
ArOH), 172.6 (ArCO2). m/z  [Cl
+, isobutene] 151 
[M+H]+ (100%), HRMS found [M+H]+ 151.0398, C8H7O3 requires 151.0395. υmax /cm
-1 (film): 
3514, 3423, 2942, 2823, 17351638, 1606. MP: 134 - 135 oC. The data observed is in accordance 
with literature values.160 
7-(Triisopropylsilyloxy)phthalide 186 
 
To a solution of 7-hydroxyphthalide 184 (2.77 g, 18.5 mmol) in anhydrous DMF (28 ml), 
imidazole (2.51 g, 36.9 mmol) was added and the resultant solution was stirred for 5 min at 0 
oC, to which TIPSCl (4.34 ml, 20.30 mmol) was added dropwise and the resultant solution was 
stirred for 60 min at 0oC, before a further 12h at RT. Completion of the reaction was indicated 
by TLC analysis. The solution was taken up in water (50 ml) and extracted with EtOAc (3 × 150 
ml). The resulting organic solution was the washed with brine (3 × 50ml) and then dried over 
anhydrous Na2SO4 and concentrated under reduced pressure to give the crude product. 
Purification by flash column chromatography, elution with 0-30% DCM:petroleum ether, 
followed by recrystallization from petroleum ether gave the desired product 7-
hydroxyphthalide 186 (3.91 g, 12.8 mmol, 69%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 
1.14 (18H, d, J = 7.6, CH3), 1.33 - 1.41 (3H, m, CH), 5.19 (2H, s), 6.84 (1H, d, J = 8.3, ArH), 6.97 
(1H, d, J = 7.6, ArH) 7.48 (1H, t, J = 8.0, ArH). 13C NMR (CDCl3, 100 MHz) δ: 12.9 (CH2Si), 18.0 
(CH3), 68.3 (ArCH2O) 114.0 (C
ArH), 115.6 (CArCO2), 119.2 (C
ArH), 135.7 (CArH), 149.0 (CArCH2), 
155.9 (CArOSi), 168.6 (ArCO2). m/z [FAB
+, NOBA]  307 [M+H]+ (94%), HRMS found [M+H]+ 
307.1731, C17H27O3Si requires 307.1729. υmax /cm
-1 (film): 2946, 2892, 2866, 1764, 1604. MP: 
69-70 oC 
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(3-(Triisopropylsilyloxy)-1,2-phenylene)dimethanol 187 
 
7-TIPS-phthalide 186 (350 mg, 1.14 mmol) was dissolved in anhydrous DCM (30 mL) and 
cooled to –78 oC. DIBAL (1 M in hexanes, 1.12 mL, 1.12 mmol) was added dropwise via syringe 
pump over 2h. The reaction was stirred for a further 2h before the reaction was diluted with 
Et2O (30 mL) and quenched by the successive addition of water (110 µL), 15% aq. NaOH 
solution (110 µL) and water (260 µL) at –40 to 0 oC. The resultant slurry was stirred for 30 min, 
anhydrous Na2SO4 was added and the resulting slurry stirred for a further 30 min. The solids 
were removed by filtration and the solution evaporated under reduced pressure. The crude 
residue was purified by flash column chromatography, elution with 0-20% EtOAc:petroleum 
ether, to afford the undesired diol 187 (60 mg, 0.19 mmol, 17%) as a white solid. Further 
elution afforded unreacted 7-TIPS-phthalide 186 (150 mg, 0.49 mmol, 43%). 1H NMR (CDCl3, 
400 MHz) δ: 1.11 (18H, d, J = 7.6, CH3), 1.27-1.38 (3H, m, CH), 3.38 (1H, br. s), 3.85 (1H, br. s), 
4.61 (2H, s, CH2)  4.80 (2H, s, CH2) 6.81 (1H, d, J = 8.2, ArH), 6.90 (1H, d, J = 7.4, ArH) 7.48 (1H, t,  
J = 7.8, ArH). 13C NMR (CDCl3, 100 MHz) δ: 13.1 (CH2Si), 18.1 (CH3), 56.7 (ArCH2OH), 64.1 
(ArCH2OH), 118.5 (C
ArH), 122.3 (CArH),128.8 (CArH), 129.5 (CArCH2OH), 141.7 (C
ArCH2OH), 154.4 
(CArOSi). m/z  [CI+, isobutane] 293 [M-OH]+ (94%), HRMS found [M-OH]+ 293.1938, C17H29O2Si  
requires 293.1937. υmax /cm
-1 (film): 3333, 2944, 2866, 1584. MP: 83-85 oC. 
7-(Benzyloxy)phthalide 193 
 
A solution of 7-benzloxyphthalide 184 (512 mg, 3.41 mmol) in anhydrous DMF (9.0 mL),under 
argon, was treated with anhydrous K2CO3 (1.41 g, 10.2 mmol) and the suspension was stirred 
for 5 min before the dropwise addition of BnBr (810 µL, 6.82 mmol). The heterogenous 
mixture was stirred at RT for 3h until reaction completion was indicated by TLC analysis. The 
reaction was quenched with water (40 mL) and extracted with EtOAc (3 × 80 mL). The 
combined organic extracts were washed with water (2 × 30 mL), brine (30 mL), dried over 
Na2SO4 and evaporated under vacuum, to yield the crude product as a white solid. Purification 
of the crude white solid by flash column chromatography, elution with 0-40% DCM:petroleum 
ether to afford phthalide 193 (731 mg, 3.04 mmol, 89%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ: 5.23 (2H, s, CH2O2C), 5.33 (2H, s, CH2Ph(Ar)), 6.91 (1H, d, J = 8.2, ArH), 6.99 (1H, dd, J = 
7.6, 0.5, ArH), 7.27-7.33 (1H, m, ArH) 7.34-7.40 (2H, m, ArH), 7.46-7.55 (3H, m, ArH). 13C NMR 
(CDCl3, 100 MHz) δ: 68.7 (CH2O2C), 70.5 (CH2Ph(OAr)), 112.6 (C
ArH), 114.0 (CArCO2), 114.0 
(CArH),126.8 (CPhH) 128.0 (p-CPhH), 128.7 (CPhH), 136.0 (CArH), 136.2 (CPhCH2), 149.4 (C
ArCH2O), 
157.7 (CArOBn) 168.8 (CO2). m/z  [EI
+] 240 [M]+ (100%), HRMS found [M]+ 240.0785, C15H12O3 
requires 240.0786. υmax /cm
-1 (film): 2933, 2870, 1746, 1614, 1602. MP: 110-111 oC. The data 
observed is in accordance with literature values.160 
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7-(Benzyloxy)-1-methoxy-1,3-dihydroisobenzofuran 194 
 
A –78 oC solution of phthalide 193 (1.72 g, 7.15 mmol) in anhydrous DCM (100 mL) was treated 
with the dropwise addition of DIBAL (1 M in hexanes, 7.08 mL, 7.08 mmol), via syringe pump 
over 2.5h.  Upon completion, as indicated by TLC analysis (after 1 hr), the reaction was 
warmed up to -40 oC, diluted with Et2O (80 mL) and quenched by the successive addition of 
water (0.3 mL), 15% aq. NaOH solution (0.3 mL) and water (0.7 mL). The resultant slurry was 
warmed up to RT and stirred for 30 min. Anhydrous Na2SO4 was then added, and the resulting 
suspension was stirred for a further 30 min. The solids were removed by filtration and the 
clear solution was evaporated under reduced pressure to afford the crude lactol intermediate, 
which was immediately dissolved in anhydrous MeOH (20 mL) in the presence of 4 Å molecular 
sieves. To the stirring solution, TsOH.H2O (68 mg, 0.36 mmol) was added and the reaction 
mixture was stirred at RT until completion by TLC analysis (30 min). The solution was 
neutralized to pH 7 by the addition of sat’d aqueous K2CO3 solution and then the 4 Å molecular 
sieves were removed by filtration through cotton wool. The solvent was evaporated under 
reduced pressure and the crude residue was taken up in Et2O (150 mL), washed with water (2 
× 50 mL), sat’d aqueous NaHCO3 solution (40 mL) and brine (2 × 40 mL), before being dried 
over anhydrous Na2SO4. Solvent removal under reduced pressure afforded a crude oil which 
was purified by flash column chromatography, elution with 0-15% Et2O:petroleum ether, 
yielded 7-benzyloxyphthalan 194 (964 mg, 3.76 mmol, 53%) as a colourless oil. 1H NMR (CDCl3, 
400 MHz) δ: 3.38 (3H, s, CH3OCH), 4.89 (1H, d, J = 12.8, CH(H)OC(OCH3)), 5.02-5.09 (3H, m, 
CH2Ph & CH(H)OC(OCH3)), 5.12 (1H, d, J = 13.4, CH(H)OC(OCH3)), 5.20 (1H, d, J = 1.7, CHOCH3), 
6.71 (1H, d, J = 8.1, ArH), 6.74 (1H, d, J = 7.5, ArH), 7.13-7.24 (1H, m, ArH), 7.25-7.30 (1H, m, 
ArH), 7.31-7.36 (1H, m, ArH). 13C NMR (CDCl3, 100 MHz) δ: 54.7 (CH3OCH), 70.0 (CH2OC(OCH3), 
72.5 (CH2Ph(OAr)), 106.6 (CH(OCH3)), 111.1 (C
ArH), 113.5 (CArH), 125.8 (CArCH(OCH3)), 127.0 
(CPhH), 127.9 (CArPh), 128.6 (CPhH), 131.2 (CArH), 137.0 (CArCH2O), 142.5 (C
ArCH2O) 154.5 
(CArOBn). m/z  [EI+] 256 [M]+ (11%), HRMS found [M]+ 256.1097, C16H16O3  requires 256.1099. 
υmax /cm
-1 (film): 3063, 3033, 2925, 2827, 1616, 1600, 1545. 
(±)-(3R,4R)-5-(Benzyloxy)-4-hydroxy-3-isopropylisochroman-1-one 195 
 
Using general procedure 1A a solution 7-benzyloxyphthalan 194 (1.06 g, 4.13 mmol) in 
anhydrous THF (23 mL) was treated with iPr2NH (58 µL, 0.41 mmol), MeLi (1.6 M in Et2O, 5.43 
µL, 8.68 mmol) and isobutyraldehyde (450 µL, 4.96 mmol) to generate the α-hydroxy-IBF 
intermediate. The oxidative rearrangement of the α-hydroxy isobenzofuran was carried out 
using mCPBA (77%, 784 mg, 4.54 mmol) in anhydrous DCM (23 mL). Oxidation was performed 
in acetone (23 mL) with 2.5 M Jones reagent to afford the keto lactone intermediate. Using 
general procedure 2B, reduction was performed at –78 oC in anhydrous DCM (21 mL), using a 
solution of cerium (III) chloride (2.04 g, 8.26 mmol) and NaBH4 (283 mg, 7.47 mmol) in 
anhydrous MeOH (21 mL). The crude adducts were purified by flash column chromatography, 
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elution with 0-50% Et2O in petroleum ether, to afford 5-benzyloxyisochromanone 182 (169 
mg, 2.54 mmol, 13% from 7-benzyloxyphthalan 194) as a white solid. 1H NMR (CDCl3, 400 MHz) 
δ: 0.92 (3H, d, J = 6.7, CH3), 1.01 (3H, d, J = 6.6, CH3), 1.39 (1H, br. s, OH), 2.14-2.23 (1H, m, 
CH(CH3)2), 3.75 (1H, d, J = 9.8, CH(O2C)), 4.97-5.05 (3H, m, CH(OH), CH2Ph), 7.02 (1H, d, J = 8.2, 
ArH), 7.07 (1H, s, ArH), 7.17-7.24 (5H, m, ArH), 7.57 (1H, d, J = 7.7, ArH). 13C NMR (CDCl3, 100 
MHz) δ: 18.4 (CH3), 19.4 (CH3), 28.7 (CH(CH3)2), 59.2 (CH(OH)), 70.9 (CH2Ph), 86.5 (CH(O2C)), 
117.5 (CArH), 122.4 (CArH), 125.7 (CArCO2) 127.3 (C
PhH) 128.4 (CArH), 128.9 (CPhH), 129.4 
(CPhCH2), 130.4 (p-C
PhH), 136.1 (CArCH(OH)), 155.0 (CArOBn), 164.9 (CO2). m/z  [CI
+, isobutane] 
313 [M+H]+ (100%), HRMS found [M+H]+ 313.1442, C19H21O4  requires 313.1440. υmax /cm
-1 
(film): 3417, 2963, 2932, 2874, 1701, 1592. MP: 166-168 oC. 
(±)-(3R,4R)-5-(Benzyloxy)-4-hydroxy-3-isopropylisochroman-1-one 196 
 
Further elution yielded 8-benzyloxyisochromanone 196 (677 mg, 2.17 mmol, 52% from 7-
benzyloxyphthalan 194) as white solids. 1H NMR (CDCl3, 400 MHz) δ: 1.06 (3H, d, J = 6.7, CH3), 
1.17 (3H, d, J = 6.5, CH3), 2.23 (1H, br s, OH), 2.27-2.35 (1H, m, CH(CH3)2), 3.90 (1H, d, J = 9.8, 
CH(O2C)), 4.70 (1H, s, CH(OH)), 5.19 (1H, d, J = 12.4, CH2Ph), 5.28 (1H, d, J = 12.3, CH2Ph), 7.01-
7.06 (2H, m, ArH), 7.27-7.31 (1H, t, J = 7.3, ArH), 7.35-7.39 (2H, t, J = 7.3, ArH), 7.48-7.55 (2H, 
m, J = 7.3, ArH). 13C NMR (CDCl3, 100 MHz) δ: 18.2 (CH3), 19.3 (CH3), 28.4 (CH(CH3)2), 66.0 
(CH(OH)), 70.7 (CH2Ph), 85.6 (CH(O2C)), 113.3 (C
ArCO2), 114.8 (C
ArH), 120.2 (CArH), 126.7 (CPhH) 
127.8 (CArH), 128.6 (CPhH), 135.1 (p-CPhH), 136.3 (CPhCH2), 143.0 (C
ArC(OH)), 160.0 (CArOBn), 
162.1 (CO2). m/z  [CI
+, isobutane] 313 [M+H]+ (100%), HRMS found [M+H]+ 313.1441, C19H21O4  
requires 313.1440. υmax /cm
-1 (film): 3430, 3065, 3033, 2963, 2874, 2637, 1709, 1599. MP: 47-
49 oC. 
7-(Tert-butyldimethylsilyloxy)phthalide 197 
 
7-hydroxyphthalide 193 (1.47 g, 9.80 mmol) was dissolved in anhydrous DMF (30 mL) under 
argon and was sequentially treated with imidazole (1.33 g, 19.6 mmol) and TBSCl (1.78 g, 11.8 
mmol). The reaction mixture was stirred at RT until completion as indicated by TLC analysis 
(3H). The reaction was diluted with water (80 mL) and extracted with Et2O (3 × 100 mL). The 
combined organic extracts were washed with water (2 × 50 mL), brine (50 mL), dried over 
anhydrous Na2SO4and the solvent was evaporated under reduced pressure to yield the crude 
product as a crude white solid. Purification by flash column chromatography, elution with 0-
33% DCM:petroleum ether) afforded 7-TBS-phthalide 197 (2.10 g, 7.91 mmol, 89%) as a white 
solid. 1H NMR (CDCl3, 400 MHz) δ: 0.27 (6H, s, Me2Si), 1.05 (9H, s, (CH3)3CSi), 5.20 (2H, s, 
CH2O2C), 6.85 (1H, d, J = 8.1, ArH), 7.01 (1H, d, J = 7.5, ArH) 7.51 (1H, t, J = 7.8, ArH). 
13C NMR 
(CDCl3, 100 MHz) δ: -4.5 (CH3)2Si), 18.4 (C(CH3)3Si), 25.6 ((CH3)3CSi), 68.4 (CH2O2C), 114.4 
(CArH), 116.3 (CArCO2),120.2 (C
ArH),135.6 (CArH),148.9 (CArCH2O), 155.5 (C
ArOSi), 168.7 (ArCO2). 
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m/z  [CI+, isobutane] 265 [M+H]+ (100%), HRMS found [M+H]+ 265.1259, C14H21O3Si requires 
265.1260. υmax /cm
-1 (film): 2929, 2886, 2859, 1768, 1601. MP: 81-83 oC. 
7-(Tert-butyldimethylsilyloxy)-1-methoxy-1,3-dihydroisobenzofuran 198 
 
A –78 oC solution of 7-TBS-phthalide 197, 26 (2.59 g, 9.77 mmol) in anhydrous DCM (100 mL) 
was treated with the dropwise addition of DIBAL (1M in hexanes, 9.87 mL, 9.87 mmol), via 
syringe pump over 4h.  The reaction was stirred at –78 oC for a furtherh, and was then diluted 
with Et2O (75 mL) and quenched by the successive addition of water (0.5 mL), 15% aq. NaOH 
solution (0.5 mL) and water (1.3 mL). The resultant slurry was allowed to warm up to RT and 
stirred for 30 min. Anhydrous Na2SO4 was added, and the resulting suspension was stirred for 
a further 30 min. The solids were removed by filtration, and the clear solution concentrated 
under reduced pressure to afford the crude lactol intermediate, which was dissolved 
immediately in anhydrous MeOH (50 mL) in the presence of 4 Å molecular sieves and treated 
with TsOH.H2O (93 mg, 0.49 mmol). The resultant solution was stirred at RT until completion 
as indicated by TLC analysis (30 min). The reaction mixture was neutralized to pH 7 by the 
addition of sat’d aq. K2CO3 solution and the 4 Å   molecular sieves were removed by filtration 
through cotton wool. The solvent was evaporated under reduced pressure and the crude 
residue was taken up in Et2O (100 mL), washed with water (2 × 50 mL), sat’d aq. Na2SO4 (20 
mL) and brine (2 × 20 mL) and was then dried over anhydrous Na2SO4. The solvent was 
evaporated under reduced pressure to give a crude oil which was purified by flash column 
chromatography, elution with 5% Et2O:petroleum ether, to afford 7-TBS-phthalan 198 (1.32 g, 
4.69 mmol, 48%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 0.24 (6H, s, (CH3)2Si), 1.02 (9H, 
s, (CH3)3CSi), 3.45 (3H, s, CH3OCH), 4.97 (1H, d, J = 12.7, CH(H)OC(OCH3)), 5.19 (1H, d, J = 12.7, 
CH(H)OC(OCH3)), 6.17 (1H, d, J = 1.6, CHOCH3), 6.70 (1H, d, J = 8.0, ArH), 6.83 (1H, d, J = 7.4, 
ArH), 7.23 (1H, t, J = 7.7, ArH). 13C NMR (CDCl3, 100 MHz) δ: -4.4 (CH3Si), -4.2 (CH3Si), 18.1 
(C(CH3)3Si), 25.6 ((CH3)3CSi), 54.7 (CH3OCH), 72.4 (CH2OC(OCH3), 106.6 (CH(OCH3)), 113.6 
(CArH), 117.9 (CArH),128.2 (CArCH(OCH3),130.8 (C
ArH),142.5 (CArCH2O), 151.5 (C
ArOSi). m/z  [CI+, 
isobutane] 281 [M+H]+ (28%), HRMS found [M+H]+ 281.1570, C15H25O3Si  requires 281.1573. 
υmax /cm
-1 (film): 3069, 3041, 2954, 2929, 2896, 2859, 2826, 1600. 
1-Methoxy-1,3-dihydroisobenzofuran 131 
 
Phthalide (5.00 g, 37.3 mmol) was dissolved in anhydrous DCM (150 mL) and cooled to –78 oC. 
DIBAL (1M in hexanes, 37.3 mL, 37.3 mmol) was added dropwise over 2H. The reaction was 
stirred until completion by TLC analysis. The reaction was diluted with Et2O (150 mL) and 
quenched by the successive addition of water (1.5 mL), 15% aq. NaOH solution (1.5 mL) and 
water (3.8 mL) at –78 oC. The resultant slurry was stirred for 30 min, anhydrous Na2SO4 was 
added and the resulting slurry stirred for a further 30 min. The solids were removed by 
filtration and the solution evaporated under reduced pressure to afford the crude lactol 
intermediate as a pale yellow oil.  
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Methylation Method B: NaH and MeI 
The crude lactol intermediate was dissolved in anhydrous THF (150 mL) and was transferred 
via cannulation to a solution of NaH (60% dispersion in mineral oil, 1.87 g, 47.0 mmol) in THF 
(150 mL) at –78 oC and stirred for 1Hr. MeI (filtered through basic alumina, 11.6 mL, 186 
mmol) was added to the reaction mixture and the resulting solution was stirred for 12H. Once 
the reaction was complete according to TLC analysis, water (150 mL) was added and the 
mixture diluted with Et2O (300 mL). The combined organic extracts were washed with water (2 
× 50 mL), brine (2 × 30 mL) and dried over anhydrous Na2SO4. Purification by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, afforded the desired phthalan 131 
(3.45g, 23.0 mmol, 62%) as a pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 3.47 (3H, s, CH3O), 
5.08 (1H, d, J = 12.7, CH2), 5.25 (1H, d, J = 12.7, CH2), 6.22 (1H, d, J = 1.7, CHOCH3), 7.25-7.44 
(4H, m, ArH). 13C NMR (CDCl3, 100 MHz) δ: 54.2 (CH3O), 72.3 (CH2), 107.6 (CHOCH3), 121.1 
(CArH), 123.0 (CArH), 127.7 (CArH), 129.2 (CArH), 137.4 (CAr CHOCH3), 140.0 (C
ArCH2O). m/z  [Cl
+, 
isobutane] 180 [M+H]+ (100%). HRMS found [M]+ 151.0757. C9H11O2  requires 151.0759. υmax 
/cm-1 (film): 2927, 2871, 2828, 1693, 1614. The data observed is in accordance with literature 
values.33 
Methylation Method B: TsOH in MeOH 
Alternatively, the lactol intermediate was dissolved in anhydrous methanol (100 mL) in the 
presence of 4 Å   molecular sieves. To the stirring solution, TsOH.H2O (70.0 mg, 0.37 mmol) 
was added and the resultant solution was stirred at room temperature for 2h. Completion of 
the reaction was indicated by TLC analysis. The solution was neutralized to pH 7 by the 
addition of sat’d aq. K2CO3 solution before the 4 Å molecular sieves were removed by 
filtration. The solvent was evaporated under reduced pressure and the resultant residue was 
taken up in EtO (100 mL), washed with water (2 × 30 mL), sat’d aq. NaHCO3 solution (30 mL) 
and brine (2 × 50 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product. Purification by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, afforded the desired phthalan 131 
(4.51 g, 30.0 mmol, 81%) as a colourless oil. 
(±)-(3R,4R)-8-(Tert-butyldimethylsilyloxy)-4-hydroxy-3-
isopropylisochroman-1-one 199 
 
Using general procedure 1B, a solution 7-TBS-phthalan 198 (833 mg, 2.97 mmol) in anhydrous 
THF (16 mL) was treated with iPr2NH (42 µL, 0.30 mmol), MeLi (1.6 M in Et2O, 3.90 mL, 6.24 
mmol) and isobutyraldehyde (323 µL, 3.57 mmol) to generate the α-hydroxy isobenzofuran 
intermediate. The oxidative rearrangement was performed using mCPBA, (77%, 732 mg, 3.27 
mmol) in anhydrous DCM (16 mL) to afford the keto-lactol intermediate. Oxidation was 
performed in anhydrous DCM (15 mL) with TEMPO (93 mg, 0.60 mmol) and BAIB (3.06 g, 9.49 
mmol) followed by filtration through a plug of silica, elution with 20% Et2O:petroleum ether,  
to generate the keto-lactone intermediate. Using general procedure 2B, the reduction was 
performed in anhydrous MeOH (15 mL) with NaBH4 (169 mg, 4.46 mmol).  Purification via flash 
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column chromatography, elution with 0-30% Et2O:petroleum ether, afforded 8-TBS-
isochromanone 199 (600 mg, 1.78 mmol, 60% from 7-TBS-phthalan 198) as a white solid. 1H 
NMR (CDCl3, 400 MHz) δ:  0.23 (6H, d, J = 7.8, (CH3)2Si), 1.03 (9H, s, (CH3)3CSi),  1.06 (3H, d, J = 
6.8, CH3), 1.16 (3H, d, J = 6.6, CH3),2.21 (1H, d, J = 7.6, OH), 2.25-2.34 (1H, m, CH(CH3)2), 3.88 
(1H, d, J = 9.8, CH(O2C)), 4.67 (1H, d, J = 7.4 CH(OH), 6.94 (1H, d, J = 8.2, ArH), 7.0 (1H, d, J = 
7.3, ArH), 7.44 (1H, d, J = 7.9, ArH). 13C NMR (CDCl3, 100 MHz) δ: -4.3 ((CH3)2Si),18.2 (CH3), 18.5 
(CH3), 19.3 (C(CH3)3Si), 25.8 ((CH3)3CSi), 28.5 (CH(CH3)2), 66.1 (CH(OH)), 85.4 (CH(O2C)), 115.2 
(CArCO2), 120.5 (ArH), 122.8 (ArH), 134.6 (ArH), 142.6 (C
ArCH(OH)), 157.8 (CArOSi), 162.0 (CO2). 
m/z  [CI+, isobutane] 337 [M+H]+ (100%), HRMS found [M+H]+ 337.1834, C18H29O4Si  requires 
337.1835. υmax /cm
-1 (film): 3408, 2958, 2930, 2859, 1715, 1598, 1581. MP: 108-110 oC. 
7-(Methoxymethoxy)phthalide 205  
 
7-hydroxyphthalide 184 (1.00 g, 6.66 mmol) was dissolved in anhydrous DCM (33 mL) to which 
DIPEA (2.82 mL, 20.0 mmol) was added. The reaction mixture was cooled to 0 oC and MOMBr 
(1.09 mL, 13.32 mmol) was added and stirred for 15 min before being warmed to room 
temperature and stirred for a further 16h. Water (40 mL) was added before extraction with 
DCM (3 × 100 mL). The combined organic extracts were washed with water (2 × 40 mL) and 
brine (30 mL), dried over anhydrous Na2SO4 and the solvent was evaporated, to yield the crude 
product as a yellow oil. Purification by flash column chromatography, elution with 0-50% 
DCM:petroleum ether, afforded the desired product, 7-MOM-phthalide 205 (1.07 g, 5.52 
mmol, 83%) as a yellow crystalline solid. 1H NMR (CDCl3, 400 MHz) δ: 3.53 (3H, s, CH3O), 5.24 
(2H, s, CH2O2C), 5.38 (1H, s, CH2(OMe)OAr), 7.06 (1H, d, J = 7.5, ArH), 7.19 (1H, d, J = 8.3, ArH) 
7.58 (1H, t, J = 7.9, ArH). 13C NMR (CDCl3, 100 MHz) δ: 56.6 (OCH3), 68.7 (ArCH2O), 94.8 
(CH2(OMe)OAr), 114.2 (C
ArCO2), 114.7 (C
ArH),114.9 (CArH), 136.1 (CArH), 149.2 (CArCH2O2C), 
156.4 (CArOCH2OCH3), 168.9 (ArCO2). m/z  [CI
+, isobutane] 195 [M+H]+ (100%), HRMS found 
[M+H]+ 195.0657, C10H11O4 requires 195.0657. υmax /cm
-1 (film): 2939, 2908, 2852, 2829, 1765, 
1614, 1603. MP: 104-107 oC. The data observed is in accordance with literature values.161 
1-Methoxy-7-(methoxymethoxy)-1,3-dihydroisobenzofuran 206 
 
7-hydroxyphthalide 184 (929 g, 4.78 mmol) was dissolved in anhydrous DCM (48 mL) and 
cooled to –78 oC. DIBAL (1 M in hexanes, 4.78 mL, 4.78 mmol) was added dropwise over 3h. 
The reaction was diluted with DCM and quenched by the successive addition of water (0.2 mL), 
15% aq. NaOH solution (0.2 mL) and water (0.5 mL) at –40 oC. The resultant slurry was warmed 
to room temperature and stirred for 30 min, anhydrous Na2SO4 was added and the resulting 
slurry stirred for a further 30 min. The solids were removed by filtration and the solution 
evaporated under reduced pressure. The crude lactol intermediate was dissolved in anhydrous 
MeOH (25 mL) in the presence of 4 Å  molecular sieves. To the stirring solution, TsOH.H2O (46 
mg, 0.24 mmol) was added and the resultant solution was stirred at room temperature for 30 
min. Completion of the reaction was indicated by TLC analysis. The solution was neutralized to 
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pH 7 by the addition of sat’d aq. NaHCO3 solution before the 4 Å molecular sieves were 
removed by filtration. The resultant solution was extacted with Et2O (3 × 80 mL) and the 
resultant organics were washed with water (2 × 50 mL), sat’d aq. NaHCO3 solution (20 mL) and 
brine (40 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated under 
reduced pressure to afford the crude product. Purification by flash column chromatography, 
elution with 0-15% Et2O:petroleum ether, afforded the desired product, 7-MOM-phthalan 206 
(642 mg, 3.06 mmol, 64%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 3.44 (3H, s, CH3O), 
3.48 (3H, s, CH3O), 4.99 (1H, d, J = 12.8, CH2O2C), 5.19-5.27 (3H, m, CH2O2C (1H) & 
CH2(OMe)OAr (2H)), 6.26 (1H, d, J = 1.7, CH(OMe)), 7.89 (1H, d, J = 7.4, ArH), 7.00 (1H, d, J = 
8.1, ArH), 7.30 (1H, t, J = 7.8, ArH). 13C NMR (CDCl3, 100 MHz) δ: 54.3 (CH3OCH), 56.1 
(CH3OCH2O), 72.5 (ArCH2O), 94.2 (CH2(OMe)OAr), 106.2 (CH(OCH3)), 113.2 (C
ArH) 114.3 (CArH), 
126.0 (CArCH(OCH3)), 131.1 (C
ArH),142.5 (CArCH2O), 152.8 (C
ArOCH2OCH3). m/z  [CI
+, isobutane] 
211 [M+H]+(100%), HRMS found [M+H]+ 211.0968, C11H15O4  requires 211.0970. υmax /cm
-1 
(film): 2929, 2905, 2870, 2827, 1618, 1600. 
(3R,4R)-4-Hydroxy-3-isopropyl-5-(methoxymethoxy)isochroman-1-one 207 
 
Using general procedure 1A, starting from a 7-MOM-phthalan 206 (538 mg, 2.56 mmol)  in 
anhydrous THF (16 mL) with DIPEA (36 µL, 0.26 mmol), MeLi (1.6 M in Et2O, 3.36 mL, 5.38 
mmol) and isobutyraldehyde (279 µL, 3.07 mmol) to generate the α-hydroxyisobenzofuran 
intermediate. The oxidative rearrangement was performed using mCPBA, (77%, 632 mg, 2.82 
mmol) in anhydrous DCM (16 mL) to afford the keto-lactol intermediate. Oxidation was 
performed in anhydrous DCM (13 mL) with TEMPO (80 mg, 0.51 mmol) and BAIB (2.60 g, 8.19 
mmol) followed by filtration through a plug of silica, elution with 100% DCM to afford the 
keto-lactone intermediate. According to general procedure 2B, reduction was performed in 
anhydrous MeOH (9 mL) with NaBH4 (104 mg, 2.74 mmol) at –78 
oC. The crude products were 
purified by flash column chromatography, elution with 0-5% Et2O: DCM, afforded 5-MOM-
isochromanone 207 (112 mg, 0.42 mmol, 16% from 7-MOM-phthalan 206) as a white solid. 1H 
NMR (CDCl3, 400 MHz) δ: 1.13 (3H, d, J = 6.8, CH3), 1.21 (3H, d, J = 6.6, CH3), 2.14 (1H, d, J = 6.1, 
OH), 2.34-2.43 (1H, m, CH(CH3)2), 3.53 (3H, s, CH3O), 3.95 (1H, dd, J = 9.8, 1.8, CH(O2C)), 5.12 
(1H, d, J = 4.2, CH(OH), 5.24 (1H, d, J = 6.8, CH2(OMe)OAr), 5.29 (1H, d, J = 6.8, CH2(OMe)OAr), 
7.387.46 (2H, m, ArH) 7.81 (1H, dd, J = 7.8, 2.8, ArH). 13C NMR (CDCl3, 100 MHz) δ: 18.3 (CH3), 
19.4 (CH3), 28.7 (CH(CH3)2), 56.6 (CH3O), 59.2 (CH(OH)), 86.5 (CH(O2C)), 95.4 (CH2(OMe)OAr), 
120.4 (CArH), 123.7 (CArH), 125.5 (CArC(OH)), 130.1 (CArCO2), 130.4 (C
ArH), 153.9 (CArOCH2OCH3), 
164.9 (CO2). m/z  [CI
+, isobbutane] 267 [M+H]+ (100%), HRMS found [M+H]+ 267.1238, 
C14H19O5 requires 267.1232. υmax /cm
-1 (film): 3438, 2963, 2876, 2829, 1713, 1593. MP: 122-
124 oC. 
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(3R,4R)-4-Hydroxy-3-isopropyl-8-(methoxymethoxy)isochroman-1-one 208 
 
Further elution with 10% Et2O:DCM afforded 8-MOM-isochromanone 208 (222 mg, 0.83 mmol, 
32% from 7-MOM-phthalan 206) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 1.07 (3H, d, J = 
6.8, CH3), 1.17 (3H, d, J = 6.6, CH3), 2.19 (1H, s, OH), 2.25-2.35 (1H, m, CH(CH3)2), 3.52 (3H, s, 
CH3O), 3.91 (1H, dd, J = 9.8, 1.3, CH(O2C)), 4.71 (1H, s, CH(OH), 5.27 (1H, d, J = 7.0, 
CH2(OMe)OAr), 5.32 (1H, d, J = 7.0, CH2(OMe)OAr), 7.07 (1H, dd, J = 7.4, 0.7, ArH), 7.26 (1H, dd, 
J = 8.5, 0.8, ArH), 7.50-7.52 (1H, m, ArH). 13C NMR (CDCl3, 100 MHz) δ: 18.2 (CH3), 19.4 (CH3), 
28.4 (CH(CH3)2), 56.6 (CH3O), 66.0 (CH(OH)), 85.6 (CH(O2C)), 95.0 (CH2(OMe)OAr), 113.8 
(CArC(OH)), 117.4 (CArH), 121.1 (CArH), 135.0 (CArH), 142.8 (CArCO2),158.7 (C
ArOCH2OCH3), 161.9 
(CO2). m/z  [CI
+, isobutane] 267 [M+H]+ (100%), HRMS found [M+H]+ 267.1234, C14H19O5 
requires 267.1232. υmax /cm
-1 (film): 3443, 2963, 2933, 2875, 2829, 2249, 1709, 1600, 1587. 
MP: 122-124 oC. 
Methyl 3-methoxybenzoate S1 
 
3-Hydroxybenzoic acid (440 mg, 3.19 mmol) was dissolved in acetone (16 mL) to which K2CO3 
(1.32 g, 9.56 mmol) and dimethyl sulphate (1.21 mL, 12.7 mmol) was added. The reaction 
mixture was stirred at reflux for 1h before being cooled to RT and filtered. From the filtrate the 
solvent was evaporated under reduced pressure and the resultant residue was taken up in 
Et2O (150 mL) and washed with water (2 × 50 mL) and brine (30 mL), dried over anhydrous 
Na2SO4 and the solvent was evaporated to yield the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 0-10% Et2O:petroleum ether, 
afforded the desired product, methyl 3-methoxybenzoate (503 mg, 3.03 mmol, 95%) as a 
colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 3.85 (3H, s, ArOCH3), 3.92 (3H, s, ArCO2CH3), 7.10 
(1H. dd, J = 8.2, 1.8 ArH), 7.34 (1H, t, J = 7.9, ArH), 7.56 (1H, s, ArH), 7.63 (1H, d, J = 7.6, ArH). 
13C NMR (CDCl3, 100 MHz) δ: 52.2 (H3CO2CAr), 55.4 (ArOCH3), 113.9 (C
ArH), 119.5 (CArH), 122.0 
(CArH), 129.4 (CArH), 131.5 (CArCO2CH3), 159.6 (C
ArOCH3), 167.0 (CO). m/z  [EI
+] 166 [M]+ (58%),  
HRMS found [M]+ 166.0629,  C9H10O3 requires 166.0630. υmax /cm
-1 (film): 3078, 3002, 2952, 
2838, 2096, 1722, 1602, 1587. The data observed is in accordance with literature values.162 
3-Methoxybenzoic acid 219 
 
Methyl-3-methoxybenzoate S1 (503 mg, 3.03 mmol) was dissolved in MeOH (10 mL) to which 
15% aq. NaOH solution (6 mL) was added and the resultant solution was stirred for 12h at RT. 
The solvent was evaporated under reduced pressure and the crude solid was taken up in water 
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(50 mL) and neutralized and adjusted to pH 5 by the addition of concentrated HCl, before 
being extracted with EtOAc (3 × 100 mL). The combined organics were washed with water (30 
mL) and brine (30 mL), dried over anhydrous Na2SO4 and the solvent was evaporated to yield 
the desired benzoic acid 219 (404 mg, 2.66 mmol, 88%) as a white solid. 1H NMR (CD3OD, 400 
MHz) δ: 3.84 (3H, s, ArOCH3), 7.14 (1H, ddd, J = 8.3, 2.7, 1.0 ArH), 7.37 (1H, t, J = 7.9, ArH), 7.54 
(1H, dd, J = 2.6, 1.5, ArH), 7.60 (1H, dt, J = 5.2, 1.3, ArH). 13C NMR (CD3OD, 400 MHz) δ: 55.9 
(ArOCH3), 115.5 (C
ArH), 120.0 (CArH), 123.0 (CArH), 130.5 (CArH), 133.3 (CArCO2H), 161.2 
(CH3OAr), 169.8 (ArCO2H). m/z  [Cl
+, isobutane] 153 [M+H]+ (100%), HRMS found [M+H]+ 
166.0555,  C8H9O3 requires 153.0552. υmax /cm
-1 (film): 3049, 2974, 2952, 2845, 1683, 1609, 
1585. MP: 107-109 oC. The data observed is in accordance with literature values.163 
N,N-Diethyl-3-hydroxybenzamide 221 
 
SOCl2 (1.70 mL, 23.28 mmol) was added to 3-methoxybenzoic acid 219 (253 mg, 1.66 mmol) 
and stirred under argon. DMF (10.3 µL, 0.10 mmol) was added dropwise after which vigorous 
effervescence occurred. The solution was stirred at reflux for 1h at which time no further 
effervescence was visible. The solution was cooled to RT and excess SOCl2 was removed under 
reduced pressure and was azeotroped with toluene (3 × 15 mL). The colourless oil obtained 
was dissolved in DCM (3 mL), cooled to 0 oC and treated slowly with Et2NH (0.64 mL, 6.15 
mmol) and stirred for 1h before being concentrated under reduced pressure. The residue was 
dissolved in DCM (120 mL) and washed with water (3 × 25 mL) and brine (2 × 5 mL) before 
being dried over anhydrous Na2SO4 and the solvent was evaporated to yield the crude product 
as a brown oil. Purification by flash column chromatography, elution with 0-30% Et2O:DCM, 
afforded the desired benzamide 221 (293 mg, 1.41 mmol, 85%), as a yellow oil. 1H NMR (CDCl3, 
400 MHz) δ: 1.12 (3H, br. s, CH3CH2N), 1.23 (3H, br. s, CH3CH2N), 3.26 (2H, br. s, NCH2CH3), 3.53 
(2H, br. s, NCH2CH3), 3.81 (3H, s, OCH3), 6.89-6.93 (3H, m, ArH), 7.26-7.30 (1H, app. td, J = 7.8, 
0.5, ArH), 13C NMR (CDCl3, 100 MHz) δ: 12.9 (CH3CH2N), 14.3 (CH3CH2N), 39.2 (NCH2CH3), 43.3 
(NCH2CH3), 55.3 (OCH3), 111.7 (C
ArH), 115.0 (CArH), 118.4 (CArH), 129.5 (CArH), 138.6 (CArCON), 
159.6 (CArOCH3), 171.0 (CON). m/z  [EI
+] 207 [M]+ (100%), HRMS found [M]+ 207.1250,  
C12H17NO2 requires 207.1259. υmax /cm
-1 (film): 2972, 2934, 2854, 1636. The data observed is in 
accordance with literature values.164 
N,N-diethyl-3-hydroxybenzamide 220 
 
SOCl2 (8.35 mL, 115 mmol) was added to 3-hydroxybenzoic acid (1.13 g, 8.18 mmol) and the 
mixture was stirred under argon. DMF (21.0 µL, 0.27 mmol) was then added dropwise which 
caused a vigorous effervescence to take place. The solution was then stirred at reflux for 1h 
after which time no further effervescence was visible. The solution was cooled down to RT, 
and the excess SOCl2 was removed under reduced pressure, with tolune azeotroping (3 × 70 
mL). The crude colourless oil obtained was dissolved in anhydrous DCM (10 mL), cooled to 0 oC 
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and treated slowly with Et2NH (3.13 mL, 30.3 mmol).  The resulting solution was then stirred 
for 60 min before being concentrated under reduced pressure. The crude residue was 
dissolved in DCM (300 mL) and washed with water (3 × 50 mL), brine (2 × 30 mL) and dried 
over anhydrous Na2SO4. Removal of the solvent under vacuum yielded a brown oil which was 
purified by flash column chromatography, elution with 0-50% Et2O:DCM, to yield benzamide 
220 (1.50 g, 7.77 mmol, 95%), as a yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 1.05 (3H, br. t, J = 
6.2, CH3), 1.21 (3H, br. t, J = 6.3, CH3), 3.22 (2H, br. d, J = 6.6, CH2), 3.51 (2H, br. d, J = 6.6, CH2), 
6.74 (2H, d, J = 7.9, ArH), 6.81 (1H, s, ArH), 7.11 (1H, t, J = 7.8, ArH), 8.85 (1H, s, OH). 13C NMR 
(CDCl3, 100 MHz) δ: 12.8, 14.1, 39.6, 43.6, 114.1, 117.0, 117.1, 129.5, 137.1, 157.1, 172.2. m/z  
[CI+, isobutane] 194 [M+H]+ (100%), HRMS found [M+H]+ 194.1182,  C11H16NO2 requires 
194.1181. υmax /cm
-1 (film): 3247, 2976, 2937, 2874, 2806, 1609, 1510. The data observed is in 
accordance with literature values.165  
N,N-Diethyl-3-hydroxybenzamide 221 
 
Benzamide 220 (1.41 g, 7.27 mmol) was dissolved in anhydrous acetone (18 mL) and treated 
sequentially with K2CO3 (1.51 g, 10.9 mmol) and dimethyl sulphate (1.17 mL, 12.4 mmol). The 
reaction mixture was stirred at reflux for 18h before being cooled down to RT and filtered. The 
filtrate was evaporated under reduced pressure, and the resultant residue was taken up in 
DCM (300 mL) and washed with water (2 × 50 mL), brine (50 mL), dried over Na2SO4 and the 
solvent was evaporated to yield a crude colourless oil. Purification of the crude residue by 
flash column chromatography, elution with 0-15% Et2O:DCM, afforded benzamide 221 (1.40 g, 
6.76 mmol, 93%), as a colourless oil. The spectral and physical data obtained for 221 matched 
that obtained when 221 was obtained from 3-methoxybenzoic acid 219. 
N,N-Diethyl-2-formyl-3-methoxybenzamide 222 
 
An oven dried flask was charged with anhydrous Et2O (40 mL) and cooled to –78 
oC under an 
argon atmosphere. Freshly distilled TMEDA (4.72 mL, 31.6 mmol) and sBuLi (1.4 M in chex, 22.6 
mL, 31.6 mmol) were added in quick succession, and the resulting mixture was and stirred for 
15 min. A –78 oC solution of benzamide 221 (5.47 g, 26.37 mmol) in anhydrous Et2O (40 mL), 
was transferred via cannular into the sBuLi/TMEDA solution and the resulting mixture was 
stirred at –78 oC for 1h. DMF (2.55 mL, 33.0 mmol) was then added dropwise with stirring at –
78 oC and the reaction was stirred for a further 5 min before allowing the reaction to warm up 
to RT. The reaction was stirred at RT for 45 min, and then cooled down to 0 oC after which the 
reaction was quenched with water (60 mL).  The pH of the solution was then adjusted to pH 5-
6 through the careful addition of 6 M aq. HCl solution The phases were then separated and the 
organic layer was washed with water (2 × 25 mL) and brine (40 mL) before being dried over 
anhydrous Na2SO4 and concentrated under reduced pressure to give a crude oil. The crude 
residue was purified by flash chromatography, elution with 0-40% EtOAc:petroleum ether, to 
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yield benzaldehyde 222 (2.98 g, 12.7 mmol, 48%), as a yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 
1.00 (3H, t, J = 7.2, CH3CH2N), 1.31 (3H, t, J = 7.1, CH3CH2N), 3.05 (2H, q, J = 7.1, NCH2CH3), 3.57 
(2H, q, J = 7.1, NCH2CH3), 3.93 (3H, s, OCH3), 6.83 (1H, d, J = 7.5, ArH), 6.99 (1H, d, J = 8.5, ArH), 
7.53 (1H, dd, J = 8.4, 7.6, ArH), 10.47 (1H, d, J = 0.3, ArCHO). 13C NMR (CDCl3, 100 MHz) δ: 12.1 
(CH3CH2N), 13.5 (CH3CH2N), 38.6 (NCH2CH3), 42.4 (NCH2CH3), 56.0 (OCH3), 111.7 (C
ArH), 119.1 
(CArH), 121.2 (CArCHO), 135.6 (CArH), 139.4 (CArCON), 162.1 (CArOCH3), 169.7 (CON), 189.3 
(ArCHO). m/z  [FAB (+ve), NOBA] 236 [M+H]+ (100%), HRMS found [M+H]+ 236.1288, C13H18NO3 
requires 236.1287. υmax /cm
-1 (film): 3360, 2974, 2936, 2873, 1693, 1637, 1579. The data 
observed is in accordance with literature values.51  
4-Methoxyphthalide 223 
 
Benzaldehyde 222 (1.68 g, 7.17 mmol) was dissolved in anhydrous MeOH (36 mL) and the 
resulting solution was cooled down to 0 oC. NaBH4 (531 mg, 14.3 mmol) was slowly added to 
the solution, and the resulting mixture was warmed to RT and stirred until completion by TLC 
analysis (45 min). The solution was then cooled back down to 0 oC and its pH was adjusted to 
pH 4-5 by the addition of 6 M aq. HCl solution. The mixture was then heated at reflux for 16h, 
during which a white precipitate formed. The solvent was removed under reduced pressure, 
and the resultant solid was dissolved in DCM (150 mL), washed with water (2 × 50 mL), brine 
(50 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure.  Trituration 
from petroleum ether afforded 4-methoxyphthalide 223 (938 mg, 5.71 mmol, 80%) as a white 
solid. 1H NMR (CDCl3, 400 MHz) δ: 3.90 (3H, s, OCH3), 5.23 (2H, s, ArCH2O2C), 7.07-7.11 (1H, m, 
ArH), 7.44-7.47 (2H, m, ArH). 13C NMR (CDCl3, 100 MHz) δ: 55.6 (OCH3), 68.2 (ArCH2O), 114.8 
(CArH), 117.2 (CArH), 127.3 (CArCO2), 130.8 (C
ArH), 134.9 (CArCH2O2C), 154.2 (C
ArOCH3), 171.2 
(ArCO2). m/z  [El
+] 164 [M+] (100%), HRMS found [M+] 164.0474, C9H8O3  requires 164.0473. 
υmax /cm
-1 (film): 3110, 3085, 2980, 2948, 2927, 2872, 2848, 1771, 1609. MP: 117-120 oC. The 
data observed is in accordance with literature values.51  
4-Hydroxyphthalide 223 
 
A solution of 4-methoxyphthalide 223 (2.78 g, 16.9 mmol) in anhydrous DMF (26 mL) and was 
treated with iodocyclohexane (11.0 mL, 84.7 mmol) and the resultant solution was heated at 
reflux until reaction completion, indicated by TLC analysis (78h). The solution was cooled down 
to RT, taken up in water (100 mL) and extracted with EtOAc (3 × 150 mL). The combined 
organic phases were washed with sat’d aq. Na2S2O3 solution (3 × 150 mL), brine (3 × 50mL), 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification of the 
crude residue by flash column chromatography, elution with 0-6% MeOH:DCM, afforded the 
desired 4-hydroxyphthalide S2 (2.02 g, 13.5 mmol, 79%) as a white solid. 1H NMR (400 MHz, 
(CD3)2SO) δ: 5.29 (2H, s, CH2), 7.11 (1H, d, J = 7.8, ArH), 7.27 (1H, d, J =7.4, ArH), 7.40 (1H, t, J = 
7.6, ArH), 10.44 (1H, br. s, ArOH). 13C NMR (100 MHz, (CD3)2SO) δ: 68.2 (ArCH2O), 115.3 (C
ArH), 
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120.1 (CArH), 126.7 (CArCO2), 130.6 (C
ArH), 133.3 (CArCH2O2C), 152.3 (C
ArOH), 170.9 (ArCO2). m/z  
[Cl+  isobutene] 151 [M+H]+ (100%), HRMS found [M+H]+ 151.0394, C8H7O3 requires 151.0395. 
υmax /cm
-1 (film): 3199, 2966, 2861, 2831, 1728, 1612. MP: 261-263 oC. The data observed is in 
accordance with literature values.64  
4-(Tert-butyldimethylsilyloxy)phthalide 224 
 
A solution of 4-hydroxyphthalide S2 (1.00 g, 6.66 mmol) in anhydrous DMF (20 mL) was 
treated sequentially with imidazole (906 g, 13.3 mmol) and TBSCl (1.21 g, 7.99 mmol). The 
resultant solution was stirred at RT under argon until completion as indicated by TLC analysis 
(16h). The reaction was quenched with water (80 mL), and the solution was extracted with 
Et2O (3 × 100 mL). The combined organic extracts were washed with water (2 × 50 mL), brine 
(50 mL), dried over NaSO4 and concentrated under reduced pressure to yield a crude white 
solid. Purification of the crude residue by flash column chromatography, elution with 0-5% 
EtOAc:hexane, yielded 4-TBS-phthalide 224 (1.35 g, 5.09 mmol, 76%) as a white solid. 1H NMR 
(CDCl3, 400 MHz) δ: 0.25 (6H, s, Me2Si), 0.99 (9H, s, (CH3)3CSi), 5.22 (2H, s, CH2O2C), 7.04 (1H, 
dd, J = 7.9, 0.6, ArH), 7.39 (1H, t, J = 7.4, ArH) 7.50 (1H, d, J = 7.5, ArH). 13C NMR (CDCl3, 100 
MHz) δ: -4.3 (CH3)2Si), 18.1 (C(CH3)3Si), 25.5 ((CH3)3CSi), 68.1 (CH2O2C), 118.3 (C
ArH), 123.5 
(CArH), 127.7 (CArCO2),130.6 (C
ArH), 137.3 (CArCH2O), 150.5 (C
ArOSi), 171.2 (ArCO2). m/z  [CI
+, 
isobutane] 265 [M+H]+ (100%), HRMS found [M+H]+ 265.1261, C14H21O3Si requires 265.1260. 
υmax /cm
-1 (film): 2954, 2931, 2885, 2859, 1774, 1607. MP: 38-40 oC. 
4-(Tert-butyldimethylsilyloxy)-1-methoxy-1,3-dihydroisobenzofuran 225 
 
A –78 oC solution of 4-TBS-phthalide 224 (1.25 g, 4.73 mmol) in anhydrous DCM (47 mL) was 
treated with the dropwise addition of DIBAL (1 M in hexanes, 5.00 mL, 5.00 mmol) via syringe 
pump, over 1h.  Once the addition was complete, the reaction mixture was then stirred at –78 
oC until completion as indicated by TLC analysis (1h). The reaction was then diluted with DCM 
(150 mL), and quenched by the successive addition of water (0.2 mL), 15% aq. NaOH solution 
(0.2 mL) and water (0.5 mL) at –40 oC. The resultant slurry was warmed up to RT and stirred for 
30 min, anhydrous Na2SO4 was added, and the resulting suspension was stirred for a further 30 
min. The solids were removed by filtration and the filtrate was concentrated under reduced 
pressure to afford the crude lactol intermediate, which was dissolved in anhydrous MeOH (23 
mL) in the presence of 4 Å molecular sieves, treated with, TsOH.H2O (45 mg, 0.24 mmol), and 
the resulting solution was stirred at RT until completion as indicated by TLC analysis (60 min). 
The solution was neutralized to pH 7 by the addition of sat’d aq. NaHCO3 solution before the 4 
Å molecular sieves were removed by filtration. The filtrate was extracted with Et2O (3 × 100 
mL) and the combined organics phases were washed with water (2 × 25 mL), sat’d aq. NaHCO3 
solution (20 mL) and brine (20 mL) and then dried over anhydrous Na2SO4. The solvent was 
evaporated under reduced pressure to afford a crude oil that was then purified by flash 
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column chromatography, elution with 0-5% Et2O:petroleum ether to yield 4-TBS-phthalan 225 
(868 mg, 3.10 mmol, 65%) as a colourless oil.1H NMR (CDCl3, 400 MHz) δ: 0.21 (3H, s, CH3Si), 
0.22 (3H, s, CH3Si), 0.98 (9H, s, (CH3)3CSi), 3.42 (3H, s, CH3OCH), 5.02 (1H, d, J = 12.8, CH(H)), 
5.16 (1H, dd, J = 12.8, 1.8, CH(H)), 6.18 (1H, d, J = 2.0, CH(OCH3)), 6.77 (1H, d, J = 7.9, ArH), 6.99 
(1H, d, J = 7.4, ArH), 7.22 (1H, t, J = 7.7, ArH). 13C NMR (CDCl3, 100 MHz) δ: -4.2 (CH3)2Si), -4.1 
(CH3)2Si), 18.2 (C(CH3)3Si), 25.7 ((CH3)3CSi), 54.2 (CH3OAr), 71.0 (CH2), 108.1 (CHOCH3), 115.8 
(CArH), 119.3 (CArH), 129.5 (CArH), 130.9 (CArCH(OCH3)O), 139.9 (C
ArCH2O), 150.1 (C
ArOCH3). m/z  
[CI+, isobutane] 281 [M+H]+ (37%), HRMS found [M+H]+ 281.1574  C15H25O3Si  requires 
281.1573. υmax /cm
-1 (film): 2957, 2929, 2885, 2860, 2826, 1602. 
(±)-(3R,4R)-8-(Tert-butyldimethylsilyloxy)-4-hydroxy-3-
isopropylisochroman-1-one 199 
 
Using general procedure 1B a solution of 4-TBS-phthalan 225 (833 mg, 2.97 mmol) in 
anhydrous THF (16 mL) was treated with iPr2NH (42 µL, 0.30 mmol), MeLi (1.6 M in Et2O, 3.90 
mL, 6.24 mmol) and isobutyraldehyde (323 µL, 3.57 mmol) to generate the α-hydroxy-IBF 
intermediate. The oxidative rearrangement was performed using mCPBA (77%, 732 mg, 3.27 
mmol) in anhydrous DCM (16 mL) to afford the keto-lactol intermediate. Oxidation of the 
lactol was performed in anhydrous DCM (15 mL) with TEMPO (93 mg, 3.06 mmol) and BAIB 
followed by filtration through a plug of silica gel eluting with 20% Et2O:petroleum ether, to 
afford the keto-lactone intermediate. Using general procedure 2B, reduction was performed in 
anhydrous MeOH (15 mL) with NaBH4 (169 mg, 4.46 mmol).  Purification of the crude residue 
by flash column chromatography, elution with 0-30% Et2O:petroleum ether, afforded the 
desired 8-TBS-isochromanone 199 (450 mg, 1.34 mmol, 45%) as a white solid. The spectral and 
physical data obtained for 199 matched that obtained when 199 was obtained from the 
regioisomeric 7-TBS-phthalan 198. 
5-(Hydroxymethyl)-2-methylphenol 230 
 
4-Methylsalicyclic acid 229 (1.50 g, 9.86 mmol) was dissolved in anhydrous THF (20 mL) and 
cooled to 0 oC under an atmosphere of argon. BH3 (1 M in THF, 16.8 mL, 16.8 mmol) was 
added dropwise over 60 min via a syringe pump. The reaction was stirred for 12h at RT. The 
reaction was then quenched with 15% aq. NaOH solution (20 mL) at 0 oC and stirred for 20 min 
before being neutralized to pH 7 with dilute aq. HCl solution. The solution was then extracted 
with EtOAc (3 × 60 mL) and the resultant organic layer washed with water (15 mL), and brine 
(15 mL) before being dried over anhydrous Na2SO4 and concentrated under reduced pressure 
to give the crude product. Purification by flash column chromatography, elution with 0-25% 
diethyl ether:petroleum ether, afforded the desired product phenol (885 mg, 6.41 mmol, 65%) 
as a white crystalline solid. 1H NMR (CDCl3, 400 MHz) δ: 2.29 (3H, s, CH3), 4.81 (2H, s, CH2OH), 
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6.67 (1H, d, J = 7.6, ArH), 6.71 (1H, s, ArH), 6.91 (1H, d, J = 7.6, ArH), 7.21 (1H, s, ArOH). 13C 
NMR (CDCl3, 100 MHz) δ: 21.2 (CH3), 64.4 (CH2OH), 117.2 (ArH), 120.8 (ArH), 121.8 (C
ArMe), 
127.8 (ArH), 139.8 (CArCH2OH), 155.9 (C
ArOH). m/z  [EI+] 138 [M]+ (63 %), HRMS found [M]+ 
138.0683, C8H10O2 requires 138.0681. υmax /cm
-1 (film): 3456, 3169, 3025, 2968, 2950, 2905, 
1590. MP: 100-101 oC. The data observed is in accordance with literature values.66  
3-hydroxy-4-methylbenzaldehyde 230 
 
NEt3 (1.70 mL, 12.2 mmol) and SnCl4 (0.53 mL, 4.56 mmol) were added dropwise to a stirring 
solution of phenol 223 (420 mg, 3.04 mmol) in anhydrous MeCN and was stirred under an 
atmosphere of argon for 20 min. Paraformaldehyde (640 mg, 21.3 mmol) was added and the 
mixture was stirred at reflux for 17h after which the mixture was cooled, filtered and then 
extracted with Et2O (3 × 100 mL). The resultant organic layer washed with water (50 mL), and 
brine (50 mL) before being dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to give a brown oil. Purification by flash column chromatography, elution with 0-20 % 
Et2O: petroleum ether, afforded the undesired product, benzaldehyde 224 (33 mg, 0.20 mmol, 
6%) as a white crystalline solid. 1H NMR (CDCl3, 400 MHz) δ: 2.36 (3H, s, CH3), 6.78 (1H, s, ArH), 
6.81 (1H, d, J = 8.0, ArH), 7.41 (1H, d, J = 7.8, ArH), 9.81 (1H, s, ArCHO), 11.03 (1H, s, ArOH). 13C 
NMR (CDCl3, 100 MHz) δ: 21.2 (CH3), 116.7 (C
Ar), 117.6 (CArCH3), 120.1 (C
Ar), 132.6 (CAr), 147.9 
(CArCHO), 160.7 (CArOH), 194.8 (CHO). m/z  [EI+] 136 [M]+ (50 %), HRMS found [M]+ 136.0524, 
C8H8O2  requires 136.0525. υmax /cm
-1 (film): 3171, 2961, 2930, 2930, 2861, 1670, 1585, 1517. 
MP: 73-75 oC. The data observed is in accordance with literature values.166 
N,N-Diethyl-2-hydroxy-3-methylbenzamide 239 
 
SOCl2 (134 mL, 1840 mmol) was added to 3-methylsalicyclic acid 237 (20.0 g, 131 mmol) and 
stirred under argon at RT. DMF (340 µL, 4.34 mmol) was added dropwise, after which vigorous 
effervescence occurred. The solution was stirred for 1h at which time no further effervescence 
was visible. Excess SOCl2 was removed under reduced pressure and was azeotroped with 
toluene (3 × 100 mL). The colourless oil obtained was dissolved in anhydrous DCM (164 mL), 
cooled to 0 oC and treated slowly with Me2NH (50 mL, 486 mmol) and stirred for 60 min before 
being concentrated under reduced pressure. The residue was dissolved in DCM (400 ml) and 
washed with water (3 × 90 mL), sat’d aq. NaHCO3 solution (100 mL) and saturated brine (2 × 70 
ml) and concentrated under reduced pressure to give a brown oil. Purification by silica gel 
flash column chromatography, elution with 0-10% Et2O: petroleum ether gave the desired 
benzamide 239 (5.60 g, 27.0 mmol, 21%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 1.25 
(6H, t, J = 7.1, (CH3CH2)2N), 2.24 (3H, s, CH3Ar), 3.50 (4H, q, J = 7.1, N(CH2CH3)2), 6.73 (1H, t, J = 
6.7, ArH), 7.09 (1H, t, J = 7.1, ArH), 7.15 (1H, d, J = 7.2, ArH), 9.89 (1H, s, ArOH). 13C NMR 
(CDCl3, 100 MHz) δ: 13.4 (CH3CH2N), 16.0 (ArCH3), 42.1 (NCH2CH3), 117.4 (C
ArCON), 117.9 
(CArH), 124.8 (CArH), 127.0 (CArCH3), 133.2 (C
ArH), 156.9 (CArOH), 171.9 (ArCON). m/z  [EI+] 207 
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[M]+ (100%). HRMS found [M+H]+ 207.1261, C12H17NO2 requires 207.1259. υmax /cm
-1 (film): 
3218, 3064, 2975, 2936, 2876, 1602, 1580. The data observed is in accordance with literature 
values.167 
2-(Diethylcarbamoyl)-6-methylphenyl-2-hydroxy-3-methylbenzoate 240 
 
Further elution with 10-25% Et2O:petroleum ether afforded ester 240 (6.88 g, 20.2 mmol, 31%) 
as a yellow crystalline solid. 1H NMR (CDCl3, 400 MHz) δ: 0.95 (3H, t, J = 7.1, (CH3CH2N), 1.10 
(3H, t, J = 7.1, (CH3CH2N), 2.27 (3H, s, ArOCH3), 2.30 (3H, s, ArOCH3) 3.22-3.23 (2H, app. q, J = 
7.0, N(CH2CH3), 3.52-3.57 (2H, app. q, J = 7.0, N(CH2CH3), 6.87 (1H, t, J = 7.7, ArH), 7.21 (1H, d, J 
= 7.0, ArH), 7.27 (1H, t, J = 7.6, ArH), 7.34 (1H, d, J = 7.3, ArH), 7.41 (1H, d, J = 7.1, ArH), 7.93 
(1H, d, J = 7.9, ArH), 10.65 (1H, s, ArOH). 13C NMR (CDCl3, 100 MHz) δ: 12.3 (CH3CH2N), 14.0 
(CH3CH2N), 15.7 (ArCH3), 16.4 (ArCH3), 38.5 (NCH2CH3), 42.8 (NCH2CH3), 110.5 (C
ArCO2Ar), 
119.0 (CArH), 124.6 (CArH), 126.5 (CArH), 126.8 (CArCON), 128.1 (CArH), 131.1 (CArCH3), 131.6 
(CArH), 131.9 (CArCH3), 137.4 (C
ArH), 145.0 (CArO2C), 160.6 (C
ArOH), 167.1 (ArCON), 168.6 
(ArCO2). m/z  [EI
+] 341 [M]+ (100%). HRMS found [M]+ 341.1625, C20H23NO4 requires 341.1627. 
υmax /cm
-1 (film): 3218, 2974, 2933, 2873, 1736, 1685, 1638, 1615. MP: 93-95 oC. 
Methyl-2-methoxy-3-methylbenzoate S3 
 
A solution of benzoic acid 237 (20.0 g, 131.5 mmol) in anhydrous acetone (250 mL) was 
treated with anhydrous K2CO3 (52.7 g, 381.2 mmol) and dimethylsulfate (36.1 mL, 381.2 
mmol). The resulting reaction mixture was stirred at reflux until completion by TLC analysis 
(16h).  The reaction was cooled down to RT and the solid residue was removed by filtration. 
The solvent was removed under reduced pressure and the crude residue was taken up in 
water (1L), and stirred for 15 min before being extracted with EtOAc (3 × 500 mL).The 
combined organics were washed with water (800 mL) and brine (2 × 100 mL) before being 
dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure to yield 
the crude product as a colourless oil. Purification by flash column chromatography, elution 
gradient 0-1% Et2O:hexane, afforded benzoate S3 (22.2 g, 124 mmol, 94%), as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 2.32 (3H, s, CH3Ar), 3.83 (3H, s, CH3OAr), 3.91 (3H, s, CH3O2CAr), 
7.05 (1H, t, J = 7.7, ArH), 7.34 (1H, dd, J = 7.5, 0.9, ArH), 7.63 (1H, dd, J = 7.8, 1.9, ArH). 13C NMR 
(CDCl3, 100 MHz) δ: 16.2 (CH3Ar), 52.3 (CH3O2CAr), 61.6 (CH3OAr), 123.7 (C
ArH), 124.7 
(CArCO2CH3), 129.3 (C
ArH), 132.9 (CArCH3), 135.3(C
ArH), 158.5 (CArOCH3), 167.1(CO2CH3). m/z  
[EI+] 180 [M]+ (68%), HRMS found [M]+ 180.0785, C10H12O3 requires 180.0786. υmax /cm
-1 (film): 
2994, 2947, 1728, 1589, 1466, 1435. The data observed is in accordance with literature 
values.168 
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2-Methoxy-3-methylbenzoic acid 241 
 
Benzoate S3 (22.2 g, 124 mmol) was dissolved in MeOH (250 mL) and treated with 15% aq. 
NaOH solution (100 mL).  The resulting solution was stirred at RT (2h) and was then 
concentrated under reduced pressure.  The crude residue was taken up in water (300 mL) and 
neutralized to pH 7 by the addition of 6 M aq. HCl solution, before being extracted with EtOAc 
(3 × 300 mL). The combined organic extracts were washed with water (50 mL) and brine (50 
mL), dried over Na2SO4 and the solvent was evaporated under reduced pressure. Trituration of 
the crude residue from petroleum ether, followed by filtration of the solid impurities gave a 
clear solution, which upon evaporation under reduced pressure yielded benzoic acid 241 (19.9 
g, 120 mmol, 97%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 2.38 (3H, s, CH3Ar), 3.93 (3H, 
s, CH3OAr), 7.18 (1H, t, J = 7.7, ArH), 7.43 (1H, br. d, J = 7.4, ArH), 7.96 (1H, dd, J = 7.8, 1.8, 
ArH). 13C NMR (CDCl3, 100 MHz) δ pp: 16.1 (CH3Ar), 62.3 (CH3OAr), 122.1 (C
ArCO2H), 125.2 
(CArH), 130.9 (CArH) 131.7 (CArCH3), 137.1 (C
ArH), 157.9 (CArOCH3), 166.4 (CO2H). m/z  [EI
+] 166 
[M]+ (100%), HRMS found [M]+ 180.0632, C9H10O3 requires 166.0630. υmax /cm
-1 (film): 2955, 
2928, 1697, 1593. MP: 82-84 oC. The data observed is in accordance with literature values.169 
N,N-Diethyl-2-methoxy-3-methylbenzamide 242 
 
SOCl2 (125 ml, 1.71 mol) was added to benzoic acid 241 (19.9 g, 120 mmol) and stirred under 
argon. DMF (306 µl, 3.96 mmol) was added dropwise, after which vigorous effervescence 
occurred. The solution was stirred for 1h at which time no further effervescence was visible. 
Excess SOCl2 was removed under reduced pressure and was azeotroped with toluene (3 × 50 
mL). The colourless oil obtained was dissolved in THF (100 mL), cooled to 0 oC and treated 
slowly with Et2NH (45.8 ml, 443 mmol) and stirred for 15 min before being concentrated under 
reduced pressure. The residue was dissolved in DCM (400 ml) and washed with water (3 × 100 
mL) and brine (3 × 77 mL) and concentrated under reduced pressure to give a brown oil. 
Purification by flash column chromatography, elution with 0-15% Et2O:petroleum ether, 
afforded the desired product, benzamide 242 (1.92 g, 8.78 mmol, 91%), as a yellow solid. 1H 
NMR (CDCl3, 400 MHz) δ: 1.01 (3H, t, J = 7.1, CH3CH2N), 1.25 (3H, t, J = 7.1, CH3CH2N), 2.28 (3H, 
s, ArCH3), 3.12-3.17 (2H, app. dq, 12.2, 6.7, NCH2CH3), 3.34 (1H, m, NCH2CH3), 3.78 (4H, br. s, 
ArOCH3, NCH2CH3), 6.99-7.06 (2H, m, ArH), 7.17 (1H, d, J = 7.0, ArH). 
13C NMR (CDCl3, 400 MHz) 
δ: 12.8 (CH3CH2N), 13.9 (CH3CH2N), 16.0 (ArCH3), 38.9 (NCH2CH3), 42.9 (NCH2CH3), 61.4 (OCH3) 
124.1 (CArH), 125.2 (CArH), 131.4 (CArCH3), 131.5 (C
ArCON), 131.7 (CArH), 154.1 (CArOCH3), 169.1 
(CON). m/z [CI+, isobutane] 222 [M+H]+ (100%), HRMS found [M+H]+ 194.1495,  C13H20NO2 
requires 222.1494. υmax /cm
-1 (film): 2973, 2935, 2873, 1634, 1596. The data observed is in 
accordance with literature values.170 
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N,N-Diethyl-6-formyl-2-methoxy-3-methylbenzamide 243 
 
To an oven dried flask, anhydrous Et2O (8 mL) was added and cooled to –78 
oC under an 
atmosphere of argon. TMEDA (0.85 mL, 5.72 mmol) and sBuLi (4.08 mL, 1.4M, 5.72 mmol) 
were added and stirred for 15 min. A solution of benzamide 242 (1.05 g, 4.76 mmol) in 
anhydrous Et2O (8 mL), cooled to –78 
oC, was added dropwise to the sBuLi/TMEDA solution 
and stirred for 1h. DMF (0.46 mL, 5.95 mmol) was added dropwise with stirring at –78 oC for 5 
min, before being allowed to rise to RT and stirred for a further 45 min. The resultant solution 
was cooled to 0 oC and quenched with water, before the solution was made mildly acidic (pH 
5-6) via the careful addition of 6M aq.  HCl solution. The organic layer was collected and was 
washed with water (2 × 20 mL) and brine (40 mL), dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to give the crude product as a yellow oil. The crude 
product could be further purified by flash chromatography, elution with 1:1:1 Et2O:petroleum 
ether:DCM to afford the benzaldehyde 243 (994 mg, 3.99 mmol, 84%) as a yellow oil. 1H NMR 
(CDCl3, 400 MHz) δ: 0.98 (3H, t, J = 7.2, CH3CH2N), 1.28 (3H, t, J = 7.1, CH3CH2N), 2.35 (3H, s, 
CH3Ar), 3.06 (2H, qd, J = 7.2, 2.8, NCH2CH3), 3.53 (1H, dq, J = 13.6, 7.1, NCH2CH3), 3.69 (1H, dq, 
J = 13.6, 7.1, NCH2CH3), 3.79 (3H, s, OCH3), 7.31 (1H, d, J = 7.9, ArH), 7.58 (1H, d, J = 7.8, ArH), 
9.90 (1H, s, ArCHO). 13C NMR (CDCl3, 100 MHz) δ: 12.6 (CH3CH2N), 13.7 (CH3CH2N), 16.6 
(CH3Ar), 39.1 (NCH2CH3), 43.0 (NCH2CH3), 61.7 (OCH3), 125.3 (C
ArH), 131.7 (CArH), 132.0 
(CArCH3), 133.8 (C
ArCHO), 139.3 (CArCON), 154.5 (CArOCH3), 166.2 (CON), 190.1 (ArCHO). m/z  
[Cl+, isobutane] 250 [M+H]+ (100%), HRMS found [M+H]+ 250.1444,  C14H20NO3 requires 
250.1443. υmax /cm
-1 (film): 2978, 2936, 2871, 2833, 2747, 1701, 1634, 1592, 1572. 
7-Methoxy-6-methylisobenzofuran-1(3H)-one 244 
 
Benzaldehyde 243 (994 mg, 7.17 mmol) was dissolved in MeOH (20 mL) and the resulting 
solution cooled down to 0 oC. NaBH4 (295 mg, 3.99 mmol) was added slowly, and the reaction 
mixture was warmed up to RT and stirred for 45 min. The reaction was then acidified to pH 4-5 
at 0 oC by the addition of aqueous 6 M aq. HCl solution, and the mixture was then heated at 
reflux for 16h during which a white precipitate formed. The solvent was removed under 
reduced pressure, and the resultant solid was dissolved in DCM (150 mL), washed with water 
(2 × 50 mL), brine (50 mL) and then dried over anhydrous Na2SO4. Solvent removal under 
reduced pressure gave a crude yellow solid, which was triturated from petroleum ether, to 
afford the phthalide 244 (583 mg, 3.27 mmol, 82%) as a white solid. 1H NMR (CDCl3, 400 MHz) 
δ: 2.32 (3H, s, ArCH3), 4.07 (3H, s, OCH3), 5.22 (2H, s, ArCH2O2C), 7.04 (1H, d, J = 7.6, ArH), 7.47 
(1H, d, J = 7.6, ArH).13C NMR (CDCl3, 100 MHz) δ: 15.6 (ArCH3), 62.2 (OCH3), 68.8 (ArCH2O), 
116.4 (CArH), 116.9 (CArCO2), 131.6 (C
ArCH2O2C), 137.5 (C
ArH), 146.7 (CArCH3), 157.6 (C
ArOCH3), 
168.9 (ArCO2). m/z  [El
+] 178 [M+] (71%), HRMS found [M+] 178.0627, C10H10O3  requires 
178.0630. υmax /cm
-1 (film): 2954, 2903, 2848, 1759, 1613, 1596. MP: 121-124 oC 
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7-Hydroxy-6-methylphthalide 245 
 
A solution of phthalide 244 (0.46 g, 2.59 mmol) in anhydrous DMF (4 mL) was treated with 
iodocyclohexane (2.35 mL, 18.2 mmol), and the resultant solution was heated at reflux for 
78h. The solution was then taken up in water (30 mL) and extracted with EtOAc (3 × 60 mL). 
The combined organic phases were washed with sat’d aq. Na2S2O3 solution (3 × 30 mL), brine 
(3 × 15ml), dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Trituration of the crude residue from petroleum ether afforded hydroxyphthalide 245 (337 mg, 
2.06 mmol, 79%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 2.29 (3H, s, CH3), 5.28 (1H, s, 
CH2), 6.86 (1H, d, J =7.5, ArH), 7.40 (1H, d, J = 7.5, ArH), 7.86 (1H, s, ArOH). 
13C NMR (CDCl3, 100 
MHz) δ: 14.6 (CH3), 70.5 (ArCH2O), 110.5 (C
ArCO2), 112.8 (C
ArH), 124.9 (CArCH3), 138.2 (C
ArH), 
144.1 (CArCH2O2C), 154.6 (C
ArOH), 173.1 (ArCO2). m/z  [EI
+] 164 [M]+ (67%). HRMS found [M]+ 
164.0473, C9H8O3 requires 164.0473. υmax /cm
-1 (film): 3438, 2958, 2924, 2871, 1743, 1630, 
1609 1507. MP: 120-123 oC. The data observed is in accordance with literature values.66  
7-(Tert-butyldimethylsilyloxy)-6-methylphthalide 246 
 
A solution of hydroxyphthalide 245 (240 mg, 1.46 mmol) in anhydrous DMF (4.5 mL) was 
treated with imidazole (199 mg, 2.92 mmol) and TBSCl (264 mg, 1.75 mmol). The resultant 
homogeneous solution was stirred at RT under argon until completion as indicated by TLC 
analysis (16h). The reaction was diluted with water (25 mL), and was then extracted with Et2O 
(3 × 50 mL). The combined organic extracts were washed with water (2 × 15 mL), brine (15 
mL), dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. 
Purification of the crude white residue by flash column chromatography, elution with 0-5% 
EtOAc:hexane yielded phthalide 246 (341 mg, 1.23 mmol, 84%) as a white solid. Phthalide 246  
could also be purified via trituration of the crude residue from petroleum ether. 1H NMR 
(CDCl3, 400 MHz) δ: 0.26 (6H, s, Me2Si), 1.05 (9H, s, (CH3)3CSi), 2.29 (3H, s, CH3Ar), 5.15 (2H, s, 
CH2O2C), 6.91 (1H, d, J = 7.6, ArH), 7.41 (1H, d, J = 7.6, ArH). 
13C NMR (CDCl3, 400 MHz) δ: -3.5 
((CH3)2Si), 16.8 (CH3Ar), 18.8 (C(CH3)3Si), 26.0 ((CH3)3CSi), 68.1 (CH2O2C), 114.4 (C
ArH), 115.9 
(CArCO2),130.2 (C
ArCH3),137.6 (C
ArH),146.3 (CArCH2O2C), 153.0 (C
ArOSi), 169.1 (ArCO2). m/z  [CI
+, 
isobutane] 279 [M+H]+ (100%). HRMS found [M+H]+ 279.1412, C15H23O3Si requires 279.1416. 
υmax /cm
-1 (film): 2953, 2930, 2860, 1765, 1607. MP: 115-117 oC. 
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7-(Tert-butyldimethylsilyloxy)-1-methoxy-6-methyl-1,3-
dihydroisobenzofuran 247 
 
A –78 oC solution of phthalide 246 (1.04 g, 3.74 mmol) in anhydrous DCM (37 mL) was treated 
with the dropwise addition of DIBAL (1 M in hexanes, 3.65 mL, 3.65 mmol) over 1Hr.   The 
reaction was then stirred for an additional 1h and was then warmed up to -40 oC, diluted with 
DCM (150 mL) and quenched by the successive addition of water (0.2 mL), 15% aq. NaOH 
solution (0.2 mL) and water (0.4 mL). The resultant slurry was warmed to RT and stirred for 30 
min, followed by the addition of anhydrous Na2SO4, and the resulting suspension was stirred 
for a further 30 min. The solids were removed by filtration, and the solution evaporated under 
reduced pressure to afford the crude lactol intermediate, which was dissolved in anhydrous 
MeOH (18 mL), in the presence of 4 Å molecular sieves and treated with TsOH.H2O (35 mg, 
0.19 mmol).  The reaction was stirred at RT until completion as indicated by TLC analysis (60 
min). The solution was then neutralized to pH 7 by the addition of sat’d aq. NaHCO3 solution 
and the 4 Å molecular sieves were removed by filtration. The clear solution was extracted with 
Et2O (3 × 100 mL) and the combined organic layers were washed with water (2 × 25 mL), sat’d 
aq. NaHCO3 solution (20 mL) and brine (20 mL) before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to yield a crude oil, which was purified by 
flash column chromatography, elution with 0-5% Et2O:petroleum ether to afford phthalan 227 
(836 mg, 2.84 mmol, 76%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 0.21 (3H, s, CH3Si), 
0.22 (3H, s, CH3Si), 1.04 (9H, s, (CH3)3CSi), 2.23 (3H, s, CH3Ar), 3.41 (3H, s, CH3OCH), 4.95 (1H, 
dt, J = 12.4, 0.7, CH(H)), 5.15 (1H, dt, J = 12.4, 1.0, CH(H)), 6.17 (1H, d, J = 2.0, CH(OCH3)), 6.77 
(1H, d, J = 7.5, ArH), 7.14 (1H, d, J = 7.5, ArH). 13C NMR (CDCl3, 100 MHz) δ: -3.3 ((CH3)2Si), -3.3 
((CH3)2Si), 17.3 (C(CH3)3Si), 18.8 (CH3Ar), 26.0 ((CH3)3CSi), 54.3 (CH3O), 72.2 (CH2), 106.5 
(CH(OCH3)), 114.0 (C
ArH), 128.4 (CArCH3), 128.4 (C
ArCH(OCH3)O), 133.0 (C
ArH), 140.1 (CArCH2O), 
149.3 (CArOCH3). m/z  [FAB
+, NOBA] 317 [M+Na]+ (61%), HRMS found [M+Na]+ 317.1561, 
C16H26NaO3Si  requires 317.1549. υmax /cm
-1 (film): 2954, 2929, 2859, 2825, 2594. 
(±)-(3R,4R)-8-(Tert-butyldimethylsilyloxy)-4-hydroxy-3-isopropyl-7-
methylisochroman-1-one 226 
 
Using general procedure 1B, a solution phthalan 227 (380 mg, 1.29 mmol) in anhydrous THF (7 
mL) was treated with iPr2NH (18 µL, 0.13 mmol), MeLi (1.6 M in Et2O, 1.69 mL, 2.71 mmol) and 
isobutyraldehyde (141 µL, 1.55 mmol) to generate the -hydroxy-IBF intermediate. Oxidative 
rearrangement of -hydroxy-IBF was performed using mCPBA (77%, 318 mg, 1.42 mmol) in 
anhydrous DCM (7 mL) to afford the keto-lactol intermediate. Oxidation of the keto-lactol was 
performed in anhydrous DCM (15 mL) with TEMPO (40 mg, 0.26 mmol) and BAIB (1.33 g, 4.13 
mmol), followed by filtration through a plug of silica gel, elution with 0-50% DCM:petroleum 
ether,  to afford the keto-lactone intermediate. According to general procedure 2B, reduction 
was performed MeOH (7 mL) with NaBH4 (50 mg, 1.33 mmol) at –78 
oC. Purification of the 
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crude residue via flash column chromatography, elution with 0-30% Et2O:petroleum ether), 
yielded 8-TBS-isochromanone 226 (232 mg, 0.66 mmol, 51%) as a white solid. 1H NMR (CDCl3, 
400 MHz) δ: 0.11 (3H, s, CH3Si), 0.19 (3H, s, CH3Si), 1.03 (9H, s, CH3)3CSi), 1.07 (3H, d, J = 6.6, 
(CH3)H), 1.17 (3H, d, J = 6.6, (CH3)H), 1.84 (1H, d, J = 7.6, OH), 2.27 (3H, s, CH3Ar), 2.28-2.30 
(1H, m, CH(CH3)2) 3.88 (1H, dd, J = 9.9, 1.5, CH(O2C)), 4.67 (1H, dd, J = 7.3, 1.5, CH(OH),), 6.95 
(1H, d, J = 7.3, ArH), 7.37 (1H, d, J = 7.6, ArH). 13C NMR (CDCl3, 100 MHz) δ: -3.5 (CH3)2Si), -3.5 
(CH3)2Si), 17.6 (CH3Ar), 18.3 (CH3(CH)), 18.8 (C(CH3)3Si), 19.4 (CH3(CH)), 26.1 ((CH3)3CSi), 28.6 
(CH(CH3)2), 66.3 (CH(OH)), 85.9 (CH(O2C)), 115.9 ((C
ArCO2), 120.6 (C
ArH), 132.8 (CArCH3), 136.4 
(CArH), 139.9 (CArCH(OH)), 155.5 ((CArOSi), 163.3 (CO2). m/z  [CI
+, isobutane] 351 [M+H]+ 
(100%), HRMS found [M+H]+ 351.1990, C19H31O4Si  requires 351.1992. υmax /cm
-1 (film): 3395, 
2955, 2932, 2862, 1705, 1589, 1474, 1420. MP: 105-108 oC. 
Ethyl oxazole-4-carboxylate 157 
 
To a solution of formic acid (1.58 mL, 42.0 mmol) in anhydrous THF (40 mL), CDI (6.81 g, 42.0 
mmol) was added portionwise and the resultant solution was stirred for 30 min,  before a 
solution of ethyl isocyanoacetate (4.83 g, 44.2 mmol) in NEt3 (11.7 mL, 84.0 mmol) was added 
to the reaction mixture The mixture was stirred at RT for 1h and then under reflux for 16h. 
Completion of the reaction was indicated by TLC analysis. The solution was taken up in water 
(150 mL) and extracted with EtOAc (3 × 200 mL). The resulting organic solution was the 
washed with water (3 × 50 mL), brine (3 × 50 mL) and then dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to give the crude product. Purification by flash column 
chromatography, elution with 0-35% Et2O:petroleum ether, afforded the desired oxazole 157 
(4.27 g, 30.2 mmol, 72%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 1.36 (3H, t, J = 7.1, 
CH3), 4.37 (2H, q, J = 7.1, CH2), 7.92 (1H, d, J = 1.0, ArH), 8.25 (1H, d, J = 1.0, ArH). 
13C NMR 
(CDCl3, 100 MHz) δ: 14.2 (CH3), 61.4 (CH2), 133.4 (C
ArCO2Et), 144.2 (C
ArH), 151.4 (CArH), 161.2 
(CO2). m/z  [Cl
+, isobutane] 142 [M+H]+ (100%), HRMS found [M+H]+ 142.0506, C6H8NO3 
requires 142.0504. υmax /cm
-1 (film): 3132, 2985, 2940, 2907, 1741, 1577, 1518. The data 
observed is in accordance with literature values.171 
Oxazol-4-ylmethanol 249 
 
Oxazole 157 (7.30 g, 51.7 mmol) was dissolved in anhydrous THF (225 mL) and cooled to –78 
oC. DIBAL (1.25 M in hexanes, 89.0 mL, 111 mmol) was added dropwise via syringe pump over 
60 min and stirred at –78 oC for 60 min, before being allowed to warm to RT, and stirred for a 
further 12h. The reaction mixture was cooled to 0 oC and diluted with Et2O (250 mL) before 
being quenched by the successive addition of water (4.5 mL), 15% aq. NaOH solution (4.5 mL) 
and water (11.2 mL) at –78 oC, with 30 min stirring time between each addition. The resultant 
slurry was warmed to RT and stirred for 60 min, before anhydrous Na2SO4 was added and the 
resulting slurry stirred for a further 30 min. The solids were removed by filtration and the 
solution evaporated under reduced pressure to afford the crude product as a yellow oil. 
Purification by flash column chromatography, elution with 100% Et2O, afforded the desired 
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alcohol 249 (4.87 g, 49.1 mmol, 95%) as yellow oil. 1H NMR (CDCl3, 400 MHz) δ:  3.21 (1H, t, J = 
6.1, OH), 4.63 (2H, d, J = 5.9, CH2OH), 7.63 (1H, d, J = 0.9, ArH), 7.89 (1H, s, ArH). 
13C NMR 
(CDCl3, 100 MHz) δ:  56.7 (CH2), 135.6 (ArH), 140.1 (C
ArCH2), 151.6 (ArH). m/z  [CI
+, isobutane] 
100 [M+H]+ (90%), HRMS found [M+H]+ 100.0394, C4H6NO2 requires 100.0399. υmax /cm
-1 
(film): 3314, 3136, 2916, 2851, 1512. The data observed is in accordance with literature 
values.172 
Oxazole-4-carbaldehyde 250 
 
A solution of oxalyl chloride (1.50 mL, 17.78 mmol) in anhydrous DCM (30 mL) was cooled to –
78 oC to which DMSO (2.53 mL, 35.6 mmol) was added dropwise and stirred for 5 min.  A 
solution of oxazole 249 (881 mg, 8.89 mmol) in DCM (30 mL) was then slowly transferred via 
cannulation into the reaction mixture and the reaction stirred for 90 min at –78 oC. NEt3 (9.90 
mL, 71.1 mmol) was then added to the reaction and stirring was continued at RT for a further 
2h. The reaction was diluted with DCM (50 mL) and quenched by the addition of 10% aq. HCl 
solution (7 mL). The resulting biphasic mixture was extracted with DCM (3 × 50 mL) and the 
combined organic phases were washed with sat’d aq. NaHCO3 (50 mL), water (2 × 30 mL), 
brine (30 mL) and dried over anhydrous Na2SO4. The solvent was removed under reduced 
pressure to afford the crude product. Purification by flash column chromatography, elution 
with 0-5% Et2O:DCM, afforded the desired aldehyde 250 (300 mg, 3.09 mmol, 35%) as a white 
solid. 1H NMR (CDCl3, 400 MHz) δ:  7.98 (1H, s, ArH), 8.31 (1H, d, J = 1.0, ArH), 9.99 (1H, s, CHO). 
13C NMR (CDCl3, 100 MHz) δ:  140.5 (C
ArCHO), 144.0 (CArH), 151.9 (CArH), 184.3 (CHO). m/z  [CI+, 
isobutane] 98 [M+H]+ (100%), HRMS found [M+H]+ 98.0238, C4H4NO2 requires 98.0242. υmax 
/cm-1 (film): 3133, 3082, 2843, 1713, 1562, 1520. The data observed is in accordance with 
literature values.173 
(E)-Ethyl 2-methyl-3-(oxazol-4-yl)acrylate 251 
 
Method A: Wittig Olefination from Aldehyde 250 
To a solution of aldehyde 250 (320 mg, 3.30 mmol) in anhydrous toluene (14 mL) was added 
(carbethoxyethylidene)triphenylphosphorane (3.60 mg, 9.89 mmol) and the solution was 
heated at reflux (130 oC) for 16h under an atmosphere of argon. The reaction mixture was 
cooled to RT before the solvent was evaporated under reduced pressure. The crude residue 
was then loaded directly onto silica and purified by flash column chromatography, elution with 
0-7.5% EtOAc:petroleum ether, to afforded the desired acrylate 251 (325 mg, 1.79 mmol, 54%) 
as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 1.34 (3H, t, J = 7.2, CH3CH2), 2.24 (3H, d, J = 1.2, 
(CH)(CO2Et)), 4.26 (2H, q, J = 7.2, CH2CH3), 7.48-7.49 (1H, m, CH(CCH3)(Ar))), 7.83 (1H, s, ArH), 
7.92 (1H, s, ArH). 13C NMR (CDCl3, 100 MHz) δ: 14.4 (CH3CH2), 14.6 (CH3C(CH)(CO2Et)), 61.1 
(CH2CH3), 126.9 (CH), 129.8 (C(CH3)(CH)(CO2Et)), 137.4 (C
ArCH), 139.3 (CArH), 151.0 (CArH), 
168.2 (CO). m/z  [EI+] 181 [M]+ (81%), HRMS found [M+H]+ 181.0740, C9H11NO3 requires 
181.0739. υmax /cm
-1 (film): 3090, 2943, 2928, 2870, 1751, 1643, 1451. MP: 35-37 oC. 
Experimental 
 
140 
 
Method B: Tandem Oxidation Wittig-Olefination from Alcohol 249 
To a solution of alcohol 249 (4.50 g, 45.4 mmol) in anhydrous toluene (225 mL) was added 
(carbethoxyethylidene)triphenylphosphorane (33.1 g, 90.8 mmol) and activated MnO2 (19.7 g, 
227 mmol) and the resulting mixture was heated at reflux (130 oC) for 16h under an 
atmosphere of argon. The reaction mixture was cooled to RT and filtered through Celite, 
before the solvent was evaporated under reduced pressure. The crude residue was purified by 
flash column chromatography, elution with 0-10% Et2O:DCM, to afford acrylate 251 (7.20 g, 
42.6 mmol, 94%) as a white solid. 
(E)-2-Methyl-3-(oxazol-4-yl)prop-2-en-1-ol 252 
 
Acrylate 251 (7.20 g, 42.6 mmol) was dissolved in anhydrous THF (215 mL) and cooled to –78 
oC. DIBAL (1 M in hexanes, 93.6 mL, 93.6 mmol) was added dropwise via syringe pump over 1h 
and stirred at –78oC for a further 1h, before being allowed to warm to RT, and stirred for a 
further 12h. The reaction mixture was cooled to 0 oC and diluted with Et2O (250 mL) before 
being quenched by the successive addition of water (3.7 mL), 15% aq. NaOH solution (3.7 mL) 
and water (9.4 mL) at –78 oC, with 30 min stirring time between each addition. The resultant 
slurry was warmed to RT and stirred for a 60 min, anhydrous Na2SO4 was added and the 
resulting slurry stirred for a further 30 min. The solids were removed by filtration and the 
solution evaporated under reduced pressure to afford the crude product as a yellow oil. 
Purification by flash column chromatography, elution with 0-50% Et2O: DCM afforded the 
desired allylic alcohol 252 (5.57 g, 40.05 mmol, 94%) as yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 
1.97 (3H, s, CH3), 2.10-2.14 (1H, m, OH), 4.18 (2H, d, J = 5.3, CH2), 6.36 (1H, s, CHC(C
Ar)), 7.62 
(1H, s, ArH), 7.85 (1H, s, ArH). 13C NMR (CDCl3, 100 MHz) δ:  16.2 (CH3), 68.3 (CH2OH), 113.9 
(CHC(CAr)), 135.8 (CArH), 137.8 (CArCH), 140.3 (CCH2OH(CH3)(CH)), 150.5 (C
ArH). m/z  [CI+, 
isobutane] 140 [M+H]+ (100%), HRMS found [M+H]+ 140.0712, C7H10NO2 requires 140.0711. 
υmax /cm
-1 (film): 3345, 2917, 2859, 1726, 1660, 1516, 1447. 
(±)-Ethyl 2-methyl-3-(oxazol-4-yl)propanoate 254 
 
A solution of acrylate 251 (4.00 g, 22.1 mmol) in EtOH (50 mL) was charged with 10% activated 
Pd/C (800 mg). The suspension was stirred under an atmosphere of hydrogen at RT for 2h. The 
suspension was filtered through a pad of Celite and the filtrate was concentrated under 
reduced pressure to afford the desired ester 254 (3.96 g, 21.6 mmol, 98%) as a colourless oil. 
1H NMR (CDCl3, 500 MHz) δ:  1.18-1.25 (6H, m, CH3(CH), CH3CH2), 2.63 (1H, dd, J = 14.5, 6.6, 
CH(H)Ar), 2.85 (1H, dd, J = 13.9, 6.9, CH), 2.95 (1H, dd, J = 14.2, 7.5, CH(H)Ar), 4.12 (2H, q, J = 
7.1, OCH2CH3), 7.43 (1H, app. q, J = 0.9, ArH), 7.80 (1H, s, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 
14.3 (CH3CH2), 17.1 (CH3(CH)), 30.0 (CH2Ar), 39.0 (CH), 60.5 (OCH2CH3), 135.3 (C
ArH), 138.1 
(CArCH2), 151.0 (C
ArH), 175.9 (CO). m/z  [EI+] 183 [M]+ (100%), HRMS found [M]+ 183.0896, 
C9H13NO3 requires 183.0895. υmax /cm
-1 (film): 2984, 2953, 1717. 
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(±)-2-Methyl-3-(oxazol-4-yl)propan-1-ol 253 
 
Method A: Hydrogenation of Allylic Alcohol 252 
A solution of allylic alcohol 252 (5.29 g, 38.0 mmol) in EtOH (100 mL) was charged with 10% 
activated Pd/C (400 mg). The suspension was stirred under an atmosphere of hydrogen at 
room temperature for 2h. The suspension was filtered through Celite and the filtrate was 
concentrated under reduced pressure to afford the crude product. Purification via flash 
column chromatography, elution with 0-40% EtOAc:hexane, afforded the desired alcohol 253 
(5.36 g, 38.0 mmol, 100%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.90 (3H, d, J = 6.9, 
CH3), 1.99-2.04 (1H, m, CHCH3(CH2OH)(CH2Ar)), 2.51 (1H, dd,  J = 14.6, 6.6, 
CH2Ar(CHCH3(CH2OH))), 2.61 (1H, dd, J = 14.6, 6.3, CH2Ar(CHCH3(CH2OH))), 3.09 (1H, br. s, OH), 
3.44 (1H, dd, J = 11.0, 6.5, CH2OH), 3.53 (1H, dd, J = 11.0, 5.2, CH2OH), 7.42 (1H, br. d, J = 1.0, 
ArH), 7.82 (1H, s, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.8 (CH3), 29.7 (CH2Ar(CHCH3(CH2OH))), 
35.3 (CHCH3(CH2OH)(CH2Ar)), 67.3 (CH2OH), 135.3 (C
ArH), 138.4 (CArCH2), 151.0 (C
ArH). m/z  
[EI+] 140 [M]+ (100%), HRMS found [M]+ 140.0790, C7H11NO2 requires 140.0790. υmax /cm
-1 
(film): 3364, 3137, 2959, 2913, 2874, 1593, 1516, 1462. 
Method B: Reduction of Ester 254 
Ester 254 (3.14 g, 17.2 mmol) was dissolved in anhydrous THF (86 mL) and cooled to 0 oC. 
DIBAL (1 M in hexanes, 37.7 mL, 37.7 mmol) was added dropwise via syringe pump over 30 
min and stirred at 0 oC for a further 30 min before being allowed to warm to RT, and stirred for 
a further 60 min. The reaction mixture was cooled to 0 oC and diluted with Et2O (100 mL) 
before being quenched by the successive addition of water (1.5 mL), 15% aq. NaOH solution 
(1.5 mL) and water (3.9 mL) with 30 min stirring time between each addition. The resultant 
slurry was warmed to RT and stirred for 60 min, before anhydrous Na2SO4 was added and the 
resulting slurry stirred for a further 30 min. The solids were removed by filtration and the 
solution was evaporated under reduced pressure to afford the crude product as a yellow oil. 
Purification by flash column chromatography, elution with 0-100% Et2O:petroleum ether, 
afforded alcohol 253 (2.40 g, 17.2 mmol, 99%) as a colourless oil. The spectral and physical 
data obtained for 253, via Method B, matched that obtained via Method A. 
(±)-2-Methyl-3-(oxazol-4-yl)propanal 248 
 
Alcohol 253 (2.33 mg, 16.5 mmol) was dissolved in anhydrous DCM (80 mL), and treated with 
BAIB (7.45 g, 23.1 mmol) and TEMPO (258 mg, 1.65 mmol). The reaction mixture was then 
stirred under argon at RT until completion as indicated by TLC analysis (16h).  The reaction 
mixture was diluted with DCM (150 mL), washed with sat’d aq. Na2S2O3 (2 × 60 mL), water (2 × 
30 mL) and brine (30 mL). The phases were separated and the organic layer was dried over 
anhydrous Na2SO4 and then concentrated under reduced pressure to afford the crude product 
as an orange oil. Purification of the crude residue by flash column chromatography, elution 
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with 0-20% EtOAc:hexane, to afford aldehyde 248 (1.93 g, 13.9 mmol, 84%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 1.13 (1H, d, J = 6.8, CH3), 2.61 (1H, dd,  J = 14.8, 6.9, CH2), 2.76-
2.86 (1H, m. CH(CH3)), 2.97 (1H, ddd, J = 14.8, 6.5, 0.5, CH2), 7.45 (1H, br. d, J = 1.0, ArH), 7.82 
(1H, s, ArH), 9.73 (1H, d, J = 1.3, CHO). 13C NMR (CDCl3, 125 MHz) δ: 13.4 (CH3), 26.9 (CH2), 45.5 
(CH), 135.5 (CArH), 137.5 (CAr), 151.2 (CArH), 204.1 (CHO). m/z  [CI+, isobutane] 140 [M+H]+ 
(100%), HRMS found [M+H]+ 140.0711, C7H10NO2 requires 140.0712. υmax /cm
-1 (film): 3137, 
2974, 2936, 1724, 1516. 
(±)- (3R,4R)-4-Hydroxy-3-((S)-1-(oxazol-4-yl)propan-2-yl)isochroman-1-one 
255 
 
Using general procedure 1B, starting from a solution phthalan 131 (1.47 mg, 9.79 mmol) in 
anhydrous THF (50 mL) with iPr2NH (137 µL, 0.98 mmol), MeLi (1.6 M in Et2O, 12.9 mL, 20.6 
mmol) and aldehyde 248 (1.50 g, 10.8 mmol) to generate the α-hydroxy-IBF intermediate. The 
oxidative rearrangement was performed using mCPBA (77%, 2.41 g, 10.8 mmol) in anhydrous 
DCM (50 mL) to afford the keto-lactol intermediate. Oxidation was performed in anhydrous 
DCM (60 mL) with TEMPO (305 mg, 1.96 mmol) and BAIB (8.82 g, 27.4 mmol). Purification via 
flash chromatography, elution with 0-10% Et2O:DCM afforded the keto-lactone intermediate. 
According to general procedure 2B, reduction was performed in anhydrous MeOH (50 mL) 
with NaBH4 (518 mg, 13.7 mmol) at –78 
oC. The crude products were purified by flash column 
chromatography, elution with 0-1.5% MeOH:DCM, to afford syn,syn-isochromanone 255 (749 
mg, 2.74 mmol, 28%) as a white solid. 1H NMR (CDCl3, 500 MHz) δ: 1.23 (3H, d, J = 6.7, CH3), 
2.56-2.64 (1H, m, CH(CH3)), 2.69 (1H, dd, J = 15.2, 5.5, CH(H)Ar), 2.78 (1H, ddd, J = 15.2, 5.4, 
0.9, CH(H)Ar), 4.23 (1H, dd, J = 9.2, 1.7, CH(O2C)), 5.02 (1H, s, CH(OH)), 7.49-7.55 (3H, m, ArH), 
7.65 (1H, td, J = 7.5, 1.4, ArH), 7.85 (1H, br. s, ArH), 8.12-8.16 (1H, m, ArH). 13C NMR (CDCl3, 125 
MHz) δ: 16.9 (CH3), 28.5 (CH2Ar), 33.1 (CH(CH3)), 65.0 (CH(OH)), 84.8 (CH(O2C)), 124.6 (C
ArCH2), 
128.2 (CArH), 129.8 (CArH), 130.4 (CArH), 134.4 (CArH), 135.7 (CArH), 137.7 (CArCO2), 140.5 
(CArCH(OH)), 151.4 (CArH), 165.2 (CO). m/z  [Cl+, isobutene] 274 [M+H]+ (100%), HRMS found 
[M+H]+ 274.1075, C15H16NO4 requires 274.1079. υmax /cm
-1 (film): 3377, 2932, 1713. MP: 160-
162 oC. 
(±)-(3S,4S)-4-Hydroxy-3-((S)-1-(oxazol-4-yl)propan-2-yl)isochroman-1-one 
256 
 
Further elution afforded the syn,anti-isochromanone 256 (1.12 g, 4.11 mmol, 42%) as a white 
solid. 1H NMR (CDCl3, 500 MHz) δ: 1.11 (3H, d, J = 6.5, CH3), 2.5-2.68 (2H, m, CH(H)Ar & 
CH(CH3)), 3.04 (1H, br d, J = 5.6, OH), 3.14 (1H, d, J = 14.0, CH(H)Ar), 4.23 (1H, dd, J = 8.7, 1.3, 
CH(O2C)), 4.78 (1H, d, J = 6.3, CH(OH)), 7.45-7.50 (2H, m, C
ArH), 7.53 (1H, td, J = 7.7, 1.3, CArH), 
7.65 (1H, td, J = 7.3, 1.0, CArH), 7.72 (1H, s, CArH), 8.13 (1H, d, J = 7.7, CArH). 13C NMR (CDCl3, 125 
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MHz) δ: 15.5 (CH3), 28.2 (CH2Ar), 33.6 (CH(CH3)), 65.6 (CH(OH)), 84.0 (CH(O2C)), 124.5 (C
ArCH2), 
128.2 (CArH), 130.1 (CArH), 130.6 (CArH), 134.5 (CArH), 135.8 (CArH), 138.2 (CArCO2), 140.4 
(CArCH(OH)), 150.9 (CArH), 164.8 (CO2). m/z  [Cl
+ (+ve), isobutene] 274 [M+H]+ (100%). HRMS 
found [M+H]+ 274.1082, C15H16NO4 requires 274.1079. υmax /cm
-1 (film): 3187, 2984, 2971, 
1707. MP: 196-98 oC. 
(±)-(3S,4R)-3-((S)-1-(oxazol-4-yl)propan-2-yl)-1-oxoisochroman-4-yl 4-
nitrobenzoate 257 
 
A solution of isochromanone 256 (413 mg, 1.51 mmol) was dissolved in anhydrous toluene (21 
mL) was treated with PPh3 (991 mg, 3.78 mmol) and 4-nitrobenzoic acid (480 mg, 3.78 mmol) 
and stirred for 3 min at RT. The resulting solution was treated dropwise with DIAD (744 μL, 
3.78 mmol), before being heated at reflux for 16h under an atmosphere of argon. The reaction 
mixture was cooled to RT before the solvent was evaporated under reduced pressure and the 
crude residue purified by flash column chromatography, elution with 0-15% EtOAc:hexane, to 
afford the nitrobenzoate ester 257 (415 mg, 0.982 mmol, 65%) as a colourless oil. 1H NMR 
(CDCl3, 400 MHz) δ: 1.04 (3H, d, J = 6.9, CH3), 2.08-2.12 (1H, m, CH(CH3)), 2.63 (1H, dd, J = 14.7, 
8.2, CH(H)Ar), 2.94 (1H, dd, J = 14.6, 4.1, CH(H)Ar), 4.71 (1H, dd, J = 8.9, 2.9, CH(O2C)), 6.35 (1H, 
d, J = 2.9, CH(OPNB)), 7.49 (1H, s, ArH), 7.56-7.57 (1H, m, ArH), 7.60 (1H, td, J = 7.6, 1.4, ArH), 
7.67 (1H, td, J = 7.5, 1.4, ArH), 7.79 (1H, s, ArH), 8.17-8.21 (3H, m, ArH), 8.25-8.28 (2H, m, ArH). 
13C NMR (CDCl3, 100 MHz) δ: 16.2 (CH3), 28.5 (CH2), 35.0 (CH(CH3)), 68.7 (CH(OH)), 84.3 
(CH(O2C)), 123.8 (C
ArH), 128.7 (CArH), 128.8 (CArCH2), 128.9 (C
ArH), 130.6 (CArH), 130.9 (CArH), 
131.2 (CArH), 132.2 (CArH), 132.3 (CArCH(OH)), 134.2 (CArCO2), 134.6 (C
ArH), 136.0 (CArH), 137.3 
(CArCO2), 151.0 (C
ArNO2), 151.2 (C
ArH), 163.1 (CO), 164.0 (CO). m/z  [EI+] 422 [M]+ (100%),  
HRMS found [M]+ 422.1119, C22H18N2O7 requires  422.1114. υmax /cm
-1 (film): 3115, 2970, 2936, 
1722, 1607, 1528. 
(±)-(3S,4R)-4-Hydroxy-3-((S)-1-(oxazol-4-yl)propan-2-yl)isochroman-1-one 
247 
 
 A solution of nitrobenzoate ester 257 (117 mg, 0.3 mmol) in anhydrous MeOH (2 mL) and was 
treated with NaN3 (72 mg, 1.1 mmol) and stirred under argon at 40 
oC for 24h. The reaction 
mixture was then cooled down to RT and quenched by the addition of water (5 mL), before 
being extracted with EtOAc (3 × 20 mL). The combined organics were washed with water (5 
mL) and brine (5 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to yield a crude product which was purified by flash column 
chromatography, elution with 0-75% EtOAc:hexane, to afford the desired anti,anti-
isochromanone 247 (58 mg, 77%) as a white crystalline solid. 1H NMR (C6D6, 400 MHz) δ: 0.93 
(3H, d, J = 7.1, CH3), 2.06 (1H, dd, J = 15.6, 6.1, CH(H)Ar), 2.37-2.46 (1H, m, CH(CH3)), 2.69 (1H, 
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ddd, J = 15.6, 5.8, 1.4, CH(H)Ar), 4.03 (1H, dd, J = 10.5, 2.2, CH(O2C)), 4.68 (1H, dd, J = 10.4, 4.9, 
CH(OH)), 5.98 (1H, d, J = 5.9, OH), 6.62 (1H, s, ArH), 6.91 (1H, s, ArH), 7.00 (1H, tt, J = 7.6, 1.0, 
ArH), 7.21 (1H, td, J = 7.6, 1.3, ArH), 7.83 (1H, d, J = 7.7, ArH), 8.21 (1H, dd, J = 7.7, 1.1, ArH). 
13C NMR (CDCl3, 100 MHz) 18.2 (CH3), 25.8 (CH2Ar), 32.3 (CH(CH3)), 65.1 (CH(OH)), 86.0 
(CH(O2C)), 123.6 (C
ArCH2), 124.6 (C
ArH), 128.2 (CArH), 130.1 (CArH), 134.3 (CArH), 135.3 (CArH), 
138.9 (CArCO2), 143.4 (C
ArCH(OH)), 151.5 (CArH), 165.3 (CO2). m/z  [EI
+ (+ve)] 273 [M]+ (100%). 
HRMS found [M]+ 273.1003, C15H15O4N  requires 273.1001. υmax /cm
-1 (film): 3213, 2963, 2922, 
2853, 1721, 1605, 1514, 1456. MP: 158-160 oC. 
(S)-2-Methyl-3-(oxazol-4-yl)propan-1-ol 264 
 
The racemic alcohol 253 was subjected to chiral HPLC sepearation. The enantiomeric alcohols 
were separated using a Chiralpak AS-H column (250x20 mm i.d.) eluting with a 18 mL/min flow 
rate using a 9:1Heptane:iPrOH mixture. The alcohols were detected using a UV detector 
operating at 220 and 254 nm. The (S)-alcohol 264 was eluted at 7.72 min and was obtained in 
49% yield and >99% ee. [α]D -41.50 (c=1.75, CHCl3). Experimental data in agreement with 
racemic alcohol 253. 
(R)-2-Methyl-3-(oxazol-4-yl)propan-1-ol 263 
 
The (R)-alcohol 263 was eluted at 7.75 min and was obtained in 49% yield and >99% ee. [α]D 
+43.98 (c=1.91, CHCl3). Experimental data in agreement with racemic alcohol 253. 
(R)-2-Methyl-3-(oxazol-4-yl)propanal 259a 
 
(R)-alcohol 263 was oxidised to (R)-aldehyde 259a, under identical conditions for the synthesis 
of aldehyde 248 in 84% yield. [α]D +41.70 (c=0.93, CHCl3). Experimental data in agreement with 
racemic aldehyde 248. 
(S)-2-Methyl-3-(oxazol-4-yl)propanal 259b 
 
(S)-alcohol 264 was oxidised to (S)-aldehyde 259b, under identical conditions for the synthesis 
of aldehyde 248 in 84% yield. [α]D -40.02 (c=0.99, CHCl3). Experimental data in agreement with 
racemic aldehyde 248. 
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(3S,4S)-8-(Tert-Butyldimethylsilyloxy)-4-hydroxy-7-methyl-3-((R)-1-(oxazol-
4-yl)propan-2-yl)isochroman-1-one 265 
 
Using general procedure 1B, a solution phthalan 227 (758 mg, 2.57 mmol) in anhydrous THF 
(10 mL) was treated with iPr2NH (36 µL, 0.26 mmol), MeLi (1.6 M in Et2O, 3.38 mL, 5.41 mmol) 
and (R)-aldehyde 259a (376 mg, 2.70 mmol) in THF (5 mL) to generate the α-hydroxy-IBF. The 
oxidative rearrangement was performed using mCPBA (77%, 635 mg, 2.83 mmol) in anhydrous 
DCM (13 mL) to afford the keto-lactol intermediate. Oxidation was performed in anhydrous 
DCM (13 mL) with TEMPO (80 mg, 0.52 mmol) and BAIB (2.65 g, 8.24 mmol). Purification via 
flash chromatography, elution with 0-25% Et2O:petroleum ether, afforded the keto-lactone 
intermediate. According to general procedure 2B, reduction was performed in anhydrous 
MeOH (50 mL) with NaBH4 (122 mg, 3.21 mmol) at –78 
oC. Purification via flash column 
chromatography, elution with 0-1% MeOH:DCM afforded the syn,syn-isochromanone 265 (258 
mg, 0.62 mmol, 24%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 0.12 (3H, s, CH3Si), 0.19 (3H, 
s, CH3Si), 1.03 (9H, s, (CH3)3C), 1.21 (3H, d, J = 6.8, CH3(CH)), 2.27 (3H, s, CH3Ar), 2.50-2.57 (1H, 
m, CH(CH3)), 2.66 (1H, dd, J = 14.9, 5.9, CH(H)Ar), 2.75-2.80 (1H, m, CH(H)Ar), 3.52 (1H, d, J = 
6.1, OH), 4.12 (1H, dd, J = 8.8, 1.4, CH(O2C)), 4.90 (1H, dd, J = 6.0, 1.0, CH(OH)), 6.98 (1H, d, J = 
7.7, ArH), 7.38 (1H, dd, J = 7.5, 1.0, ArH), 7.48 (1H, br. d, J = 0.9, ArH), 7.84 (1H, br. d, J = 1.0, 
ArH). 13C NMR (CDCl3, 100 MHz) δ: -3.5 (CH3Si), 16.8 (CH3(CH)), 17.7 (CH3Ar), 18.8 (SiC(CH3)3), 
26.1 ((CH3)3C), 28.6 (CH2), 33.2 (CH(CH3)), 66.3 (CH(OH)), 83.7 (CH(O2C)), 116.1 (C
ArCO2), 120.5 
(CArH), 132.6 (CArCH2), 135.6 (C
ArH), 136.4 (CArH), 138.0 (CArCH3), 139.9 (C
ArCH(OH)), 151.3 
(CArH), 155.4 (CArOSi), 163.1 (CO). m/z  [Cl+, isobutene] 418 [M+H]+ (100%), HRMS found 
[M+H]+ 418.2054, C22H32NO5Si requires 418.2050. υmax /cm
-1 (film): 3385, 2948, 2937, 2923, 
2834, 1709, 1701, 1427. MP: 160-162 oC. [α]D +80.77 (c=1.04, CHCl3). 
(3R,4R)-8-(Tert-Butyldimethylsilyloxy)-4-hydroxy-7-methyl-3-((R)-1-
(oxazol-4-yl)propan-2-yl)isochroman-1-one 266 
 
Further elution afforded the syn,anti-isochromanone 265 (376 mg, 0.90 mmol, 35%) as a white 
solid. 1H NMR (CDCl3, 400 MHz) δ: 0.12 (3H, s, CH3Si), 0.20 (3H, s, CH3Si), 1.04 (9H, s, (CH3)3C), 
1.13 (3H, d, J = 6.9, CH3(CH)), 2.05 (1H, d, J = 7.2, OH), 2.27 (3H, s, CH3Ar), 2.51-2.59 (1H, m, 
CH(CH3)), 2.79 (1H, dd, J = 14.5, 7.6, CH(H)Ar), 3.03 (1H, dd, J = 14.6, 3.2, CH(H)Ar), 4.07 (1H, 
dd, J = 9.7, 1.3, CH(O2C)), 4.67 (1H, dd, J = 7.2, 1.3, CH(OH)), 6.94 (1H, d, J = 7.5, ArH), 7.37 (1H, 
d, J = 7.9, ArH), 7.48 (1H, s, ArH), 7.79 (1H, s, ArH). 13C NMR (CDCl3, 100 MHz) δ: -3.5 (CH3Si), -
3.5 (CH3Si), 15.3 (CH3(CH)), 17.6 (CH3Ar), 18.8 (SiC(CH3)3), 26.1 ((CH3)3C), 28.1 (CH2), 33.1 
(CH(CH3)), 66.3 (CH(OH)), 82.9 (CH(O2C)), 115.9 (C
ArCO2), 120.6 (C
ArH), 133.0 (CArCH2), 135.9 
(CArH), 136.5 (CArH), 138.0 (CArCH3), 139.7 (C
ArCH(OH)), 150.8 (CArH), 155.6 (CArOSi), 163.0 (CO). 
m/z  [Cl+, isobutene] 418 [M+H]+ (100%), HRMS found [M+H]+ 418.2047, C22H32NO5Si requires 
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418.2050. υmax /cm
-1 (film): 3370, 2955, 2392, 2860, 1719, 1417. MP: 138-140 oC. [α]D -226.42 
(c=0.53, CHCl3). 
4-Hydroxy-3-isopropylisochroman-1-one 136f 
 
Reduction Method C: ZnI2 and NaBH3CN 
To a solution of keto-lactone 135f (140 mg, 0.69 mmol) in anhydrous DCE (4 mL), ZnI2 (329 mg, 
1.03 mmol) and NaBH3CN (323 mg, 5.15 mmol) were added and the resultant suspension was 
heated at reflux under an atmosphere of argon for 16h. The resultant orange solution was 
cooled to RT and diluted with DCM (30 mL) and filtered through a pad of Celite, before the 
solvent was evaporated under reduced pressure. The crude residue was taken up in EtOAc 
(100 mL) and washed with water (2 × 20 mL) and brine (20 mL) before being dried over 
anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the crude 
product as a yellow oil. Purification by flash column chromatography, elution with 0-35% 
Et2O:petroleum ether, afforded isochromanone 136f (74 mg, 0.36 mmol, 52%) as a white solid. 
Reduction Method D: Meerwein Ponndorf Verley Reduction 
To a solution of keto-lactone 135f (131 mg, 0.64 mmol) in anhydrous toluene (4 mL), Me2AlCl 
(1M in hexane, 130 µL, 130 µmol) and iPrOH (196 µg, 2.57 mmol) were added and the 
resultant solution was stirred at RT for 8H before being heated at 50 oC under an atmosphere 
of argon for 24h in microdistillation apparatus. TLC analysis indicated incomplete reaction 
therefore further Me2AlCl (1M in hexane, 130 µL, 130 µmol) and 
iPrOH (196 µg, 2.57 mmol) 
were added and the solution was heated at 50 oC for a further 48H. The reaction was 
quenched at RT by the addition of water (20 mL) and extracted with Et2O (3 × 30 mL). The 
combined organics were washed with water (2 × 5 mL) and brine (10 mL) before being dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the 
crude product as a yellow oil. Purification by flash column chromatography, elution with 0-25% 
Et2O:petroleum ether, afforded unreacted keto-lactone 135f  (21 mg, 103 µmol, 16%). Further 
elution with 50% Et2O:petroleum ether afforded isochromanone 136f (94 mg, 0.46 mmol, 71%, 
85% brsm) as a white crystalline solid. 
Reduction Method E: Samarium Mediated Meerwein Ponndorf Verley 
Reduction 
To a flask containing Samarium (78 mg, 0.52 mmol) and I2 (5 - 8 mg) was added anhydrous 
iPrOH (1 mL) and the resulting mixture was stirred at RT for 1Hr. The colour change from 
brown to deep purple indicated the formation of Sm(iPrO)3. To this a solution of keto-lactone 
135f (106 mg, 0.52 mmol) in anhydrous iPrOH (1 mL) was added and the reaction mixture was 
stirred at room temperature for 72h. TLC analysis indicated reaction completion. The reaction 
was quenched at room temperature by the addition of water (20 mL) and extracted with Et2O 
(3 × 30 mL). The combined organics were washed with water (2 × 5 mL) and brine (10 mL) 
before being dried over anhydrous Na2SO4. The solvent was evaporated under reduced 
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pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-40% Et2O:petroleum ether, afforded the isochromanone 136f, 
(69 mg, 0.33 mmol, 64 %) as a white crystalline solid.  
The spectral and physical data obtained for 136f via reduction methods C to E matched that 
obtained when 136f was synthesised via methods A and B. 
(±)-(1R,3R)-3-Isopropyl-4-oxoisochroman-1-yl benzoate 280 
 
Keto-lactol 134f (231 mg, 1.12 mmol) was dissolved in anhydrous DCM (6.5 mL) and cooled to 
–78 oC, under an atmosphere of argon. NEt3 (0.94 mL, 6.72 mmol) was added, together with 
DMAP (14 mg, 0.11 mmol), before the dropwise addition of BzCl (133 µL, 1.14 mmol). After 
stirring for 60 min, TLC analysis indicated reaction completion. The reaction was quenched by 
the addition of sat’d aq. NaHCO3 solution and extracted with Et2O (2 × 50 mL). The organics 
were collected and washed with water (10 mL) and brine (10 mL). Solvent evaporation 
afforded the crude product. Purification via flash column chromatography, elution with 0-5% 
Et2O:petroleum ether, afforded α-diastereoisomer 280 (137 mmol, 0.44 mmol) as a colourless 
oil. 1H NMR (CDCl3, 500 MHz) δ: 0.93 (3H, d, J = 6.9, (CH3(CH)), 1.09 (3H, d, J = 7.1, CH3(CH)), 
2.56-2.65 (1H, m, CH(CH3)2), 4.67 (1H, d, J = 2.8, CH(CHMe2)), 7.43 (1H, s, CH(OBz)), 7.41-7.44 
(2H, m, ArH), 7.50 (1H, br. d, J = 7.6, ArH), 7.54-7.59 (2H, m, ArH), 7.65 (1H, td, J = 7.5, 1.4, 
ArH), 8.00-8.03 (2H, m, ArH), 8.07 (1H, dd, J = 7.8, 1.0, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.1 
(CH3(CH)), 19.3 (CH3(CH)), 26.7 (CH(CH3)2), 80.0 CH(CHMe2)), 91.1 (CH(OBz)), 126.2 (C
ArH), 
126.4 (CArH), 128.5 (CArH), 129.5 (CAr), 129.5 (CAr), 129.9 (CArH), 130.0 (CArH), 133.6 (CArH), 134.5 
(CArH) 138.0 (CAr), 165.1 (CO), 195.2 (CO). m/z  [CI+, isobutane] 311 [M+H]+ (100%), HRMS 
found [M+H]+ 311.1280, C19H19O4  requires 311.1283. υmax /cm
-1 (film): 2965, 2932, 2876, 1724, 
1695, 1603, 1540. 
(±)-(1S,3R)-3-Isopropyl-4-oxoisochroman-1-yl benzoate 281 
 
Further elution afforded the β-diastereoisomer 281 (73 mg, 0.24 mmol) as a colourless oil. 
1H 
NMR (CDCl3, 500 MHz) δ: 0.99 (3H, d, J = 6.7, (CH3(CH)), 1.07 (3H, d, J = 6.9, CH3(CH)), 2.51-2.58 
(1H, m, CH(CH3)2), 4.19 (1H, d, J = 6.0, CH(CHMe2)), 7.32 (1H, s, CH(OBz)), 7.44-7.51 (3H, m, 
ArH), 7.55 (1H, td, J = 7.6, 0.7, ArH), 7.61-67 (2H, m, ArH), 8.08 (1H, dd, J = 7.8, 1.0, ArH), 8.13-
8.15 (2H, m, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 17.9 (CH3(CH)), 19.0 (CH3(CH)), 30.3 (CH(CH3)2), 
84.9 CH(CHMe2)), 90.6 (CH(OBz)), 125.1 (C
ArH), 126.4 (CArH), 128.6 (CArH), 129.3 (CAr), 129.6 
(CArH), 129.8 (CAr), 130.1 (CArH), 133.6 (CArH), 134.5 (CArH) 139.1 (CAr), 165.3 (CO), 195.2 (CO). 
m/z  [CI+, isobutane] 311 [M+H]+ (100%), HRMS found [M+H]+ 311.1281, C19H19O4  requires 
311.1283. υmax /cm
-1 (film): 2966, 2930, 2876, 1725, 1690, 1603, 1542. 
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(±)-4-(3-(Tert-butyldiphenylsilyloxy)-2-methylpropyl)oxazole 304 
 
Alcohol 253 (959 mg, 6.79 mmol) was dissolved in anhydrous DMF (14 mL) together with finely 
ground imidazole (924 mg, 13.59 mmol) and TBDPSCl (2.12 mL, 8.15 mmol) and stirred under 
argon at RT for 4h. The reaction mixture was then diluted with Et2O (300 mL) and washed 
sequentially with water (5 × 60 mL) and brine (50 mL), before being dried over anhydrous 
Na2SO4 and the solvent was evaporated to afford the crude product. Purification by flash 
column chromatography, elution with 0-10% Et2O:petroleum ether) afforded the silyl ether 
304 (2.51 g, 6.60 mmol, 97%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ: 0.95 (3H, d, J = 6.8, 
CH3CH), 1.06 (6H, s, (CH3)2C(CH3)Si)  1.07 (3H, s, CH3C(CH3)2Si), 2.05-2.13 (1H, m, CHCH3), 2.38 
(1H, dd, J = 14.6, 8.0, CH2Ar(CH)), 2.75 (1H, dd, J = 14.5, 5.9, CH2Ar(CH)), 3.53 (2H, d, J = 5.6, 
CH2OTBDPS), 7.30 (1H, s, ArH), 7.36-7.45 (6H, m, ArH), 7.66 (3H, d, J = 6.8, ArH), 7.71-7.73 (1H, 
m, ArH), 7.79 (1H, s, ArH). 13C NMR (CDCl3, 100 MHz) δ: 16.7 (CH3CH), 19.5 (C(CH3)3Si), 26.7 
(CH3C(CH3)2), 27.0 ((CH3)2C(CH3)), 29.7 (CH2Ar), 35.3 (CHCH3), 68.2 (CH2OSi), 127.8(C
Ar), 
127.9(CAr), 129.7(CAr), 129.8(CAr), 134.0(CAr), 134.0(CAr), 134.9(CAr), 135.0(CAr), 135.8(CAr), 
135.8(CAr), 139.2(CAr), 150.8 (CAr). m/z  [CI+, isobutane] 380 [M+H]+ (100%), HRMS found 
[M+H]+ 380.2050, C23H30NO2Si requires 380.2046. υmax /cm
-1 (film): 2959, 2932, 2859, 1427. 
(±)-4-(3-(Tert-butyldiphenylsilyloxy)-2-methylpropyl)-2-(prop-1-en-2-
yl)oxazole 305 
 
Method A: Pd(0) Catalyzed C-H Activation 
Oxazole 304 (80 mg, 0.21 mmol), Pd(PPh3)4 (13 mg, 11 µmol), LiO
tBu (34 mg, 0.42 mmol) and 
2-bromopropene (38 µL, 0.42 mmol) in anhydrous 1,4-dioxane (0.6 mL) was stirred in a sealed 
tube at 110 oC for 24h under an atmosphere of argon.  The reaction mixture was cooled to RT, 
before being quenched with water (5 mL) and extracted with EtOAc (3 × 20 mL). The resultant 
organics were washed with water (2 × 7 mL) and brine (10 mL) before being dried over 
anhydrous Na2SO4 and solvent evaporated to afford the crude product. Purification by flash 
column chromatography, elution with 0-0.5% EtOAc:pentane, afforded the desired alkenyl 
oxazole 305 (51 mg, 0.12 mmol, 58%, 64% brsm) as a colourless oil. Further elution with 5% 
EtOAc:pentane afforded the recovered oxazole 304 (9 mg, 24 µmol, 11%) as a colourless oil. 1H 
NMR (CDCl3, 500 MHz) δ: 1.00 (3H, d, J = 6.7, CH3CH(CH2)(CH2’)), 1.07 (9H, s, (CH3)3CSi), 2.05-
2.12 (1H, m, CH), 2.14-2.16 (3H, m, CH3C(CH2)(Ar)), 2.39 (1H, ddd, J = 14.6, 7.8, 0.9, CH(H)Ar), 
2.71 (1H, ddd, J = 14.6, 6.3, 0.9, CH(H)Ar), 3.54 (1H, dd, J = 9.9, 5.6, CH(H)OSi), 3.59 (1H, dd, J = 
9.9, 5.3, CH(H)OSi), 5.32-5.33 (1H, m, CalkeneH), 5.89-5.91 (1H, m, CalkeneH), 7.20 (1H, br. s, ArH), 
7.36-7.44 (6H, m, ArH), 7.65-7.68 (4H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.9 (CH3(CH)), 
19.3 (CH3), 19.5 (SiC(CH3)3), 27.0 ((CH3)3C), 30.0 (CH2Ar), 35.2 (CH), 68.1 (CH2OSi), 117.6 
(CalkeneH2), 127.7 (C
ArH), 129.7 (CArH), 132.0 (CArCH2), 134.0 (C
ArSi), 134.0 (CArSi), 134.5 (CArH), 
135.7 (CArH), 140.6 (Calkene(CH3), 162.3 (C
Ar(alkene)). m/z  [FAB+, NOBA] 420 [M+H]+ (100%), 
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HRMS found [M+H]+ 420.2354, C26H34NO2Si requires 420.2359. υmax /cm
-1 (film): 2959, 2930, 
2857, 1589, 1532, 1462, 1427. 
Method B: Pd(0)/Cu(I) Catalyzed C-H Activation 
Oxazole 304 (80 mg, 0.21 mmol), trans-N,N'-dimethylcyclohexane-1,2-diamine (6 mg, 42 
µmol), CuI (4 mg, 21 µmol), LiOtBu (34 mg, 0.42 mmol) and 2-bromopropene (38 µL, 0.42 
mmol) in anhydrous 1,4-dioxane (0.6 mL) was stirred in a sealed tube at 110 oC for 24h under 
an atmosphere of argon.  The reaction mixture was cooled to RT, before being quenched with 
water (5 mL) and extracted with EtOAc (3 × 20 mL). The resultant organics were washed with 
water (2 × 7 mL) and brine (10 mL) before being dried over anhydrous Na2SO4 and solvent 
evaporated to afford the crude product. Purification by flash column chromatography, elution 
with 0-1% EtOAc:pentane, afforded the desired alkenyl oxazole 305 (55 mg, 0.13 mmol, 62%, 
73% brsm) as a colourless oil. Further elution with 5% EtOAc:pentane afforded the recovered 
oxazole 304 (10 mg, 25 µmol, 12%) as a colourless oil.  
(±)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)oxazole 309 
 
Alcohol 253 (1.31 g, 9.27 mmol) was dissolved in anhydrous DMF (15 mL) together with finely 
ground imidazole (1.26 g, 18.5 mmol) and TBSCl (1.66 g, 10.7 mmol) and stirred under argon at 
RT for 16h. The reaction mixture was then diluted with Et2O (300 mL) and washed sequentially 
with water (5x60 mL) and brine (50 mL) before being dried over anhydrous Na2SO4 and the 
solvent was evaporated to afford the crude product. Purification by flash column 
chromatography, elution with 0-10% Et2O:petroleum ether, afforded the silyl ether 309 (2.09 
g, 8.18 mmol, 88%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.03 (6H, s, (CH3)3Si), 0.90 
(12H, m, (CH3)3C, CH3(CH)), 1.98-2.02 (1H, m, CH), 2.32 (1H, dd, J = 14.6, 8.2, CH(H)Ar), 2.68 
(1H, ddd, J = 14.6, 5.8, 1.0, CH(H)Ar), 3.43-3.49 (2H, m, CH2OSi), 7.40 (1H, m, ArH), 7.81 (1H, s, 
ArH). 13C NMR (CDCl3, 125 MHz) δ:-5.3 (CH3Si), -5.2 (CH3Si), 16.6 (CH3(CH)), 18.5 (SiC(CH3)3), 
26.1 (CH3)3C), 29.6 (CH2Ar), 35.3 (CH), 67.5 (CH2OSi), 135.0 (C
ArH), 139.3 (CArCH2), 150.8 (C
ArH). 
m/z  [CI+, isobutane] 256 [M+H]+ (100%). HRMS found [M+H]+ 256.1737, C13H26NO2Si requires 
256.1733. υmax /cm
-1 (film): 2959, 2930, 2859. 
(±)-4-(3-(Tert-butyldiphenylsilyloxy)-2-methylpropyl)-2-deuterooxazole 
312 
 
Oxazole 309 (40 mg, 105 µmol) was dissolved in anhydrous Et2O (1 mL) to which 
nBuLi (2.5M in 
hexane, 46 µL, 116 µmol) was added and the solution was stirred at –78 oC for 30 min under 
an atmosphere of argon. The reaction mixture was then quenched by the dropwise addition 
D2O (1 mL) before being warmed to RT. The mixture was diluted with Et2O (20 mL) and the 
organics were sequentially washed with water (3 × 5 mL) and brine (8 mL) before being dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the 
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crude product. Purification by flash column chromatography, elution with 0-10% 
Et2O:petroleum ether, afforded the deutero-oxazole 312 (34 mg, 89 µmol, 85%) as a colourless 
oil. 1H NMR (CDCl3, 500 MHz) δ: 0.03 (6H, s, (CH3)3Si), 0.90 (12H, m, (CH3)3C, CH3(CH)), 1.98-
2.02 (1H, m, CH), 2.32 (1H, dd, J = 14.6, 8.2, CH(H)Ar), 2.68 (1H, ddd, J = 14.6, 5.8, 1.0, 
CH(H)Ar), 3.43-3.49 (2H, m, CH2OSi), 7.40 (1H, m, ArH). 
13C NMR (CDCl3, 125 MHz) δ: -5.3 
(CH3Si), -5.2 (CH3Si), 16.6 (CH3(CH)), 18.5 (SiC(CH3)3), 26.1 (CH3)3C), 29.6 (CH2Ar), 35.3 (CH), 
67.5 (CH2OSi), 135.0 (C
ArH), 139.3 (CArCH2). m/z  [CI
+
, isobutane] 381 [M+H]
+ (100%). HRMS 
found [M+H]+ 381.2104, C23H29DNO2Si2 requires 381.2124. υmax /cm
-1 (film): 2961, 2932, 2859, 
1471, 1427. 
General Procedure 3: C2 Functionalization of Oxazoles 
The general procedure for the BH3-mediated C2 functionalisation of oxazoles is exemplified in 
the synthesis of stannyl-oxazole 310. 
(±)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-
(tributylstannyl)oxazole 310 
 
Oxazole 309 (78 mg, 0.21 mmol) was dissolved in anhydrous THF (1 mL) to which BH3 (1 M in 
THF, 216 µL, 0.22 mmol) was added and the solution was stirred at RT for 30 min under an 
atmosphere of argon. After cooling to –78 oC, nBuLi (2.5 M in hexane, 86 µL, 0.22 mmol) was 
added dropwise over 5 min and the solution was allowed to stir for a further 25 min before 
being quenched with the dropwise addition of Bu3SnCl (59 µL, 0.21 mmol). The reaction 
mixture was stirred for 30 min at –78 oC before being warmed to 0 oC and quenched with 
water (4 mL). The mixture was diluted with Et2O (25 mL) and the organics were sequentially 
washed with water (3 × 5 mL) and brine (8 mL) before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product. Purification by 
flash column chromatography, elution with 0-2% Et2O:petroleum ether, afforded the stannyl-
oxazole 310 (98 mg, 0.15 mmol, 71%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.89 
(18H, m, (CH3)3C, (CH3(CH2))3), 0.94 (3H, d, J = 6.7, CH3(CH)), 1.26-1.35 (12H, m, (CH2CH2)3), 
1.55-1.61 (6H, m, (SnCH2)3), 2.07-2.12 (1H, m, CH), 2.49 (1H, ddd, J = 15.4, 8.0, 0.9, CH(H)Ar), 
2.81 (1H, ddd, J = 15.4, 6.2, 1.0, CH(H)Ar), 3.46-3.51 (2H, m, CH2OSi), 7.58 (1H, s, ArH). 
13C NMR 
(CDCl3, 125 MHz) δ: -5.3 ((CH3)Si), -5.3 ((CH3)Si), 12.1 (SnCH2), 13.8 (CH3(CH2)), 16.8 (CH3(CH)), 
18.5 (CH2Ar), 26.1 ((CH3)3C), 27.0 (C(CH3)3), 27.2 (CH2(CH3)), 28.8 (CH2(CH2Sn)(CH2CH3)), 34.1 
(CH), 67.4 (CH2OSi), 137.4 (C
ArCH2), 139.9 (C
ArH), 177.5 (CArSn). m/z  [CI+] 546 [M+H]+ (100%), 
HRMS found [M+H]+ 546.2792, C25H52NO2Si
118Sn requires 546.2794. υmax /cm
-1 (film): 2957, 
2928, 2854, 1462. 
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(±)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-chlorooxazole 319 
 
Using general procedure 3, oxazole 309 (2.16 g, 8.44 mmol) was dissolved in anhydrous THF 
(40 mL) was treated with BH3 (1 M in THF, 8.86 mL, 8.86 mmol), 
nBuLi (1.6 M in hexane, 5.54 
mL, 8.86 mmol) and quenched with C2Cl6 (3.99 g, 16.9 mmol). Purification of the crude 
material by flash column chromatography, elution with 0-5% Et2O:petroleum ether, afforded 
the chloro oxazole 319 (2.12 g, 7.31 mmol, 87%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) 
δ: 0.02 (6H, s, (CH3)2Si), 0.88, (9H, s, (CH3)C), 0.89 (3H, d, J = 6.5), 1.97-1.99 (1H, m, CH), 2.25 
(1H, ddd, J = 14.7, 8.2, 0.9, CH(H)Ar), 2.63 (1H, ddd, J = 14.7, 5.8, 1.1, CH(H)Ar), 3.42-3.47 (2H, 
m, CH2OSi), 7.35 (1H, br. t, J = 1.1, ArH). 
13C NMR (CDCl3, 125 MHz) δ: -5.3 ((CH3)2Si), 16.5 
(CH3(CH)), 18.4 (SiC(CH3)3), 26.0 ((CH3)3C), 29.9 (CH2Ar), 35.0 (CH), 67.3 (CH2OSi), 137.2 (C
ArH), 
142.2 (CArCH2), 146.4 (C
ArCl). m/z  [CI+, isobutane] 290 [M+H]+ (100%), HRMS found [M+H]+ 
290.1350, C13H25
35ClNO2Si requires 290.1343. υmax /cm
-1 (film): 2957, 2930, 2886, 2857, 1520, 
1472, 1464. 
(±)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-
(trimethylsilyl)oxazole 311 
 
Using general procedure 3, oxazole 309 (237 mg, 0.93 mmol) was dissolved in anhydrous THF 
(5 mL) was treated with BH3 (1 M in THF, 974 µL, 0.97 mmol), 
nBuLi (1.6M in hexane, 609 µL, 
0.97 mmol) and quenched with TMSCl (135 µL, 1.07 mmol). Purification of the crude material 
by flash column chromatography, elution with 0-1.5% Et2O:petroleum ether, afforded the silyl 
oxazole 311 (231 mg, 0.71 mmol, 76%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.04 
(6H, s, (CH3)2Si), 0.50 (9H, s, (CH3)3Si), 0.89 (9H, s, (CH3)3C), 0.95 (3H, d, J = 6.7, CH3(CH)), 2.06-
2.13 (1H, m, CH), 2.51 (1H, ddd, J = 15.5, 8.0, 1.1, CH(H)Ar), 2.84 (1H, ddd, J = 15.5, 6.1, 1.2, 
CH(H)Ar), 3.50 (2H, d, J = 5.5, CH2OSi), 7.55 (1H, s, ArH). 
13C NMR (CDCl3, 125 MHz) δ: -5.3 
((CH3)2Si), -5.3 ((CH3)2Si), -1.9 ((CH3)3Si), 16.9 (CH3(CH)), 18.5 (SiC(CH3)3), 26.1 ((CH3)3C), 26.9 
(CH2Ar), 33.9 (CH), 67.4 (CH2OSi), 138.6 (C
ArCH2), 138.7 (C
ArH), 171.7 (CArSi). m/z  [CI+] 4328 
[M+H]+ (100%), HRMS found [M+H]+ 328.2132, C16H34NO2Si2 requires 328.2128. υmax /cm
-1 
(film): 2957, 2930, 2857, 1471, 1464. 
Tributyl(prop-1-en-2-yl)stannane 323 
 
A round bottom flask charged with magnesium turnings (175 mg, 7.2 mmol), was treated with 
anhydrous THF (36 mL), followed by Bu3SnCl (1.50 mL, 5.5 mmol). The heterogeneous mixture 
was then sonicated at RT under an argon atmosphere for 2 min before being treated with the 
dropwise addition of 2-bromopropene (639 µL, 7.2 mmol). The reaction mixture was sonicated 
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for a further 3h, by which time no magnesium turnings were longer visible. The reaction was 
quenched by the addition of water (50 mL) and extracted with Et2O (3 × 50 mL). The combined 
organics were washed with water (15 mL) and brine (20 mL) before being dried over 
anhydrous Na2SO4 and concentrated under reduced pressure to afford a colourless oil. 
Purification of the crude residue by flash column chromatography, elution with petroleum 
ether, stannane 323 (1.95 g, 96%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.89-0.92 
(15H, m, CH3(CH2), CH2Sn), 1.30-1.35 (6H, m, CH2(CH3)), 1.47-1.54 (6H, m, 
CH2(CH2Sn)(CH2CH3)), 1.97 (3H, t, J = 1.6, CH3C(CH2)), 5.09 (1H, dq, J = 3.0, 1.4, CalkeneH), 5.69 
(1H, dq, J = 3.1, 1.7, CalkeneH). 
13C NMR (CDCl3, 125 MHz) δ: 9.3 (CH2Sn), 13.9 (CH3(CH2)), 27.5 
(CH2(CH3)), 27.6 (CH2(CH3)), 29.3 (CH2(CH2Sn)(CH2CH3)), 125.7 (CalkeneH2), 150.5 (C
Q
alkene). m/z  
[EI+] 332 [M]+ (100%), HRMS found [M]+ 332.1534, C15H32
120Sn requires 332.1529; υmax / cm
-1 
(film): 2957, 2928, 2872, 2853, 1458. The data observed is in accordance with literature 
values.175 
(±)-4-(3-(Tert-Butyldimethylsilyloxy)-2-methylpropyl)-2-(prop-1-en-2-
yl)oxazole 324 
 
Method A: Stille Cross-Coupling 
Chloro oxazole 319 (60 mg, 0.21 mmol), stannane 323 (83 mg, 2.28 mmol) and Pd(PPh3)2Cl2 (12 
mg, 17 µmol) were combined in an oven dried MW vial and degassed anhydrous DMF (2 mL) 
was added.  The resulting heterogeneous solution was heated under an atmosphere of argon 
under MW irradiation at 130 oC for 12h. The reaction was cooled and the crude mixture was 
passed through a pad of Celite and eluted with Et2O (10 mL). The organics were then washed 
with water (4 × 4 mL) and brine (5 mL) before being dried over anhydrous Na2SO4. The solvent 
was evaporated under reduced pressure to afford the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 0-2% Et2O:petroleum ether, 
afforded alkenyl oxazole 324 (50 mg, 86%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.03 
(6H, s, (CH3)2Si ), 0.89 (9H, s, (CH3)3C), 0.92 (3H, d, J = 6.7, (CH3)CH), 1.96-2.04 (1H, m, CH), 2.15 
(3H, dd, J = 1.5, 1.0, CH3(Calkene)), 2.32 (1H, ddd, J = 14.6, 7.9, 0.9, CH(H)Ar), 2.64 (1H, ddd, J = 
14.6, 6.1, 1.0, CH(H)Ar), 3.45 (1H, dd, J = 9.8, 5.9, CH(H)OSi), 3.50 (1H, dd, J = 9.9, 5.5, 
CH(H)OSi), 5.32 (1H, quint, J = 1.5, CalkeneH), 5.87-5.90 (1H, m, CalkeneH), 7.30 (1H, s, ArH). 
13C 
NMR (CDCl3, 125 MHz) δ: -5.2 (CH3)2Si), 16.8 (CH3(CH)), 18.5 (SiC(CH3)), 19.3 (CH3(Calkene)), 26.1 
((CH3)3C), 29.9 (CH2Ar), 35.2 (CH), 67.5 (CH2OSi), 117.6 (CalkeneH2), 132.0 (C
ArCH2), 134.5 (C
ArH), 
140.7 (C=CH2), 162.4 (C
ArCalkene). m/z  [CI
+, isobutane] 296 [M+H]+ (100%), HRMS found [M+H]+ 
296.2049, C16H30NO2Si requires  296.2046; υmax /cm
-1 (film): 2959, 2930, 2858, 1671, 1541, 
1548, 1465. 
Method B: Nucleophilic Aromatic Substitution 
To an oven dried flask containing magnesium turnings (10 mg, 0.41 mmol) in anhydrous THF 
(0.5 mL) was added 2-bromopropene (37 µL, 0.41 mmol) under an atmosphere of argon. The 
flask was submerged in a sonic water bath and subjected to sonication for 45 min by which 
time a white precipitation formed. The reaction mixture was cooled to 0 oC before being 
transferred via cannulation to a solution of chloro oxazole 319 (60 mg, 0.21 mmol) in 
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anhydrous THF (0.5 mL) at 0 oC. The resultant reaction mixture was warmed to RT and stirred 
for a further 6h before being quenched by the addition of water (5 mL) and extracted with 
Et2O (3 × 20 mL). The combined organics were washed with water (2 × 5 mL) and brine (5 mL) 
before being dried over anhydrous Na2SO4. The solvent was evaporated under reduced 
pressure to afford the crude product as a colourless oil. Purification by flash column 
chromatography, elution with 0-2% Et2O:petroleum ether, afforded unreacted chloro oxazole 
319 (30 mg, 103 µmol). Further elution afforded the desired alkenyl oxazole 324 (19 mg, 64 
µmol, 31%, 62% brsm) as a colourless oil. The spectral and physical data obtained for 324, via 
Method B, matched that obtained via Method A. 
2,2'-(4-Methylpent-4-ene-2,2-diyl)bis(4-(3-(tert-butyldimethylsilyloxy)-2-
methylpropyl)oxazole) 332 
 
To an oven dried flask containing magnesium turnings (60 mg, 2.47 mmol) in anhydrous THF (2 
mL) was added 2-bromopropene (219 µL, 2.47 mmol) under an atmosphere of argon. The flask 
was submerged in a sonic water bath and subjected to sonication for 2h by which time a white 
precipitation formed. The reaction mixture was cooled to 0 oC before being transferred, via 
cannulation, to a solution of chloro oxazole 319 (120 mg, 0.41 mmol) in anhydrous THF (1 mL) 
at 0 oC. The resultant reaction mixture was warmed to RT and stirred for a further 6H before 
being quenched by the addition of water (20 mL) and extracted with Et2O (3 × 40 mL). The 
combined organics were washed with water (2 × 10 mL) and brine (10 mL) before being dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the 
crude product as a colourless oil. Purification by flash column chromatography, elution with 0-
5% Et2O:petroleum ether, afforded the bis-oxazole 332 (103 mg, 179 µmol, 44%) as a 
colourless oil. 1H NMR (CDCl3, 500 MHz) δ: -0.01 (12H, s, (CH3)2Si), 0.85 (18H, s, (CH3)3C), 0.86-
0.89 (6H, m, CH3(CH) ), 1.31 (3H, s, CH3(CAr(Ar’))), 1.74 (3H, s, CH3(Calkene)), 1.91-1.99 (2H, m, 
CH), 2.28 (2H, ddt, J = 14.7, 7.7, 0.9, CH(H)Ar), 2.57 (2H, dd, J = 14.7, 6.0, CH(H)Ar), 3.00 (2H, s, 
CH2(Calkene)), 3.38 (2H, ddd, J = 9.8, 6.0, 3.8, CH(H)OSi), 3.45 (2H, dd, J = 9.8, 5.3, CH(H)OSi), 
4.60 (1H, s, CalkeneH(H)), 4.77-4.81 (1H, m, CalkeneH(H)), 7.26 (2H, s, ArH).
 13C NMR (CDCl3, 125 
MHz) δ: -5.3 (CH3Si), 16.7 (CH3(CH)), 16.8 (CH3(CH)), 18.5 (SiC(CH3)3), 21.9 (CH3(Calkene), 22.9 
(CH3(CArAr’)), 26.1 (CH3)3CSi), 29.8 (CH2Ar), 29.8 (CH2Ar), 35.1 (CH(CH3)), 35.2 (CH(CH3)), 42.3 
(C(CH3)(Ar)(Ar’)(CH2R)), 46.3 (CH2(Calkene), 67.4 (CH2OSi), 67.5 (CH2OSi), 116.1 (CalkeneH2), 134.9 
(CArH), 134.9 (CArH), 139.7 (CArCH2), 139.7 (C
ArCH2), 140.7 (C
Q
alkene), 164.9 (C
ArC(CH3)). m/z  [CI
+, 
isobutane] 591 [M+H]+ (100%), HRMS found [M+H]+ 591.4019, C32H59N2O4Si2 requires  
591.4013. υmax /cm
-1 (film): 2954, 2929, 2896, 2857, 1558, 1471, 1463. 
(±)-3-(2-Chlorooxazol-4-yl)-2-methylpropan-1-ol 342 
 
A 0 oC solution of chloro oxazole 319 (2.00 g, 6.90 mmol) in anhydrous THF (28 mL) was 
treated with the dropwise addition of TBAF (1 M in THF, 10.4 mL, 10.4 mmol). After 30 min, 
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the reaction mixture was warmed up to RT and stirred for 16H before being quenched with 
water (20 mL) and extracted with Et2O (3 × 50 mL). The combined organics were washed 
sequentially with water (3 × 10 mL) and brine (20 mL) before being dried over anhydrous 
Na2SO4. The solvent was evaporated under reduced pressure to give a crude product that was 
purified by flash column chromatography, elution with 0-50% Et2O:petroleum ether to yield 
alcohol 342 (1.15 g, 6.57 mmol, 95%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.92 (3H, 
d, J = 6.7, CH3), 1.97-2.06 (1H, m, CH), 2.29 (1H, br. s, OH), 2.43 (1H, ddd, J = 14.7, 7.0, 0.8, 
CH(H)Ar), 2.58 (1H, ddd, J = 14.7, 6.2, 1.1, CH(H)Ar), 3.47 (1H, dd, J = 11.0, 6.4, CH(H)OH), 3.54 
(1H, dd, J = 10.9, 5.4, CH(H)OH), 7.40 (1H, br. t, J = 0.9, 0.9, ArH). 13C NMR (CDCl3, 125 MHz) δ: 
16.6 (CH3), 29.8 (CH2Ar), 35.0 (CH), 67.0 (CH2OH), 137.4 (C
ArH), 141.5 (CArCH2), 146.6 (C
ArCl). 
m/z  [EI+] 175 [M]+ (100%), HRMS found [M]+ 175.0404, C7H10NO2Cl requires 175.0400. υmax 
/cm-1 (film): 3390, 2963, 2930, 2875, 1520. 
(±)-3-(2-Chlorooxazol-4-yl)-2-methylpropanal 343 
 
A solution of alcohol 342 (1.15 mg, 6.57 mmol) in anhydrous DCM (30 mL) was treated 
sequentially with BAIB (2.54 g, 7.88 mmol) and TEMPO (103 mg, 0.66 mmol). The resulting 
mixture was stirred at RT under an atmosphere of argon for 16h before being diluted with 
DCM (250 mL) and washed with sat’d aq. Na2S2O3 solution (2 × 60 mL), water (2 × 30 mL) and 
brine (30 mL). The organic fraction was then dried over anhydrous Na2SO4 and concentrated 
under reduced pressure to afford a crude orange oil. Purification of the crude residue by flash 
column chromatography, elution with 0-10% Et2O:petroleum ether, afforded aldehyde 343 
(1.09 g, 6.24 mmol 95%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.15 (3H, d, J = 7.2), 
2.53 (1H, ddd, J = 14.9, 7.1, 0.9, CH(H)Ar), 2.76-2.84 (1H, m, CH), 2.93 (1H, ddd, J = 14.9, 6.6, 
1.1, CH(H)Ar), 7.42 (1H, t, J = 1.0, ArH), 9.71 (1H, d, J = 1.1, CHO). 13C NMR (CDCl3, 125 MHz) δ: 
13.5 (CH3), 27.1 (CH2Ar), 45.2 (CH), 137.7 (C
ArH), 140.4 (CArCH2), 146.9 (C
Ar), 203.5 (CHO). m z 
[CI+, isobutane] 174 [M+H]+ (100%), HRMS found [M+H]+ 174.0321, C7H9NO2Cl requires 
174.0322. υmax /cm
-1 (film): 2967, 2930, 2884, 2856, 1724. 
(±)-(3S,4S)-3-((R)-1-(2-chlorooxazol-4-yl)propan-2-yl)-4-
hydroxyisochroman-1-one 344 
 
Using general procedure 1A, a solution of phthalan 131 (1.36 mg, 9.08 mmol) in anhydrous 
THF (45 mL) was treated with iPr2NH (2.67 mL, 19.1 mmol), nBuLi (1.6 M in hexanes, 11.9 mL, 
19.1 mmol) and aldehyde 343 (1.67 g, 9.63 mmol) to generate the α-hydroxy-IBF intermediate. 
Oxidative rearrangement of the crude intermediate was performed using mCPBA, (77%, 2.24 g, 
9.99 mmol) in anhydrous DCM (45 mL) to afford the crude keto-lactols. Oxidation of the lactol 
unit was performed in acetone (45 mL) using 2.5 M Jones reagent (6 mL). Purification of the 
crude residue using flash chromatography, elution with 0-20% Et2O:petroleum ether, afforded 
the keto-lactone intermediates (1.60 g, 5.21 mmol 58%) as a 2:3 ratio of syn:anti 
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diastereoisomers, as a yellow oil. According to general procedure 2A, reduction was 
performed in anhydrous DCM (20 mL) with anhydrous CeCl3 (2.19 g, 8.90 mmol), MeOH (16 
mL) and NaBH4 (243 mg, 6.68 mmol) at –78 
oC. The crude products were purified by flash 
column chromatography, elution with 0-1% MeOH:DCM, to afford the syn,syn-isochromanone 
344 (581 mg, 1.89 mmol, 21%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.20 (3H, d, J = 
6.7, CH3), 2.56-2.65 (2H, m, CH(CH3) & CH(H)Ar), 2.77-2.81 (1H, m, CH(H)Ar), 3.05 (1H, br. d, J = 
6.1, OH), 4.25 (1H, dd, J = 8.5, 1.7, CH(O2C)), 4.98 (1H, d, J = 3.6, CH(OH)), 7.47 (1H, s, ArH), 
7.50 (1H, br. d, J = 7.6, ArH), 7.53 (1H, td, J = 7.7, 1.2, ArH), 7.66 (1H, td, J = 7.5, 1.3, ArH), 8.13 
(1H, dd, J = 7.8, 1.3, ArH). 13C NMR (CDCl3, 125 MHz) 16.2 (CH3), 28.9 (CH2Ar), 33.1 (CH(CH3)), 
65.3 (CH(OH)), 84.0 (CH(O2C)), 124.3 (C
Ar), 128.0 (CArH), 129.8 (CArH), 130.4 (CArH), 134.4 (CArH), 
137.7 (CArH), 140.2 (CAr), 140.5 (CAr), 146.9 (CAr), 164.8 (CO2). m/z  [EI
+] 307 [M]+ (100%). HRMS 
found [M]+ 307.0613, C15H14NO4Cl requires 307.0611. υmax /cm
-1 (film): 3399, 3134, 2976, 2934, 
1715, 1518, 1462. 
(±)-(3R,4R)-3-((R)-1-(2-chlorooxazol-4-yl)propan-2-yl)-4-
hydroxyisochroman-1-one 345 
 
Further elution afforded afford the syn,anti-isochromanone 345 (889 mg, 2.89 mmol, 32%) as 
a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.13 (3H, d, J = 6.7, CH3), 2.27-2.28 (1H, m, OH), 
2.56-2.65 (2H, m, CH(CH3) & CH(H)Ar), 3.08 (1H, dd, J = 11.2, 1.0, CH(H)Ar), 4.21 (1H, dd, J = 
9.1, 1.6, CH(O2C)), 4.76 (1H, d, J = 3.8, CH(OH)), 7.46-7.47 (2H, m, ArH), 7.54 (1H, td, J = 7.6, 
1.2, ArH), 7.66 (1H, td, J = 7.5, 1.3, ArH), 8.13 (1H, dd, J = 7.8, 1.3, ArH). 13C NMR (CDCl3, 125 
MHz) 15.1 (CH3), 28.5 (CH2Ar), 33.1 (CH(CH3)), 65.2 (CH(OH)), 83.7 (CH(O2C)), 124.2 (C
Ar), 128.1 
(CArH), 130.0 (CArH), 130.5 (CArH), 134.5 (CArH), 137.9 (CArH), 140.1 (CAr), 140.9 (CAr), 146.4 (CAr), 
164.6 (CO2). m/z  [EI
+] 307 [M]+ (100%), HRMS found [M]+ 307.0616, C15H14NO4Cl requires 
307.0611. υmax /cm
-1 (film): 3399, 3129, 2974, 2934, 1717, 1518. 
(±)-(3R,4R)-4-hydroxy-3-((R)-1-(2-(prop-1-en-2-yl)oxazol-4-yl)propan-2-
yl)isochroman-1-one 346 
 
Syn,anti-isochromanone 345  (197 mg, 0.64 mmol), stannane 323 (251 mg, 0.69 mmol) and 
Pd(PPh3)2Cl2 (36 mg, 51 µmol) were combined together in an oven dried MW vial with 
degassed, anhydrous DMF (3.2 mL), and heated at 120 oC under MW for 12h under an 
atmosphere of argon. The crude mixture was passed through a pad of Celite and eluted with 
Et2O (50 mL). The organics were then washed with water (2 × 10) and brine (10 mL) before 
being dried over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to 
afford the crude product as a yellow oil. Purification by flash column chromatography, elution 
with 0-10% Et2O:DCM, afforded the alkenyl oxazole 346 (140 mg, 0.45 mmol, 70%), as a pale 
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yellow oil 1H NMR (CDCl3, 500 MHz) δ: 1.16 (3H, d, J = 6.7, CH3(CH)), 2.12 (3H, br. s, 
CH3(alkene)), 2.53-2.63 (2H, m, CH2Ar, CH), 2.93 (1H, d, J = 6.8, OH), 3.13-3.16 (1H, m, CH2Ar),  
4.23 (1H, dd,  J = 8.5, 1.6, CH(O2C)), 4.79 (1H, d, J = 5.4, CH(OH)), 5.32 (1H, br. t, J = 1.5, 
CalkeneH), 5.89 (1H, s, CalkeneH), 7.39 (1H, s, C
Ar
oxazoleH), 7.46 (1H, d, J = 7.7, ArH), 7.52 (1H, td, J = 
7.6, 1.2, ArH), 7,64 (1H, td, J = 7.5, 1.4, ArH), 8.14 (1H, dd, J = 7.7, 1.2, ArH). 13C NMR (CDCl3, 
125 MHz) δ: 15.9 (CH3(CH)), 19.2 (CH3(Calkene)), 28.4 (CH2Ar), 33.9 (CH(CH3)), 65.7 (CH(OH)), 
84.1 (CH(O2C)), 117.9 (CalkeneH2), 124.5 (C
ArCH2), 128.1 (C
ArH), 130.0 (CArH), 130.6 (CArH),131.8 
(CArCO2), 134.5 (C
ArH), 135.1 (CArH), 139.7 (CArCH(OH)), 140.5 (CQalkene(CH2)), 162.5 (C
Ar(alkene)), 
164.9 (CO2). m/z  [CI
+, isobutane] 314 [M+H]+ (100%), HRMS found [M+H]+ 314.1390, 
C18H20NO4 requires 314.1392. υmax /cm
-1 (film): 3372, 2961, 2928, 2880, 1713, 1666, 1605, 
1556, 1463. 
2-(3-Bromopropoxy)tetrahydro-2H-pyran S4 
 
3-bromopropanol (3.00 mL, 34.32 mmol), DHP (7.78 mL, 85.79 mmol) and TsOH.H2O (326 mg, 
1.72 mmol) were added to an oven dried flask together with anhydrous DCM (150 mL) and the 
resultant solution was stirred at RT for 16h under an atmosphere of argon. The reaction 
mixture was diluted with DCM (150 mL) before being quenched by the addition of sat’d 
aqueous NaHCO3 solution (60 mL). The organics were collected and further washed with brine 
(50 mL) and dried over anhydrous Na2SO4. The solvent was evaporated under reduced 
pressure to afford the crude product as a brown oil. Purification by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, afforded the desired alkyl bromide 
S4 (7.32 g, 33.6 mmol, 98%) as a colourless liquid. 1H NMR (CDCl3, 500 MHz) δ: 1.50-1.60 (4H, 
m, 1H: CH2(CH2)(CH2CH2O), 1H: CH2(CH2O)(CH2CH2), 2H: CH2(CH)), 1.68-1.75 (1H, m, CH2(CH)), 
1.77-1.84 (1H, m, CH2(CH2)(CH2CH2O)), 2.10-2.16 (2H, m, CH2(CH2Br)(CH2OTHP)), 3.48-3.55 (4H, 
m, 1H: CH2OTHP, 1H: CH2O(CH2CH2CH2), 2H: CH2Br), 3.83-3.89 (2H, m, 1H: CH2OTHP, 1H: 
CH2O(CH2CH2CH2)), 4.60 (1H, t, J = 2.8, CH). 
13C NMR (CDCl3, 100 MHz) δ: 19.6 
(CH2(CH2)(CH2CH2O)), 25.6 (CH2(CH2O)(CH2CH2)), 30.7 (CH2Br), 30.8 (CH2(CH)), 33.0 
(CH2(CH2Br)(CH2OTHP)), 62.4 (CH2O), 65.0 (CH2OTHP), 99.0 (CH). m/z  [CI
+, isobutane] 223 
[M+H]+ (100%), HRMS found [M+H]+ 223.0335, C8H16O2Br requires 223.0334. υmax /cm
-1 (film): 
2941, 2870, 1441. The data observed is in accordance with literature values.175 
2-(hepta-4,6-diynyloxy)tetrahydro-2H-pyran 347 
 
To a flame dried flask was added diyne 341 (300 mg, 1.54 mmol) and anhydrous THF (3 mL) 
and cooled to –78 oC under an atmosphere of argon. MeLi.LiBr (1.5 M in Et2O, 1.06 mL, 1.59 
mmol) was added dropwise and after 5 min the reaction mixture was warmed to RT and 
stirred for a further 2h. TLC analysis indicated all of starting material had been consumed. An 
anhydrous solution of bromide S4 (387 mg, 1.77 mmol) in DMPU (3 mL) was added dropwise 
at –78 oC and stirred for a further 30 min before being warmed to RT and stirred for a further 
30 min. The reaction was quenched by the addition of water (20 mL) before being extracted 
with Et2O (3 × 50 mL). The combined organics were collected and washed with water (20 mL) 
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and brine (20 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude intermediate, as a brown oil, which was dissolved 
in anhydrous THF (5 mL) and TBAF (1 M in THF, 1.70 mL, 1.70 mmol) was added and the 
reaction mixture was stirred at RT for 4h before being quenched by the addition of water (10 
mL) and extracted with Et2O (3 × 30 mL). The combined organics were washed with water (10 
mL) and brine (10 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a brown oil. Purification by flash 
column chromatography, elution with 0-7% Et2O:petroleum ether, afforded the diyne 347 (200 
mg, 1.04 mmol, 67%) as a pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 1.50-1.59 (4H, m, 1H: 
CH2(CH2)(CH2CH2O), 1H: CH2(CH2O)(CH2CH2), 2H: CH2(CH)), 1.67-1.74 (1H, m, CH2(CH)), 1.77-
1.80 (1H, m, CH2(CH2)(CH2CH2O)), 1.82 (2H, quint, J = 6.5, CH2(CH2OTHP)(CH2’)), 1.95 (1H, J = 
1.2, CalkyneH), 2.39 (2H, t, J = 7.0, CH2(alkyne)(CH2’)), 3.43-3.53 (2H, m, 1H: CH2OTHP, 1H: 
CH2O(CH2CH2CH2)), 3.78-3.88 (2H, m, 1H: CH2OTHP, 1H: CH2O(CH2CH2CH2)), 4.58 (1H, t, J = 7.0, 
CH). 13C NMR (CDCl3, 100 MHz) δ: 16.2 (CH2(alkyne)(CH2’)), 19.6 (CH2(CH2)(CH2CH2O)), 25.6 
(CH2(CH2O)(CH2CH2)), 28.4 (CH2(CH2OTHP)(CH2’), 30.7 (CH2(CH)), 62.3 (CH2O), 64.7 (CalkyneH), 
65.0 (CQalkyne), 65.8 (CH2OTHP), 68.5 (C
Q
alkyne), 77.9 (C
Q
alkyne), 99.0 (CH). m/z  [CI
+, isobutane] 193 
[M+H]+ (100%). HRMS found [M+H]+ 193.1228, C12H17O2 requires 193.1229. υmax /cm
-1 (film): 
3295, 2940, 2870, 2295, 2222, 1443, 1350. The data observed is in accordance with literature 
values.108  
(Bromoethynyl)triisopropylsilane 353 
 
Ethynyltriisopropylsilane (0.50 mL, 2.25 mmol), AgNO3 (38 mg, 0.23 mmol) and freshly 
recrystalized  NBS (441 mg, 2.48 mmol) were dissolved in acetone (12 mL) and the resultant 
solution was stirred at RT for 50 min by which time a white precipitate had formed. The 
suspension was then filtered (washed with petroleum ether) and the supernatant was 
collected and the solvent evaporated to afford the crude product as a white gum. The crude 
gum was then triturated with petroleum ether and the supernatant was collected and solvent 
evaporated to afford the bromo acetylene 353 (582 mg, 2.23 mmol, 99%) as a colourless 
liquid. 1H NMR (CDCl3, 400 MHz) δ: 1.07 (21H, app. s, TIPS). 
13C NMR (CDCl3, 100 MHz) δ: 11.4 
(CH), 18.6 (CH3), 61.8 (CalkyneBr), 83.6 (CalkyneTIPS).m/z  [EI
+] 262 [M]+ (100%), HRMS found [M]+ 
260.0602, C11H21BrSi requires 260.0596. υmax /cm
-1 (film): 2959, 2943, 2892, 2866, 2121, 1463. 
The data observed is in accordance with literature values.176 
7-(triisopropylsilyl)hepta-4,6-diyn-1-ol 354 
 
CuCl (64 mg, 0.65 mmol) was added to a flask containing nBuNH2 (30% w/w in H2O, 10 mL) 
resulting in a blue solution. NH2OH.HCl crystals were added until the blue colour dissipated, 
followed by the addition of 4-pentyn-1-ol (1.01 mL, 10.9 mmol). Within 2 min a bright orange 
salt has formed and the reaction mixture was immediately cooled to 0 oC before the dropwise 
addition of bromo acetylene 353 (2.82 g, 10.9 mmol). Immediately the reaction mixture turned 
to a burnt orange colour. After stirring for a further 5 min the reaction was diluted with water 
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(50 mL) before being extracted with Et2O (3 × 100 mL). The combined organics were washed 
with water (2 × 25 mL) and brine (25 mL) before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product as an oil. 
Purification by flash column chromatography, elution with 0-50% DCM:petroleum ether, 
afforded the desired product, diyne 354 (2.80 g, 10.6 mmol, 97%) as a pale yellow oil. 1H NMR 
(CDCl3, 500 MHz) δ:  1.06 (21H, app. s, TIPS), 1.77 (2H, quint, J = 6.6, CH2(CH2OH)(CH2Calkyne)), 
1.88 (1H, br.  s, OH), 2.40 (2H, t, J = 7.0, CH2(Calkyne)), 3.73 (2H, t, J = 6.1, CH2OH). 
13C NMR 
(CDCl3, 125 MHz) δ: 11.4 (SiCH(CH3)2), 15.9 (CH2(Calkyne)), 18.6 ((CH3)2CH), 30.9 
(CH2(CH2OSi)(CH2Calkyne)), 61.4 (CH2OH), 66.4 (Calkyne(CalkyneCH2)), 78.0 (CalkyneTIPS), 80.5 
(Calkyne(CH2)), 90.0 (Calkyne(CalkyneTIPS)). m/z  [CI
+, isobutane] 265 [M+H]+ (100%), HRMS found 
[M+H]+ 265.1990, C16H29OSi requires 265.1988. υmax /cm
-1 (film): 3325, 2940, 2862, 2222, 2106, 
1466.  
Hepta-4,6-diyn-1-ol 355 
 
Diyne 354 (219 mg, 0.83 mmol) was dissolved in anhydrous THF (4 mL) before the dropwise 
addition of TBAF (1 M in THF, 1.00 mL, 1.00 mmol) under an atmosphere of argon at RT. The 
reaction mixture was stirred for a further 2h before being quenched with water (5 mL) and 
extracted with Et2O (3 × 10 mL). The combined organics were washed with water (2 × 5 mL) 
and brine (5 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a colourless oil. Purification by flash 
column chromatography, elution with 0-100% DCM:petroleum ether, afforded diyne 355 (83 
mg, 0.77 mmol, 93%) as a pale brown oil. 1H NMR (CDCl3, 500 MHz) δ:  1.38 (1H, t, J = 5.1, OH), 
1.79 (2H, quint, J = 6.5, CH2(CH2OH)(CH2Calkyne)), 1.97 (1H, s, CalkyneH), 2.40 (2H, t, J = 7.0, 
CH2(Calkyne)), 3.75 (2H, q,  J = 5.7, CH2OH). 
13C NMR (CDCl3, 125 MHz) δ: 15.7 (CH2(Calkyne)), 30.8 
(CH2(CH2OSi)(CH2Calkyne)), 61.4 (CH2OH), 64.9 (CalkyneH), 65.2 (Calkyne(CalkyneH)), 68.4 
(Calkyne(CalkyneCH2), 77.7 (Calkyne(CH2)). m/z  [CI
+, isobutane] 109 [M+H]+ (100%), HRMS found 
[M+H]+ 109.0666, C7H9O requires 109.0653. υmax /cm
-1 (film): 3356, 3302, 2947, 2886, 2230, 
1427. The data observed is in accordance with literature values.177 
Tert-butyl(hepta-4,6-diynyloxy)dimethylsilane 356 
 
Diyne 355 (41 mg, 0.38 mmol) was dissolved in anhydrous DMF (1 mL) together with finely 
ground imidazole (52 mg, 0.76 mmol) and TBSCl (69 mg, 0.46 mmol) and stirred under argon at 
RT  for 2h. The reaction mixture was quenched with water (10 mL) and extracted with DCM (3 
× 30 mL) and the combined organics were washed sequentially with water (5 × 20 mL) and 
brine (30 mL) before being dried over anhydrous Na2SO4 and the solvent evaporated to afford 
the crude product. Purification by flash column chromatography, elution with 0-2.5% 
Et2O:petroleum ether, afforded  silyl ether 356 (79 mg, 0.36 mmol, 94%) as colourless oil. 
1H 
NMR (CDCl3, 500 MHz) δ: 0.06 (6H, s, (CH3)2Si), 0.89 (9H, s, (CH3)3CSi), 1.70-1.77 (2H, m, 
CH2(CH2OH)(CH2Calkyne)), 1.95 (1H, t,  J = 1.1, CalkyneH), 2.36 (2H, td, J = 7.1, 1.1, CH2(Calkyne)), 
3.68 (2H, t, J = 5.9, CH2OSi). 
13C NMR (CDCl3, 125 MHz) δ: -5.2 ((CH3)2Si),  15.7 (CH2(Calkyne)), 18.4 
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(SiC(CH3)3), 26.0 ((CH3)3CSi),  31.2 (CH2(CH2OSi)(CH2Calkyne)), 61.4 (CH2OSi), 64.6 (CalkyneH), 64.9 
(Calkyne(CalkyneH)), 68.6 (Calkyne(CalkyneCH2), 78.3 (Calkyne(CH2)). m/z  [CI
+, isobutane] 223 [M+H]+ 
(100%), HRMS found [M+H]+ 223.1523, C13H23OSi requires 223.1518. υmax /cm
-1 (film): 3310, 
2955, 2932, 2862, 2308, 2222, 1466. 
4-Bromopent-4-en-1-ynyl)trimethylsilane 360 
 
To a flame dried flask was added anhydrous THF (17 mL) and ethynyltrimethylsilane (0.50 mL, 
3.54 mmol) and the solution was cooled to 0 oC under an atmosphere of argon. EtMgBr (1 M in 
THF, 3.54 mL, 3.54 mmol) was added dropwise and the resultant solution was warmed to RT 
and then heated at 50 oC for 30 min before being cooled back down to RT. CuBr.Me2S was 
added to the reaction mixture and was heated to 40 oC for 30 min before 2,3-dibromopropene 
was added and the resultant mixture heated to 55 oC for 2h, under a atmosphere of argon. 
Upon cooling to 0 oC the reaction was quenched by the addition of sat’d aq. NH4Cl solution (40 
mL) and extracted with Et2O (3 × 75 mL). The combined organics were washed with water (2 × 
40 mL) and brine (40 mL) before being dried over anhydrous Na2SO4. The solvent was 
evaporated under reduced pressure to afford the crude product as a pale yellow oil. 
Purification by flash column chromatography, elution with petroleum ether, afforded vinyl 
bromide 360 (606 mg, 2.79 mmol, 79%) as a colourless liquid. 1H NMR (CDCl3, 500 MHz) δ: 0.18 
(9H, s, Si(CH3)3), 3.37 (2H, t, J = 1.6, CH2), 5.56 (1H, q, J = 1.6, CalkeneH2), 6.02 (1H, q, J = 1.6, 
CalkeneH2).
 13C NMR (CDCl3, 125 MHz) δ: 0.0 (Si(CH3)3), 32.8 (CH2), 89.0 (Calkyne(CH2)), 101.1 
(CalkyneTMS), 118.1 (CalkeneH2), 126.8 (Calkene(CH2)(CH2
’)Br). m/z  [EI+] 217 [M]+ (100%). HRMS 
found [M]+ 217.0022, C8H14BrSi requires 217.0048.
 υmax /cm
-1 (film): 2963, 2901, 2183, 1636, 
1412. 
Trimethyl(4-(tributylstannyl)pent-4-en-1-ynyl)silane 361 
 
To a flask containing magnesium turnings (282 mg, 11.6 mmol), anhydrous THF (30 mL) was 
added followed by Bu3SnCl (2.64 mL, 9.74 mmol). The mixture was sonicated under an 
atmosphere of argon at RT for 2 min before vinyl bromide 360 (2.01 g, 9.27 mmol) in 
anhydrous THF (10 mL) was added dropwise. The reaction mixture was subjected to sonication 
for 60 min. The reaction was quenched by the addition of water (50 mL) and extracted with 
Et2O (3 × 100 mL). The combined organics were washed with water (40 mL), sat’d aq. KF 
solution (2 × 50 mL) and brine (50 mL), before being dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to afford the crude product as a yellow oil. Purification 
by flash column chromatography, elution with petroleum ether, afforded the stannane 361 
(3.32 g, 7.77 mmol, 84%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 0.16 (9H, s, (CH3)3Si), 
0.88-0.97 (15H, m, CH3(CH2), CH2Sn), 1.27-1.36 (6H, m, (CH2(CH3)), 1.47-1.55 (6H, m, 
CH2(CH2Sn)(CH2CH3)), 3.17 (2H, t,  J = 1.7, CH2(alkene)(alkyne)), 5.22-5.23 (1H, m, CHalkene), 
5.90-5.91 (1H, m, CHalkene). 
13C NMR (CDCl3, 100 MHz) δ: 0.3 ((CH3)3Si), 10.0 (CH2Sn), 13.9 
(CH3(CH2)), 27.6 (CH2(CH3)), 29.3 (CH2(CH2Sn)(CH2CH3)), 31.5 (CH2(alkene)(alkyne)), 87.4 
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(Calkyne(CH2)), 104.9 (Calkyne(TMS)), 126.3 (CalkeneH2), 148.7 (Calkene). υmax /cm
-1 (film): 2955, 2924, 
1466. 
Tributyl(pent-1-en-4-yn-2-yl)stannane 362 
 
Method A: K2CO3  
Stannane 361 (191 mg, 0.45 mmol) was dissolved in MeOH (2.5 mL), together with K2CO3 (65 
mg, 0.47 mmol), and the resultant mixture was stirred at RT for 24h before being quenched by 
the addition of water (10 mL) and extracted with Et2O (3 × 30 mL). The combined organics 
were washed with water (2 × 20 mL), and brine (20 mL) before being dried over anhydrous 
Na2SO4 and concentrated under reduced pressure, to afford the crude product as a colourless 
oil. Purification by flash column chromatography, elution with petroleum ether, afforded the 
desired acetylene 362 (135 mg, 0.38 mmol, 84%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) 
δ: 0.88-0.94 (15H, m, CH3(CH2), CH2Sn), 1.26-1.33 (6H, m, (CH2(CH3)), 1.44-1.52 (6H, m, 
CH2(CH2Sn)(CH2CH3)), 2.12 (1H, J = 2.6, CalkyneH), 3.09-3.10 (2H, m, CH2(alkene)(alkyne)), 5.22-
5.23 (1H, m, CHalkene), 5.92-5.93 (1H, m, CHalkene). 
13C NMR (CDCl3, 100 MHz) δ: 9.8 (CH2Sn), 13.8 
(CH3(CH2)), 27.5 (CH2(CH3)), 29.2 (CH2(CH2Sn)(CH2CH3)), 29.7 (CH2(alkene)(alkyne)), 71.2 
(CalkyneH), 82.2 (Calkyne(CH2)), 126.4 (CalkeneH2), 148.3 (Calkene). υmax /cm
-1 (film): 3310, 2955, 2947, 
2855, 2122, 1458, 1422. 
Method B: TBAF 
Stannane 361 (114 mg, 0.27 mmol) was dissolved in anhydrous THF (1.3 mL) and cooled to 0 oC 
under an atmosphere of argon, before the dropwise addition of TBAF (1 M in THF, 0.29 mL, 
0.29 mmol) and the resultant mixture was stirred for 30 min, before being warmed to RT and 
stirred for an additional 2h. The reaction was quenched by the addition of water (10 mL) and 
extracted with Et2O (3 × 20 mL). The combined organics were washed with water (2 × 10 mL), 
and brine (15 mL) before being dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to afford the crude product as a colourless oil. Purification by flash column 
chromatography, elution with petroleum ether, afforded the desired acetylene 362 (71 mg, 
0.20 mmol, 75%) as a colourless oil. The spectral and physical data obtained for 362, via 
Method B, matched that obtained via Method A. 
Tert-butyldimethyl(pent-4-ynyloxy)silane S5 
 
4-pentyn-1-ol (940 µL, 10.34 mmol) was dissolved in anhydrous DMF (10 mL) together with 
finely ground imidazole (1.41 g, 20.7 mmol) and TBSCl (1.64 g, 10.86 mmol) and stirred under 
argon at RT for 2h. The reaction mixture was diluted with Et2O (50 mL) before being washed 
sequentially with water (5 × 80 mL) and brine (50 mL) before being dried over anhydrous 
Na2SO4, and the solvent evaporated to afford the crude product. Purification by flash column 
chromatography, elution with 0-1.5% Et2O:petroleum ether, afforded the desired silyl ether S5 
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(1.99 g, 10.0 mmol, 97%) as colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 0.06 (6H, s, (CH3)2Si)), 
0.89 (9H, s, (CH3)3CSi), 1.69-1.76 (2H, m, CH2(CH2OSi)(CH2Calkyne), 1.92 (1H, t, J = 2.7, CalkyneH), 
2.27 (2H, td, J = 7.1, 2.7, CH2(Calkyne)), 3.70 (2H, t, J = 6.1, CH2OSi). 
13C NMR (CDCl3, 100 MHz) δ: -
5.2 ((CH3)2Si), 15.0 (CH2Br), 18.4 (SiC(CH3)3), 26.0 ((CH3)3CSi), 31.7 (CH2(CH2OSi)(CH2Calkyne)), 
61.6 (CH2OSi), 68.3 (CalkyneH), 84.4 (Calkyne(CH2)). m/z  [CI
+, isobutane] 199 [M+H]+ (100%), HRMS 
found [M+H]+ 199.1517, C11H23OSi requires 199.1518. υmax /cm
-1 (film): 3310, 2955, 2932, 
2862, 2235, 1466. The data observed is in accordance with literature values.178 
(5-bromopent-4-ynyloxy)(tert-butyl)dimethylsilane 363 
 
Acetylene S5 (1.62 mg, 8.16 mmol), AgNO3 (139 mg, 0.82 mmol) and freshly recrystallised NBS 
(1.53 g, 8.57 mmol) were dissolved in anhydrous acetone (40 mL), and the resultant solution 
was stirred at RT under an atmosphere of argon. The reaction mixture was stirred for 50 min 
by which time a white precipitate had formed. Reaction completion was indicated by TLC 
analysis. The suspension was filtered (elution with petroleum ether) and the supernatant was 
collected and the solvent evaporated to afford the crude product as a white gum. The crude 
gum was then triturated with petroleum ether and the supernatant was collected and solvent 
evaporated to afford bromo acetylene 363 (2.23 g, 8.04 mmol, 99%) as a colourless liquid. 1H 
NMR (CDCl3, 400 MHz) δ: 0.06 (6H, s, (CH3)2Si), 0.90 (9H, s, (CH3)3CSi), 1.72 (2H, m, 
CH2(CH2OTBS)(CH2Calkyne)), 2.30 (2H, t,  J = 7.1, CH2(Calkyne)), 3.68 (2H, t, J = 5.9, CH2OTBS). 
13C 
NMR (CDCl3, 100 MHz) δ: -5.2 ((CH3)2Si), 16.3 (CH2(Calkyne)), 18.5 (SiC(CH3)3), 26.1 ((CH3)3CSi),  
31.4 (CH2(CH2OSi)(CH2Calkyne)), 61.5 (CH2OTBS), 77.4 (Calkyne), 80.1 (Calkyne). m/z  [CI
+, isobutane] 
277 [M+H]+ (100%), HRMS found [M+H]+ 277.0626, C11H22OBrSi requires 277.0623. υmax /cm
-1 
(film): 2955, 2932, 2863, 1466. The data observed is in accordance with literature values.177 
5-Bromopent-4-yn-1-ol 364 
 
Method A: Desilylation of Silyl Ether 363 
Silyl ether 363 (849 mg, 3.06 mmol) was dissolved in anhydrous THF (12 mL), before the 
dropwise addition of TBAF (1 M in THF, 3.52 mL, 3.52 mmol) under an atmosphere of argon at 
RT. The reaction mixture was stirred for a further 60 min before being quenched with water 
(10 mL) and extracted with Et2O (3 × 20 mL). The combined organics were washed with water 
(2 × 5 mL) and brine (5 mL), before being dried over anhydrous Na2SO4. The solvent was 
evaporated under reduced pressure to afford the crude product as a colourless oil. Purification 
by flash column chromatography, elution with 0-25% Et2O:petroleum ether, afforded alcohol 
364 (493 mg, 3.02 mmol, 99%) as a pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 1.57 (1H, s, 
OH), 1.76 (2H, app. quint, J = 6.6, CH2(CH2OH)(CH2’)), 2.34 (2H, t, J = 7.0, CH2(alkyne)), 3.74 (2H, 
t, J = 6.1, CH2OH). 
113 NMR (CDCl3, 100 MHz) δ: 16.3 (CH2(alkyne)), 31.0 (CH2(CH2OH)(CH2’)), 
38.4 (Calkyne) 61.5 (CH2OH), 79.7 (Calkyne). The data observed is in accordance with literature 
values.115 
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Method B: Bromination of Acetylene 364 
In the absence of light, KOH (4.94 g, 88.1 mmol) was dissolved in distilled water (85 mL), 
cooled to 0 oC, before Br2 (1.18 mL, 23.1 mmol) was added, followed by the addition of pent-4-
yn-1-ol (2.00 mL, 22.0 mmol). The resultant reaction mixture was stirred at 0 oC for 3h. The 
aqueous reaction mixture was extracted with Et2O (3 × 100 mL) and the combined organics 
were washed with water (20 mL) and brine (20 mL), before being dried over anhydrous 
Na2SO4. The solvent was evaporated under reduced pressure to afford the crude product. 
Purification by flash column chromatography, elution with 0-25% Et2O:petroleum ether, 
afforded alcohol 364 (2.33 g, 14.3 mmol, 65%) as a pale yellow oil. The spectral and physical 
data obtained for 2364, via Method B, matched that obtained via Method A. 
9-(Tributylstannyl)deca-9-en-4,6-diyn-1-ol 367 
 
CuCl (14 mg, 0.14 mmol) was added to a flask containing nBuNH2 (30% w/w in H2O, 2 mL) 
resulting in a blue solution. NH2OH.HCl crystals were added until the blue colour dissipated, 
followed by the addition of acetylene 362 (815 mg, 2.30 mmol) Within 2 min a bright orange 
salt has formed and the reaction mixture was immediately cooled to 0 oC before the dropwise 
addition of bromo acetylene 364 (450 mg, 2.76 mmol). Immediately the reaction mixture 
turned to a burnt orange colour. After stirring for a further 5 min, the reaction was diluted 
with water (10 mL) before being extracted with Et2O (3 × 50 mL). The combined organics were 
washed with water (2 × 15 mL) and brine (25 mL), before being dried over anhydrous Na2SO4. 
The solvent was evaporated under reduced pressure to afford the crude product as an oil. 
Purification by flash column chromatography, elution with 0-75% DCM:petroleum ether, 
afforded the desired diyne 367 (802 mg, 1.83 mmol, 80%) as a pale yellow oil. 1H NMR (CDCl3, 
400 MHz) δ: 0.88-0.97 (15H, m, CH3(CH2), CH2Sn), 1.27-1.36 (6H, m, (CH2(CH3)), 1.46-1.55 (6H, 
m, CH2(CH2Sn)(CH2CH3)), 1.78 (2H, quint, J = 6.4, CH2(CH2OH)(CH2’)), 2.40 (2H, t, J = 6.9, 
CH2(alkyne)(CH2’)), 3.18 (2H, br. s, CH2(alkene)(alkyne), 3.75 (2H, q, J = 5.9, CH2OH), 5.24-5.24 
(1H, m, CalkeneH), 5.91-5.92 (1H, m, CalkeneH). 
13C NMR (CDCl3, 100 MHz) δ: 9.8 (CH2Sn), 13.8 
(CH3(CH2)), 15.9 (CH2(alkyne)(CH2’)), 27.5 (CH2(CH3)), 29.2 (CH2(CH2Sn)(CH2CH3)), 30.5 
(CH2(alkene)(alkyne)), 31.2 (CH2(CH2OH)(CH2’)), 61.5 (CH2OH), 65.9 (Calkyne), 68.1 (Calkyne), 75.2 
(Calkyne), 77.5 (Calkyne), 126.9 (CalkeneH2), 147.9 (Calkene).  m/z  [CI
+, isobutane] 437 [M+H]+ (100%). 
HRMS found [M+H]+ 437.1871, C22H37O
120Sn requires 437.1871. υmax /cm
-1 (film): 3315, 2955, 
2927, 2871, 2854, 1458. 
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Tert-butyldimethyl(9-(tributylstannyl)deca-9-en-4,6-diynyloxy)silane 365 
 
Method A: Cadiot-Chodkiewicz Coupling from Acetylene 362 
CuCl (9 mg, 89 µmol) was added to a flask containing nBuNH2 (30% w/w in H2O, 1.5 mL) 
resulting in a blue solution. NH2OH.HCl crystals were added until the blue colour dissipated, 
followed by the addition of acetylene 362 (525 mg, 1.48 mmol) was added. Within 2 min a 
bright orange salt has formed and the reaction mixture was immediately cooled to 0 oC before 
the dropwise addition of bromo acetylene 363 (373 mg, 1.35 mmol). Immediately the reaction 
mixture turned to a burnt orange colour. After stirring for a further 5 min the reaction was 
diluted with water (10 mL) before being extracted with Et2O (3 × 50 mL). The combined 
organics were washed with water (2 × 15 mL) and brine (25 mL), before being dried over 
anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the crude 
product as an oil. Purification by flash column chromatography, elution with 0-1% 
Et2O:petroleum ether, afforded diyne 365 (511 mg, 0.93 mmol, 69%) as a colourless oil. 
1H 
NMR (CDCl3, 500 MHz) δ: 0.05 (6H, s, (CH3)2Si), 0.88-0.96 (15H, m, CH3(CH2), CH2Sn), 0.89 (9H, 
s, (CH3)3CSi), 1.28-1.35 (6H, m, (CH2(CH3)), 1.47-1.55 (6H, m, CH2(CH2Sn)(CH2CH3)), 1.72 (2H, 
quint, J = 6.5, CH2(CH2OTBS)(CH2’)), 2.35 (2H, t, J = 7.0, CH2(alkyne)(CH2’)), 3.18 (2H, s, 
CH2(alkene)(alkyne), 3.68 (2H, t, J = 6.0, CH2OTBS), 5.24 (1H, br. d, J = 1.7, CalkeneH), 5.91 (1H, 
br. d, J = 1.7, CalkeneH). 
13C NMR (CDCl3, 125 MHz) δ: -5.2 ((CH3)2Si), 9.8 (CH2Sn), 13.8 (CH3CH2), 
15.8 (CH2(alkyne)(CH2’)), 18.4 (SiC(CH3)3), 26.0 ((CH3)3CSi), 27.5 (CH2(CH3)), 29.2 
(CH2(CH2Sn)(CH2CH3)), 30.6 (CH2(alkene)(alkyne)), 31.5 (CH2(CH2OTBS)(CH2’)), 61.5 (CH2OTBS), 
65.5 (Calkyne), 68.3 (Calkyne), 74.8 (Calkyne), 78.1 (Calkyne), 126.8 (CalkeneH2), 148.0 (Calkene). m/z  [CI
+, 
isobutane] 553 [M+H]+ (100%), HRMS found [M+H]+ 553.2890, C28H53OSi
120Sn requires 
553.2893. υmax /cm
-1 (film): 2954, 2928, 2856, 1472, 1464. 
Method B: Silylation of Alcohol 367 
Alcohol 367 (1.88 g, 4.30 mmol) was dissolved in anhydrous DMF (7 mL), to which imidazole 
(585 mg, 8.60 mmol) and TBSCl (745 mg, 4.94 mmol) were added. The resultant suspension 
was stirred at RT under an atmosphere of argon. After 3h, TLC analysis indicated reaction 
completion. Water (30 mL) was added before extraction with Et2O (3 × 50 mL). The combined 
organic extracts were washed with water (2 × 30 mL) and brine (30 mL), dried over anhydrous 
Na2SO4, and the solvent was evaporated to yield the crude product as a pale yellow oil. 
Purification by flash column chromatography, elution with 0-2% Et2O:petroleum ether, yielded 
diyne 365 (2.24 g, 4.06 mmol, 94%) as a colourless oil. The spectral and physical data obtained 
for 365, via Method B, matched that obtained via Method A. 
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4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(10-(tert-
butyldimethylsilyloxy)deca-1-en-4,6-diyn-2-yl)oxazole 368 
 
Chloro oxazole 319 (131 mg, 0.45 mmol), stannane 365 (270 mg, 0.49 mmol) and Pd(PPh3)4 (32 
mg, 45 µmol) were combined together in an oven dried MW vial with degassed anhydrous 
DMF (2 mL), and heated under MW irradiation at 120 oC for 12h, under an atmosphere of 
argon. The crude mixture was passed through a pad of Celite and eluted with Et2O (30 mL). 
The organics were then washed with water (4x10 mL) and brine (10 mL), before being dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the 
crude product as a brown oil. Purification by flash column chromatography, elution with 0-2% 
Et2O:petroleum ether, afforded alkenyl oxazole 368 (164 mg, 0.32 mmol, 70%) as a pale yellow 
oil. 1H NMR (CDCl3, 400 MHz) δ: 0.03 (6H, s, (CH3)2Si), 0.06 (6H, s, (CH3)2Si), 0.89 (18H, br. s, 
(CH3)3Si x2), 0.90 (3H, d, J = 6.9, CH3(CH)), 1.73 (2H, quint, J = 6.5, CH2(CH2OTBS)(CH2’)), 1.94-
2.02 (1H, m, CH(CH3)), 2.30 (1H, dd, J = 14.9, 7.5, CH(H)Ar), 2.37 (2H, t, J = 7.0, 
CH2(alkyne)(CH2’)), 2.62 (1H, dd, J = 14.0, 6.9, CH(H)Ar), 3.43-3.51 (2H, m, CH2OTBS(CH)), 3.51 
(2H, br. s, CH2(alkene)(alkyne), 3.69 (2H, t, J = 5.9, CH2OTBS), 5.78 (1H, br. s, CalkeneH), 6.09 (1H, 
br. s, CalkeneH), 7.31 (1H, s, ArH). 
13C NMR (CDCl3, 100 MHz) δ: -5.3 ((CH3)2Si), -5.2 ((CH3)2Si), 15.8 
(CH2(alkyne)(CH2’)), 16.7 (CH3(CH)), 18.4 (SiC(CH3)3), 18.5 (SiC(CH3)3, 23.0 (CH2(alkene)(alkyne), 
26.1 ((CH3)3CSi), 26.1 ((CH3)3CSi),  29.8 (CH2Ar), 31.4 (CH2(CH2OTBS)(CH2’)), 35.2 (CH(CH3)), 61.5 
(CH2OTBS), 65.2 (Calkyne), 67.5 (CH2OTBS(CH)), 68.9 (Calkyne), 72.6 (Calkyne), 78.6 (Calkyne), 118.2 
(CalkeneH2), 130.6 (C
Ar(CH2)), 134.9 (C
ArH), 140.8 (Calkene(C
Ar)), 160.6 (CAr(alkene)). m/z  [FAB+, 
NOBA] 516 [M+H]+ (100%), HRMS found [M+H]+ 516.3329, C29H50O3Si2  requires 516.3329. υmax 
/cm-1 (film): 2954, 2928, 2857, 1590, 1531. 
1-((3-Bromobut-3-enyloxy)methyl)-4-methoxybenzene 375 
 
3-bromobut-3-en-1-ol (1.22 g, 8.13 mmol) was dissolved in anhydrous DCM (40 mL) and 
cooled to 0 oC before the dropwise addition of freshly prepared 4-methoxybenzyl-2,2,2-
trichloroacetimidate (2.76 g, 9.76 mmol). CSA (94 mg, 0.41 mmol) was added to the reaction 
mixture and the resultant solution was stirred at 0 oC under argon before being warmed to RT 
and stirred for a further 16h. The reaction mixture was filtered through a pad of Celite, and the 
resultant organics were washed sequentially with sat’d aq. NaHCO3 solution (10 mL), water (2 
× 10 mL) and brine (10 mL), before being dried over anhydrous Na2SO4, and the solvent 
evaporated to afford the crude product. Purification by flash column chromatography, elution 
with 0-2.5% Et2O:petroleum ether, afforded PMB-ether 375 (1.87 g, 6.91 mmol, 85%) as 
colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 2.71 (2H, td, J = 6.4, 0.6, CH2(alkene)(CH2OPMB)), 
3.63 (2H, t, J = 6.4, CH2OPMB), 5.48 (1H, br. d, J = 1.6, CalkeneH), 5.66 (1H, br. d, CalkeneH), 6.88 
(2H, d, J = 8.6, CArH), 7.26 (2H, d, J = 8.6, CArH). 13C NMR (CDCl3, 125 MHz) δ: 41.9 
(CH2(alkene)(CH2OPMB)), 55.4 (CH3O), 67.6 (CH2OPMB), 72.9 (OCH2Ar) 113.9 (ArH), 118.5 
(CalkeneH2), 129.4 (C
ArH), 159.4 (CQalkene). m/z  [EI
+] 270 [M]+ (100%), HRMS found [M]+ 270.0258, 
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C12H15O2Br requires 270.0255. υmax /cm
-1 (film): 2936, 2909, 2859, 2835, 1632, 1613 1586, 
1512, 1462. 
Tributyl(4-(4-methoxybenzyloxy)but-1-en-2-yl)stannane 376 
 
Vinyl bromide 375 (1.22 g, 4.52 mmol) was dissolved in anhydrous THF (15 mL) and cooled to –
78 oC under an atmosphere of argon. tBuLi (1.9 M in pentane, 4.75 mL, 9.03 mmol) was added 
quickly over 1 min, and the resultant solution was stirred for 10 min, before Bu3SnCl (1.26 mL, 
4.65 mmol) was added. After stirring to 10 min at –78 oC, the reaction was quenched by the 
addition of water (20 mL), and allowed to warm to RT, before being extracted with Et2O (3 × 50 
mL). The resultant organics were washed sequentially with water (20 mL) and brine (20 mL) 
before being dried over anhydrous Na2SO4, and the solvent evaporated, to afford the crude 
product. Purification by flash column chromatography, elution with 0-1.25% Et2O:petroleum 
ether, afforded vinyl stannane 376 (1.86 g, 3.86 mmol, 86%) as a colourless oil. 1H NMR (CDCl3, 
500 MHz) δ: 0.84-0.90 (15H, m, CH3(CH2), CH2Sn), 1.25-1.34 (6H, m, CH2(CH3)), 1.42-1.50 (6H, 
m, CH2(CH2Sn)(CH2CH3)), 2.55 (2H, t, J = 7.1, CH2(alkene)(CH2OPMB)), 3.45 (2H, t, J = 7.1, 
CH2OPMB), 3.80 (3H, s, OCH3), 4.44 (2H, s, CH2Ph(p-OMe)), 5.18-5.18 (1H, m, CalkeneH), 5.73-
5.75 (1H, m, CalkeneH), 6.87 (2H, d, J = 8.6, ArH), 7.26 (2H, d, J = 8.6, ArH). 
13C NMR (CDCl3, 125 
MHz) δ: 9.8 (CH2Sn), 13.8 (CH3(CH2)), 27.6 (CH2(CH3)), 29.2 (CH2(CH2Sn)(CH2CH3)), 41.5 
(CH2(alkene)(CH2OPMB)), 55.4 (OCH3), 70.1 (CH2OPMB), 72.8 (CH2Ph(p-OMe)), 113.9 (C
ArH),  
127.0 (CalkeneH2), 129.5 (C
ArH), 130.7 (CAr(CH2O)), 151.7 (C
Q
alkene), 159.3 (C
Ar(OCH3)). m/z  [CI
+, 
isobutane] 483 [M+H]+ (100%), HRMS found [M+H]+ 483.2313,  C24H43O2
120Sn requires 
483.2290. υmax /cm
-1 (film): 2955, 2924, 2851, 1613, 1512, 1462. 
(4-(4-methoxybenzyloxy)but-1-en-2-yl)trimethylstannane 377 
 
Vinyl bromide 375 (2.29 g, 8.46 mmol) was dissolved in anhydrous THF (56 mL) and cooled to –
78 oC under an atmosphere of argon. tBuLi (1.9 M in pentane, 9.34 mL, 17.7 mmol) was added 
over 5 min, and the resultant solution was stirred for 10 min before being treated Me3SnCl (1 
M in THF, 11.0 mL, 11.0 mmol). The resultant solution was stirred at –78 oC for 20 min before 
being quenched by the addition of water (20 mL) and was allowed to warm to RT before being 
extracted with Et2O (3 × 50 mL). The resultant organics were washed sequentially with water 
(20 mL) and brine (20 mL), before being dried over anhydrous Na2SO4 and the solvent was 
evaporated to afford the crude product. Purification by flash column chromatography, elution 
with 0-1.5% Et2O:petroleum ether, afforded the desired stanane 377 (2.65 g, 7.45 mmol, 88%) 
as colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.10 (9H, s, (CH3)3Sn), 2.57 (2H, tt, J = 6.8, 1,2, 
CH2(alkene)), 3.47 (2H, t, J = 6.8, CH2OPMB), 3.80 (3H, s, OCH3), 4.43 (2H, s, CH2Ar), 5.22 (1H, 
dt, J = 2.7, 1.1, CalkeneH), 5.72 (1H, dt, J = 2.7, 1.5, CalkeneH), 6.87 (2H, d, J = 8.7, ArH), 7.25 (2H, d, 
J = 8.8, ArH). 13C NMR (CDCl3, 125 MHz) δ: -9.2 ((CH3)3Sn), 40.9 (CH2(alkene)), 55.3 (OCH3), 69.9 
(CH2OPMB), 72.7 (CH2Ar), 113.8 (C
ArH),  126.5 (CalkeneH2), 129.4 (C
ArH), 130.5 (CAr(CH2O)), 152.4 
(CQalkene), 159.1 (C
Ar(OCH3)). m/z  [CI
+, isobutane] 357 [(M+H]+ (28%), HRMS found [M+H]+ 
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357.0875, C15H25O
120Sn  requires 357.0877. υmax /cm
-1 (film): 2934, 2907, 2853, 2839, 1613, 
1513, 1464.  
4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(4-(4-
methoxybenzyloxy)but-1-en-2-yl)oxazole 378 
 
Method A: Stille Coupling with Tributylstannane 377 
Chloro oxazole 319 (57 mg, 197 µmol), stannane 377 (2.09 g, 210 µmol) and Pd(PPh3)4 (18 mg, 
16 µmol) were combined together in an oven dried MW with degassed anhydrous DMF (1 mL) 
and heated at 120 oC under MW irradiation for 12h under an atmosphere of argon. The crude 
mixture was passed through a pad of Celite and silica, and eluted with Et2O (30 mL). The 
organics were then washed with water (2 × 5 mL) and brine (5 mL) before being dried 
anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the crude 
product as a yellow oil. Purification by flash column chromatography, elution with 0-10% 
Et2O:petroleum ether, afforded alkenyl oxazole 378 (65 mg, 0.15 mmol, 74%), as a colourless 
oil. 1H NMR (CDCl3, 500 MHz) δ: 0.04 (6H, s, (CH3)2Si ), 0.90 (9H, s, (CH3)3C), 0.91 (3H, d, J = 7.2, 
(CH3(CH)), 1.94-2.02 (1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.28 (1H, ddd, J = 15.2, 7.2, 0.8, 
CH2Ar), 2.62 (1H, ddd, J = 14.7, 8.4, 0.6, CH2Ar), 2.83 (2H, td, J = 6.4, 0.8, 
CH2(alkene)(CH2OPMB)), 3.44 (1H, dd, J = 9.2, 5.6, CH2OTBS), 3.49 (1H, dd, J = 9.7, 5.6, 
CH2OTBS), 3.70 (2H, t, J = 6.8, CH2OPMB), 3.80 (3H, s, OCH3), 4.46 (2H, s, OCH2Ph(p-OCH3)), 
5.41 (1H, br. d, J = 1.2, CalkeneH), 5.99 (1H, br. s, CalkeneH), 6.86 (2H, d, J = 8.4, ArH), 7.24 (2H, d, J 
= 8.8, ArH), 7.29 (1H, s, CoxazoleH). 
13C NMR (CDCl3, 125 MHz) δ: -5.2 ((CH3)2Si), 16.7 (CH3(CH)), 
18.5 (SiC(CH3)3), 26.1 ((CH3)3CSi), 29.9 (CH2Ar), 33.2 (CH2(alkene)(CH2OPMB)), 35.3 (CH(CH3)), 
55.4 (OCH3), 67.6 (CH2OTBS), 68.6 (CH2OPMB), 72.6 (CH2Ph(p-OCH3)), 113.9 (C
ArH), 118.5 
(CalkeneH2), 129.4 (C
ArH), 130.7 (Coxazole(CH2)), 133.3 (C
Ar(CH2O)), 134.5 (CoxazoleH),, 140.7 
(CQalkene), 159.3 (C
Ar(OCH3)), 161.7 (C
Ar(Calkene)). m/z  [CI
+, isobutane] 446 [M+H]+ (100%), HRMS 
found [M+H]+ 446.2729, C25H40NO4Si requires 446.2727. υmax /cm
-1 (film): 2955, 2928, 2855, 
1613, 1589, 1512, 1462. 
Method B: Stille Coupling with Trimethylstannane 377 
Under analogous conditions to Method A above, starting from chloro oxazole 319 (1.18 g, 4.08 
mmol), stannane 376 (4.35 mmol), Pd(PPh3)4 (377 mg, 0.33 mmol), and DMF (16 mL), the 
desired alkenyl oxazole 378 1.53 mg, 3.43 mmol, 84%) was accessed as a colourless oil. The 
spectral and physical data obtained for 378, via Method B, matched that obtained via Method 
A. 
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3-(4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)oxazol-2-yl)but-3-en-1-
ol 379 
 
PMB ether 378 (1.08 g, 2.52 mmol) was dissolved in DCM (12 mL) and water (0.6 mL) and 
cooled to 0 oC. DDQ was added and the resultant solution was stirred for 10 min before being 
warmed to RT and stirred for a further 25 min. The crude mixture was passed through a pad of 
Celite and eluted with DCM (30 mL). The organics were then washed with sat’d aq. NaHCO3 
solution (2 × 5 mL) and brine (2 × 5 mL), before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product as a brown oil. 
Purification by flash column chromatography, elution with 0-30 % Et2O:petroleum ether, 
afforded alcohol 379 (696 mg, 2.14 mmol, 88%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) 
δ: 0.03 (6H, s, (CH3)2Si ), 0.89 (9H, s, (CH3)3C), 0.90 (3H, d, J = 6.8, (CH3(CH)), 1.95-2.01 (1H, m, 
CH(CH3)(CH2Ar)(CH2OTBS)), 2.29 (1H, ddd, J = 14.6, 8.1, 0.8, CH2Ar), 2.64 (1H, ddd, J = 14.6, 5.9, 
0.9, CH2Ar), 2.76-2.78 (2H, m, CH2(alkene)(CH2OH)), 3.44 (2H, d, J = 5.7, CH2OTBS), 3.82 (2H, 
dd, J = 11.0, 5.6, CH2OH), 4.06 (1H, t, J = 5.8, OH), 5.41 (1H, br. d, J = 1.0, CalkeneH), 5.97 (1H, br. 
d, J = 1.0, CalkeneH), 7.32 (1H, s, ArH). 
13C NMR (CDCl3, 125 MHz) δ: -5.3 ((CH3)2Si), -5.2 ((CH3)2Si), 
16.6 (CH3(CH)), 18.5 (SiC(CH3)3), 26.1 ((CH3)3CSi), 29.6 (CH2Ar), 35.2 (CH(CH3)), 37.5 
(CH2(alkene)(CH2OH)), 62.3 (CH2OH), 67.5 (CH2OTBS), 119.5 (CalkeneH2), 134.6 (Coxazole(CH2)), 
134.9 (CoxazoleH), 140.4 (C
Q
alkene), 162.3 (C
Ar(Calkene)). m/z  [CI
+, isobutane] 326 [M+H]+ (100%), 
HRMS found [M+H]+ 326.2153, C17H32NO3Si requires 326.2151. υmax /cm
-1 (film): 3356, 2955, 
2928, 2886, 2859, 1593, 1528, 1462. 
4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(5-(trimethylsilyl)pent-
1-en-4-yn-2-yl)oxazole 384 
 
Chloro oxazole 319 (84 mg, 0.29 mmol), stannane 361 (136 mg, 0.32 mmol) and Pd(PPh3)2Cl2 
(16 mg, 23 µmol) were combined together in an oven dried MW vial with degassed anhydrous 
DMF (2 mL) and heated 120 oC under MW for 12h under an atmosphere of argon. The crude 
mixture was passed through a pad of Celite and eluted with Et2O (30 mL). The organics were 
then washed with water (2 × 5) and brine (5 mL) before being dried over anhydrous Na2SO4. 
The solvent was evaporated under reduced pressure to afford the crude product as a yellow 
oil. Purification by flash column chromatography, elution with 0-2% Et2O:petroleum ether, 
afforded alkenyl oxazole 384 (94 mg, 0.24 mmol, 83%), as a colourless oil. 1H NMR (CDCl3, 400 
MHz) δ:  0.03 (6H, s, (CH3)2Si ), 0.19 (9H, s, (CH3)3Si), 0.90 (9H, s, (CH3)3C), 0.91 (3H, d, J = 6.7, 
(CH3)CH), 1.95-2.03 (1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.30 (1H, ddd, J = 14.4, 7.8, 0.8, 
CH(H)Ar), 2.63 (1H, ddd, J = 14.6, 6.2, 0.9, CH(H)Ar), 3.43-3.50 (4H, m,  CH2OTBS, CH2(Calkyne)), 
5.81 (1H, br. d, J = 0.8, CalkeneH), 6.09 (1H, br. d, J = 0.9, CalkeneH), 7.31 (1H, s, ArH). 
13C NMR 
(CDCl3, 100 MHz) δ: -5.2 ((CH3)2Si), 0.2 ((CH3)3Si), 16.7 (CH3(CH)), 18.5 (SiC(CH3)3), 23.5 
(CH2(Calkyne)(Calkene), 26.1 ((CH3)3CSi), 29.8 (CH2Ar), 35.2 (CH(CH3)), 67.5 (CH2OTBS), 88.8 
(Calkyne(CH2)), 102.5 (Calkyne (TMS)), 118.0 (CalkeneH2), 131.1 (C
Ar(CH2)), 134.8 (C
ArH), 140.8 
(Calkene(C
Ar)), 160.9 (CAr(Calkene)). m/z  [FAB
+, NOBA] 392 [M+H]+ (100%), HRMS found [M+H]+ 
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392.2438,  C21H38NO2Si2 requires 392.2441. υmax /cm
-1 (film): 2955, 2932, 2901, 2855, 2183, 
1589, 1525, 1466. 
4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(pent-1-en-4-yn-2-
yl)oxazole 385 
 
TMS-acetylene 384 (70 mg, 0.18 mmol) was dissolved in MeOH (1 mL), together with K2CO3 (26 
mg, 0.19 mmol), and the resultant mixture was stirred at RT for 24h, before being quenched by 
the addition of water (5 mL), and extracted with Et2O (3 × 15 mL). The combined organics were 
washed with water (2 × 5 mL) and brine (5 mL), before being dried over anhydrous Na2SO4, 
and concentrated under reduced pressure to afford the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 0-5% Et2O:petroleum ether, 
afforded the desired acetylene 385 (51 mg, 0.16 mmol, 89%) as a colourless oil. 1H NMR (CDCl3, 
400 MHz) δ: 0.03 (6H, s, (CH3)2Si ), 0.90 (9H, s, (CH3)3C), 0.91 (3H, d, J = 6.7, (CH3)CH), 1.95-2.03 
(1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.21 (1H, t, J = 2.6, CalkyneH), 2.31 (1H, dd, J = 14.4, 7.9, 
CH(H)Ar), 2.63 (1H, ddd, J = 14.6, 6.1, 0.5, CH(H)Ar), 3.43-3.51 (4H, m,  CH2OTBS, CH2(Calkyne)), 
5.82 (1H, br. s, CalkeneH), 6.10 (1H, br s, CalkeneH), 7.31 (1H, s, ArH). 
13C NMR (CDCl3, 100 MHz) δ: -
5.2 ((CH3)2Si), 16.7 (CH3(CH)), 18.5 (SiC(CH3)3), 22.2 (CH2(Calkyne)(Calkene), 26.1 ((CH3)3CSi), 29.9 
(CH2Ar), 35.3 (CH(CH3)), 67.5 (CH2OTBS), 72.0 (CalkyneH), 80.2 (Calkyne(CH2)), 118.0 (CalkeneH2), 
130.9 (CAr(CH2)), 134.8 (C
ArH), 140.9 (Calkene(C
Ar)), 160.8 (CAr(Calkene)). 
(E)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(pent-2-en-4-yn-2-
yl)oxazole 386 
 
Under analogous conditions and scale to the procedure described above for the synthesis of 
acetylene 385, except with a reaction temperature of 35 oC, enyne 386 (30 mg, 94 µmol, 52%) 
was generated, as a colourless oil. 1H NMR (CDCl3, 400 MHz) δ: 0.03 (6H, s, (CH3)2Si ), 0.89 (9H, 
s, (CH3)3C), 0.91 (3H, d, J = 6.8, (CH3)CH), 1.96-2.04 (1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.30 
(3H, br. d, J = 0.8, CH3(Calkene)), 2.32 (1H, ddd, J = 14.5, 7.8, 0.6, CH2Ar), 2.64 (1H, ddd, J = 14.6, 
6.1, 0.8, CH2Ar), 3.43-3.50 (3H, m,  CH2OTBS, CalkyneH), 6.39-6.40 (1H, m, CalkeneH), 7.32 (1H, s, 
ArH). 13C NMR (CDCl3, 400 MHz) δ: -5.2 ((CH3)2Si), 16.0 (CH3(Calkene)) 16.7 (CH3(CH)), 18.5 
(SiC(CH3)3), 26.1 ((CH3)3CSi), 29.9 (CH2Ar), 35.2 (CH(CH3)), 67.5 (CH2OTBS), 80.9 (C
Q
alkyne), 86.7 
(CalkyneH), 110.1 (CalkeneH), 135.1 (C
ArH), 137.3 (CAr(CH2)), 141.6 (Calkene(C
Ar)), 161.7 (CAr(Calkene)). 
m/z  [CI+, isobutane] 320 [M+H]+ (100%). HRMS found [M+H]+ 320.2045,  C18H30NO2Si requires 
320.2046. υmax /cm
-1 (film): 3310, 2955, 2938, 2857, 1587, 1534, 1472, 1462. 
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(±)-(3R,4R)-4-Hydroxy-3-((R)-1-(2-isopropyloxazol-4-yl)propan-2-
yl)isochroman-1-one 387 
 
A solution of alkenyl oxazole 346 (72 mg, 230 µmol) in EtOH (3 mL) was charged with 10% 
activated Pd/C (11 mg). The suspension was stirred under an atmosphere of hydrogen at RT 
for 4h. TLC analysis indicated reaction completion. The suspension was filtered through a plug 
of Celite and silica, and the filtrate was concentrated under reduced pressure to afford the 
isopropyl oxazole 287 (71 mg, 225 µmol, 98%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 
1.15 (3H, d, J = 6.7, CH3(CH)), 1.30 (6H, d, J = 6.9, (CH3)2CH), 2.50-2.57 (2H, m, CH2Ar, 
CH(CH2)(CH2’)), 3.02 (1H, sept, J = 7.0, CH(CH3)2), 3.11-3.16 (1H, m, CH2Ar), 3.19 (1H, d, J = 6.7, 
OH), 4.23 (1H, dd, J = 7.9, 1.7, CH(O2C)), 4.79 (1H, d, J = 5.0, CH(OH)), 7.34 (1H, s, C
Ar
oxazoleH), 
7.47 (1H, d, J = 7.5, ArH), 7.52 (1H, td, J = 7.5, 1.2, ArH), 7,64 (1H, td, J = 7.5, 1.3, ArH), 8.14 (1H, 
dd, J = 7.8, 1.1, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.2 (CH3(CH)), 20.5 (CH3(CH(CH3))), 20.6 
(CH3(CH(CH3))) 28.2 (CH2Ar), 28.6 (CH(CH3)2) 34.1 (CH(CH3)(CH2)(CH2’)), 65.9 (CH(OH)), 84.2 
(CH(O2C)), 124.5 (C
ArCH2), 128.1 (C
ArH), 129.9 (CArH), 130.6 (CArH), 134.4 (CArH), 134.6 (CArH), 
138.3 (CArCO2), 140.6 (C
ArCH(OH)), 165.0 (CO2), 168.9 (C
ArCH(CH3)2). m/z  [CI
+, isobutane] 316 
[M+H]+ (100%), HRMS found [M+H]+ 316.1551 C18H22NO4 requires 316.1549.  υmax /cm
-1 (film): 
3374, 2972, 2936, 2878, 1717, 1605, 1566. 
(±)-(3R,4S)-4-Hydroxy-3-((R)-1-(2-isopropyloxazol-4-yl)propan-2-
yl)isochroman-1-one 388 
 
A solution of syn,anti-isochromanone 387 (58 mg, 184 µmol) in anhydrous toluene (1.8 mL) 
was treated with PPh3 (121 mg, 460 µmol) and 4-nitrobenzoic acid (58 mg, 460 µmol) and 
cooled to 0 oC. The resulting solution was treated dropwise with DIAD (91 μL, 460 µmol) and 
stirred for 10 min, before being heated at 80 oC for 16h, under an atmosphere of argon. The 
reaction mixture was cooled to RT before the solvent was evaporated under reduced pressure. 
The crude residue was purified by flash column chromatography, elution with 0-100% 
DCM:petroleum ether, to afford the p-nitrobenzoate intermediate (43 mg, 92 µmol, 50%) as a 
pale yellow oil. The intermediate was then dissolved in MeOH (1.5 mL) and treated with NaN3 
(53 mg, 0.82 mmol) and stirred at 30 oC for 16h. The solvent was evaporated and the crude 
residue was purified by flash column chromatography, elution with 0-35% Et2O:petroleum 
ether, to afford anti,anti-isochromanone 388 (23 mg, 72 µmol, 39%) as a colourless oil. 1H 
NMR (CDCl3, 400 MHz) δ: 1.27 (3H, d, J = 7.2, CH3(CHCH2Ar)), 1.34 (3H, d, J = 7.0, (CH3)2CH), 
1.35 (3H, d, J = 7.0, (CH3)2CH), 2.42 (2H, ddd, J = 16.3, 3.5, 0.6, CH2Ar) 2.60-2.65 (1H, m, 
CH(CH3)2), 3.03 (1H, ddd, J = 16.3, 7.2, 1.7, CH2Ar), 3.03-3.12 (1H, m, CH(CH2Ar)), 4.25 (1H, dd, J 
= 10.8, 2.2, CH(O2C)), 4.92 (1H, br. d, J = 10.8, CH(OH)), 7.34-7.35 (1H, m, ArH), 7.39-7.44 (1H, 
m, ArH), 7.64 (1H, td, J = 7.6, 1.3, ArH), 7.77-7.79 (1H, m, ArH), 8.03 (1H, dd, J = 7.8, 1.0, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 18.6 (CH3(CHCH2Ar)), 20.2 ((CH3)2CH), 20.2 ((CH3)2CH),  25.6 
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(CH2Ar), 28.4 (CH(CH2Ar)), 32.0 (CH(CH3)2), 64.9 (CH(OH)), 86.0 (CH(O2C)), 123.4 (C
ArCH2), 124.1 
(CArH), 127.8 (CArH), 129.9 (CArH), 133.9 (CArH), 134.1 (CArH), 138.7 (CArCO2), 143.9 (C
ArCH(OH)), 
165.5 (CO2), 169.7 (C
ArCH(CH3)2). m/z  [CI
+, isobutane] 316 [M+H]+ (43%). HRMS found [M+H]+ 
316.1552, C18H22NO4  requires 316.1549. υmax /cm
-1 (film): 3310, 2972, 2878, 1728, 1607, 1566, 
1460. 
(±)-3-(4-(3-(tert-butyldimethylsilyloxy)-2-methylpropyl)oxazol-2-yl)butan-
1-ol S6 
 
A solution of alkenyl oxazole 379 (67 mg, 206 µmol) in EtOH (1 mL) was charged with 10% 
activated Pd/C (10 mg). The suspension was stirred under an atmosphere of hydrogen at RT 
for 50 min. TLC analysis indicated reaction completion. The suspension was filtered through a 
plug of Celite and silica, and the filtrate was concentrated under reduced pressure to afford 
the alcohol S6 (67 mg, 204 µmol, 99%), as a colourless oil. 1H NMR (C6D6, 500 MHz) δ: 0.05 (6H, 
s, (CH3)2Si ), 0.94 (3H, d, J = 6.8, CH3(CH(CH2(oxazole))), 0.98 (9H, s, (CH3)3C), 1.15 (3H, d, J = 7.1, 
CH3(CH(oxazole))), 1.59-1.66 (1H, m, CH2(CH2OH), 1.85-1.91 (1H, m, CH2(CH2OH) 2.08-2.15 (1H, 
m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.26 (1H, dd, J = 14.4, 7.9, CH2Ar), 2.41 (1H, br. s, OH), 2.63 (1H, 
ddd, J = 14.4, 5.9, 1.0, CH2Ar), 2.98 (1H, sext, J = 6.9, CH(CH3)(oxazole)(CH2)), 3.41 (1H, dd, J = 
9.8, 5.7, CH2OTBS), 3.45 (1H, dd, J = 9.8, 5.5, CH2OTBS), 3.49-3.52 (1H, m, CH2OH), 6.93 (1H, s, 
ArH). 13C NMR (C6D6, 125 MHz) δ: -5.2 ((CH3)2Si), 16.8 CH3(CH(CH2(oxazole)) diastereoisomer A), 
16.8 CH3(CH(CH2(oxazole)) diastereoisomer B) 18.6 (CH3(CH(oxazole))), 18.7 (SiC(CH3)3), 26.2 
((CH3)3CSi), 29.9 (CH2Ar), 31.6 (CH(CH3)(oxazole)(CH2)), 35.6 (CH(CH3)(CH2Ar)(CH2OTBS) 
diastereoisomer A), 35.6 (CH(CH3)(CH2Ar)(CH2OTBS) diastereoisomer B), 38.1 (CH2(CH)(CH2OH) 
diastereoisomer A), 38.1 (CH2(CH)(CH2OH) diastereoisomer B), 60.4 (CH2OH), 67.8 (CH2OTBS 
diastereoisomer A), 67.8 (CH2OTBS diastereoisomer A), 134.3 (Coxazole(CH2)), 139.6 (CoxazoleH), 
168.2 (CAr(CH)). m/z  [CI+, isobutane] 328 [M+H]+ (100%), HRMS found [M+H]+ 328.2310, 
C17H34NO3Si requires 328.2308. υmax /cm
-1 (film): 3352, 2955, 2932, 2886, 2859, 1566, 1462. 
(±)-3-(4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)oxazol-2-yl)butanal 
392 
 
Alcohol S6 (58 mg, 177 µmol) was dissolved in anhydrous DCM (1.8 mL) and treated with BAIB 
(68 g, 212 µmol) and TEMPO (3 mg, 18 µmol). The reaction mixture was stirred under argon at 
RT for 4h.  The reaction mixture was diluted with DCM (20 mL) and washed with sat’d aq. 
Na2S2O3 solution (2 × 8 mL), water (2 × 5 mL) and brine (5 mL). The organic layer was dried 
over anhydrous Na2SO4 and concentrated under reduced pressure to afford the crude product 
as an orange oil. Purification by flash column chromatography, elution with 0-20% 
Et2O:petroleum ether, afforded the desired product aldehyde 392 ((55 mg, 169 µmol, 95%) as 
a colourless oil. 1H NMR (C6D6, 500 MHz) δ: 0.05 (6H, s, (CH3)2Si), 0.94 (3H, d, J = 6.7, 
CH3(CH(CH2(oxazole))), 0.98 (9H, s, (CH3)3C), 1.07 (3H, d, J = 7.1, CH3(CH(oxazole))), 2.01 (1H, 
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dd, J = 17.6, 6.5, CH2(CHO)),  2.08-2.15 (1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 2.25 (1H, dd, J = 
14.4, 7.9, CH2Ar), 2.58 (1H, dd, J = 17.6, 7.2, CH2(CHO)), 2.62 (1H, dd, J = 14.4, 5.9, CH2Ar), 3.19 
(1H, sext, J = 7.0, CH(CH3)(oxazole)(CH2)), 3.41 (1H, dd, J = 10.0, 5.9, CH2OTBS), 3.46 (1H, ddd, J 
= 9.7, 5.6, 2.4, CH2OTBS), 6.91 (1H, s, ArH), 9.31 (1H, s, CHO). 
13C NMR (C6D6, 125 MHz) δ: -5.2 
((CH3)2Si), 16.8 CH3(CH(CH2(oxazole))), 18.5 (CH3(CH(oxazole))), 18.6 (SiC(CH3)3), 26.2 
((CH3)3CSi), 28.3 (CH(CH3)(oxazole)(CH2)), 30.0 (CH2Ar), 35.6 (CH(CH3)(CH2Ar)(CH2OTBS) 
diastereoisomer A), 35.6 (CH(CH3)(CH2Ar)(CH2OTBS) diastereoisomer B), 48.0 (CH2(CHO)), 67.8 
(CH2OTBS), 134.5 (Coxazole(CH2)), 139.9 (CoxazoleH), 166.6 (C
Ar(CH)), 198.7 (CHO). m/z  [CI+, 
isobutane] 326 [M+H]+ (100%), HRMS found [M+H]+ 326.2148, C17H32NO3Si requires 326.2151. 
υmax /cm
-1 (film): 2955, 2932, 2889, 2859, 1728, 1570, 1462. 
(Z)-4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(5-iodopent-4-en-
2-yl)oxazole 391 
 
In the absence of light, a solution of NaHMDS (1 M in THF, 0.93 mL, 0.93 mmol) in anhydrous 
THF (4 mL) was prepared at 10 oC. To this, a suspension of (iodomethyl)triphenylphosphonium 
iodide (493 mg, 0.93 mmol) in HMPA ( 2.80 mL, 16.1 mmol) was added via cannular. After 
stirring for 1 min, the resultant mixture was cooled to –78 oC. A solution of aldehyde 392 (202 
mg, 0.62 mmol) in anhydrous THF (1.5 mL) was added dropwise to the reagent mixture and 
was stirred for 30 min at –78 oC. TLC analysis indicated reaction completion. The reaction was 
quenched by the addition of sat’d aq. Na2S2O3 (10 mL). After warming to RT, the solution was 
extracted with Et2O (3 × 15 mL). The combined organics were washed with water (2 × 5 mL) 
and brine (15 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a yellow oil. Purification by flash 
column chromatography, elution with 0-7% Et2O:petroleum ether, afforded the vinyl iodide 
391 (212 mg, 0.47 mmol, 76%), as a colourless oil. 1H NMR (C6D6, 500 MHz) δ: 0.05 (3H, s, 
(CH3)2Si ), 0.05 (3H, s, (CH3)2Si ), 0.96 (3H, dd, J = 6.8, 0.9, CH3(CH(CH2(oxazole))), 0.98 (9H, s, 
(CH3)3C), 1.17 (3H, d, J = 7.0, CH3(CH(oxazole))), 2.12-2.19 (1H, m, CH(CH3)(CH2Ar)(CH2OTBS)), 
2.29 (1H, dd, J = 14.4, 7.8, CH2Ar), 2.36-2.41 (1H, m, CH2(CH)(alkene)), 2.51-2.58 (1H, m, 
CH2(CH)(alkene)), 2.66 (1H, dd, J = 14.4, 7.8, CH2Ar), 2.84 (1H, sext, J = 7.0, 
CH(CH3)(oxazole)(CH2)), 3.43 (1H, dd, J = 9.7, 5.9, CH2OTBS), 3.48 (1H, ddd, J = 9.7, 5.6, 0.9, 
CH2OTBS), 5.84 (1H, q, J = 7.0, Calkene(CH2)(CHI)), 5.91 (1H, dt, J = 7.4, 1.1, CalkeneHI), 6.95 (1H, s, 
ArH). 
5-Iodopent-4-yn-1-ol 393 
 
Pent-4-yn-1-ol (2.54 g, 30.9 mmol) was dissolved in MeOH (30 mL) and cooled to 0 oC before 
the addition of 12.5 M aq. NaOH solution (6.2 mL, 77.5 mmol). After stirring for 10 min, I2 
crystals (8.62 g, 34.0 mmol) were added in a single portion and the resultant solution was 
warmed to RT and stirred for a further 3h. Dilution with water (30 mL) was followed by 
extraction with Et2O (3 × 50 mL). The combined organics were washed with sat’d aq. Na2S2O3 
(3 × 80 mL) and brine (2 × 25 mL), before being dried over anhydrous Na2SO4. The solvent was 
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evaporated under reduced pressure to afford the crude product as a yellow oil. Purification by 
flash column chromatography, elution with 0-100% DCM:petroleum ether, afforded iodo 
alkyne 393 (5.51 g, 26.3 mmol, 85%), as a pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ: 1.57 (1H, 
br. s, OH), 1.72-1.78 (2H, m, CH2(CH2OH)(CH2
’)), 2.48 (2H, t, J = 7.0, CH2(alkyne)), 3.72 (2H, t, J = 
6.1, CH2OH). 
13C NMR (CDCl3, 100 MHz) δ: -6.4 (CalkyneI), 17.4 (CH2(alkyne)), 31.2 
(CH2(CH2OH)(CH2
’)), 61.5 (CH2OH), 93.9 (Calkyne(CH2)). m/z  [EI
+] 210 [M]+ (43%), HRMS found 
[M]+ 209.9534, C5H7OI requires 209.9542. υmax /cm
-1 (film): 3329, 2947, 2877, 2184, 1431. The 
data observed is in accordance with literature values.179 
(Z)-5-Iodopent-4-en-1-ol 77 
 
Iodo alkyne 393 (10.5 g, 50.2 mmol) was dissolved in MeOH (90 mL) together with pyridine (24 
mL) and potassium azodicarboxylate (29.2 g, 151 mmol) at RT, under an atmosphere of argon. 
Acetic acid (100% w/w, 18 mL) was added to the reaction mixture dropwise via syringe pump 
over 3h. The reaction mixture was then allowed to stir for a further 16h. 1 M aq. HCl solution 
(100 mL) was added and the resultant solution stirred for 5 min before extraction with Et2O (3 
× 200 mL). The combined organics were washed with 1 M aq. HCl solution (50 mL), sat’d aq. 
NaHCO3 solution (100 mL), sat’d aq. CuSO4 solution (5x100 mL) and brine (2 × 50 mL). The 
solvent was evaporated under reduced pressure to afford a yellow oil, which was dissolved in 
Et2O (50 mL) and water (15 mL), before 
nBuNH2 (13 mL) was added and the resultant mixture 
stirred at RT for 30 min. The organics were washed with 1 M aq. HCl solution (2 × 30 mL) and 
brine (2 × 25 mL), before being dried over anhydrous Na2SO4. Solvent evaporation afforded the 
crude product as a yellow oil. Purification by flash column chromatography, elution with 0-15% 
Et2O:petroleum ether, afforded viny iodide 77 (6.63 g, 31.3 mmol, 62%), as a colourless oil. 
1H 
NMR (C6D6, 400 MHz) δ: 0.65 (1H, br. s, OH), 1.25-1.35 (2H, m, CH2(CH2OH)(CH2
’)), 1.99-2.05 
(2H, m, CH2(alkene)), 3.21 (2H, t, J = 6.1, CH2OH), 5.68 (1H, q, J = 7.0, Calkene(CH2)), 5.85 (1H, dt, 
J = 7.3, 2.0, CalkeneHI). 
13C NMR (C6D6, 125 MHz) δ: 31.1 (CH2(CH2OH)(CH2
’)), 31.5 (CH2(alkene)), 
61.8 (CH2OH), 82.7 (CalkeneHI), 141.0 (Calkene(CH2)). m/z  [EI
+] 212 [M]+ (100 %), HRMS found [M]+ 
211.9700, C5H9OI requires 211.9698. υmax /cm
-1 (film): 3310, 2936, 2866, 1609, 1435. The data 
observed is in accordance with literature values.27 
(2E,6Z)-Methyl 7-iodohepta-2,6-dienoate 78 
 
Alcohol 77 was disolved in anhydrous DCM (100 mL) at 0 oC and treated with PCC (9.94 g, 46.1 
mmol) and the resultant mixture was stirred for 2h, before being warmed to RT and stirred for 
a further 3h. The reaction mixture was filtered through a pad of Florisil and eluted with DCM. 
The solvent was carefully evaporated until approx 100 mL remained.  The resultant crude 
aldehyde intermediate, dissolved in DCM, was treated with methyl 
(triphenylphosphoranylidene)acetate (13.1 g, 14.4 mmol) and stirred at RT for 1h, under an 
atmosphere of argon. The crude mixture was pre-absorbed onto silica and purified by flash 
column chromatography, elution with 0-5% Et2O:petroleum ether, to afford acrylate 78 (5.60 
g, 21.1 mmol, 91%), as a colourless oil. 1H NMR (C6D6, 500 MHz) δ: 1.79-1.83 (2H, m, 
CH2(alkene(E)), 1.96-2.01 (2H, m, CH2(alkene(Z)), 3.51 (3H, s, CH3O2C), 5.61 (1H, q, J = 7.0, 
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Calkene(I)H(CH2)(CHI)), 5.85 (1H, dt, J = 15.6, 1.6, Calkene(E)H(CO2Me)), 5.93 (1H, dt, J = 7.4, 1.3, 
Calkene(Z)HI), 6.95 (1H, dt, J = 15.6, 6.9, Calkene(E)(CH2)). 
13C NMR (C6D6, 125 MHz) δ: 30.3 
(CH2(alkene(E)), 33.3 (CH2(alkene(Z)), 51.0 (CH3O), 83.6 (CalkeneHI), 122.2 (Calkene(E)H(CO2Me), 
139.6 (Calkene(Z)H(CH2)(CHI)), 147.4 (Calkene(E)(CH2)),  166.3 (CO2Me). m/z  [CI
+, isobutane] 267 
[M+H]+ (100 %). HRMS found [M+H]+ 266.9883, C8H12O2I requires 266.9882. υmax /cm
-1 (film): 
3067, 2990, 2947, 2847, 1721, 1659, 1609, 1435. The data observed is in accordance with 
literature values.27 
(2E,6Z)-7-Iodohepta-2,6-dien-1-ol 394 
 
Ester 78 (5.10 g, 19.2 mmol) was disolved in anhydrous DCM (130 mL) at 0 oC, and treated with 
DIBAL (1 M in hexanes, 42.2 mL, 42.2 mmol) and the resultant mixture was warmed to RT 
stirred for 16h. After re-cooling to 0 oC, the reaction mixture was diluted with DCM (100 mL) 
and quenched by the successive addition of water (1.1 mL), 15% aq. NaOH solution (1.65 mL) 
and water (4.1 mL), at 30 min intervals. The resultant slurry was warmed to RT and stirred for 
30 min, anhydrous Na2SO4 was added, and the resulting slurry was stirred for a further 30 min. 
The solids were removed by filtration and the solvent was evaporated under reduced pressure. 
Purification by flash column chromatography, elution with 0-25% Et2O:petroleum ether, 
afforded the allylic alcohol 394 (4.34 g, 18.2 mmol, 95%) as a colourless oil. 1H NMR (C6D6, 500 
MHz) δ: 0.71 (1H, br. s, OH), 1.93-1.97 (2H, m, CH2(alkene(E)), 2.11-2.16 (2H, m, CH2(alkene(Z)), 
3.88 (2H, br. d, J = 3.9, CH2OH), 5.43-5.52 (2H, m, Calkene(E)H(CH2OH) & Calkene(E)(CH2)), 5.81 (1H, 
q, J = 6.9, Calkene(Z)H(CH2)(CHI)), 5.98 (1H, dt, J = 7.3, 1.4, Calkene(Z)HI). 
13C NMR (CDCl3, 125 MHz) 
δ: 30.5 (CH2(alkene(E)), 34.2 (CH2(alkene(Z)), 63.3 (CH2OH), 83.0 (Calkene(Z)HI), 130.0 (Calkene(E)H), 
131.5 (Calkene(E)), 140.3 (Calkene(Z)H(CH2)(CHI)). m/z  [CI
+, isobutane] 221 [M-OH]+ (100%), HRMS 
found [M-OH]+ 220.9825, C8H12O2I requires 220.9827. υmax /cm
-1 (film): 3321, 2920, 2851, 
1670, 1435. The data observed is in accordance with literature values.27 
(1Z,5E)-7-Bromo-1-iodohepta-1,5-diene 395 
 
NBS (5.83 g, 32.8 mmol) was added to an oven-dried flask, together with anhydrous DCM (100 
mL), under an atmosphere of argon. After cooling to 0 oC, DMS (3.61 mL, 49.1 mmol) was 
added, and the resultant suspension was cooled to   10 oC. A solution of alcohol 394 (3.90 g, 
16.4 mmol), in anhydrous DCM (50 mL), was added via cannular, to the reaction vessel. After 
the addition, the reaction mixture was warmed to RT and stirred for 90 min, before being 
filtered through a pad of Celite, followed by solvent evaporation under reduced pressure to 
afford the crude product. Purification by flash column chromatography, elution with 
petroleum ether, afforded the allylic bromide 395 (3.37 g, 11.2 mmol, 68%) as a colourless oil. 
1H NMR (CDCl3, 500 MHz) δ: 2.20-2.26 (4H, m, CH2(alkene(Z), CH2(alkene(E)), 3.95 (2H, d, J = 
6.6, CH2Br), 5.70-5.82 (2H, m, CH2(Calkene(Z)H(CH2)) & CH2(Calkene(E)H(CH2))), 6.17 (1H, q, J = 6.6, 
Calkene(Z)H(CH2)(CHI)), 6.25 (1H, dt, J = 7.4, 1.3, Calkene(Z)HI). 
13C NMR (CDCl3, 125 MHz) δ: 30.5 
(CH2(alkene), 33.2 (CH2Br), 34.0 (CH2(alkene), 83.4 (Calkene(Z)HI), 127.5 (Calkene(E)(CH2CH2)), 131.5 
(Calkene(E)(CH2Br)),  140.1 (Calkene(Z)H(CH2)(CHI)). m/z  [EI
+] 300 [M(Br79)]+ and 302 [M(81Br)] 100%. 
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HRMS found [M(79Br)]+ 299.9021, C7H10
79BrI requires 299.9011. υmax /cm
-1 (film): 2959, 2928, 
2847, 1690, 1659, 1609, 1435. The data observed is in accordance with literature values.27 
(E)-Methyl 3-methoxybut-2-enoate S7 
 
Trimethyl orthoformate (14.0 g, 132 mmol) was added to neat methyl acetoacetate (15.0 g, 
129 mmol) and to this stirring solution was added 5 drops of conc. H2SO4. The resulting 
mixture was stirred at RT for 24h. 10 drops of quinoline were added to neutralise the acid, 
before vacuum distillation (98 oC, 30 mbar) afforded ester S7 (15.6 g, 120 mmol, 93%) as a 
colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 2.29 (3H, br. d, J = 1.2, CH3(alkene)), 3.62 (3H, br. d, 
J = 1.1, CH3O(alkene)), 3.67 (3H, br. d, J = 1.4, CH3O2C), 5.02 (1H, s, CalkeneH). 
13C NMR (CDCl3, 
125 MHz) δ: 19.0 (CH3(alkene)), 50.9 (CH3O2C), 55.5 (CH3O(alkene)), 90.6 (CalkeneH), 168.5 
(CO2Me), 173.4 (Calkene(CH3)(OCH3)). m/z  [EI
+] 130 [M]+ (100 %). HRMS found [M]+ 130.0626, 
C6H10O3 requires 130.0630. υmax /cm
-1 (film):  2952, 2843, 1709, 1620, 1435. The data observed 
is in accordance with literature values.29 
(E)-3-Methoxybut-2-enoic acid 56 
 
Ester S7 (15.6 g, 120 mmol) was dissolved in a mixture of THF (380 mL) and water (150 mL) and 
cooled to 0 oC. KOH (20.2 g, 360 mmol) was added and the resultant solution was warmed to 
RT, before being stirred at 70 oC for 24h. After cooling to 0 oC, the reaction mixture was 
acidified to approx. pH 3, by the careful addition of 6 M aq. HCl solution. The acidified solution 
was extracted with Et2O (3 × 300 mL) and the combined organics were washed with water (75 
mL) and brine (75 mL), before being dried over anhydrous Na2SO4. Solvent evaporation 
afforded the crude product. Trituration from petroleum ether, followed by drying under 
vacuum, afforded acid 56 (13.0 g, 112 mmol, 93%) as a colourless crystalline solid. 1H NMR 
(CDCl3, 400 MHz) δ: 2.30 (3H, s, CH3(alkene)), 3.66 (3H, s, CH3O(alkene)), 5.04 (1H, s, CalkeneH), 
11.94 (1H, br. s, CO2H). 
13C NMR (CDCl3, 100 MHz) δ: 19.4 (CH3(alkene)), 55.8 (CH3O(alkene)), 
90.6 (CalkeneH), 173.6 (Calkene(CH3)(OCH3)), 175.4 (CO2H). m/z  [CI
+, isobutane] 117 [M+H]+ 
(100%), HRMS found [M+H]+ 117.0551, C5H9O3 requires 117.0552. υmax /cm
-1 (film):  2966, 
2872, 2840, 1690, 1667, 1597. MP: 125-127 oC. The data observed is in accordance with 
literature values.29 
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(E)-N-((2E,6Z)-7-Iodohepta-2,6-dienyl)-3-methoxy-N-methylbut-2-enamide 
72 
 
Bromide 395 (2.20 g, 7.31 mmol) was dissolved in anhydrous THF (17 mL) and cooled to 0 oC 
under an atmosphere of argon. MeNH2 (2 M in THF, 18.3 mL, 36.5 mmol) was added and the 
resultant reaction mixture was stirred at 0 oC for 1h, before being warmed to RT and stirred for 
a further 1h until reaction completion, as indicated by TLC analysis. The solvent and excess 
MeNH2 was evaporation to afforded the crude product.  Purification by SCX ion-exchange 
chromatography, elution with MeOH and then 7 M NH3/MeOH, afforded the amine 
intermediate (1.71 g, 6.80 mmol, 93%) as a pale orange oil which was used immediately in the 
next step. The amine intermediate was combined with acid 56 (908 mg, 7.82 mmol) in 
anhydrous DCM (50 mL) and the resultant solution was cooled to 0 oC under an atmosphere of 
argon. HBTU (3.10 g, 8.16 mmol) was added before the dropwise addition of DIPEA (2.37 mL, 
13.6 mmol). The reaction mixture was stirred at 0 oC for 20 min before being warmed to RT 
and stirred for a further 2h. The solvent was evaporated and the resultant slurry was 
partitioned between Et2O (100 mL) and water (50 mL). The organics were collected and further 
washed with sat’d aq. NaHCO3 solution (20 mL), 10% aq. citric acid solution (20 mL) and brine 
(2 × 25 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated under 
reduced pressure to afford the crude product as an orange oil. Purification by flash column 
chromatography, elution with 0-67% Et2O:petroleum ether, afforded the desired amide 72 
(1.84 g, 5.28 mmol, 72%), as a pale yellow oil. 1H NMR (CDCl3, 500 MHz, 3:2 rotamer ratio, 
asterisk denotes minor rotamer peaks) δ: 2.21-2.34 (7H, m, CH3(alkene), CH2CH2), 2.94 (3H, s, 
CH3N), 3.59 (3H, br. s, CH3O), 3.61 (3H, br. s, CH3O*), 3.88 (2H, br. s, CH2N), 3.97 (2H, br. s, 
CH2N*), 5.16 (1H, br. s, CHalkene(CON)), 5.18 (1H, br. s, CHalkene(CON)*), 5.45 (1H, dtt, J = 15.4, 
5.7, 1.3, CHalkene(CH2CH2)), 5.58 (1H, dtt, J = 15.3, 6.5, 1.3, CHalkene(CH2N)), 6.15 (1H, q, J = 6.8, 
CHalkene(CHI)), 6.22 (1H, d, J = 7.3, CHalkeneI). 
13C NMR (CDCl3, 125 MHz, 3:2 rotamer ratio, 
asterisk denotes minor rotamer peaks) δ: 18.8 (CH3(alkene)), 30.5 (CH2(alkene)), 33.4 (CH3N*), 
34.3 (CH2(alkene)), 35.1 (CH3N), 49.0 (CH2N*), 52.1 (CH2N), 54.9 (CH3O), 82.8 (CalkeneHI*), 83.1 
(CalkeneHI), 91.2 (Calkene(CON)), 125.7 (CalkeneH(CH2CH2)), 126.3 (CalkeneH(CH2CH2)*),  131.5 
(CalkeneH(CH2N)), 132.0 (CalkeneH(CH2N)*), 140.2 (CalkeneH(CHI)), 140.5 (CalkeneH(CHI)*), 167.8 
(CQalkene), 168.4 (CO).  m/z  [CI
+, isobutane] 350 [M+H]+ (100%). HRMS found [M+H]+ 350.0616, 
C13H21NO2I  requires 350.0617. υmax /cm
-1 (film): 3292, 2955, 2924, 2851, 1643, 1601, 1477, 
1439. The data observed is in accordance with literature values.27 
(E)-3-methoxy-N-methyl-N-((2E,6Z)-7-(trimethylstannyl)hepta-2,6-
dienyl)but-2-enamide 396 
 
Vinyl iodide 72 (204 mg, 584 µmol) was dissolved in degassed, anhydrous NMP (3 mL) before 
Pd2(dba)3 (27 mg, 29 µmol) was added under an atmosphere of argon. After stirring for 2 min, 
(Me3Sn)2 (145 µL, 701 µmol) was added and the reaction mixture was stirred in the dark for 4 
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days.  Additional Pd2(dba)3 (27 mg, 29 µmol) and (Me3Sn)2 (145 µL, 701 µmol) were added and 
the reaction was stirred for a further 3 days, before being filtered through a pad of Celite and 
Florisil, eluting with Et2O (50 mL) The organics were then washed with water (2 × 5 mL) and 
brine (10 mL) before being dried over anhydrous Na2SO4. The solvent was evaporated under 
reduced pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-25% Et2O:petroleum ether, afforded vinyl stannane 396 (65 
mg, 169 µmol, 29%, 45% brsm), as a colourless oil. 1H NMR (CDCl3, 500 MHz, 3:2 rotamer ratio, 
asterisk denotes minor rotamer peaks) δ: 0.15 (9H, s, (CH3)3Sn),  2.12-2.19 (4H, m, CH2CH2), 
2.21 (3H, s, CH3(alkene)), 2.93 (3H, s, CH3N), 3.57 (3H, br. s, CH3O), 3.61 (3H, br. s, CH3O*), 3.87 
(2H, br. s, CH2N), 3.97 (2H, br. s, CH2N*), 5.15 (1H, br. s, CHalkene(CON)), 5.17 (1H, br. s, 
CHalkene(CON)*), 5.42 (1H, dt, J = 15.3, 5.8, CHalkene(CH2CH2)), 5.53-5.60 (1H, m,, CHalkene(CH2N)), 
5.83 (1H, d, J = 12.4, CHalkeneSn), 6.41-6.46 (1H, m, CHalkene(CHn)). 
13C NMR (CDCl3, 125 MHz, 3:2 
rotamer ratio, asterisk denotes minor rotamer peaks) δ: -8.6 ((CH3)3Sn), 18.8 (CH3(alkene)), 
32.5 (CH2(alkene)), 33.3 (CH3N), 35.0 (CH3N*), 35.9 (CH2(alkene)), 49.0 (CH2N*), 52.2 (CH2N), 
54.8 (CH3O), 91.3 (CalkeneH(CON)), 125.2 (Calkene(E)H(CH2CH2)), 125.8 (Calkene(E)(CH2CH2)*),  129.8 
(Calkene(E)(CH2N)*), 130.1 (Calkene(E)(CH2N)), 132.3 (Calkene(Z)Hn*), 133.0 (Calkene(Z)Hn), 147.8 
(Calkene(Z)(CHn)), 148.1 (Calkene(Z)(CHn)*), 167.9 (C
Q
alkene), 168.4 (CO). m/z  [CI
+, isobutane] 388 
[M+H]+ (100%). HRMS found [M+H]+ 388.1308, C16H30NO2
120Sn  requires 388.1299 . υmax /cm
-1 
(film): 2963, 2918, 2847, 1651, 1603, 1479, 1441. 
5-(Trimethylsilyl)pent-4-yn-1-ol 399 
 
Pent-4-yn-1-ol (4.80 g, 58.5 mmol) was dissolved in anhydrous THF (200 mL) and cooled to 0 oC 
under an atmosphere of argon. EtMgBr (3 M in diethyl ether, 58.5 mL, 175 mmol) was added 
and the resultant solution was warmed to RT and stirred for 1h before being recooled to 0 oC. 
TMSCl (22.3 mL, 175 mmol) was added and the resultant solution was warmed to RT and 
stirred for 16h. The reaction was quenched by the addition of 10% aq. HCl solution (50 mL) and 
stirred for 10 min before being before extraction with Et2O (3 × 100 mL). The combined 
organics were washed with sat’d aq. NaHCO3 solution (50 mL), water (50 mL) and brine (2 × 50 
mL), before being dried over anhydrous Na2SO4. The solvent was evaporated under reduced 
pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-4% Et2O:DCM, afforded TMS-acetylene 399 (9.09 g, 56.9 
mmol, 97%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.15 (9H, s, (CH3)3Si), 1.59 (1H, t, J 
= 5.5, OH), 1.77 (2H, quint, J = 6.5, CH2(CH2OH)(CH2’)), 2.34 (2H, t, J = 6.5, CH2(alkyne)), 3.76 
(2H, q, J = 6.0, CH2OH). 
13C NMR (CDCl3, 125 MHz) δ: 0.0 ((CH3)3Si), 16.5 (CH2(CH2OH)(CH2’)), 
31.1 (CH2(alkyne)), 61.9 (CH2OH), 85.2 (C
Q
alkyneSi),106.6 (C
Q
alkyne(CH2)). m/z  [CI
+, isobutane] 157 
[M+H]+ (100%), HRMS found [M+H]+ 157.1046, C8H17OSi  requires 157.1049. υmax /cm
-1 (film): 
3331, 2957, 2899, 2176. The data observed is in accordance with literature values.180 
Experimental 
 
177 
 
(E)-Methyl 7-(trimethylsilyl)hept-2-en-6-ynoate 400 
 
TMS-acetylene 399 (5.45 g, 34.9 mmol) was dissolved in anhydrous DCM (175 mL) and cooled 
to 0 oC under an atmosphere of argon. PCC (15.6 g, 69.7 mmol) was added portionwise over 45 
min, and the resultant reaction mixture was stirred for 5h at 0 oC until reaction completion, 
indicated by TLC analysis. The resultant mixture was filtered through Florisil, with DCM elution. 
The solvent was concentrated in vacuo until approximately 175 mL remained. Methyl 
(triphenylphosphoranylidene)acetate (170g, 52.3 mmol) was added to the solution of crude 
aldehyde and the resultant reaction mixture was stirred for 16h at RT, under an atmosphere of 
argon. The solvent was evaporated before the resultant slurry was filtered, elution with 
petroleum ether. Solvent evaporation afforded the crude product. Purification by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, afforded the acrylate 400 (5.92 g, 
28.1 mmol, 81%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.14 (9H, s, (CH3)3Si), 2.35-
2.45 (4H, m, CH2CH2), 3.73 (3H, s, OMe), 5.88 (1H, dt, J = 15.6, 1.6, CH(CO2Me)), 6.97 (1H, dt, J 
= 15.6, 6.4, CH(CH2)). 
13C NMR (CDCl3, 125 MHz) δ: 0.0 ((CH3)3Si), 18.8 (CH2(alkyne)), 31.2 
(CH2(alkene)), 51.5 (CH3O), 85.9 (C
Q
alkyneSi), 105.3 (C
Q
alkyne(CH2)), 122.0 (CalkeneH(CO2Me)), 146.8 
(CalkeneH(CH2)), 166.8 (CO2). m/z  [CI
+, isobutane] 211 [M+H]+ (100%), HRMS found [M+H]+ 
211.1157, C11H19O2Si  requires 211.1154. υmax /cm
-1 (film): 2957, 2903, 2178, 1726, 1661. 
(E)-7-(trimethylsilyl)hept-2-en-6-yn-1-ol 401 
 
Ester 400 (2.02 g, 9.60 mmol) was dissolved in anhydrous Et2O (50 mL) and cooled to 0 
oC. 
DIBAL (1 M in hexanes, 21.1 mL, 21.1 mmol) was added and the reaction was stirred at 0 oC for 
30 min before being allowed to warm to RT over 16h. The reaction mixture was cooled to 0 oC 
and diluted with Et2O (100 mL), before being quenched by the successive addition of water 
(0.5 mL), 15% aq. NaOH solution (0.5 mL) and water (2.1 mL) with 30 min stirring time 
between each addition. The resultant slurry was warmed to RT and stirred for 90 min before 
anhydrous Na2SO4 was added. The resulting slurry stirred for a further 30 min. The solids were 
removed by filtration and the solution was evaporated under reduced pressure to afford the 
crude product as a colourless oil. Purification by flash column chromatography, elution with 0-
40% Et2O: petroleum ether, afforded the desired alcohol 401 (1.49 g, 8.17 mmol, 85%) as a 
colourless oil. 1H NMR (C6D6, 400 MHz) δ: 0.21 (9H, s, (CH3)3Si), 2.03-2.08 (4H, m, CH2CH2), 3.77 
(2H, br. t, J = 4.8, CH2OH), 5.38-5.50 (2H, m, CHalkeneCHalkene). 
13C NMR (CDCl3, 125 MHz) δ: 0.1 
((CH3)3Si), 19.8 (CH2(alkyne)), 31.2 (CH2(alkene)), 63.5 (CH2OH), 84.9 (C
Q
alkyneSi), 106.4 
(CQalkyne(CH2), 130.2 (CalkeneH), 130.7 (CalkeneH). m/z  [CI
+, isobutane] 183 [M+H]+ (43%), HRMS 
found [M+H]+ 183.1207, C10H19OSi  requires 183.1205. υmax /cm
-1 (film): 3333, 2957, 2903, 
2861, 2176. 
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(E)-N-Methyl-7-(trimethylsilyl)hept-2-en-6-yn-1-amine 402 
 
A solution of freshly recrystallised NBS (2.87 g, 16.1 mmol) in anhydrous DCM (40 mL) was 
cooled to 0 oC under an atmosphere of argon. DMS (1.78 mL, 16.1 mmol) was added and the 
resultant solution was cooled to -10 oC, to which a solution of alcohol 401 (1.47 g, 8.06 mmol) 
in anhydrous DCM (10 mL) was added dropwise. The reaction mixture was warmed to RT over 
45 min and stirred for a further 2h, before being filtered through a pad of Celite, followed by 
elution with petroleum ether. Solvent evaporation afforded the crude allyl bromide 
intermediate which was rapidly purified via passing it through a pad of silica, elution with 0-1% 
Et2O:petroleum ether, to afforded the allyl bromide intermediate (1.41 g, 6.16 mmol, 76%), as 
a colourless oil. The allyl bromide intermediate was immediately dissolved in anhydrous THF 
(17 mL) and cooled to 0 oC under an atmosphere of argon. Methylamine (2 M in THF, 23.0 mL, 
46.2 mmol) was added and the resultant reaction mixture was stirred at 0 oC for 1h before 
being warmed to RT and stirred for a further 3h until reaction completion, as indicated by TLC 
analysis. Solvent evaporation afforded the crude product.  Purification by flash column 
chromatography, elution with 0.2:1:1 methanol:DCM:petroleum ether, afforded the allylic 
amine 402 (1.13 g, 5.80 mmol, 72%), as a pale yellow oil. 1H NMR (CDCl3, 500 MHz) δ: 0.13 (9H, 
s, (CH3)3Si), 2.32-2.34 (CH2CH2), 2.63 (3H, s, (CH3)NH), 3.59 (2H, d, J = 7.2, CH2N), 5.74 (1H, dt, J 
= 15.4, 7.2, CalkeneH(CH2CH2)), 5.97 (1H, dt, J = 15.4, 6.7, CalkeneH(CH2N)). 
13C NMR (CDCl3, 125 
MHz) δ: 0.0 ((CH3)3Si), 19.4 (CH2(alkyne)), 30.9 (CH3N), 31.2 (CH2(alkene)), 50.1 (CH2N), 85.5 
(CQalkyneSi), 105.5 (C
Q
alkyne(CH2), 119.7 (CalkeneH(CH2CH2)), 140.0 (CalkeneH(CH2N)). m/z  [CI
+, 
isobutane] 196 [M+H]+ (100%), HRMS found [M+H]+ 196.1523, C11H22NSi  requires 196.1522. 
υmax /cm
-1 (film): 3013, 2957, 2901, 2783, 2729, 2172, 1672, 1580, 1458. 
(E)-3-Methoxy-N-methyl-N-((E)-7-(trimethylsilyl)hept-2-en-6-ynyl)but-2-
enamide 403 
 
Amine 402 (475 mg, 2.43 mmol) and acid 56 (257 mg, 2.21 mmol) were dissolved in anhydrous 
DCM (12 mL) and the resultant solution was cooled to 0 oC under an atmosphere of argon. 
HBTU (965 mg, 2.55 mmol) was added before the dropwise addition of DIPEA (0.77 mL, 4.42 
mmol). The reaction mixture was stirred at 0 oC for 15 min, before being warmed to RT and 
stirred for a further 2h. The solvent was evaporated and the resultant slurry was partitioned 
between Et2O (50 mL) and water (30 mL). The organics were collected and further washed 
with sat’d aq. NaHCO3 solution (10 mL), 10% aq. HCl solution (10 mL) and brine (2 × 10 mL), 
before being dried over anhydrous Na2SO4. The solvent was evaporated under reduced 
pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-50% Et2O:petroleum ether, afforded amide 403 (512 mg, 1.74 
mmol, 79%), as a colourless oil. 1H NMR (CDCl3, 500 MHz, 55 
oC) δ: 0.14 (9H, s, (CH3)3Si), 2.21 
(3H, s, CH3(alkene)), 2.23-2.31 (4H, m, CH2CH2), 2.95 (3H, s, CH3N), 3.60 (3H, s, CH3O), 3.94 (2H, 
br. s, CH2N), 5.18 (1H, s, CHalkene(CON)), 5.49 (1H, dtt, J = 15.4, 5.8, 1.4, CHalkene(CH2CH2), 5.63 
(1H, dtt, J = 15.4, 6.4, 1.3, CHalkene(CH2N). 
13C NMR (CDCl3, 125 MHz, 55 
oC) δ: 0.0 ((CH3)3Si), 18.5 
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(CH3(alkene)), 19.9 (CH2(alkyne)), 31.2 (CH2(alkene)), 33.2 (CH3N* only observed at 25 
oC), 34.9 
(CH3N only observed at 25 
oC), 48.7 (CH2N* only observed at 25 
oC), 52.0 (CH2N only observed 
at 25 oC), 54.6 (CH3O), 89.2 (C
Q
alkyneSi), 91.3 (Calkene(CON)), 106.3 (C
Q
alkyneSi(CH2)), 126.4 
(CHalkene(CH2CH2), 131.2 (CalkeneH(CH2N)), 168.3 (C
Q
alkene), 168.4 (CO). m/z  [CI
+, isobutane] 294 
[M+H]+ (100%), HRMS found [M+H]+ 294.1887, C16H28NO2Si  requires 294.1889. υmax /cm
-1 
(film): 2958, 2922, 2783, 2174, 1722, 1709, 1646, 1603, 1430. 
 (E)-N-((E)-hept-2-en-6-ynyl)-3-methoxy-N-methylbut-2-enamide 
 
TMS-acetylene 403 (249 mg, 0.85 mmol) was dissolved in MeOH (4 mL) and the resultant 
solution was treated with K2CO3 (123 mg, 0.89 mmol) and stirred at 30 
oC for 16h, after which 
TLC analysis indicated reaction completion. The solvent was evaporated and the resultant 
residue was partitioned between Et2O (30 mL) and water (15 mL). The organics were collected 
and further washed with brine (2 × 5 mL), before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 0-50% Et2O:petroleum ether, 
afforded acetylene 398 (180 mg, 0.81 mmol, 96%), as a colourless oil. 1H NMR (CDCl3, 500 
MHz, 55 oC) δ: 1.93 (1H, br. t, CHalkyne), 2.21 (3H, br. d, CH3(alkene)), 2.26-2.28 (4H, m, CH2CH2), 
2.95 (3H, s, CH3N), 3.60 (3H, s, CH3O), 3.94 (2H, br. s, CH2N), 5.18 (1H, s, CHalkene(CON)), 5.50 
(1H, dtt, J = 15.4, 5.8, 1.3, CHalkene(CH2CH2)), 5.64 (1H, dtt, J = 15.4, 6.5, 1.5, CHalkene(CH2N)). 
13C 
NMR (CDCl3, 125 MHz, 55 
oC) δ: 18.6 (CH3(alkene)), 18.6 (CH2(alkyne)), 31.1 (CH2(alkene)), 33.4 
(CH3N* only observed at 25 
oC), 35.1 (CH3N only observed at 25 
oC) 48.4 (CH2N* only observed 
at 25 oC), 52.1 (CH2N only observed at 25 
oC), 54.7 (CH3O), 68.7 (CalkyneH), 83.5 (C
Q
alkyne), 91.3 
(Calkene(CON)), 126.6 (CalkeneH(CH2CH2)), 131.0 (CalkeneH(CH2N)), 168.1 (C
Q
alkene), 168.5 (CO). m/z  
[CI+, isobutane] 222 [M+H]+ (100%), HRMS found [M+H]+ 222.1496, C13H20NO2  requires 
222.1494. 
4-(3-(tert-butyldimethylsilyloxy)-2-methylpropyl)-2-(pent-4-yn-2-yl)oxazole 
405 
 
NaN3 (23 mg, 0.36 mmol), MsCl (28 µL, 0.36 mmol) and anhydrous MeCN (1 mL) were added to 
an oven dried flask and stirred at RT for 16h, under an atmosphere of argon. The resultant 
cloudy solution was cooled to 0 oC before dimethyl 2-oxopropylphosphonate (29 µL, 0.31 
mmol) was added. After 2 min, CssCO3 (111 mg, 0.34 mmol) was added and the solution was 
stirred at 0 oC for a further 30 min, before being warmed to RT and stirred for a further 3h. The 
solution was recooled to 0 oC and diluted with MeOH (0.5 mL) and stirred for 1hr. Aldehyde 
392 (50 mg, 0.15 mmol) in MeOH (0.5 mL) was added, followed by CssCO3 (90 mg, 0.28 mmol). 
The reaction mixture was allowed to warm to RT and stirred for 16h. The reaction was 
quenched with water (10 mL) and extracted with Et2O (3 × 15 mL). The combined organics 
were washed with water (2 × 5 mL) and brine (10 mL), before being dried over sodium Na2SO4. 
The solvent was evaporated under reduced pressure to afford the crude product as a yellow 
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oil. Purification by flash column chromatography, elution with 0-5% Et2O:petroleum ether, 
afforded acetylene 405 (33 mg, 0.10 mmol, 67%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) 
δ: 0.02 (6H, s, (CH3)2Si), 0.89 (9H, s, (CH3)3CSi), 0.91 (3H, d, J = 6.7, CH3(CHCH2Ar)), 1.43 (3H, d, J 
= 7.0, CH3(CHAr)), 1.93-2.02 (1H, m, CH(CH3)(CH2Ar)), 1.98 (1H, t, J = 2.7, CalkyneH), 2.28 (1H, 
ddd, J = 13.7, 7.9, 0.9, CH2Ar), 2.51 (1H, ddd, J = 16.7, 8.1, 2.7, CH2(alkyne)), 2.59 (1H, ddd, J = 
14.6, 8.4, 1.0, CH2Ar), 2.69 (1H, ddd, J = 16.7, 5.7, 2.7, CH2(alkyne)), 3.11-3.18 (1H, 
CH(CH3)(Ar)), 3.43 (1H, dd, J = 9.8, 5.9, CH2OSi), 3.49 (1H, dd, J = 9.8, 5.4, CH2OSi), 7.28 (1H, t, J 
= 1.0, ArH). 13C NMR (CDCl3, 125 MHz) δ: -5.4 ((CH3)2Si), 16.6 (C(CH3)3), 17.6 (CH3(CHCH2Ar)), 
17.6 (CH3(CHAr)), 23.8 (CH2(alkyne)), 24.3 ((CH3)3CSi), 29.7 (CH2Ar), 33.2 (CH(CH3)(Ar)), 35.1 
(CH(CH3)(CH2Ar)), 67.4 (CH2OSi), 70.0 (CalkyneH), 81.5 (C
Q alkyne), 134.3 (C
ArH), 139.3 (CAr), 166.0 
(CAr). m/z  [CI+, isobutane] 322 [M+H]+ (70%), HRMS found [M+H]+ 322.2205, C18H32NO2Si  
requires 322.2202. υmax /cm
-1 (film): 3314, 2955, 2930, 2886, 1570, 1471, 1462. 
(Z)-N-((2E,8Z)-11-(4-(3-(Tert-butyldimethylsilyloxy)-2-
methylpropyl)oxazol-2-yl)dodeca-2,8-dien-6-ynyl)-3-methoxy-N-methylbut-
2-enamide 397 
 
Vinyl iodide 391 (134 mg, 0.30 mmol) and acetylene 398 (106 mg, 0.48 mmol) were dissolved 
in anhydrous MeCN (3 mL) and degrassed by passing a stream of argon through the solution, 
before being cooled to 0 oC. The reaction was carried out in the absence of light. Pd(PPh3)4Cl2 
(15 mg, 21 µmol) and CuI (11 mg, 60 µmol) were added to the reaction mixture before the 
addition of NEt3 (190 µmol, 1.34 mmol) and the resultant solution was stirred at 0 
oC for 15 
min and then warmed to RT and stirred for a further 90 min, after which TLC analysis indicated 
reaction completion. The solvent was evaporated and the resultant residue was purified by 
flash column chromatography, elution with 0-30% Et2O:petroleum ether, to afford the enyne 
397 (132 mg, 0.24 mmol, 82%), as a colourless oil. 1H NMR (CDCl3, 500 MHz, 55 
oC) δ: 0.04 (6H, 
br. s, (CH3)2Si), 0.90 (9H, s, (CH3)3CSi), 0.92 (3H, d, J = 6.7, CH3(CHCH2Ar)), 1.33 (3H, dd, J = 7.0, 
0.8, CH3(CHAr)), 1.95-2.02 (1H, m, CH(CH2Ar)), 2.21 (3H, s, CH3(alkene)), 2.27-2.31 (3H, m, 
CH2(CHalkene(E))(CH2), CH2Ar), 2.42 (2H, td, J = 6.9, 1.8, CH2(alkyne)), 2.59 (1H, dd, J = 14.6, 6.1, 
CH2Ar), 2.62-2.73 (2H, m, CH2(CHalkene(Z))(CH)), 2.94 (3H, s, CH3N), 3.02-3.09 (1H, m, 
CH(CH3)(Ar)), 3.45 (1H, dd, J = 9.8, 6.0, CH2OSi), 3.51 (1H, ddd, J = 9.8, 5.5, 0.7, CH2OSi), 3.59 
(3H, br. s, CH3O), 3.94 (2H, br. s, CH2N), 5.18 (1H, br. s, CHalkene(CON)), 5.48-5.53 (2H, m, 
CHalkene(Z)(alkyne)), CHalkene(E)(CH2N)), 5.66 (1H, dt, J = 15.4, 6.6, CHalkene(E)(CH2CH2)), 5.78 (1H, dt, 
J = 10.7, 7.3, CHalkene(Z)(CH2)), 7.25 (1H, br. q, J = 0.9, ArH). 
13C NMR (CDCl3, 125 MHz, 55 
oC, 3:2 
rotamer ratio, asterisk denotes minor rotamer peaks) δ: -5.5 (CH3)2Si, 16.5 (CH3(CHCH2Ar)), 
17.8 (CH3(CHAr)), 18.3 (SiC(CH3)3)), 18.6 (CH3(alkene)), 19.7 (CH2(alkyne)), 25.9 ((CH3)3CSi), 29.8 
(CH2Ar), 31.5 (CH2(Calkene(E)H)(CH2)),33.5 (CH(CH3)(Ar)), 33.5 (CH3N* only observed at 25 
oC), 
35.2 (CH(CH2Ar)), 35.2 (CH3N only observed at 25 
oC), 35.3 CH2(Calkene(Z)H)(CH)), 48.9 (CH2N* 
only observed at 25 oC), 52.1 (CH2N only observed at 25 
oC), 54.7 (CH3O), 67.6 (CH2OSi), 77.7 
(Calkyne(Calkene(Z)H)), 82.8 (Calkyne(CH2) only observed at 25 
oC), 91.3 (Calkene(CON)), 111.4 
(Calkene(Z)H(alkyne)), 126.5 ((Calkene(E)H(CH2N)), 131.5 (Calkene(E)H(CH2CH2)), 133.9 (C
ArH), 138.8 
(Calkene(Z)H(CH2)), 139.3 (C
Ar), 167.0 (CAr), 168.5 (CO).bm/z  [CI+, isobutane] 543.6 [M+H]+ 
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(100%), HRMS found [M+H]+ 543.3621, C31H51N2O4Si  requires 543.3618. υmax /cm
-1 (film): 
2955, 2928, 2857, 1647, 1603, 1568, 1456, 1439.  
(E)-N-((2E,6Z)-11-(4-(3-(Tert-butyldimethylsilyloxy)-2-
methylpropyl)oxazol-2-yl)dodeca-2,6-dien-8-ynyl)-3-methoxy-N-methylbut-
2-enamide 404 
 
Acetylene 405 (145 mg, 450 µmol) and vinyl iodide 72 (98 mg, 281 µmol) were dissolved in 
anhydrous MeCN (3 mL) and degassed by passing a stream of argon through the solution, 
before being cooled to 0 oC. The reaction was carried out in the absence of light. Pd(PPh3)4Cl2 
(14 mg, 20 µmol) and CuI (11 mg, 60 µmol) were added to the reaction mixture before the 
addition of NEt3 (181 µmol, 1.30 mmol) and the resultant solution was stirred at 0 
oC for 15 
min, before being warmed to RT and stirred for 16h, after which TLC analysis indicated 
reaction completion. The solvent was evaporated and the resultant residue was purified by 
flash column chromatography, elution with 0-100% Et2O:petroleum ether, to afford the 
reverse enyne 404 (128 mg, 235 µmol, 84%), as a colourless oil. 1H NMR (CDCl3, 500 MHz, 3:2 
rotamer ratio, asterisk denotes minor rotamer peaks) δ: 0.02 (6H, s, (CH3)2Si), 0.89 (9H, s, 
(CH3)3CSi), 0.90 (3H, d, J = 6.8, CH3(CHCH2Ar)), 1.43 (3H, d, J = 6.7, CH3(CHAr)), 1.94-2.00 (1H, 
m, CH(CH2Ar)), 2.13-2.17 (2H, m, CH2(CHalkene(E))(CH2)), 2.21 (3H, br. s, CH3(alkene)), 2.26 (1H, 
dd, J = 14.6, 8.0, CH2Ar), 2.32 (2H, q, J = 7.1, CH2(CHalkene(Z))(CH2)), 2.59 (1H, dd, J = 14.6, 6.0, 
CH2Ar), 2.65 (1H, ddd, J = 16.8, 8.4, 2.0, CH2(alkyne)), 2.83 (1H, ddd, J = 16.9, 5.6, 2.0, 
CH2(alkyne)), 2.93 (3H, s, CH3N), 3.11-3.19 (1H, m, CH(CH3)(Ar)), 3.43 (1H, dd, J = 9.8, 5.9, 
CH2OSi), 3.48 (1H, dd, J = 9.8, 5.5, CH2OSi), 3.57 (3H, br. s, CH3O), 3.61 (3H, br. s, CH3O*), 3.87 
(2H, br. s, CH2N), 3.97 (2H, br. s, CH2N*), 5.15 (1H, br. s, CHalkene(CON)), 5.18 (1H, br. s, 
CHalkene(CON)*), 5.39-5.44 (2H, m, CHalkene(Z)(alkyne)), CHalkene(E)(CH2N)), 5.56 (1H, dt, J = 15.3, 
6.8, CHalkene(E)(CH2CH2)), 5.75-5.79 (1H, m, CHalkene(Z)(CH2CH2)), 7.27 (1H, s, ArH). 
13C NMR (CDCl3, 
125 MHz, 55 oC, 3:2 rotamer ratio, asterisk denotes minor rotamer peaks) δ: -5.5 (CH3)2Si, 16.5 
(CH3(CHCH2Ar)), 17.6 (CH3(CHAr)), 18.3 (SiC(CH3)3)), 18.6 (CH3(alkene)), 25.5 CH2(alkyne), 25.9 
((CH3)3CSi), 29.5 (CH2(CHalkene(E))), 29.8 (CH2Ar),  31.4 (CH2(Calkene(Z)H)), 33.6 (CH3N* only 
observed at 25 oC), 33.6 (CH(CH3)(Ar)), 35.1 (CH3N only observed at 25 
oC), 35.1 (CH(CH2Ar)), 
49.0 (CH2N* only observed at 25 
oC), 52.2 (CH2N only observed at 25 
oC), 54.8 (CH3O), 67.5 
(CH2OSi), 78.9 (Calkyne(Calkene(Z) H)), 91.4 (Calkene(CON)), 91.7 (Calkyne(CH2)), 109.0 (Calkene(Z)H 
(alkyne)), 125.2 (Calkene(E)H(CH2N)), 132.7 Calkene(E) H(CH2CH2)), 134.1 (C
ArH), 139.5 (CAr), 141.6 
Calkene(Z)H(CH2CH2)), 166.2 (C
Ar), 168.4 (CO). N.B: (CQalkene) not observed. m/z  [CI
+, isobutane] 
543 [M+H]+ (100%), HRMS found [M+H]+ 543.3621, C31H51N2O4Si  requires 543.3618. 
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N-((2E,6Z,8Z)-11-(4-(3-(Tert-butyldimethylsilyloxy)-2-methylpropyl)oxazol-
2-yl)dodeca-2,6,8-trienyl)-3-methoxy-N-methylbut-2-enamide 390 
 
Method A: Stille Coupling 
Vinyl iodide 391 (13.0 mg, 28.9 µmol) and vinyl stannane 396 (13.4 mg, 34.7 µmol) were 
dissolved in degassed anhydrous DMF (0.5 mL) before Pd(PPh3)4 (2.7 mg, 2.3 µmol) was added, 
under an atmosphere of argon. The reaction mixture was stirred for 12h at 60 oC under MW 
irradiation. The crude mixture was passed through a pad of Celite and eluted with Et2O (20 
mL). The organics were then washed with water (2 × 5 mL) and brine (5 mL) before being dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to afford the 
crude product as a yellow oil. Purification by HPLC, using a Waters Aquidity UPLC BEH C18 
column (50 nm x 2.1 mm i.d. 1.7 µm) at 40 oC, eluting with 0.1% v/v HCO2H/H2O-0.1% v/v 
HCO2H/MeCN, to afford Z,Z-diene 390 (8.7 mg, 16.0 µmol, 55%), as a colourless oil. 
1H NMR 
(CDCl3, 500 MHz, 55 
oC) δ: 0.04 (6H, br. s, (CH3)2Si), 0.91 (9H, s, (CH3)3CSi), 0.92 (3H, d, J = 6.8, 
CH3(CHCH2Ar)), 1.32 (3H, d, J = 7.0, CH3(CHAr)), 1.95-2.02 (1H, m, CH(CH2Ar), 2.12-2.17 (2H, m, 
CH2(CHalkene(E))(CH2)), 2.21 (3H, s, CH3(alkene)), 2.23-2.32 (3H, m, CH2(CHalkene(Z))(CH2), CH2Ar), 
2.46-2.53 (1H, m, CH2(CHalkene(Z))(CHCH3)), 2.54 (1H, ddd, J = 14.6, 6.1, 1.0, CH2Ar), 2.60-2.67 
(1H, m, (CHalkene(Z))(CHCH3)), 2.93 (3H, s, CH3N), 2.97-3.04 (1H, m, CH(CH3)(Ar)), 3.45 (1H, ddd, J 
= 9.7, 6.0, 1.0, CH2OSi), 3.51 (1H, ddd, J = 9.8, 5.4, 1.2, CH2OSi), 3.59 (3H, br. s, CH3O), 3.91 (2H, 
br. s, CH2N), 5.17 (1H, br. s, CHalkene(CON)), 5.39-5.46 (3H, m, CHalkene(E)(CH2N), 
CHalkene(Z)(CH2CH2), CHalkene(Z)(CH2CHCH3)), 5.58 (1H, dtt, J = 15.4, 6.6, 1.4, CHalkene(E)(CH2CH2)), 
6.21-6.31 (2H, m, CHalkene(Z)(CHalkene(Z)(CH2CH2)), CHalkene(Z)(CHalkene(Z)(CH2CHCH3))), 7.24 (1H, t, J = 
1.1, ArH). 13C NMR (CDCl3, 125 MHz, 55 
oC) δ: -5.5 (CH3)2Si, 16.5 (CH3(CHCH2Ar)), 18.0 
(CH3(CHAr)), 18.3 (SiC(CH3)3)), 18.6 (CH3(alkene)), 25.9 ((CH3)3CSi), 27.2 (CH2(CHalkene(Z))(CH2)),  
29.8 (CH2Ar), 32.0 (CH2(Calkene(E)H)(CH2)), 32.9 (CH2(Calkene(Z) H)(CHCH3)), 34.0 (CH(CH3)(Ar)), 35.1 
(CH(CH2Ar)), 35.1 (CH3N), 52.5 (CH2N), 54.6 (CH3O), 67.6 (CH2OSi), 91.4 (Calkene(CON)), 124.0 
(Calkene(Z)H(Z-alkene(CH2CH2))), 125.4 (Calkene(E)H(CH2N)), 125.4 (Calkene(Z)H(CHalkene(Z)(CH2CHCH3))), 
128.4 Calkene(Z)H(CHCH3)), 131.7 (Calkene(Z)H(CH2CH2)), 132.9 (Calkene(E)H(CH2CH2)),  133.9 (C
ArH), 
139.3 (CAr), 167.2 (CAr), 167.2 (CO). N.B: (CQalkene) not observed. m/z  [CI
+ (+ve), isobutane] 545 
[M+H]+ (100%), HRMS found [M+H]+ 545.3771, C31H53N2O4Si  requires 545.3775  υmax /cm
-1 
(film): 2951, 2928, 2857, 1726, 1645, 1601, 1454.  
Method B: P-2 Ni Reduction from Enyne 397 
In the absence of light, Ni(OAc)2.4H2O (62 mg, 248 µmol) was dissolved in degassed EtOH (2 
mL), before NaBH4 (9 mg, 239 µmol) was added. The resultant black solution was stirred under 
an atmosphere of argon for 2 min before being placed under a hydrogen atmosphere. EDA (59 
µL, 884 µmol) was added before a solution of enyne 397 (48 mg, 88 µmol) in degassed EtOH 
(1.5 mL). The reaction mixture was stirred at RT under an atmosphere of hydrogen for 3h, 
before being passed through Celite, and eluted with EtOH, followed by solvent evaporation, to 
afford the crude product. Purification by HPLC, using a Waters Aquidity UPLC BEH C18 column 
(50 nm x 2.1 mm i.d. 1.7 µm) at 40 oC, eluting with 0.1% v/v HCO2H/H2O-0.1% v/v 
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HCO2H/MeCN, to afford Z,Z-diene 390 (26 mg, 49 µmol, 55%), as a colourless oil. The spectral 
and physical data obtained for 390, via Method B, matched that obtained via Method A. 
Method C: P-2 Ni Reduction from Reverse-Enyne 404 
Under analogous conditions and scale to that described in Method B above, reverse enyne 404 
(48 mg, 88 µmol) was reduced to afford Z,Z-diene 390 (25 mg, 47 µmol, 53%), as a colourless 
oil. The spectral and physical data obtained for 390, via Method C, matched that obtained via 
Methods A and B. 
(S)-3-(Tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol 412b 
 
(R)-methyl 3-hydroxy-2-methylpropanoate (9.82 g, 83.1 mmol) was dissolved in anhydrous 
DMF (30 mL) and cooled to 0 oC under an atmosphere of argon. TBDSCl (23.4 g, 85.2 mmol) 
and imidazole (11.3 g, 166 mmol) were added, and the resultant solution was stirred for 30 
min until TLC analysis of the reaction indicated completion. The reaction was quenched with 
water (250 mL) and was extraction with Et2O (3 × 300 mL). The combined organic extracts 
were washed with water (2 × 100 mL) and brine (3 × 100 mL), dried over anhydrous Na2SO4, 
and the solvent was evaporated to yield the crude  ester intermediate, (R)-methyl 3-(tert-
butyldiphenylsilyloxy)-2-methylpropanoate (29.8 g, 83.6 mmolm 100%), as a colourless oil. The 
intermediate was dissolved in Et2O (275 mL) and cooled to –78 
oC under an atmosphere of 
argon before DIBAL (1 M in THF, 183 mL, 183 mmol) was added. The resultant solution was 
stirred at –78 oC for 2h before being warmed to 0 oC and was slowly added to a rapidly stirring 
solution of Rochelle’s salt (150 g) in water (500 mL) at 0 oC. The slurry was warmed to RT and 
stirred for a further 2h until the organic and aqueous layers became transparent. The organic 
layer was collected and the aqueous layer was extraction with Et2O (3 × 100 mL). The 
combined organic extracts were washed with water (2 × 75 mL) and brine (75 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated to yield the crude product as a colourless 
oil. Purification by flash column chromatography, elution with 0-15% Et2O:petroleum ether, 
afforded the desired S-alcohol 412b (27.3 g, 83.6 mmol, 100%), as a colourless oil. 1H NMR 
(CDCl3, 500 MHz) δ: 0.83 (3H, d, J = 7.0, CH3), 1.06 (9H, s, (CH3)3CSi), 1.96-2.04 (1H, m, CH(CH3)), 
2.49 (1H, t, J = 5.7, OH), 3.59 (1H, dd, J = 10.0, 7.7, CH2OH), 3.67 (2H, t, J = 5.8, CH2OH, CH2OSi), 
3.72 (1H, dd, J = 10.0, 4.5, CH2OSi), 7.38-7.44 (6H, m, ArH), 7.66-7.69 (4H, m, ArH). 
13C NMR 
(CDCl3, 125 MHz) δ: 13.3 (SiC(CH3)3), 19.3 (CH3(CH)), 27.0 ((CH3)3CSi), 37.5 (CH(CH3)), 67.9 
(CH2OSi), 68.9 (CH2OH), 127.9(C
ArH), 129.9(CArH), 133.3 (CQ
Ar), 135.7 (CArH). m/z  [CI+, 
isobutane] 329 [M+H]+ (100%), HRMS found [M+H]+ 329.1942, C20H29O2Si  requires 329.1937. 
υmax /cm
-1 (film): 3385, 2957, 2930, 2859, 1471. [α]D
22.0 -11.77 (c=1.70, CHCl3). The data 
observed is in accordance with literature values.128 
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(R)-3-(Tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol 412a 
 
R-alcohol 412a was obtained in the same quantity, yield and purity as S-alcohol 412b, under 
analagous experimental conditions, starting from (S)-methyl 3-hydroxy-2-methylpropanoate. 
[α]D
21.8 10.04 (c=1.50, CHCl3). The data observed is in accordance with literature values.
128 
(R)-Tert-butyl(3-iodo-2-methylpropoxy)diphenylsilane 413 
 
S-alcohol 412b was dissolved in anhydrous DCM (350 mL) and cooled to 0 oC under an 
atmosphere of argon. Imidazole (6.18 g, 90.8 mmol), PPh3 (21.1 g, 80.4 mmol) and I2 (20.4 g, 
80.4 mmol) were added sequentially and the resultant solution was stirred at 0 oC for 10 min, 
before being warmed to RT and and stirred for a further 70 min, until TLC analysis of the 
reaction indicated completion. The reaction was quenched with sat’d aq. Na2S2O3 solution 
(250 mL) and extraction with DCM (3 × 300 mL). The combined organic extracts were washed 
with sat’d aq. Na2S2O3 solution (2 × 75 mL) and brine (2 × 75 mL), dried over anhydrous Na2SO4 
and the solvent was evaporated to yield the crude product. Purification by flash column 
chromatography, elution with petroleum ether, afforded the iodide 413 (30.2 g, 66.3 mmol, 
95%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.96 (3H, d, J = 6.7, CH3), 1.06 (9H, s, 
(CH3)3CSi), 1.69-1.76 (1H, m, CH(CH3)), 2.49 (1H, t, J = 5.7, OH), 3.34 (1H, dd, J = 9.5, 5.8, 
CH2OSi), 3.40 (1H, dd, J = 9.5, 5.8, CH2OSi), 3.46 (1H, dd, J = 10.1, 6.9, CH2I), 3.58 (1H, dd, J = 
10.1, 4.9, CH2I), 7.38-7.44 (6H, m, ArH), 7.66-7.69 (4H, m, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 
13.8 (CH2I), 17.5 (CH3(CH)), 19.4 (SiC(CH3)3), 26.9 ((CH3)3CSi), 37.7 (CH(CH3)), 67.4 (CH2OSi), 
127.8(CArH), 129.8 (CArH), 133.7 (CQ
Ar), 135.8 (CArH). m/z  [CI+, isobutane] 439 [M+H]+ (100%), 
HRMS found [M+H]+ 439.0953, C20H28IOSi  requires 439.0954. υmax /cm
-1 (film): 2959, 2930, 
2857, 1471. [α]D
21.6 -9.72 (c=1.44, CHCl3). 
(S)-4-(tert-butyldiphenylsilyloxy)-3-methylbutanal 416 
 
Anhydrous DCM (400 mL) was added to a flame-dried flask and cooled to –78 oC, before the 
addition of oxalyl chloride (11.6 mL, 137 mmol). A solution of DMSO (16.2 mL, 229 mmol) in 
anhydrous DCM (35 mL) was added dropwise over 30 min via syringe pump, ensuring that the 
internal temperature did not exceed –70 oC. The mixture was stirred for a further 20 min. A 
solution of S-alcohol 412b (27.3 g, 83.1 mmol) in anhydrous DCM (30 mL) was added dropwise, 
via syringe pump, over a period of 20 min, ensuring that the internal temperature did not 
exceed –70 oC. After stirring for a further 45 min at –78 oC, NEt3 (69.0 mL, 499 mmol) was 
added dropwise, via syringe pump, over a period of 40 min, ensuring that the internal 
temperature did not exceed –70 oC. The resultant mixture was then stirred for a further 10 min 
at –78 oC before being warmed to 0 oC over 45 min. TLC analysis of the reaction indicated 
completion. The reaction was quenched with water (250 mL) and the organic layer was 
collected. The aqueous layer was extraction with DCM (3 × 150 mL). The combined organic 
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extracts were washed with water (2 × 75 mL) and brine (2 × 75 mL), dried over anhydrous 
Na2SO4, and the solvent was evaporated to yield the crude aldehyde intermediate, 415 (27.1 g, 
83.1 mmol 100%), as a colourless oil. (Methoxymethyl)triphenylphosphonium chloride (62.5 g, 
182 mmol) was dissolved in anhydrous THF (375 mL) and cooled to –78 oC under an 
atmosphere of argon, before NaHMDS (1 M in THF, 164 mL, 164 mmol) was added. After 
stirring at –78 oC for 1h, a solution of the R-aldehyde intermediate 415 (27.1 g, 83.1 mmol) in 
anhydrous THF (50 mL) was added dropwise over 10 min. The reaction was stirred at –78 oC 
for 30 min before being warmed to RT stirred for a further 90 min. TLC analysis of the reaction 
indicated completion. The reaction was quenched by the addition of sat’s aq. NaHCO3 solution 
(150 mL) and was extracted with Et2O (3 × 200 mL). The combined organic extracts were 
washed with water (2 × 75 mL) and brine (75 mL), dried over anhydrous Na2SO4, and the 
solvent was evaporated, to yield the crude enol ether intermediate as a colourless oil. The 
intermediate was dissolved in THF and cooled to 0 oC. 6 M aq. HCl solution (156 mL, 936 mmol) 
was slowly added and the solution was warmed to RT and stirred for 90 min, after which TLC 
analysis indicated completion. The reaction was extracted with Et2O (3 × 200 mL) and the 
combined organic extracts were washed with water (2 × 75 mL) and brine (75 mL), dried over 
anhydrous Na2SO4, and the solvent was evaporated to yield the crude product as a pale yellow 
oil. Purification by flash column chromatography, elution with 0-3.5% Et2O:petroleum ether, 
afforded the desired homologated aldehyde 416 (22.6 g, 66.5 mmol, 80%), as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 0.97 (3H, d, J = 6.5, CH3), 1.07 (9H, s, (CH3)3CSi), 2.27-2.40 (2H, m, 
CH(CH3), CH2(CHO)), 2.63 (1H, ddd, J = 15.6, 5.6, 2.0, CH2(CHO)), 3.46 (1H, dd, J = 10.0, 6.8, 
CH2OSi), 3.61 (1H, dd, J = 10.0, 4.5, CH2OSi), 3.72 (1H, dd, J = 10.0, 4.5, CH2OSi), 7.39-7.49 (6H, 
m, ArH), 7.66-7.69 (4H, m, ArH), 9.82 (1H, s, CHO). 13C NMR (CDCl3, 100 MHz) δ: 16.8 
(SiC(CH3)3), 19.3 (CH3(CH)), 26.9 ((CH3)3CSi), 31.3 (CH(CH3)),48.2 (CH2(CHO)), 68.4 (CH2OSi), 
127.7 (CArH), 129.8 (CArH), 133.5 (CQ
Ar), 135.7 (CArH), 202.5 (CHO). m/z  [CI+, isobutane] 341 
[M+H]+ (100%), HRMS found [M+H]+ 341.1939, C21H29O2Si  requires 341.1937 . υmax /cm
-1 (film): 
2930, 2858, 1720, 1471. [α]D
21.6 -2.50 (c=1.00, CHCl3). The data observed is in accordance with 
literature values.133  
(S)-Tert-butyl(2-methylpent-4-enyloxy)diphenylsilane 414 
 
Method A: Negishi Coupling with Vinyl Iodide 413 
Vinyl iodide 413 (14.9 g, 33.9 mmol) was dissolved in anhydrous Et2O (50 mL) and cooled to –
78 oC under an atmosphere of argon. tBuLi (1.9 M in hexanes, 37.4 mL, 71.1 mmol) was added 
and the resultant solution stirred for 30 min. In a separate flask, ZnBr2 (4.96 g, 22.0 mmol) was 
flame dried and dissolved in anhydrous THF and cooled to 0 oC, before being added dropwise, 
via cannulation, to the solution of lithiate in Et2O. The resultant suspension was stirred at –78 
oC for 45 min, before being warmed to 0 oC and stirred for a further 20 min. In a separate flask, 
Pd(PPh3)4 (1.17 g, 1.02 mmol) and vinyl bromide (1 M in THF, 102 mL, 102 mmol) were 
combined and the resultant suspension was added dropwise, via cannular, to the zincate. The 
reaction mixture was stirred at 0 oC for 1h before being warmed to RT and stirred for 72h. The 
reaction was quenched with water (200 mL) and extracted with Et2O (3 ×  200 mL). The 
combined organic extracts were washed with water (100 mL) and brine (2 x 75mL), dried over 
anhydrous Na2SO4, and the solvent was evaporated to yield the crude product. Purification by 
flash column chromatography, elution with petroleum ether, afforded the desired olefin 414 
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(9.11 g, 26.9 mmol, 79%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.90 (3H, d, J = 6.8, 
CH3), 1.06 (9H, s, (CH3)3CSi), 1.72-1.79 (1H, m, CH(CH3)), 1.87-1.93 (1H, m, CH2(alkene)), 2.23-
2.29 (1H, m, CH2(alkene)), 3.34 (1H, dd, J = 9.5, 5.8, CH2OSi), 3.49 (2H, dd, J = 6.0, 3.7, CH2OSi), 
4.95-5.02 (2H, m, CalkeneH2), 5.72-5.80 (1H, m, CalkeneH(CH2)(CH2
’)), 7.36-7.42 (6H, m, ArH), 7.66-
7.68 (4H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.4 (CH3(CH)), 19.3 (SiC(CH3)3), 26.9 
((CH3)3CSi), 35.7 (CH(CH3)), 37.6 (CH2(alkene)), 68.4 (CH2OSi), 115.7 (CalkeneH2), 127.6 (C
ArH), 
129.5 (CArH), 134.0 (CQ
Ar), 135.6 (CArH), 137.3 (CalkeneH(CH2)(CH2
’)). m/z  [CI+, isobutane] 339 
[M+H]+ (100%),HRMS found [M+H]+ 339.2147, C22H31OSi  requires 339.2144 . υmax /cm
-1 (film): 
2959, 2932, 2859, 1641, 1589, 1471. [α]D
21.7 -11.5 (c=1.56, CHCl3). The data observed is in 
accordance with literature values.128 
Method B: Wittig Olefination with Aldehyde 416 
Methyltriphenylphosphonium bromide (31.7 g, 88.8 mmol) was dissolved in anhydrous THF 
(300 mL) and cooled to 0 oC under an atmosphere of argon. tBuLi (1.9 M in hexanes, 40.1 mL, 
76.1 mmol) was added and the resultant mixture was stirred for 30 min, before a solution of 
aldehyde 416 (17.3 g, 50.7 mmol), in anhydrous THF (50 mL), was added dropwise over 10 min. 
The reaction was stirred at 0 oC for 1h before being warmed to RT stirred for a further 10h. TLC 
analysis of the reaction indicated completion. The reaction mixture was diluted with 
petroleum ether and filtered. The supernatant was collected and solvent evaporated. The 
crude material was taken up in petroleum ether and filtered for a second time to remove the 
majority of excess methyltriphenylphosphonium bromide and PPh3O solids. Solvent 
evaporation afforded the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-1% Et2O:petroleum ether, afforded the desired olefin 414 
(15.0 g, 44.2 mmol, 87%), as a colourless oil. The spectral and physical data obtained for 414, 
via Method B, matched that obtained via Method A.128 
(4S)-5-(Tert-butyldiphenylsilyloxy)-4-methylpentane-1,2-diol 
 
 
Olefin 414 (10.4 g, 30.8 mmol) was dissolved in anhydrous MeCN (30 mL) and cooled to 0 oC 
under an atmosphere of argon. Water (10 mL), NMO (7.93 g, 67.7 mmol) and then OsO4 (4% 
w/w in H2O, 2.0 mL, 0.32 mmol) was added, and the resultant solution was warmed to RT and 
stirred for 3h, after which TLC analysis indicated reaction completion. The reaction was 
quenched with a solution of sat’d aq. Na2SO3 (50 mL) and extracted with Et2O (3 × 100 mL). 
The combined organic extracts were washed with water (50 mL) and brine (2 × 50 mL), dried 
over anhydrous Na2SO4, and the solvent was evaporated to yield the crude product. 
Purification by flash column chromatography, elution with 0-100% Et2O:petroleum ether, 
afforded diol 417 (11.5 g, 30.8 mmol, 100%), as a colourless oil and a 1.3:1 mixture of 
diastereoisomers. 1H NMR (CDCl3, 500 MHz, 1.3:1 mixture of diastereoisomers, A & B) δ: 0.86 
(3H, d, J = 6.9, CH3(CH), A), 0.92 (3H, d, J = 6.9, CH3(CH), B), 1.06 (9H, s, (CH3)3CSi), 1.37 (1H, 
ddd,  J = 14.3, 6.4, 2.9, CH2(CHCH3)(CHOH), A), 1.47-1.53 (1H, m, CH2(CHCH3)(CHOH)), 1.52-1.55 
(1H, m, CH2(CHCH3)(CHOH), B), 1.85-1.94 (1H, m, CH(CH3)), 1.97 (1H, dd, J = 7.3, 4.7, OH(CH), 
B), 2.02 (1H, dd, J = 7.1, 4.9, OH(CH), A), 2.86 (1H, d, J = 4.1, OH, B), 3.67 (1H, d, J = 3.5, OH, A), 
3.41-3.64 (4H, m, CH2OSi, CH2OH), 3.80-3.87 (1H, m, CH(OH)), 7.38-7.45 (6H, m, ArH), 7.65-
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7.68 (4H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 15.3 (CH3(CH), B), 15.3 (CH3(CH), A), 19.2 
(SiC(CH3)3, B), 19.2 (SiC(CH3)3, A), 26.8 ((CH3)3CSi, A), 26.9 ((CH3)3CSi, B), 32.2 (CH(CH3), B), 33.6 
(CH(CH3), A), 37.8 (CH2(CHCH3)(CHOH), B), 38.8 (CH2(CHCH3)(CHOH), A), 67.1 (CH2OH, B), 67.4 
(CH2OH, A), 68.9(CH2OSi,B), 69.8 (CH(OH), B), 70.0 (CH2OSi, A), 70.7 (CH(OH), A) 127.7 (C
ArH), 
129.8 (CArH), 133.3 (CAr, A), 133.3 (CAr, A), 133.3 (CAr, B), (CAr, B), 135.6 (CArH, B), 135.6 (CArH, A), 
135.7 (CArH, B). m/z  [CI+, isobutane] 373 [M+H]+ (100%), HRMS found [M+H]+ 373.2202, 
C22H33O3Si  requires 373.2199. υmax /cm
-1 (film): 3372, 2957, 2930, 2857, 1471. 
(4S)-1-[Tert-butyl(dimethyl)silyl]oxy-5-[tert-butyl(diphenyl)silyl]oxy-4-
methyl-pentan-2-amine 410 
 
Diol 417 (15.0 g, 44.2 mmol) was dissolved in anhydrous DMF (44 mL) and cooled to 0 oC under 
an atmosphere of argon. TBSCl (6.92 g, 45.9 mmol) and imidazole (6.01 g, 88.3 mmol) were 
added and the resultant solution was stirred for 90 min, until TLC analysis of the reaction 
indicated completion. The reaction was quenched with water (100 mL) and was extracted with 
Et2O (3 × 100 mL). The combined organic extracts were washed with water (2 × 75 mL) and 
brine (4 × 75 mL), dried over anhydrous Na2SO4, and the solvent was evaporated to yield the 
crude alcohol intermediate (21.3 g, 43.8 mmol, 99%), as a colourless oil. The crude alcohol 
intermediate was dissolved in anhydrous DCM (150 mL) and cooled to 0 oC under an 
atmosphere of argon. MsCl (3.73 mL, 48.1 mmol) was added, followed by NEt3 (12.2 mL, 87.5 
mmol) and the resultant solution was stirred for 15 min. TLC analysis indicated reaction 
completion. The reaction was quenched with water (100 mL) and was extracted with DCM (3 × 
100 mL). The combined organic extracts were washed with water (3 × 75 mL) and brine (75 
mL), dried over anhydrous Na2SO4, and the solvent was evaporated to yield the crude mesylate 
intermediate 418 (25.0 g, 44.3 mmol, 99% from diol 417), as a colourless oil. The mesylate 
intermediate was dissolved in anhydrous DMF (110 mL), before NaN3 (8.53 g, 131 mmol) was 
added and the resultant solution was heated to 80 oC for 4h. TLC analysis indicated reaction 
completion. The reaction was quenched with water (100 mL) and was extracted with Et2O (3 × 
100 mL). The combined organic extracts were washed with water (2 × 75 mL) and brine (50 
mL), dried over anhydrous Na2SO4 and the solvent was evaporated. The crude material was 
passed through a plug of silica, elution with 0-2% Et2O:petroleum ether, to afforded the azide 
intermediate (19.6 g, 38.4 mmol, 88% from diol 417), as a pale yellow oil. The azide 
intermediate was dissolved in anhydrous EtOH (120 mL) and charged with 10% activated Pd/C 
(1.2 g). The suspension was stirred under an atmosphere of hydrogen at RT for 4h. TLC analysis 
indicated reaction completion. The suspension was filtered through Celite and the filtrate was 
concentrated under reduced pressure to afford the crude product. Purification via flash 
column chromatography, elution with 0-7% MeOH:DCM, afforded the amine 410 (14.6 g, 30.0 
mmol, 78%) as a colourless oil. 1H NMR (CDCl3, 500 MHz, 1.3:1 mixture of diastereoisomers, A 
& B) δ: 0.05 (6H, s, (CH3)2Si), 0.90 (9H, s, (CH3)3CSi), 0.90 (9H, s, (CH3)3CSi), 0.94 (3H, d, J = 6.7, 
CH3(CH), B), 0.96 (3H, d, J = 6.8, CH3(CH), A), 1.05 (9H, s, (CH3)3CSi), 1.05 (9H, s, (CH3)3CSi), 1.04-
1.11 (1H, m, CH2(CHNH2), A), 1.13-1.18 (1H, m, CH2(CHNH2), B), 1.27-1.38 (1H, m, CH2(CHNH2), 
A), 1.43-1.48 (1H, m, CH2(CHNH2), B), 1.72-1.81 (CH(CH3), A) 1.82-1.91 (CH(CH3), B), 2.85-2.90 
(1H, m, CH(NH2)), 3.25 (1H, dd, J = 9.8, 7.6, CH2OSi, A), 3.30 (1H, dd, J = 9.7, 7.6, CH2OSi, B), 
3.41-3.56 (3H, dd, J = 9.7, 7.6, CH2OSi), 7.35-7.44 (6H, m, ArH), 7.65-7.67 (4H, m, ArH). 
13C NMR 
(CDCl3, 125 MHz) δ: -5.4 ((CH3)2Si, A), -5.3 ((CH3)2Si, B), 16.6 (CH3(CH), B), 17.9 (CH3(CH), A), 
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18.3 (SiC(CH3)3, A), 19.3 (SiC(CH3)3, B), 25.9 ((CH3)3CSi, B), 26.9 ((CH3)3CSi, A), 32.6 (CH(CH3), B), 
32.7 (CH(CH3), A), 37.5 (CH2(CHNH2), B), 38.3 (CH2(CHNH2), A), 50.5 (CH(NH2), A), 50.8 
(CH(NH2), B), 68.6 (CH2OSi, A), 68.7 (CH2OSi, A), 69.2 (CH2OSi, B), 69.8 (CH2OSi, B), 127.9 (C
ArH, 
A), 127.6 (CArH, B), 129.5 (CArH, A), 129.5 (CArH, B), 133.9 (CAr, A), 139.9 (CAr, B), 134.0 (CAr, B), 
134.0 (CAr, A). m/z  [CI+, isobutane] 486 [M+H]+ (100%), HRMS found [M+H]+ 486.3222, 
C28H48O2NSi  requires 486.3224. υmax/cm
-1 (film): 3033, 2959, 2929, 2857, 1471. 
(R)-4-(Tert-butyldiphenylsilyloxy)-3-methylbutanenitrile 419a 
 
R-alcohol 412a (7.30 g, 21.3 mmol) was dissolved in anhydrous DCM (100 mL) and cooled to 0 
oC under an atmosphere of argon. MsCl (2.00 mL, 25.6 mmol) was added, followed by NEt3 
(5.92 mL, 42.6 mmol) and the resultant solution was stirred for 5 min. TLC analysis indicated 
reaction completion. The reaction was quenched with water (100 mL) and was extracted with 
DCM (3 × 100 mL). The combined organic extracts were washed with water (3 × 75 mL) and 
brine (100 mL), dried over anhydrous Na2SO4, and the solvent was evaporated to yield the 
crude mesylate intermediate as a colourless oil. The mesylate intermediate was dissolved in 
anhydrous DMF (60 mL), before KCN (5.55 g, 85.2 mmol) was added and the resultant solution 
was heated to 65 oC for 16h, under an atmosphere of argon. TLC analysis indicated reaction 
completion. The reaction was quenched with water (100 mL) and was extracted with Et2O (3 × 
150 mL). The combined organic extracts were washed with water (2 × 75 mL) and brine (100 
mL), dried over anhydrous Na2SO4, and the solvent was evaporated to yield the crude product 
as a yellow oil. Purification via flash column chromatography, elution with 0-20% 
Et2O:petroleum ether, afforded nitrile 419a (6.47 g, 18.3 mmol, 86%) as a colourless oil. 
1H 
NMR (CDCl3, 500 MHz) δ: 0.97 (3H, d, J = 7.0, CH3), 1.06 (9H, s, (CH3)3CSi), 2.00-2.08 (1H, m, 
CH(CH3)), 2.38 (1H, dd, J = 16.5, 7.0, CH2CN), 2.55 (1H, dd, J = 17.0, 5.5, CH2CN), 3.46 (1H, dd, J 
= 10.5, 7.5, CH2OSi), 3.63 (1H, dd, J = 10.0, 4.5, CH2OSi), 7.38-7.44 (6H, m, ArH), 7.63-7.65 (4H, 
m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 15.9 (CH3(CH)), 19.3 (SiC(CH3)3), 21.1 (CH2CN), 26.8 
((CH3)3CSi), 33.3 (CH(CH3)), 66.9 (CH2OSi), 68.9 (CH2OH), 119.9 (CN), 127.8 (C
ArH), 129.8 (CArH), 
133.2 (CQ
Ar), 135.5 (CArH). m/z  [CI+, isobutane] 338 [M+H]+ (100%), HRMS found [M+H]+ 
338.1943, C21H28ONSi  requires 338.1940. υmax /cm
-1 (film): 2961, 2930, 2859, 1471, 1427. 
[α]D
21.4 5.96 (c=1.41, CHCl3). 
(S)-4-(Tert-butyldiphenylsilyloxy)-3-methylbutanenitrile 419b 
 
S-Nitrile 419b was obtained in the same quantity, yield and purity as R-nitrile 412a, under 
analagous experimental conditions, starting from S-alcohol 412b. [α]D
21.4 -6.41 (c=1.53, CHCl3).
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(R)-4-(Tert-butyldiphenylsilyloxy)-3-methylbutan-1-ol 420a 
 
Nitrile 419a (4.68 g, 13.2 mmol) was dissolved in anhydrous DCM (130 mL) and cooled to –78 
oC under an atmosphere of argon. DIBAL (1M in THF, 14.6 mL, 14.6 mmol) was added 
dropwise, via syringe pump, over 1h and the reaction mixture was then stirred for a further 2h 
at –78 oC. TLC analysis indicated reaction completion. The reaction mixture was slowly added 
to a rapidly stirring solution of Rochelle’s salt (15 g) in water (150 mL) at 0 oC. The slurry was 
warmed to RT and stirred for a further 2h until the organic and aqueous layers became 
transparent. The organic layer was collected and the aqueous layer was extraction with DCM 
(3 × 100 mL). The combined organic extracts were washed with water (2 × 75 mL) and brine 
(50 mL), dried over anhydrous Na2SO4 and the solvent was evaporated to yield the crude 
aldehyde intermediate as a colourless oil. The intermediate was immediately dissolved in 
anhydrous MeOH (65 mL) and DCM (30 mL) and cooled to –78 oC. NaBH4 (900 mg, 23.8 mmol) 
was added portionwise over 5 min and the resulting reaction mixture was stirred at –78 oC for 
2h. TLC analysis indicated reaction completion The reaction mixture was warmed to 0 oC and 
quenched with water (50 mL) and 10% aq. citric acid solution (40 mL) and stirred at RT for 10 
min before being extracted with DCM (3 × 100 mL). The combined organic extracts were 
washed with water (3 × 20 mL), brine (50 mL), dried over anhydrous Na2SO4 and concentrated 
under reduced pressure to yield the crude product as a colourless oil. Purification via flash 
column chromatography, elution with 0-40% Et2O:petroleum ether, afforded R-alcohol 420a 
(3.15 g, 9.24 mmol, 70%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.89 (3H, d, J = 8.5, 
CH3), 1.06 (9H, s, (CH3)3CSi), 1.50-1.55 (1H, m, CH2(CH)(CH2OH)), 1.66-1.71 (1H, m, 
CH2(CH)(CH2OH)), 1.82-1.90 (1H, m, CH(CH3)), 2.10 (1H, br. s, OH), 3.47-3.53 (2H, m, CH2OSi), 
3.68-3.76 (2H, m, CH2OH), 7.37-7.43 (6H, m, ArH), 7.65-7.68 (4H, m, ArH). 
13C NMR (CDCl3, 125 
MHz) δ: 17.2 (CH3(CH)), 19.3 (SiC(CH3)3), 26.9 ((CH3)3CSi), 33.3 (CH(CH3)), 37.4 
(CH2(CH)(CH2OH)), 61.2 (CH2OSi), 69.3 (CH2OH), 127.6 (C
ArH), 129.7 (CArH), 133.5 (CQ
Ar), 135.6 
(CArH). m/z  [CI+, isobutane] 343 [M+H]+ (100%), HRMS found [M+H]+ 343.2091, C21H31O2Si  
requires 343.2093. υmax / cm
-1 (film): 3352, 2957, 2930, 2857, 1472. [α]D
22.6 1.69 (c = 1.40, 
CHCl3). 
(S)-4-(Tert-butyldiphenylsilyloxy)-3-methylbutan-1-ol 420b 
 
S-Alcohol 420b was obtained in the same quantity, yield and purity as R-alcohol 420a, under 
analagous experimental conditions, starting from S-nitrile 419b. [α]D
22.4 -2.88 (c=1.02, CHCl3). 
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(R)-4-(Benzyloxy)-2-methylbutan-1-ol 421a 
 
NaH (60% w/w in mineral oil, 489 g, 12.3 mmol) was washed with petroleum ether (× 3) under 
an atmosphere of argon, before anhydrous THF (50 mL) was added and the suspension was 
cooled to 0 oC, under an atmosphere of argon. A solution of alcohol 420a (3.23 g, 9.42 mmol) 
in THF (15 mL) was added and the resultant mixture was stirred at 0 oC for 30 min and then at 
RT for 30 min. BnBr (1.57 mL, 13.2 mL) was added and the reaction was stirred for 1h before 
being heated at 45 oC for 72h. After cooling to RT, the reaction was quenched with water (75 
mL) and extracted with Et2O (3 × 75 mL).The combined organic extracts were washed with 
water (2 × 40 mL) and brine (40 mL), dried over anhydrous Na2SO4 and the solvent was 
evaporated to yield the crude intermediate as a yellow oil. This was passed through a plug of 
silica, elution with 0-3% Et2O:petroleum ether, to afforded the benzylated intermediate as a 
colourless oil. The intermediate was dissolved in anhydrous THF (30 mL) and cooled to 0 oC 
under an atmosphere of argon. TBAF (1 M in THF, 28.0 mL, 28.0 mmol) was added, and after  
stirring for 30 min at 0 oC, the reaction mixture was warmed to RT and stirred for a further 
16h, before being quenched with water (20 mL), and extracted with Et2O (3 × 50 mL). The 
combined organics were washed sequentially with water (2 × 10 mL) and brine (20 mL) before 
being dried over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to 
afford the crude product as a colourless oil. Purification via flash column chromatography, 
elution with 0-100% Et2O:petroleum ether, afforded R-alcohol 421a (1,28 g, 6.57 mmol, 69%) 
as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.91 (3H, d, J = 6.8, CH3), 1.53-1.61 (1H, m, 
CH2(CH2OBn)), 1.65-1.74 (1H, m, CH2(CH2OBn)), 1.79-85 (1H, m, CH(CH3)), 2.82 (1H, br. s, OH), 
3.42 (1H, dd, J = 10.9, 6.6, CH2OBn), 3.47-3.55 (2H, m, CH2OBn, CH2OH), (1H, m, CH2OH), 4.52 
(2H, s, OCH2Ph), 7.28-38 (5H, m, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 17.3 (CH3), 34.1 
(CH2(CH2OBn), 34.2 (CH(CH3)), 68.2 (CH2OH), 68.8 (CH2OBn), 73.3 (OCH2Ph), 127.8 (C
ArH), 127.9 
(CArH), 128.6 (CArH), 138.2 (CAr). m/z  [CI+, isobutane] 195 [M+H]+ (100%), HRMS found [M+H]+ 
195.1384, C12H19O2  requires 195.1385. υmax /cm
-1 (film): 3393, 2955, 2928, 2868, 1454. [α]D
21.8 
-3.87 (c = 0.93, CHCl3). 
(S)-4-(Benzyloxy)-2-methylbutan-1-ol 421b 
 
S-Alcohol 421b was obtained in the same quantity, yield and purity as R-alcohol 421a, under 
analagous experimental conditions, starting from S-alcohol 420b. [α]D
21.8 5.11 (c=1.00, CHCl3). 
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(R)-4-(Benzyloxy)-2-methylbutanoic acid 411a 
 
Method A: Oxidation of Alcohol 421a 
To a stirring solution of DCM (90 mL) at 0 oC, NaHCO3 (3.60 g, 42.9 mmol), 
tBuOH (5 mL) and 
DMP (4.52 g, 10.7 mmol) were added sequentially. A solution of R-alcohol 421a (1.80 g, 9.27 
mmol) in DCM (15 mL)  was added dropwise to the reaction mixture and the resultant 
suspension was stirred for 1h at 0 oC, until TLC analysis indicated reaction completion. Half of 
the solvent was removed under reduced pressure and the crude material was passed through 
a plug of silica, elution with 0-50% Et2O:petroleum ether, to afford the aldehyde intermediate 
as a colourless oil, which was immediately dissolved in THF (20 mL) and tBuOH (10 mL). The 
resultant solution was cooled to 0 oC and solution of NaH2PO4.2H2O (6.51g, 41.7 mmol) and 2-
methyl-2-butene (11.3 mL, 107 mmol) in water (20 mL) was added dropwise to the reaction 
mixture and was stirred for 1h at 0 oC and then for 16h at RT, after which TLC analysis 
indicated reaction completion. The reaction was diluted with water (30 mL) and was extracted 
with Et2O (3 × 50 mL). The combined organic extracts were washed with water (2 × 20 mL) and 
brine (20 mL), dried over anhydrous Na2SO4, and the solvent was evaporated to yield the crude 
product as a pale yellow. Purification via flash column chromatography, elution with 0-20% 
Et2O:petroleum ether, afforded R-acid 411a (1.50 g, 7.21 mmol, 78%) as a colourless oil. 
1H 
NMR (CDCl3, 500 MHz) δ: 1.26 (3H, d, J = 7.0, CH3), 1.74-1.81 (1H, m, CH2(CH2OBn)), 2.06-2.13 
(1H, m, CH2(CH2OBn)), 2.70-2.77 (1H, m, CH(CH3)), 3.59 (2H, t, J = 6.0, CH2OBn), 4.55 (2H, s, 
OCH2Ph), 7.31-40 (5H, m, ArH). 
13C NMR (CDCl3, 125 MHz) δ: 17.1 (CH3), 33.3 (CH2(CH2OBn), 
36.6 (CH(CH3)), 67.9 (CH2OBn), 73.1 (OCH2Ph), 127.7 (C
ArH), 127.8 (CArH), 128.4 (CArH), 138.4 
(CAr), 182.3 (CO). m/z  [EI+] 208 [M]+ (100%), HRMS found [M]+ 208.1105, C12H16O3  requires 
208.1099. υmax /cm
-1 (film): 3090, 2934, 2857, 1705, 1456. [α]D
24.0 -1.78 (c = 1.00, CHCl3). 
(S)-4-(Benzyloxy)-2-methylbutanoic acid 411b 
 
Method A: Oxidation of Alcohol 421b 
S-Acid 411b was obtained in the same quantity, yield and purity as R-Acid 411a, under 
analagous experimental conditions, starting from S-alcohol 421b. [α]D
24.1 2.91 (c=1.45, CHCl3). 
2-(Benzyloxy)ethanol 425 
 
NaH (60% w/w in mineral oil, 8.80 g, 220 mmol) was washed with petroleum ether (× 3) under 
an atmosphere of argon, before anhydrous THF (175 mL) was added. To this suspension, a 
solution of ethylene glycol (60.0 mL, 1.00 mol) in THF (175 mL) was added via cannular. After 
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stirring for 1h at RT, the reaction mixture became homogeneous. NaI (3.00g, 20.0 mmol) and 
benzyl chloride (25.4 g, 200 mmol) were added and the resultant solution was heated at reflux 
for 12h under an atmosphere of argon. After cooling to RT, the reaction was quenched with 
water (200 mL) and extracted with Et2O (3 × 200 mL).The combined organic extracts were 
washed with water (2 × 75 mL) and brine (100 mL), dried over anhydrous Na2SO4, and the 
solvent was evaporated to yield the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-100% Et2O:petroleum ether, afforded the desired product, 
alcohol 425 (27.0 g, 177 mmol, 89%), as a pale yellow oil. 1H NMR (CDCl3, 500 MHz) δ: 2.14 (1H, 
t, J = 6.0, OH), 3.63 (2H, t, J = 4.5, CH2OH), 3.78-3.90 (2H, m, CH2OBn), 4.60 (2H, s, CH2Ph), 7.31-
7.40 (5H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 61.9 (CH2OH), 71.4 (CH2OBn), 73.6 (CH2Ar), 
128.1 (CArH), 128.1 (CArH), 128.8 (CArH), 138.0 (CAr). m/z  [CI+, isobutane] 153 [M+H]+ (100%), 
HRMS found [M+H]+ 153.0914, C9H13O2  requires 153.0916. υmax /cm
-1 (film): 3390, 2959, 2927, 
2855, 1456. The data observed is in accordance with literature values.181 
1-Benzyloxy-2-iodoethane 426 
 
Alcohol 425 (25.2 g, 165 mol) was dissolved in anhydrous THF (400 mL) and cooled to 0 oC 
under an atmosphere of argon. Imidazole (13.5 g, 199 mmol), PPh3 (46.8 g, 179 mmol) and I2 
(45.3 g, 179 mmol) were added sequentially and the resultant suspension was stirred at 0 oC 
for 30 min, before being warmed to RT, and was stirred for a further 2h. TLC analysis indicated 
reaction completion. The reaction was quenched by the addition of sat’d aq. Na2S2O3 solution 
(300 mL) and extracted with Et2O (3 × 300 mL).The combined organic extracts were washed 
with sat’d aq. Na2S2O3 solution (2 × 75 mL) and brine (2 × 50 mL), dried over anhydrous Na2SO4 
and the solvent was evaporated to yield a cloudy oil. This was taken up in petroleum ether at 0 
oC, filtered, and the supernatant was collected and evaporated to yield the crude product as a 
colourless oil  Purification by flash column chromatography, elution with 0-5% Et2O:petroleum 
ether, afforded iodide 425 (42.5 g, 162 mmol, 98%), as a colourless oil. 1H NMR (CDCl3, 500 
MHz) δ: 3.29 (2H, t, J = 7.0, CH2I), 3.75 (2H, t, J = 6.5 CH2OBn), 4.59 (2H, s, CH2Ph), 7.29-7.37 
(5H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 2.9 (CH2I), 70.8 (CH2OBn), 72.9 (CH2Ar), 127.8 (C
ArH), 
127.9 (CArH), 128.5 (CArH), 137.8 (CAr). m/z  [CI+, isobutane] 263 [M+H]+ (100%), HRMS found 
[M+H]+ 263.9930, C9H12IO2  requires 263.9933. υmax /cm
-1 (film): 3028, 2859, 1495, 1452. The 
data observed is in accordance with literature values.182 
N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpropionamide 423a 
 
(+)-Pseudoephedrine (422a) (8.84 g, 53.5 mmol) was dissolved in anhydrous DCM (100 mL) at 
RT, under an atmosphere of argon. NEt3 (8.93 mL, 64.2 mL) was added followed by the 
dropwise addition of propionic anhydride, over 10 min. The resultant solution was stirred for 
30 min, after which TLC analysis indicated reaction completion. The reaction was quenched by 
the addition of water (200 mL) and extracted with DCM (3 × 200 mL). The combined organic 
extracts were washed with sat’d aq. NaHCO3 solution (2 × 50 mL), 1 M aq. HCl solution (2 × 50 
mL) and brine (2 × 50 mL), before being dried over anhydrous Na2SO4. The solvent was 
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concentrated in vacuo to afford a colourless oil. The crude product was triturated from 
petroleum ether at 0 oC and dried under reduced pressure to yield amide 423a (12.4 g, 56.0 
mmol, 94%), as a white solid. 1H NMR (C6D6, 500 MHz, 2:1 rotamer ratio, asterisk denotes 
minor rotamer peaks) δ: 0.58 (3H, d, J = 7.0, CH3(CH)*), 0.94 (3H, d, J = 7.0, CH3(CH)), 1.01 (3H, 
t, J = 7.5, CH3CH2), 1.20 (3H, t, J = 7.5, CH3CH2*), 1.69-1.83 (2H, m, CH2CH3), 2.08-2.13 (1H, m, 
CH2CH3*), 2.13 (3H, s, CH3N), 2.46-2.51 (1H, m, CH2CH3*), 2.84 (3H, s, CH3N*), 3.71-3.74 (1H, 
CH(CH3)*), 3.79 (1H, br. s, OH*), 4.26 (1H, d, J = 8.8, CH(OH)*), 4.32 (1H, br. s, CH(CH3)), 4.53 
(1H, br. t, J = 5.7, CH(OH)), 4.95 (1H, br. s, OH), 7.06-7.34 (5H, ArH). 13C NMR (CDCl3, 125 MHz) 
δ: 9.3 (CH3CH2), 9.8 (CH3CH2*), 14.2 (CH3(CH)), 15.1 (CH3(CH)*), 26.6 (CH3N*), 26.8 (CH2CH3*), 
27.4 (CH2CH3), 32.3 (CH3N), 58.4 (CH(CH3)*), 58.8 (CH(CH3)), 75.2 (CH2OH*), 76.3 (CH2OH), 
126.8 (CArH), 127.3 (CArH*), 127.3 (CArH), 128.2 (CArH*), 128.2 (CArH), 128.4 (CArH*), 142.8 
(CAr*), 143.7 (CAr), 174.3 (CO*), 175.1 (CO). m/z  [CI+, isobutane] 222 [M+H]+ (100%), HRMS 
found [M+H]+ 222.1497, C13H20O2N  requires 222.1494. υmax /cm
-1 (film): 3364, 2978, 2937, 
1614, 1452. MP: 114-115 oC. [α]D
21.6 77.60 (c=1.92, CHCl3). The data observed is in accordance 
with literature values.143  
N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpropionamide 423b 
 
Amide 423b was obtained in the same quantity, yield and purity as amide 423a, under 
analagous experimental conditions, starting from (-)-pseudoephedrine (422a). MP: 113-115 oC. 
[α]D
21.6 -73.00 (c=1.50, CHCl3). The data observed is in accordance with literature values.
143  
(R)-4-(Benzyloxy)-N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N,2-
dimethylbutanamide 424a 
 
LiCl (13.2 g, 312 mmol) was flame dried under vacuum and allowed to cool to RT, before being 
placed under an atmosphere of argon. Anhydrous THF (100 mL) was added to the flask before 
cooling to –78 oC. iPr2NH (13.1 mL, 100 mmol) was added, followed by 
nBuLi (2.5 M in hexanes, 
37.4 mL, 37.4 mmol) and the resultant suspension was stirred for 20 min at –78 oC, 5 min at 0 
oC, followed by 5 min at RT, before recooling back to –78 oC. A solution of pseudoephedrine 
amide 423a (9.85 g, 44.5 mmol) in anhydrous THF (100 mL) was added dropwise via 
cannulation. The reaction mixture was at was stirred for 45 min at –78 oC, 20 min at 0 oC, 
followed by 5 min at RT, before recooling to 0 oC. Iodide 426 (14.0 g, 53.4 mmol) was added 
dropwise over 10 min, and the resultant mixture was warmed to RT over 14h. TLC analysis 
indicated reaction completion. The reaction was quenched by the addition of water (200 mL) 
and extracted with Et2O (3 × 300 mL). The combined organic extracts were washed with water 
(2 × 100 mL) and brine (2 × 75 mL), dried over anhydrous Na2SO4 and the solvent was 
evaporated to yield the crude product as a colourless oil. Purification by flash column 
chromatography, elution with 0-85% Et2O:petroleum ether, afforded the desired 
pseudoephedrin amide 424a (14.2 g, 40.0 mmol, 90%), as a colourless oil. The data observed is 
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in accordance with literature values.144 Amide 424a was taken onto the hydrolysis step and 
characterised as R-acid 411a (vide infra). 
(S)-4-(Benzyloxy)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N,2-
dimethylbutanamide 424a 
 
Amide 424b was obtained in the same quantity, yield and purity as amide 424a, under 
analagous experimental conditions, starting from amide 423b. The data observed is in 
accordance with literature values.144 Amide 424b was taken onto the hydrolysis step and 
characterised as S-acid 411b (vide infra). 
(R)-4-(Benzyloxy)-2-methylbutanoic acid 411a 
 
Method B: Hydrolysis of Pseudoephedrine Amide 424a 
Pseudoephedrin amide 424a (15.3 g, 43.0 mmol) was dissolved in anhydrous THF (120 mL) 
under an atmosphere of argon. MsOH (4.00 mL, 62.0 mmol) was added and the reaction 
mixture was heated at 70 oC for 1h. The solution was then cooled to 0 oC and LiBH4 (2 M in 
THF, 32.3 mL, 64.4 mL) was added dropwise over 10 min and stirred for a further 10 min at 0 
oC, and then warmed to RT and stirred for 10 min, before being recooled back to 0 oC.  1.5 M 
aq. NaOH solution (143 mL, 215 mmol) was then cautiously added, and the resulting mixture 
was stirred for 18h at RT.  The aqueous layer was separated extracted with DCM (3 × 250 mL) 
and cooled to 0 oC before being acidified to pH ≤ 2, by the slow addition of 3 M aq. HCl 
solution. Extraction with DCM (5 × 200 mL) followed by drying over anhydrous Na2SO4 and 
solvent evaporation, yielded the R-acid 411a (8.04 g, 38.6 mmol, 90%), as a colourless oil. 
[α]D
23.9 -2.00 (c=0.98, CHCl3).  
(S)-4-(Benzyloxy)-2-methylbutanoic acid 411b 
 
Method B: Hydrolysis of Pseudoephedrine Amide 424b 
[α]D
23.9 2.59 (c=1.20, CHCl3). The spectral and physical data obtained for 411b, via Method B, 
matched that obtained via Method A. 
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(2R) R -4-(Benzyloxy)-N-((4S)-5-(tert-butyldiphenylsilyloxy)-1-hydroxy-4-
methylpentan-2-yl)-2-methylbutanamide 409a 
 
Amine 410 (10.81 g, 22.3 mmol) and R-acid 411a (4.86 g, 23.4 mmol) were dissolved in 
anhydrous DCM (100 mL) and the resultant solution was cooled to 0 oC under an atmosphere 
of argon. EDC.HCl (5.12 g, 26.7 mmol) and HOBt (3.60, 26.7 mmol) were added was added 
before the dropwise addition of DIPEA (7.75 mL, 44.5 mmol). The reaction mixture was stirred 
at 0 oC for 2h and then at RT for 16h. TLC analysis indicated reaction completion. The solvent 
was evaporated and the resultant slurry was partitioned between Et2O (200 mL) and water 
(100 mL). The organics were collected and further washed with sat’d aq. NaHCO3 (50 mL), 10% 
aq. HCl solution (40 mL) and brine (2 × 50 mL), before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude amide product as a 
colourless oil. The crude intermediate was dissolved in MeOH (100 mL), CSA (516 mg, 2.23 
mmol) was added and the resultant solution was stirred at RT for 4h, until TLC analysis 
indicated reaction completion. NEt3 (0.44 mL, 3,34 mL) was added to the reaction mixture 
prior to solvent evaporation. Purification by flash column chromatography, elution with 0-80% 
Et2O:petroleum ether, afforded β-hydroxy amide 409a (9.88 g, 17.6 mmol, 79%), as a 
colourless oil. m/z  [CI+, isobutane] 562 [M+H]+ (100%), HRMS found [M+H]+ 562.3350, 
C34H48NO4Si  requires 562.3353. υmax /cm
-1 (film): 3283, 2959, 2930, 2857, 1645, 1541, 1518, 
1471. β-Hydroxy amide 409a was taken on to the oxidation and cyclodehydration steps, and 
subsequently fully characterised as oxazole 427a. 
(2S) S -4-(Benzyloxy)-N-((4R)-5-(tert-butyldiphenylsilyloxy)-1-hydroxy-4-
methylpentan-2-yl)-2-methylbutanamide 409b 
 
β-Hydroxy amide 409b was obtained in the same quantity, yield and purity as β-hydroxy amide 
409a, under analagous experimental conditions, starting from amine 410 and S-acid 411b. β-
Hydroxy amide 409b was taken on to the oxidation and cyclodehydration steps, and 
subsequently fully characterised as oxazole 427b. 
2-((R)-4-(Benzyloxy)butan-2-yl)-4-((S)-3-(tert-butyldiphenylsilyloxy)-2-
methylpropyl)oxazole 427a 
 
Anhydrous DCM (30 mL) was added to a flame-dried flask and cooled to –78 oC, before the 
addition of oxalyl chloride (1.09 mL, 12.9 mmol). A solution of DMSO (1.52 mL, 21.5 mmol) in 
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anhydrous DCM (4 mL) was added dropwise over 20 min via syringe pump, ensuring that the 
internal temperature did not exceed  –70 oC. The mixture was stirred for a further 20 min. A 
solution of β-hydroxy amide 409a (4.16 g, 7.80 mmol) in anhydrous DCM (8 mL) was added 
dropwise, via syringe pump, over a period of 20 min, ensuring that the internal temperature 
did not exceed –70 oC. After stirring for a further 30 min at –78 oC, NEt3 (6.72 mL, 48.4 mmol) 
was added dropwise, via syringe pump, over a period of 40 min, ensuring that the internal 
temperature did not exceed –70 oC. The resultant mixture was then stirred for a further 10 min 
at –78 oC before being warmed to 0 oC over 45 min. TLC analysis of the reaction indicated 
completion. The reaction was quenched with water (50 mL) and the organic layer was 
collected. The aqueous layer was extraction with DCM (3 × 75 mL). The combined organic 
extracts were washed with water (2 × 30 mL) and brine (30 mL), dried over anhydrous Na2SO4, 
and the solvent was evaporated to yield the crude aldehyde intermediate as a pale yellow oil. 
The aldehyde intermediate was immediately dissolved in anhydrous DCM (50 mL) and cooled 
to 0 oC under an atmosphere of argon. PPh3 (5.73 g, 21.8 mmol), DTBMP (5.60 g, 27.3 mmol) 
and (BrCCl2)2 (7.62 g, 23.4 mmol) were added sequentially to the reaction vessel. After stirring 
at 0 oC for 10 min, the reaction was warmed to RT and stirred for a further 45 min. DIPEA (6.80 
mL, 39.0 mmol) was added and the reaction was stirred for a further 45 min. The solvent was 
removed under reduces pressure and the crude residue was purified by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, to afford the oxazole 427a (3.17 g, 
6.18 mmol, 79%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.95 (3H, d, J = 6.7, 
CH3(CHCH2Ar)), 1.05 (9H, s, (CH3)3CSi), 1.30 (3H, d, J = 7.1, CH3(CHAr)), 1.84-1.90 (1H, m, 
CH2(CH2OBn)), 2.02-2.14 (2H, m, CH(CH2Ar), CH2(CH2OBn)), 2.32 (1H, ddd, J = 14.7, 8.0, 0.6, 
CH2Ar), 2.66 (1H, ddd, J = 14.6, 6.1, 0.8, CH2Ar), 3.12-3.19 (1H, m, CH(CH3)(Ar)), 3.40-3.51 (3H, 
m, CH2OBn, CH2OSi), 3.55 (1H, dd, J = 9.9, 5.1, CH2OSi), 4.44 (2H, d, J = 2.3, OCH2Ph), 7.15 (1H, 
br. s, ArH), 7.24-7.43 (10H, m, ArH), 7.64-7.67 (5H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 16.7 
(CH3(CHCH2Ar), 18.7 (CH3(CHAr)), 19.4 (SiC(CH3)3), 26.9 ((CH3)3CSi), 29.8 (CH2Ar), 30.8 
(CH(CH3)(Ar)), 35.0 (CH2(CH2OBn)), 35.1 (CH(CH2Ar)), 67.9 (CH2OBn), 68.1 (CH2OSi), 72.9 
(OCH2Ph), 127.5 (C
ArH), 127.6 (CArH), 128.3 (CArH), 129.5 (CArH), 133.9 (CArH), 134.0 (CAr), 135.6 
(CArH), 135.6 (CArH), 138.5 (CAr), 139.0 (CAr), 167.5 (CAr). m/z  [CI+, isobutane] 542 [M+H]+ 
(100%), HRMS found [M+H]+ 542.3087, C34H44O3NSi  requires 542.3090. υmax /cm
-1 (film): 2959, 
2930, 2857, 1719, 1568, 1471. [α]D
22.0 -25.85 (c=0.82, CHCl3). 
2-((S)-4-(Benzyloxy)butan-2-yl)-4-((R)-3-(tert-butyldiphenylsilyloxy)-2-
methylpropyl)oxazole 427b 
 
Oxazole 427b was obtained in the same quantity, yield and purity as oxazole 427a, under 
analagous experimental conditions, starting from β-Hydroxy amide 409b. [α]D
22.0 15.00 
(c=0.70, CHCl3). 
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(S)-3-(2-((R)-4-(benzyloxy)butan-2-yl)oxazol-4-yl)-2-methylpropanal 408a 
 
Oxazole 427a (2.70 g, 5.26 mmol) was dissolved in anhydrous THF (25 mL) and cooled to 0 oC 
under an atmosphere of argon. TBAF (1 M in THF, 21.0 mL, 21.0 mmol) was added and, after 
stirring for 30 min at 0 oC, the reaction mixture was warmed to RT and stirred for a further 
16h, before being quenched with water (30 mL) and extracted with Et2O (3 × 50 mL). The 
combined organics were washed sequentially with water (2 × 10 mL) and brine (20 mL), before 
being dried over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to 
afford the crude intermediate as a colourless oil. This was passed through a plug of silica gel, 
elution with 0-60% Et2O:petroleum ether, to afforded the alcohol intermediate 428a, as a 
colourless oil. To a stirring solution of DCM (12 mL) at 0 oC, NaHCO3 (1.85 g, 22.01 mmol), 
tBuOH (3 mL) and DMP (2.28 g, 5.38 mmol) were added sequentially. A solution of the alcohol 
intermediate 428a in DCM (5 mL) was added dropwise to the reaction mixture and the 
resultant suspension was stirred for 45 min at 0 oC, until TLC analysis indicated reaction 
completion. Half of the solvent was removed under reduced pressure and the crude material 
was purified by flash column chromatography, elution with 0-40% Et2O:petroleum ether, to 
afford the desired aldehyde 408a (1.28 g, 4.25 mmol, 81% over 2 steps) as a colourless oil. 1H 
NMR (CDCl3, 500 MHz) δ: 1.08 (3H, d, J = 7.1, CH3(CHCH2Ar)), 1.31 (3H, d, J = 7.1, CH3(CHAr)), 
1.84-1.91 (1H, m, CH2(CH2OBn)), 2.07-2.14 ( 2.28 (CH2(CH2OBn), 2.54 (1H, ddd, J = 14.8, 7.1, 
0.8, CH2Ar), 2.77-2.80 (1H, m, CH(CH2Ar)), 2.90 (1H, ddd, J = 14.8, 6.6, 0.9, CH2Ar), 3.13-3.20 
(1H, m, CH(CH3)(Ar)), 3.42-3.46 (1H, m, CH2OBn), 3.48-3.52 (1H, m, CH2OBn), 4.46 (2H, s, 
OCH2Ph), 7.25-7.34 (6H, m, ArH), 9.71 (1H, d, J = 1.3, CHO). 
13C NMR (CDCl3, 125 MHz) δ: 13.3 
(CH3(CHCH2Ar), 18.6 (CH3(CHAr)), 27.2 (CH2Ar), 30.7 (CH(CH3)(Ar)), 35.0 (CH2(CH2OBn)), 45.4 
(CH(CH2Ar)), 67.8 (CH2OBn), 72.9 (OCH2Ph), 127.5 (C
ArH), 127.6 (CArH), 128.3 (CArH), 134.3 
(CArH), 137.3 (CAr), 138.4 (CAr), 168.1 (CAr), 204.1 (CHO). m/z  [CI+, isobutane] 302 [M+H]+ 
(100%), HRMS found [M+H]+ 302.1752, C18H24O3NSi  requires 302.1756. υmax /cm
-1 (film): 2972, 
2932, 2874, 2861, 1722, 1568, 1454. [α]D
21.5 -40.00 (c=0.66, CHCl3). 
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(R)-3-(2-((S)-4-(benzyloxy)butan-2-yl)oxazol-4-yl)-2-methylpropanal 408b 
 
Aldehyde 408b was obtained in the same quantity, yield and purity as aldehyde 408a, under 
analagous experimental conditions, starting from oxazole 427b. [α]D
21.6 21.72 (c=1.16, CHCl3). 
(3S,4S)-3-((S)-1-(2-((R)-4-(benzyloxy)butan-2-yl)oxazol-4-yl)propan-2-yl)-
8-(tert-butyldimethylsilyloxy)-4-hydroxy-7-methylisochroman-1-one 407a 
 
Using general procedure 1B, starting from a solution phthalan 227 (3.42 g, 11.6 mmol) in 
anhydrous THF (50 mL) with iPr2NH (2.80 mL, 21.4 mmol), MeLi (1.6 M in Et2O, 15.1 mL, 24.1 
mmol) and aldehyde 408a (1.75 g, 5.81 mmol) to generate the α-hydroxy-IBF intermediate. 
The oxidative rearrangement was performed using mCPBA (77%, 1.30 g, 5.81 mmol) in 
anhydrous DCM (50 mL) to afford the crude keto-lactols. Oxidation was performed in 
anhydrous DCM (20 mL) with TEMPO (63 mg, 0.40 mmol) and BAIB (3.87 g, 12.1 mmol). 
Purification via flash chromatography, elution with 0-13% EtOAc:petroleum ether, afforded 
the keto-lactone intermediates (1.54 g, 2.67 mmol, 46%) as a yellow oil. According to general 
procedure 2A, reduction was performed in anhydrous DCM (10 mL) with CeCl3.7H2O (3.05 g, 
8.19 mmol), MeOH (10 mL) and NaBH4 (137 mg, 3.60 mmol) at –78 
oC. The crude products 
were purified by flash column chromatography, elution with 0-60% Et2O:petroleum ether, to 
afford the isochromanone products 430a and 407a (1.01 g, 1.74 mmol, 30% overall yield from 
aldehyde 408a, as a colourless oil, in a 1:2 mixture of diastereoisomers.  HPLC separation, 
conducted on a Sunfire C18 column (150mm x 30mm i.d. 5µm) at RT, allowed for the isolation 
of syn,anti-isochromanone 407a (662 mg, 1.14 mmol, 20% overall yield from aldehyde 408a) 
as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 0.11 (3H, s, CH3Si), 0.19 (3H, s, CH3Si), 1.04 (9H, 
s, (CH3)3CSi), 1.10 (3H, d, J = 6.9, CH3(CHCH2Ar)), 1.29 (3H, d, J = 7.1, CH3(CHAr)), 1.83-1.89 (1H, 
m, CH2(CH2OBn)), 2.05-2.14 (1H, m, CH2(CH2OBn)), 2.27 (3H, s, CH3Ar), 2.44-2.50 (1H, m, 
CH(CH2Ar)), 2.63 (1H, dd, J = 14.7, 7.6, CH2Ar), 3.01 (1H, dd, J = 14.6, 2.5, CH2Ar), 3.11-3.18 (1H, 
m, CH(CH3)(Ar)), 3.40-3.50 (2H, m, CH2OBn), 4.06 (1H, dd, J = 9.3, 1.2, CH(O2C)), 4.43 (2H, s, 
OCH2Ph), 4.66 (1H, br. d, J = 0.8, CH(OH)), 6.94 (1H, d, J = 7.6, ArH), 7.23-7.33 (6H, m, ArH), 
7.37 (1H, dd, J = 7.5, 0.6, ArH). 13C NMR (CDCl3, 125 MHz) δ: -3.7 (CH3Si), -3.6 (CH3Si), 15.4 
(CH3(CHCH2Ar), 17.5 (CH3Ar), 18.6 (CH3(CHAr)), 18.6 (SiC(CH3)3), 25.9 ((CH3)3CSi), 28.1 (CH2Ar), 
30.3 (CH(CH3)(Ar)), 33.2 (CH(CH2Ar)), 35.0 (CH2(CH2OBn)), 66.6 (CH(OH)), 67.8 (CH2OBn), 73.0 
(OCH2Ph), 83.0 (CH(O2C)), 115.8 (C
Ar), 120.4 (CArH), 127.5 (CArH), 127.6 (CArH), 128.3 (CArH), 
132.7 (CAr), 134.6 (CArH), 136.3 (CArH), 138.0 (CAr), 138.4 (CAr), 139.7 (CAr), 155.4 (CAr), 162.9 
(CAr), 167.6 (CO). m/z  [CI+, isobutane] 581 [M+H]+ (100%), HRMS found [M+H]+ 580.8071, 
C33H46NO6Si  requires 580.8069. υmax /cm
-1 (film): 3383, 2951, 2930, 2859, 1729, 1597, 1584, 
1472, 1455. [α]D
24.5 20.21 (c = 0.40, CHCl3). 
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(3R,4R)-3-((S)-1-(2-((S)-4-(benzyloxy)butan-2-yl)oxazol-4-yl)propan-2-yl)-
8-(tert-butyldimethylsilyloxy)-4-hydroxy-7-methylisochroman-1-one 407b 
 
Syn,anti-isochromanone 407b was obtained in the same quantity, yield and purity as syn,anti-
isochromanone 407a, under analagous experimental conditions, starting from aldehyde 408b. 
[α]D
24.5 68.42 (c=0.38, CHCl3).  
3-Isopropyl-1H-isochromen-1-one 436 
 
Anti-isochromanone 136f (31 mg, 150 µmol) was dissolved in anhydrous THF (1.5 mL) and 
sequentially treated with 4-nitrobenzoic acid (28.7 mg, 226 µmol) and 2-PyPPh2 (51.4 mg, 195 
µmol) before the portionwise addition of DTBAD (45.0 mg, 195 µmol). The resultant reaction 
mixture was stirred at RT for 10h, under an atmosphere of argon. TLC analysis indicated 
reaction completion. The reaction was quenched with 3 M aq. HCl solution (5 mL) and the 
resultant solution was stirred for 20 min, before being extracted with Et2O (3 × 15 mL). The 
combined organics were washed with 3 M aq. HCl solution (5 mL), sat’d aq. NaHCO3 solution (5 
mL) and brine (7 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a yellow oil. Purification by flash 
column chromatography, elution with 0-5% Et2O:petroleum ether, afforded the side-product, 
436 (7.1 mg, 37.7 µmol, 25%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.29 (6H, d, J = 
6.8, CH3), 2.74-2.84 (1H, m, CH(CH3)2), 6.26 (1H, s, CHalkene), 7.37 (1H, d, J = 7.8, ArH), 7,45 (1H, 
td, J = 7.6, 1.1, ArH), 7.67 (1H, td, J = 7.6, 1.4, ArH), 8.25 (1H, d, J = 7.8, ArH). 13C NMR (CDCl3, 
125 MHz) δ: 20.2 (CH3), 29.7 (CH(CH3)2), 100.6 (CalkeneH), 120.3 (C
Ar), 125.2 (CArH), 127.6 (CArH), 
129.5 (CArH), 134.7 (CArH), 137.7 (CAr), 163.0 (CO), 163.1 (CQalkene). m/z  [EI
+] 188 [M]+ (100%), 
HRMS found [M]+ 188.0836, C12H12O2  requires 188.0837. υmax /cm
-1 (film): 2969, 2928, 2874, 
1724, 1653, 1605, 1570, 1483. The data observed is in accordance with literature values.183 
(±)-(3R,4S)-3-isopropyl-1-oxoisochroman-4-yl 4-nitrobenzoate 437 
 
Further elution with 5-10% Et2O:petroleum ether, afforded the nitrobenzoate ester 437 (27.0 
mg, 76.2 µmol, 51%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.06 (3H, d, J = 6.3, CH3), 
1.10 (3H, d, J = 6.8, CH3), 1.77-1.84 (1H, m, CH(CH3)2), 4.54 (1H, dd, J = 8.1, 3.3 CH(O2C)), 6.34 
(1H, d, J = 3.3, CH(OPNB)), 7.55 (1H, d, J = 7.6, ArH), 7,59 (1H, td, J = 7.6, 1.3, ArH), 7.67 (1H, td, 
J = 7.5, 1.4, ArH), 8.18-8.21 (3H, m, ArH), 8.26-8.29 (2H, m, ArH). 13C NMR (CDCl3, 125 MHz) δ: 
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18.4 (CH3), 19.1 (CH3), 30.6 (CH(CH3)), 68.7 (CH(OPNB)), 85.7 (CH(O2C)),  123.7 (C
ArH), 125.3 
(CAr), 128.5 (CArH), 130.4 (CArH), 130.5 (CArH), 131.1 (CArH), 134.4 (CArH), 134.5 (CAr), 134.6 (CAr), 
150.9 (CAr), 163.2 (CO), 163.0 (CO). m/z  [CI+, isobutane] 356 [M+H]+ (100%). HRMS found 
[M+H]+ 356.1132, C19H18NO6  requires 356.1134. υmax /cm
-1 (film): 2969, 2928, 2870, 1729, 
1680, 1527, 1463.  
8-Hydroxy-3-isopropyl-1H-isochromen-1-one 436 
 
Method A: From Protected Phenol 199 
Isochromanone 136f (146 mg, 434 µmol) was dissolved in anhydrous THF (4.5 mL) and 
sequentially treated with 4-nitrobenzoic acid (110 mg, 868 µmol) and 2-PyPPh2 (228 mg, 868 
µmol) before the portionwise addition of DTBAD (200 mg, 868 µmol). The resultant reaction 
mixture was stirred at RT for 16h, under an atmosphere of argon. TLC analysis indicated 
reaction completion.  The reaction mixture was cooled to 0 oC and diluted with THF (5 mL) and 
pyridine (1 mL),  before the dropwise addition of HF.Py (0.5 mL). The resultant mixture was 
stirred at 0 oC for 2h before being carefully quenched by the dropwise addition of sat’d aq. 
NaHCO3 solution (20 mL). The solution was extraction with Et2O (3 × 30 mL). The combined 
organics were washed with 3 M aq. HCl solution (2 × 15 mL), sat’d aq. NaHCO3 solution (15 mL) 
and brine (15 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude products as a yellow oil. Purification by flash 
column chromatography, elution with 0-5% Et2O:petroleum ether, afforded the side-product 
441 (33 mg, 161 µmol, 37%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.29 (6H, d, J = 
6.9, CH3), 2.74-2.82 (1H, m, CH(CH3)2), 6.26 (1H, s, CHalkene), 6.83 (1H, dd, J = 7.7, 0.7, ArH), 6.92 
(1H, dd, J = 8.3, 0.9, ArH), 7.56 (1H, t, J = 8.0, ArH), 11.02 (1H, s, OH). 13C NMR (CDCl3, 125 MHz) 
δ: 19.1 (CH3), 31.1 (CH(CH3)2), 100.8 (CalkeneH), 113.6 (C
ArH), 114.5 (CArH), 136.2 (CArH), 137.1 
(CAr), 158.2 (CAr), 160.6 (CQalkene), 161.3 (C
Ar) 165.9 (CO). m/z  [CI+, isobutane] 205 [M+H]+ 
(100%), HRMS found [M+H]+ 205.0862, C12H12O3  requires 205.0865. υmax /cm
-1 (film): 3115, 
2976, 2938, 2874, 1771, 1685, 1643, 1458.  
Method A (cont): From Protected Phenol 199 
(±)-(3R,4S)-8-Hydroxy-3-isopropyl-1-oxoisochroman-4-yl 4-nitrobenzoate 
442 
 
Further elution with 5-10% Et2O:petroleum ether, afforded the desired nitrobenzoate 442 (71 
mg, 191 µmol, 44%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.08 (3H, d, J = 6.8, CH3), 
1.11 (3H, d, J = 6.7, CH3), 1.84-1.91 (1H, m, CH(CH3)2), 4.56 (1H, dd, J = 8.4, 3.0  CH(O2C)), 6.30 
(1H, d, J = 3.0, CH(OPNB)), 7.01 (1H, d, J = 7.4, ArH), 7.59 (1H, dd, J = 8.5, 1.0, ArH), 7.54 (1H, 
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dd, J = 8.4, 7.5, ArH), 8.18-8.20 (2H, m, ArH), 8.27-8.30 (2H, m, ArH). 13C NMR (CDCl3, 125 MHz) 
δ: 18.5 (CH3), 19.0 (CH3), 30.5 (CH(CH3)), 68.4 (CH(OPNB)), 86.7 (CH(O2C)), 107.9 (C
Ar), 119.5 
(CArH), 119.6 (CArH), 123.7 (CArH), 131.1 (CArH), 134.5 (CAr), 134.5 (CAr), 136.8 (CArH), 150.9 (CAr), 
162.2 (CAr), 163.8 (CO), 167.6 (CO). m/z  [EI+] 371 [M]+ (100%). HRMS found [M]+ 371.1006, 
C19H17NO7  requires 371.1005. υmax /cm
-1 (film): 3111, 2970, 2928, 2874, 1728, 1682, 1611, 
1609, 1527, 1464.  
8-Hydroxy-3-isopropyl-1H-isochromen-1-one 436 
 
Method B: From Phenol 200 
Isochromanone 136f (101 mg, 434 µmol) was dissolved in anhydrous THF (4.5 mL) and 
sequentially treated with 4-nitrobenzoic acid (110 mg, 868 µmol) and 2-PyPPh2 (228 mg, 868 
µmol) before the portionwise addition of DTBAD (200 mg, 868 µmol). The resultant reaction 
mixture was stirred at RT for 16h, under an atmosphere of argon. TLC analysis indicated 
reaction completion. The reaction mixture was extracted with Et2O (3 × 30 mL). The combined 
organics were washed with 3 M aq. HCl solution (2 × 15 mL), sat’d aq. NaHCO3 solution (15 mL) 
and brine (15 mL), before being dried over Na2SO4. The solvent was evaporated under reduced 
pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-5% Et2O:petroleum ether, afforded the by-product 442 (27 
mg, 130 µmol, 37%), as a colourless oil. The spectral and physical data obtained for 441, via 
Method B, matched that obtained via Method A. 
(±)-(3R,4S)-8-Hydroxy-3-isopropyl-1-oxoisochroman-4-yl 4-nitrobenzoate 
442 
 
Method B (cont.): From Phenol 200  
Further elution with 5-10% Et2O:petroleum ether, afforded the nitrobenzoate ester 442 (50 
mg, 135 µmol, 44%), as a colourless oil. The spectral and physical data obtained for 442, via 
Method B, matched that obtained via Method A. 
Experimental 
 
202 
 
(±)-(3R,4S)-4,8-Dihydroxy-3-isopropylisochroman-1-one 443 
 
Method A: NaN3/MeOH 
Nitrobenzoate ester 442 (22 mg, 59 µmol) was dissolved in MeOH (1.5 mL) and treated with 
NaN3 (64 mg, 0.99 mmol) and stirred at RT for 36h. The reaction was quenched with water (10 
mL) and extracted with with Et2O (3 × 10 mL). The combined organics were washed with brine 
(2 × 5 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated under 
reduced pressure to afford the crude product as a yellow oil. Purification by flash column 
chromatography, elution with 0-25% Et2O:petroleum ether, afforded the anti,anti-
isochromanone 443 (11 mg, 47 µmol, 79%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 
1.08 (3H, d, J = 6.7, CH3), 1.09 (3H, d, J = 6.7, CH3), 2.09-2.15 (1H, m, CH(CH3)2), 2.19 (1H, d, J = 
7.2, OH), 4.28 (1H, dd, J = 7.3, 4.9 CH(O2C)), 4.83 (1H, t, J = 7.2, CH(OH)), 6.98 (1H, br. d, J = 8.4, 
ArH), 7.02 (1H, dt, J = 7.5, 0.9, ArH), 7.53 (1H, dd, J = 8.3, 7.6, ArH). 13C NMR (CDCl3, 125 MHz) 
δ: 16.5 (CH3), 19.2 (CH3), 28.9 (CH(CH3)2), 65.7 (CH(OH)), 87.9 (CH(O2C)), 106.8 (C
Ar), 116.1 
(CArH), 117.7 (CArH), 136.8 (CArH), 141.6 (CAr), 161.9 (CAr), 168.7 (CO). m/z  [CI+, isobutane] 223 
[M+H]+ (100%). HRMS found [M+H]+ 223.0973, C12H15O4  requires 223.0970. 
Method B: TBAF 
Nitrobenzoate ester 442  (22 mg, 59 µmol) was dissolved in THF (1.5 mL) and treated with 
TBAF (1 M in THF, 1.00 mL, 1.00 mmol) and the resultant solution was stirred at RT for 24h. 
The reaction was quenched with water (10 mL) and extracted with with Et2O (3 × 10 mL). The 
combined organics were washed with brine (2 × 5 mL) before being dried over anhydrous 
Na2SO4. The solvent was evaporated under reduced pressure to afford the crude product as a 
yellow oil. Purification by flash column chromatography, elution with 0-25% Et2O:petroleum 
ether, afforded the anti,anti-isochromanone 443 (9.0 mg, 41 µmol, 69%), as a colourless oil. 
The spectral and physical data obtained for 443, via Method B, matched that obtained via 
Method A. 
(±)-(3R,4S)-8-(Tert-butyldimethylsilyloxy)-3-isopropyl-1-oxoisochroman-4-
yl 4-nitrobenzoate 444 
 
Isochromanone 443 (18.0 mg, 48.5 µmol) was dissolved in anhydrous DCM (1 mL) and cooled 
to  –10 oC under an atmosphere of argon. TBSOTf (13.2 µL, 72.8 µmol) was added, followed by 
2,6-lutidine (11.3 µL, 97.0 µmol). The reaction mixture was stirred for 5 min, after which TLC 
analysis indicated reaction completion. The reaction was quenched with water (5 mL) and 
extracted with with Et2O (3 × 10 mL). The combined organics were washed with sat’d aq. 
CuSO4 solution (2 × 5 mL) and brine (2 × 5 mL), before being dried over anhydrous Na2SO4. The 
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solvent was evaporated under reduced pressure to afford the crude product as a yellow oil. 
Purification by flash column chromatography, elution with 0-10% Et2O:petroleum ether, 
afforded the silyl phenol 444 (21.0 mg, 43.2 µmol, 89%), as a colourless oil. 1H NMR (CDCl3, 500 
MHz) δ: 0.25 (3H, s, CH3Si), 0.26 (3H, s, CH3Si), 1.04 (3H, d, J = 6.8, CH3), 1.04 (9H, s, (CH3)3CSi)), 
1.09 (3H, d, J = 6.7, CH3), 1.72-1.79 (1H, m, CH(CH3)2), 4.39 (1H, dd, J = 8.4, 3.5, CH(O2C)), 6.25 
(1H, d, J = 3.5, CH(OPNB)), 7.01 (1H, br. d, J = 7.4, ArH), 7.08 (1H, dd, J = 8.4, 1.0, ArH), 7.46 
(1H, dd, J = 8.3, 7.6), 8.18-8.21 (2H, m, ArH), 8.25-8.28 (2H, m, ArH). 13C NMR (CDCl3, 125 MHz) 
δ: 4.4 (CH3Si), 18.4 (CH3), 19.0 (CH3), 30.3 (CH(CH3)2), 69.6 (CH(OPNB)), 84.6 (CH(O2C)), 116.2 
(CAr), 121.0 (CArH), 123.6 (CArH), 123.9 (CArH), 131.1 (CArH), 134.6 (CArH), 134.7 (CAr), 136.4 (CAr), 
150.9 (CAr), 157.6 (CAr), 160.2 (CO), 163.9 (CO). m/z  [CI+, isobutane] 486 [M+H]+ (100%). HRMS 
found [M+H]+ 486.1945, C25H32NO7Si  requires 486.1948. υmax /cm
-1 (film): 2961, 2930, 2859, 
1726, 1599, 1582, 1530.  
(±)-(3R,4S)-8-Hydroxy-3-isopropyl-7-methyl-1-oxoisochroman-4-yl 4-
nitrobenzoate 446 
 
Isochromanone 226 (18.9 mg, 53.9 µmol) was dissolved in anhydrous THF (1 mL) and 
sequentially treated with 4-nitrobenzoic acid (9.2 mg, 72.8 µmol) and 2-PyPPh2 (17.7 mg, 67.4 
µmol) before the portionwise addition of DTBAD (15.5 mg, 67.4 µmol). The resultant reaction 
mixture was stirred at RT for 16h, under an atmosphere of argon. TLC analysis indicated 
reaction completion.  The reaction mixture was cooled to 0 oC and diluted with THF (2 mL) and 
pyridine (0.5 mL), before the dropwise addition of HF.Py (100 µL). The resultant mixture was 
stirred at 0 oC for 2h before being carefully quenched by the dropwise addition of sat’d aq. 
NaHCO3 solution (5 mL). The solution was extraction with Et2O (3 × 10 mL). The combined 
organics were washed with 3 M aq. HCl solution (2 × 5 mL), sat’d aq. NaHCO3 solution (5 mL) 
and brine (5 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a yellow oil. Purification by flash 
column chromatography, elution with 5-10% Et2O:petroleum ether, afforded the 
nitrobenzoate 446 (8.8 mg, 22.8 µmol, 42%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 
1.07 (3H, d, J = 6.8, CH3), 1.10 (3H, d, J = 6.7, CH3), 1.82-1.89 (1H, m, CH(CH3)2), 2.29 (3H, s, 
CH3Ar), 4.56 (1H, dd, J = 8.7, 2.6 CH(O2C)), 6.26 (1H, d, J = 2.6, CH(OPNB)), 6.93 (1H, d, J = 7.5, 
ArH), 7.39 (1H, d, J = 7.5, ArH), 8.16-8.19 (2H, m, ArH), 8.25-8.28 (2H, m, ArH). 13C NMR (CDCl3, 
125 MHz) δ: 15.8 (CH3Ar), 18.7 (CH3), 19.0 (CH3), 30.6 (CH(CH3)2), 68.7 (CH(OPNB)), 87.0 
(CH(O2C)), 107.1 (C
Ar), 119.2 (CArH), 123.6 (CArH), 129.2 (CAr), 131.0 (CArH), 131.5 (CAr), 134.7 
(CAr), 137.3 (CArH), 150.9 (CAr), 160.4 (CAr), 163.8 (CO), 168.1 (CO). m/z  [CI+, isobutane] 386 
[M+H]+ (100%), HRMS found [M+H]+ 386.1237, C20H20NO7  requires 386.1240. υmax /cm
-1 (film): 
3107, 2970, 2926, 2874, 1728, 1678, 1613, 1609, 1530, 1459.  
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(±)-(R)-7-(benzyloxy)-3-((R)-1-hydroxy-2-methylpropyl)isobenzofuran-
1(3H)-one 448 
 
Method A: KH/THF 
Isochromanone 196 (50 mg, 160 µmol) was dissolved in anhydrous THF (5 mL) and cooled to –
20 oC under an atmosphere of argon, before KH (30% w/w in mineral oil, 85 mg, 640 µmol). 
TLC analysis after 20 min indicated reaction completion. The reaction was quenched by the 
addition of water (10 mL). The solution was extraction with Et2O (3 × 10 mL). The combined 
organics were washed with brine (5 mL) before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 30% Et2O:petroleum ether, 
afforded phthalide 448 (31 mg, 99.0 µmol, 62%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) 
δ: 1.12 (3H, d, J = 6.7, CH3), 1.12 (3H, d, J = 6.7, CH3), 2.07-2.13 (1H, m, CH(CH3)2), 3.58 (1H, td, J 
= 7.5, 2.8, CH(OH)), 5.33 (2H, s, OCH2Ph), 5.48 (1H, d, J = 2.7, (CH(O2C)), 6.93 (1H, d, J = 8.3, 
ArH), 6.98 (1H, d, J = 7.6, ArH), 7.31 (1H, t, J = 7.4, ArH), 7.38 (2H, t, J = 7.5, ArH), 7.49 (2H, d, J 
= 7.5, ArH), 7.55 (1H, t, J = 7.9, ArH). 13C NMR (CDCl3, 125 MHz) δ: 18.5 (CH3), 19.4 (CH3), 31.5 
(CH(CH3)2), 70.5 (OCH2Ph), 77.7 (CH(OH)), 80.3 (CH(O2C)), 112.9 (C
ArH), 113.8 (CArH), 114.8 
(CAr), 126.8 (CArH), 128.0 (CArH), 128.7 (CArH), 136.2 (CArH), 150.6 (CAr), 157.8 (CAr), 168.2 (CO). 
m/z  [CI+, isobutane] 313 [M+H]+ (100%), HRMS found [M+H]+ 313.1443, C19H21O3  requires 
313.1440. υmax /cm
-1 (film): 3482, 2961, 2914, 2872, 1759, 1605, 1485. 
Method B: K2CO3/MeOH 
Isochromanone 196 (50 mg, 160 µmol) was dissolved in MeOH (5 mL) and treated with K2CO3 
(28 mg, 0.20 mmol) ansdstirred for 12h at RT. The reaction was quenched by the addition of 
water (10 mL). The solution was extraction with Et2O (3 × 10 mL). The combined organics were 
washed with brine (5 mL) before being dried over anhydrous Na2SO4. The solvent was 
evaporated under reduced pressure to afford the crude product as a colourless oil. Purification 
by flash column chromatography, elution with 30% Et2O:petroleum ether, afforded phthalide 
448  (35 mg, 112 µmol, 70%), as a colourless oil. The spectral and physical data obtained for 
448, via Method B, matched that obtained via Method A. 
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3-((S)-1-(2-((R)-4-(Benzyloxy)butan-2-yl)oxazol-4-yl)propan-2-yl)-8-
hydroxy-7-methyl-1H-isochromen-1-one 449 
 
Syn,anti-isochromanone 407a (110 mg, 190 µmol) was dissolved in anhydrous THF (5 mL) and 
sequentially treated with 4-nitrobenzoic acid (43.5 mg, 342 µmol) and 2-PyPPh2 (90.0 mg, 342 
µmol), before the portionwise addition of DTBAD (79 mg, 340 µmol). The resultant reaction 
mixture was stirred at RT for 16h, under an atmosphere of argon. TLC analysis indicated 
reaction completion.  The reaction mixture was cooled to 0 oC and diluted with THF (5 mL) and 
pyridine (1 mL), before the dropwise addition of HF.Py (0.2 mL). The resultant mixture was 
stirred at 0 oC for 2h before being carefully quenched by the dropwise addition of sat’d aq. 
NaHCO3 solution (10 mL). The solution was extraction with Et2O (3 × 15 mL). The combined 
organics were washed with 3 M aq. HCl solution (2 × 4 mL), sat’d aq. NaHCO3 solution (4 mL) 
and brine (5 mL), before being dried over anhydrous Na2SO4. The solvent was evaporated 
under reduced pressure to afford the crude product as a yellow oil. Purification by flash 
column chromatography, elution with 0-20% Et2O:petroleum ether, afforded isochromen-1-
one by-product 449 (33.6 mg, 70.3 µmol, 37%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 
1.28 (6H, d, J = 7.0, CH3(CHAr), CH3(CHCH2Ar)), 1.83-1.89 (1H, m, CH2(CH2OBn)), 2.04-2.11 (1H, 
m, CH2(CH2OBn)), 2.28 (3H, s, CH3Ar), 2.70 (1H, dd, J = 14.5, 7.2, CH2Ar), 2.91 (1H, dd, J = 14.5, 
7.5, CH2Ar), 3.00-3.07 (1H, m, CH(CH2Ar), 3.11-3.18 (1H, m, CH(CH3)(Ar)), 3.36-3.41 (1H, m, 
CH2OBn), 3.44-3.48 (1H, m, CH2OBn), 4.42 (2H, s, OCH2Ph), 6.16 (1H, s, CHalkene), 6.69 (1H, d, J = 
7.7, ArH), 7.23 (1H, s, ArH), 7.25-7.34 (5H, m, ArH), 7.40 (1H, d, J = 7.8, ArH), 11.24 (1H, s, OH). 
13C NMR (CDCl3, 125 MHz) δ: 15.5 (CH3Ar), 18.0 (CH3(CH)), 18.7 ((CH3(CH)), 30.7 (CH(CH3)(Ar)), 
31.0 (CH2Ar), 35.0 (CH2(CH2OBn)), 37.3 (CH(CH2Ar)), 67.8 (CH2OBn), 72.9 (OCH2Ph), 103.8 
(CalkeneH), 105.4 (C
Q
alkene), 114.8 (C
ArH), 124.2 (CAr), 127.5 (CArH), 127.6 (CArH), 128.3 (CArH), 
134.3 (CArH), 135.4 (CAr), 135.8 (CAr), 137.6 (CAr), 138.4 (CArH), 158.9 (CAr), 159.5 (CAr), 167.2 
(CAr), 168.0 (CO). m/z  [EI+] 447 [M]+ (100%), HRMS found [M]+ 447.2049, C27H29NO5  requires 
447.2046. υmax /cm
-1 (film): 3065, 2971, 2928, 2857, 1724, 1682, 1648, 1622, 1570, 1454. 
[α]D
25.3 3.16 (c = 0.20, CHCl3). 
(3S,4R)-3-((S)-1-(2-((R)-4-(Benzyloxy)butan-2-yl)oxazol-4-yl)propan-2-yl)-
8-hydroxy-7-methyl-1-oxoisochroman-4-yl 4-nitrobenzoate 
 
Further elution with 20-25% Et2O:petroleum ether, afforded the nitrobenzoate ester 450 (12.4 
mg, 20.2 µmol, 11%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.01 (3H, d, J = 6.8, 
CH3(CHCH2Ar)), 1.28 (3H, d, J = 7.1, CH3(CHAr)), 1.81-1.88 (1H, m, CH2(CH2OBn)), 2.04-2.11 (1H, 
m, CH2(CH2OBn)), 2.10-2.18 (1H, m, CH(CH2Ar)), 2.29 (3H, s, CH3Ar), 2.53 (1H, dd, J = 14.7, 8.0, 
CH2Ar), 2.84 (1H, dd, J = 14.7, 4.6, CH2Ar), 3.10-3.17 (1H, m, CH(CH3)(Ar)), 3.40-3.49 (2H, m, 
CH2OBn), 4.43 (2H, s, OCH2Ph), 4.71 (1H, dd, J = 9.0, 2.0, CH(O2C)),  6.27 (1H, d, J = 2.1, 
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CH(OPNB)), 6.95 (1H, d, J = 7.5, ArH), 7.23-7.34 (6H, m, ArH), 7.39 (1H, d, J = 7.5, ArH), 8.14-
8.17 (2H, m, ArH), 8.23-8.26 (2H, m, ArH), 11.21 (1H, s, OH). 13C NMR (CDCl3, 125 MHz) δ: 15.7 
(CH3Ar), 16.0 (CH3(CHCH2Ar), 18.6 (CH3(CHAr)), 28.9 (CH2Ar), 30.8 (CH(CH3)(Ar)), 34.8 
(CH(CH2Ar)), 34.9 (CH2(CH2OBn)), 66.6 (CH(OPNB)), 67.8 (CH2OBn), 72.9 (OCH2Ph), 85.9 
(CH(O2C)), 107.2 (C
Ar), 113.8 (CArH), 118.6 (CAr), 118.9 (CArH), 127.5 (CArH), 127.6 (CArH), 128.3 
(CArH), 128.4 (CAr),132.1 (CArH), 132.8 (CAr), 134.7 (CArH), 137.2 (CArH), 137.4 (CAr), 138.4 (CAr), 
151.4 (CAr), 160.2 (CAr), 165.5 (CO), 167.8 (CO), 168.3 (CAr). m/z  [EI+] 600 [M]+ (100%). HRMS 
found [M]+ 600.2107, C18H24O3NSi  requires 600.2108. υmax /cm
-1 (film): 3270, 2950, 2930, 
2859, 1729, 1682, 1597, 1584, 1472, 1456. [α]D
24.5 20.21 (c = 0.40, CHCl3). 
8-Hydroxy-7-methyl-3-((S)-1-(2-((R)-pent-4-yn-2-yl)oxazol-4-yl)propan-2-
yl)-1H-isochromen-1-one 
 
Benzyl ether 449 (20.0 mg, 44.7 µmol) was dissolved in anhydrous EtOH (120 mL) and charged 
with 10% activated Pd/C (1.2 mg). The suspension was stirred under an atmosphere of 
hydrogen at RT for 16h. TLC analysis indicated reaction completion. The suspension was 
filtered through a pad of Celite and the filtrate was concentrated under reduced pressure to 
afford the crude alcohol intermediate as a colourless oil, and was oxidised without further 
purification. The alcohol intermediate was dissolved in anhydrous DCM (2 mL) and treated 
with BAIB (57.6 mg, 178 µmol) and TEMPO (2.1 mg, 13.4 µmol). The reaction mixture was 
stirred under argon at RT for 16h until reaction completion, as indicated by TLC analysis. The 
crude reaction mixture was purified by flash column chromatography, elution with 0-100% 
Et2O:petroleum ether, to afforded the aldehyde intermediate 451 (10.3 mg, 29.1 µmol, 65%) 
as a yellow oil. The aldehyde intermediate 451 (10.3, 29.1 µmol) was immediately dissolved in 
anhydrous MeOH (1.5 mL), before the sequential addition of dimethyl (1-diazo-2-
oxopropyl)phosphonate (8.4 mg, 43.7 µmol) in MeOH (0.2 mL), and K2CO3 (12.1 mg, 87.3 
µmol). The resultant mixture was stirred at RT for 3h until TLC analysis indicated reaction 
completion. The solvent was evaporated and the crude residue was purified by flash column 
chromatography, elution with 0-15% Et2O:petroleum ether, to afford acetylene 452 (7.4 mg, 
21.1 µmol, 73%) as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.30 (3H, d, J = 6.9, 
CH3(CHCH2Ar)), 1.40 (3H, d, J = 7.0, CH3(CHAr)), 1.94 (1H, t, J = 2.6, CHalkyne), 2.29 (3H, s, CH3Ar), 
2.48 (1H, ddd, J = 16.7, 7.8, 2.6, CH2(alkyne)), 2.64 (1H, ddd, J = 16.7, 6.0, 2.7, CH2(alkyne)), 
2.72 (1H, ddd, J = 14.5, 7.1, 0.9, CH2Ar), 2.93 (1H, ddd, J = 14.4, 7.6, 0.8, CH2Ar), 3.01-3.10 (1H, 
m, CH(CH2Ar), 3.10-3.17 (1H, m, CH(CH3)(Ar)), 6.19 (1H, s, CHalkene), 6.71 (1H, d, J = 7.7, ArH), 
7.26 (1H, s, ArH), 7.42 (1H, d, J = 7.8, ArH), 11.24 (1H, d, J = 0.4, OH). 13C NMR (CDCl3, 125 MHz) 
δ: 15.5 (CH3Ar), 17.6 (CH3(CHAr)), 18.0 (CH3(CHCH2Ar)), 24.3 (CH2(alkyne)), 30.9 (CH2Ar), 33.2 
(CH(CH3)(Ar)), 37.3 (CH(CH2Ar)), 70.0 (CalkyneH), 81.4 (Calkyne(CH2)), 103.9 (CalkeneH), 105.4 
(CQalkene), 114.8 (C
ArH), 134.7 (CArH), 135.5 (CAr), 137.8 (CAr), 138.4 (CArH), 158.8 (CAr), 159.5 
(CAr), 166.4 (CAr), 167.2 (CO). m/z  [EI+] 351 [M]+ (100%), HRMS found [M]+ 351.1473, C21H21NO4  
requires 351.1471. υmax /cm
-1 (film): 3304, 2957, 2926, 2854, 1724, 1684, 1647, 1622, 1456. 
[α]D
26.3 51.35 (c=0.07, CHCl3). 
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(E)-N-((R,2E,6Z)-11-(4-((S)-2-(8-hydroxy-7-methyl-1-oxo-1H-isochromen-3-
yl)propyl)oxazol-2-yl)dodeca-2,6-dien-8-ynyl)-3-methoxy-N-methylbut-2-
enamide 453 
 
8-hydroxy-7-methyl-3-((S)-1-(2-((R)-pent-4-yn-2-yl)oxazol-4-yl)propan-2-yl)-1H-isochromen-1-
one 452 (6.0 mg, 17.1 µmol) and (E)-N-((2E,6Z)-7-iodohepta-2,6-dienyl)-3-methoxy-N-
methylbut-2-enamide 72 (7.4 mg, 21.3 µmol) were dissolved in anhydrous MeCN (1.0 mL) and 
degassed by passing a stream of argon through the solution, before being cooled to 0 oC. The 
reaction was carried out in the absence of light. Pd(PPh3)4Cl2 (1.2 mg, 1.8 µmol) and CuI (0.7 
mg, 3.6 µmol) were added to the reaction mixture before the addition of NEt3 (12.4 µmol, 89.0 
mmol) and the resultant solution was stirred at 0 oC for 15 min and then warmed to room 
temperature and stirred for 24h, after which TLC analysis indicated reaction completion. The 
solvent was evaporated and the resultant residue was purified by flash column 
chromatography, elution with 0-70% Et2O:petroleum ether, to afford the desired enyne 453 
(6.6 mg, 11.5 µmol, 65%), as a colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.29 (3H, d, J = 6.9, 
CH3(CHCH2Ar)), 1.41 (3H, d, J = 7.1, CH3(CHAr)), 2.13-2.17 (2H, m, CH2(CHalkene(E))(CH2)), 2.21 
(3H, br. s, CH3(alkene)), 2.27-2.34 (2H, m, CH2(CHalkene(Z))(CH2)),  2.29 (3H, s, CH3Ar), 2.63 (1H, 
ddd, J = 16.8, 8.1, 2.2, CH2(alkyne)), 2.70 (1H, dd, J = 14.5, 7.3, CH2Ar), 2.80 (1H, ddd, J = 16.8, 
5.7, 2.0, CH2(alkyne)), 2.90-2.96 (1H, m, CH2Ar), 2.93 (3H, s, CH3N), 3.01-3.08 (1H, m, 
CH(CH2Ar)), 3.10-3.17 (1H, m, CH(CH3)(Ar)), 3.59 (3H, br. s, CH3O), 3.92 (2H, br. s, CH2N), 5.17 
(1H, br. s, CHalkene(CON)), 5.39-5.45 (2H, m, CHalkene(Z)(alkyne)), CHalkene(E)(CH2N)), 5.56 (1H, dt, J 
= 15.4, 6.6, CHalkene(E)(CH2CH2)), 5.74-5.82 (1H, m, CHalkene(Z)(CH2CH2)), 6.19 (1H, s, CHalkeneAr), 
6.71 (1H, d, J = 7.8, ArH), 7.26 (1H, s, ArH), 7.42 (1H, d, J = 7.8, ArH). 13C NMR (CDCl3, 125 MHz, 
3:2 rotamer ratio, asterisk denotes minor rotamer peaks, 55 oC) δ: 15.5 (CH3Ar), 17.6 
(CH3(CHAr)), 18.0 (CH3(CHCH2Ar)), 18.7 (CH3(alkene)), 25.4 CH2(alkyne), 29.6 (CH2(CHalkene(Z))), 
31.0 (CH2Ar), 31.4 (CH2(CHalkene(E))(CH2)), 33.6 (CH(CH3)(Ar)), 34.2 (CH3N), 37.3 (CH(CH2Ar)), 49.0 
(CH2N* only observed on DEPT135), 52.2 (CH2N only observed on DEPT135), 54.8 (CH3O), 77.2 
(Calkyne), 78.9 (Calkyne), 91.2 (CalkeneH(CON)), 103.5 (CalkeneHAr), 105.6 (C
Ar), 109.9 
(CHalkene(Z)(alkyne)), 114.7 (C
ArH), 124.2 (CAr), 125.3 (Calkene(E)H(CH2N)), 125.8 (C
Ar), 132.3 
Calkene(E)H(CH2CH2)), 134.4 (C
ArH), 135.6 (CAr), 138.2 (CArH), 141.4 (Calkene(Z)H(CH2CH2)), 159.1 
(CQ), 159.7 (CQ), 166.5 (CQ), 166.9 (CQ), 168.4 (CQ). m/z  [EI+] 572 [M]+ (27%), HRMS found [M]+ 
572.2882, C34H40N2O6  requires 572.2886. υmax /cm
-1 (film): 3296, 2958, 2925, 2851, 1730, 
1685, 1647, 1606, 1455, 1431. [α]D
23.5 42.50 (c=0.32, CHCl3). 
(S)-3-(4-((S)-2-((3S,4S)-8-(Tert-butyldimethylsilyloxy)-4-hydroxy-7-methyl-
1-oxoisochroman-3-yl)propyl)oxazol-2-yl)butanal 459 
 
Benzyl ether 407b (60.0 mg, 103 µmol) was dissolved in anhydrous EtOH (2 mL) and charged 
with 10% activated Pd/C (10 mg). The suspension was stirred under an atmosphere of 
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hydrogen at RT for 14h. TLC analysis indicated reaction completion. The suspension was 
filtered through a pad of Celite and the filtrate was concentrated under reduced pressure to 
afford the crude alcohol intermediate as a colourless oil that was taken on the next step 
without further purification. The alcohol intermediate was dissolved in anhydrous DCM (2 mL) 
and cooled to 0 oC under an atmosphere of argon. DMSO (500 µL) and NEt3 (172 µL, 1.24 
mmol) were added, before the portionwise addition of SO3.Py (131 mg, 824 µmol). The 
reaction mixture was allowed to warm to RT and stirred for 14h until reaction completion, as 
indicated by TLC analysis. The crude reaction mixture was quenched with water (10 mL) and 
diluted with Et2O (30 mL). The organics were collected and further washed with sat’d aq. 
CuSO4 solution (3 × 5 mL) and brine (3 × 5 mL), before being dried over anhydrous Na2SO4. The 
solvent was evaporated under reduced pressure to afford the crude product as a colourless oil. 
Purification by flash column chromatography, elution with 0-100% Et2O: petroleum ether 
afforded aldehyde 459 (33.2 mg, 68.1 µmol, 66% over 2 steps) as a colourless oil. 1H NMR 
(CDCl3, 500 MHz) δ: 0.14 (3H, s, CH3Si), 0.22 (3H, s, CH3Si), 1.05 (9H, s, (CH3)3CSi), 1.11 (3H, d, J 
= 6.9, CH3(CHCH2Ar)), 1.36 (3H, d, J = 7.1, CH3(CHAr)), 2.15 (1H, d, J = 6.8, OH), 2.28 (3H, s, 
CH3Ar), 2.46-2.54 (1H, m, CH(CH2Ar)), 2.63-2.69 (2H, m, CH2Ar, CH2(CHO)), 2.97-3.04 (2H, m, 
CH2Ar, CH2(CHO)), 3.44-3.51 (1H, m, CH(CH3)(Ar)), 4.06 (1H, dd, J = 9.3, 1.1, CH(O2C)), 4.66 (1H, 
br. d, J = 5.4, CH(OH)), 6.94 (1H, d, J = 7.6, ArH), 7.34 (1H, s, ArH), 7.37 (1H, d, J = 7.5, ArH). 13C 
NMR (CDCl3, 125 MHz) δ: -3.6 (CH3Si), -3.5 (CH3Si), 15.3 (CH3(CHCH2Ar), 17.4 (CH3Ar), 18.5 
(CH3(CHAr)), 18.7 (SiC(CH3)3), 25.9 ((CH3)3CSi), 28.2 (CH2Ar), 28.2 (CH(CH3)(Ar)), 33.1 
(CH(CH2Ar)), 48.0 (CH2(CHO)), 66.4 (CH(OH)), 82.9 (CH(O2C)), 115.8 (C
Ar), 120.2 (CArH), 132.7 
(CAr), 135.1 (CArH), 136.2 (CArH), 138.3 (CAr), 139.8 (CAr), 155.5 (CAr), 162.6 (CAr), 166.1 (CO2), 
199.9 (CHO). m/z  [EI+] 487 [M+H]+ (100%), HRMS found [M]+ 487.2394, C26H37O6NSi  requires 
487.2390. υmax /cm
-1 (film): 3385, 2957, 2930, 2854, 1728, 1588, 1584, 1464. [α]D
24.1 64.00 
(c=0.35, CHCl3). 
(3S,4S)-4,8-dihydroxy-7-methyl-3-((S)-1-(2-((S)-pent-4-yn-2-yl)oxazol-4-
yl)propan-2-yl)isochroman-1-one 458 
 
Aldehyde 459 (27.8 mg, 57.0 µmol) was dissolved in anhydrous MeOH (1.0 mL), before the 
sequential addition of dimethyl (1-diazo-2-oxopropyl)phosphonate (21.9 mg, 114 µmol) in 
MeOH (0.2 mL) and K2CO3 (23.6 mg, 171 µmol). The resultant mixture was stirred at RT for 6h 
under an atmosphere of argon, until TLC analysis indicated reaction completion. The solvent 
was evaporated and the crude residue was purified by flash column chromatography, elution 
with 0-35% Et2O:petroleum ether, afforded acetylene 458 (11.6 mg, 31.5 µmol, 55%) as a 
colourless oil. 1H NMR (CDCl3, 500 MHz) δ: 1.13 (3H, d, J = 6.7, CH3(CHCH2Ar)), 1.42 (3H, d, J = 
7.0, CH3(CHAr)), 1.95 (1H, br. s, CHalkyne), 2.28 (3H, s, CH3Ar), 2.42-2.62 (2H, m, CH(CH2Ar), 
CH2Ar), 2.50 (1H, ddd, J = 16.8. 7.9, 2.6, CH2(alkyne)), 2.67 (1H, ddd, J = 16.8. 5.9, 2.7, 
CH2(alkyne)), 3.06-3.19 (2H, m, CH2Ar, CH(CH3)(Ar)), 4.24 (1H, dd, J = 8.5, 1.6, CH(O2C)), 4.73 
(1H, br. d, J = 4.4, CH(OH)), 6.82 (1H, d, J = 7.4, ArH), 7.37-7.39 (2H, m, ArH). 13C NMR (CDCl3, 
125 MHz) δ: 15.6 (CH3(CHCH2Ar), 15.7 (CH3Ar), 17.5 (CH3(CHAr)), 24.3 (CH2(alkyne)), 28.2 
(CH2Ar), 33.1 (CH(CH3)(Ar)), 33.6 (CH(CH2Ar)), 65.4 (CH(OH)), 77.2 (CalkyneH) 85.0 (CH(O2C)), 
106.4 (CAr), 117.8 (CArH), 128.0 (CAr), 135.0 (CArH), 137.3 (CArH), 138.1 (CAr), 138.2 (CAr), 160.5 
(CAr), 166.2 (CAr), 169.5 (CO). N.B: CQalkyne not observed. m/z  [EI
+] 369 [M]+ (100%), HRMS 
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found [M]+ 369.1581, C21H23O5N  requires 369.1576. υmax /cm
-1 (film): 3304, 2959, 2924, 2854, 
1734, 1672, 1618, 1568, 1560, 1458, 1427. [α]D
23.6 -24.00 (c=0.05, CHCl3). 
(E)-N-((S,2E,6Z)-11-(4-((S)-2-((3S,4S)-4,8-dihydroxy-7-methyl-1-
oxoisochroman-3-yl)propyl)oxazol-2-yl)dodeca-2,6-dien-8-ynyl)-3-methoxy-
N-methylbut-2-enamide 457 
 
Acetylene 458 (10.0 mg, 27.0 µmol) and vinyl iodide 72 (11.3 mg, 32.4 µmol) were dissolved in 
anhydrous MeCN (1.0 mL) and degassed by passing a stream of argon through the solution, 
before being cooled to 0 oC. The reaction was carried out in the absence of light. Pd(PPh3)4Cl2 
(1.9 mg, 2.7 µmol) and CuI (1.0 mg, 5.4 µmol) were added to the reaction mixture before the 
addition of NEt3 (23.0 µmol, 162 mmol) and the resultant solution was stirred at 0 
oC for 15 
min and then warmed to RT. After stirring for 14h, TLC analysis indicated reaction completion. 
The reaction mixture was partitioned between Et2O (20 mL) and water (5 mL). The organics 
were collected and further washed with brine (2 × 3 mL), before being dried over anhydrous 
Na2SO4. The solvent was evaporated under reduced pressure to afford the crude product as a 
yellow oil. Purification by flash column chromatography, elution with 0-100% Et2O:petroleum 
ether, afforded enyne 457 (8.5 mg, 14.4 µmol, 53%), as a colourless oil. 1H NMR (CDCl3, 500 
MHz) δ: 1.13 (3H, d, J = 6.8, CH3(CHCH2Ar)), 1.43 (3H, d, J = 7.0, CH3(CHAr)), 2.12-2.16 (2H, m, 
CH2(CHalkene(E))(CH2)), 2.15 (3H, br. s, CH3(alkene)), 2.27-2.34 (2H, m, CH2(CHalkene(Z))(CH2)),  2.28 
(3H, s, CH3Ar), 2.53-2.63 (2H, m, CH2Ar, CH(CH2Ar)), 2.67 (1H, dd, J = 16.6, 6.5, CH2(alkyne)), 
2.80 (1H, ddd, J = 17.0, 6.1, 2.0, CH2(alkyne)), 2.93 (3H, s, CH3N), 3.07-3.19 (1H, m, CH(CH3)(Ar), 
CH2Ar), 3.59 (3H, br. s, CH3O), 3.92 (2H, br. s, CH2N), 4.22 (1H, dd, J = 8.7, 1.6, CH(O2C)), 4.71 
(1H, d, J = 4.4, CH(OH)), 5.16 (1H, br. s, CHalkene(CON)), 5.39 (1H, br. d, J = 10.7, 
CHalkene(Z)(alkyne)), 5.44 (1H, dt, J = 15.4, 5.8, CHalkene(E)(CH2N)), 5.57 (1H, dt, J = 15.4, 6.6, 
CHalkene(E)(CH2CH2)), 5.76 (1H, dt, J = 10.7, 7.3, CHalkene(Z)(CH2CH2)), 6.82 (1H, d,  J = 7.4, ArH), 
7.36 (1H, s, ArH), 7.37 (1H, d, J = 7.4, ArH). 13C NMR (CDCl3, 125 MHz) δ: 15.4 (CH3Ar), 15.4 
(CH3(CHCH2Ar)), 17.6 (CH3(CHAr)), 18.6 (CH3(alkene)), 25.5 CH2(alkyne), 28.4 (CH2Ar), 29.5 
(CH2(CHalkene(Z))), 31.4 (CH2(CHalkene(E))(CH2)), 33.5 (CH(CH2Ar)), 33.6 (CH(CH3)(Ar)), 34.2 (CH3N), 
54.7 (CH3O), 65.3 (CH(OH)), 77.5 (Calkyne), 78.9 (Calkyne), 85.2 (CH(O2C)),  91.3 (CalkeneH(CON)), 
106.6 (CAr), 109.8 (CHalkene(Z)(alkyne)), 117.7 (C
ArH), 125.4 (Calkene(E)H(CH2N)), 127.7 (C
Ar), 132.4 
Calkene(E)H(CH2CH2)), 134.8 (C
ArH), 137.1 (CArH), 138.4 (CAr), 138.5 (CAr), 141.7 
(Calkene(Z)H(CH2CH2)), 160.5 (C
Q), 166.4 (CQ),  168.4 (CQ), 168.5 (CQ), 168.5 (CQ), 169.5 (CQ). N.B; 
CH2N not observed. m/z  [CI
+, isobutane] 591 [M+H]+ (100%). HRMS found [M+H]+ 591.3065, 
C34H43N2O7  requires 591.3070. υmax / cm
-1 (film): 3100, 2958, 2925, 2851, 1730, 1685, 1647, 
1606, 1455, 1431. [α]D
23.7 -11.33 (c=0.35, CHCl3). 
Experimental 
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(E)-N-((S,2E,6Z,8Z)-11-(4-((S)-2-((3S,4S)-4,8-dihydroxy-7-methyl-1-
oxoisochroman-3-yl)propyl)oxazol-2-yl)dodeca-2,6,8-trienyl)-3-methoxy-N-
methylbut-2-enamide 456 
 
In the absence of light, Ni(OAc)2.4H2O (26 mg, 105 µmol) was dissolved in degassed EtOH (2 
mL) before NaBH4 (3.4 mg, 90.3 µmol) was added. The resultant black solution was stirred 
under an atmosphere of argon for 2 min before being placed under a hydrogen atmosphere. 
EDA (70 µL, 1.05 mmol) was added, followed by a solution of enyne 457 (17.0 mg, 30.1 µmol) 
in degassed EtOH (0.5 mL). The reaction mixture was stirred at RT under an atmosphere of 
hydrogen for 90 min, before being passed through Celite, elution with EtOH, followed by 
solvent evaporation to afford the crude product. Purification by HPLC, using a Waters Aquidity 
UPLC BEH C18 column (50 nm x 2.1 mm i.d. 1.7 µm) at RT, eluting with 0.1% v/v HCO2H/H2O-
0.1% v/v HCO2H/MeCN, afforded ent-C8-epi-ajudazol B 456 (9.5 mg, 16.0 µmol, 53%), as a 
colourless oil. 1H NMR ((CD3)2CO), 500 MHz) δ: 1.09 (3H, d, J = 6.8, CH3(CHCH2Ar)), 1.30 (3H, d, 
J = 7.0, CH3(CHAr)), 2.12-2.16 (2H, m, CH2(CHalkene(E))(CH2)), 2.14 (3H, br. s, CH3(alkene)), 2.23-
2.28 (2H, m, CH2(CHalkene(Z))(CH2)),  2.24 (3H, s, CH3Ar), 2.46-2.52 (1H, m, 
CH2(CHalkene(Z))(CHCH3)), 2.54 (1H, dd, J = 14.2, 8.8, CH2Ar), 2.60-2.67 (2H, m, 
CH2(CHalkene(Z))(CHCH3)), CH(CH2Ar)), 2.91 (3H, br. s, CH3N), 2.98-3.03 (1H, m, CH(CH3)(Ar)), 3.04 
(1H, ddd, J = 14.3, 3.4, 0.9, CH2Ar), 3.62 (3H, br. s, CH3O), 3.93 (2H, dd, J = 5.7, 0.9, CH2N), 4.37 
(1H, dd, J = 7.7, 1.7, CH(O2C)), 4.56 (1H, d, J = 6.1, OH), 4.81 (1H, dd, J = 5.9, 1.5, CH(OH)), 5.33 
(1H, br. s, CHalkene(CON)), 5.40-5.51 (3H, m, CHalkene(Z)(CH2CHCH3), CHalkene(Z)(CH2CH2), 
CHalkene(E)(CH2N)), 5.62 (1H, dt, J = 15.4, 6.7, CHalkene(E)(CH2CH2)), 6.25 (1H, ddt, J = 11.7, 10.7, 
1.4, CH(Z)(CH(Z)(CH2CH2))), 6.29 (1H, ddt, J = 11.7, 10.7, 1.4, CH(Z)(CH(Z)(CH2CHCH3))), 6.91 (1H, d, 
J = 7.5, ArH), 7.44 (1H, dd, J = 7.5, 0.6, ArH), 7.58 (1H, s, ArH), 11.37 (1H, s, ArOH). 13C NMR 
(((CD3)2CO), 125 MHz) δ: 15.0 (CH3(CHCH2Ar)), 15.4 (CH3Ar), 18.3 (CH3(CHAr)), 18.6 
(CH3(alkene)), 27.9 (CH2(CHalkene(Z))(CH2)), 29.3 (CH2Ar), 32.8 (CH2(CHalkene(E))(CH2)), 33.6 
(CH2(CHalkene(Z))(CHCH3)), 33.9 (CH(CH2Ar)), 34.7 (CH(CH3)(Ar)), 55.2 (CH3O), 65.1 (CH(OH)), 86.5 
(CH(O2C)), 92.3 (CalkeneH(CON)), 107.9 (C
Ar), 119.1 (CArH), 124.7 (Calkene(Z)H(CH(Z)CH2CH2)), 126.2 
(Calkene(Z)H(CH(Z)CH2CHCH3), 127.1 (Calkene(E)H(CH2N)), 127.2 (C
Ar), 129.2 (Calkene(Z)H(CH2CHCH3)), 
132.3 (Calkene(Z)H(CH2CH2)), 133.0 (Calkene(E)H(CH2CH2)), 135.8 (C
ArH), 137.7 (CArH), 139.4 (CAr), 
140.7 (CAr), 160.7 (CAr), 167.9 (CQ), 168.6 (CQ), 170.5 (CQ), 170.7 (CQ). N.B. CH3N and CH2N not 
observed. m/z  [CI+, isobutane] 543 [M+H]+ (100%), HRMS found [M+H]+ 593.3206, C34H43O7N2  
requires 593.3227. υmax /cm
-1 (film): 3306, 2967, 2924, 2855, 1670, 1642, 1456, 1427. [α]D
23.8 -
18.57 (c=0.84, CHCl3). 
Experimental 
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(E)-N-((S,2E,8Z)-11-(4-((S)-2-((3S,4S)-4,8-Dihydroxy-7-methyl-1-
oxoisochroman-3-yl)propyl)oxazol-2-yl)dodeca-2,8-dienyl)-3-methoxy-N-
methylbut-2-enamide 451 
 
Further elution afforded the over-reduced product 451 (4.5 mg, 7.6 µmol, 25%) as a colourless 
oil. 1H NMR ((CD3)2CO), 500 MHz) δ: 1.09 (3H, d, J = 6.8, CH3(CHCH2Ar)), 1.29 (3H, d, J = 7.0, 
CH3(CHAr)), 1.30-1.46 (4H, m, CH2(CH2CHalkene(E)), CH2(CH2CHalkene(Z))), 1.97-2.08 (4H, m, 
CH2(CHalkene(Z))(CH2CH2CH2), CH2(CHalkene(E))(CH2CH2CH2)), 2.13 (3H, br. s, CH3(alkene)), 2.24 (3H, 
s, CH3Ar), 2.33-2.39 (1H, m, CH2(CHalkene(Z))(CHCH3)), 2.47-2.56 (2H, m, CH2(CHalkene(Z))(CHCH3), 
CH2Ar), 2.61-2.68 (1H, m, CH(CH2Ar)), 2.91 (3H, br. s, CH3N), 2.93-3.00 (1H, m, CH(CH3)(Ar)), 
3.05 (1H, ddd, J = 14.6, 3.4, 0.9, CH2Ar), 3.61 (3H, br. s, CH3O), 3.93 (2H, dd, J = 5.8, 1.0, CH2N), 
4.37 (1H, dd, J = 9.7, 1.6, CH(O2C)), 4.57 (1H, d, J = 6.0, OH), 4.81 (1H, dd, J = 6.0, 1.5, CH(OH)), 
5.30-5.47 (3H, m, CHalkene(Z)(CH2CHCH3), CHalkene(Z)(CH2CH2CH2), CHalkene(E)(CH2N)),  5.34 (1H, br. 
s, CHalkene(CON)), 5.61 (1H, dtt, J = 15.4, 6.7, 1.3, CHalkene(E)(CH2CH2CH2)), 6.90 (1H, d, J = 7.5, 
ArH), 7.44 (1H, dd, J = 7.5, ArH), 7.58 (1H, s, ArH), 11.37 (1H, s, ArOH). 13C NMR (((CD3)2CO), 
125 MHz) δ: 15.0 (CH3(CHCH2Ar)), 15.4 (CH3Ar), 18.2 (CH3(CHAr)), 18.6 (CH3(alkene)), 27.6 
(CH2(CHalkene(Z))(CH2CH2 CH2)), 29.3 (CH2Ar), 32.6 (CH2(CHalkene(E))(CH2CH2CH2)), 33.4 
(CH2(CHalkene(Z))(CHCH3)), 33.9 (CH(CH2Ar)), 34.7 (CH(CH3)(Ar)), 55.2 (CH3O), 65.1 (CH(OH)), 86.5 
(CH(O2C)), 92.3 (CalkeneH(CON)), 107.9 (C
Ar), 119.0 (CArH), 127.2 (CAr), 127.4 
(Calkene(Z)H(CH2CHCH3)), 130.0 (Calkene(E)H(CH2N)),  (Calkene(Z)H(CH2CHCH3)), 132.3 
(Calkene(Z)H(CH2CH2CH2)), 133.7 (Calkene(E)H(CH2CH2CH2)), 135.8 (C
ArH), 137.7 (CArH), 139.4 (CAr), 
140.7 (CAr), 160.7 (CAr), 168.0 (CQ), 168.1 (CQ), 170.7 (CQ), 170.7 (CQ). N.B: CH3N and CH2N not 
observed. m/z  [EI+] 594 [M]+ (100%), HRMS found [M]+ 594.3309, C34H46O7N2 requires 
594.3305. υmax /cm
-1 (film): 3296, 2967, 2924, 2855, 1670, 1645, 1593, 1456, 1427. [α]D
23.5 -
24.00 (c = 0.45, CHCl3). 
 13 X-Ray Crystallographic Data 
X-ray diffraction data for crystals of 23a, 23b, 29b and 20 were collected at 100 K on a Rigaku 
R-Axis RAPID Image Plate diffractometer equipped with an Oxford Cryosystems Cryostream 
low-temperature device and using graphite monochromated Mo Kα radiation (λ = 0.71069 Å) 
radiation Data reduction was carried out using CrystalClear software version 1.4.0 
[CRYSTALCLEAR 1.4.0. Rigaku, 9009 New Trails Dr., The Woodlands, Texas 77381, USA, 1998]. 
X-ray data for 48b were collected at 150 K on a Nonius KappaCCD diffractometer equipped 
with an Oxford Cryosystems Cryostream low-temperature device and using graphite 
monochromated Mo Kα radiation (λ = 0.71069 Å) radiation. Data reduction and empirical 
absorption corrections were carried out with DENZO [Otwinowski, Z.; Minor, W. Methods in 
Enzymology, 1997, 276, 307-326.]. No absorption correction was applied to either dataset due 
to the light atom contents. The structures were both solved by direct methods using the 
program SHELXS [SHELXS86. Sheldrick, G.M. (1986)]. Program for the solution of crystal 
structures. Univ. of Göttingen, Germany] and refined using full-matrix least-squares 
refinement on F (I > 2σI) using CRYSTALS [Betteridge, P.W.; Carruthers, J.R.; Cooper, R.I.; Prout, 
K.; Watkin, D.J. J. Appl. Cryst., 2003, 36, 1487]. All non-hydrogen atoms were refined 
anisotropically. H atoms were placed in geometrically calculated positions and refined as riding 
groups, except for the atoms involved in hydrogen bonding, which were located on a 
difference map in each case, and their positions allowed to refine.  
 
X-Ray Crystallographic Data 
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Crystal data for 182: C13H16O4, Mr=236.26, orthorhombic, Pbcn, a=13.500(3), b=15.178(3), 
c=11.351(12) Å, β=90 o, T=100 K, Z=8, R=0.0386 for 2086 data with F0>2σ(F), wR2=0.1519 for 2670 
unique data, GOF=0.518. CCDC809799 contains the supplementary crystallographic data for this 
structure. This data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 22 X-Ray Structure of 182 
X-Ray Crystallographic Data 
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Crystal data for 183: C13H16O4, Mr=236.26, orthorhombic, P212121, a=8.8027(2), b=9.9264(2), 
c=13.7092(3) Å, β=90 o, T=100 K, Z=4, R=0.0251 for 2630 data with F0>2σ(F), wR2=0.0750 for 
2723 unique data, GOF=0.418. CCDC809800 contains the supplementary crystallographic data 
for this structure. This data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
 
Figure 23 X-Ray Structure of 183 
X-Ray Crystallographic Data 
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Crystal data for 196: C19H20O4, Mr=312.35, monoclinic, P2(1)/c, a=8.0746(1), b=10.5381(1), 
c=19.0147(3) Å, β=98.000(1)o, T=100 K, Z=4, R=0.0461 for 2638 data with F0>2σ(F), wR2=0.1261 
for 3687 unique data, GOF=0.923. CCDC809801 contains the supplementary crystallographic 
data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
 
Figure 24 X-Ray Structure of 196 
X-Ray Crystallographic Data 
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Crystal data for 208: C14H18O5, Mr=266.28, monoclinic, P2(1)/c, a=5.4288(3), b=26.7497(16), 
c=12.1509(8) Å, β=99.520(4)o, T=100 K, Z=4, R=0.0503 for 1855 data with F0>2σ(F), wR2=0.1400 
for 2230 unique data, GOF=1.103. 
 
Figure 25 X-Ray Structure of 208 
X-Ray Crystallographic Data 
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Crystal data for 255: C15H15NO4, Mr=273.28, monoclinic, P2(1)/c, a=12.7652(10), b=10.9486(9), 
c=10.4039(8) Å, β=111.548(4)o, T=100 K, Z=4, R=0.0343 for 2020 data with F0>2σ(F), wR2=0.0898 
for 2488 unique data, GOF=1.049.  
 
Figure 26 X-Ray Structure of 255 
X-Ray Crystallographic Data 
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Crystal data for 256: C15H15NO4, Mr=273.28, monoclinic, P2(1)/c, a=12.7055(10), b=9.9875(9), 
c=11.4011(9) Å, β=111.377(4)o, T=100 K, Z=4, R=0.0373 for 1729 data with F0>2σ(F), wR2=0.0954 
for 2446 unique data, GOF=1.028.  
 
Figure 27 X-Ray Structure of 256 
 
 
X-Ray Crystallographic Data 
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Crystal data for 247: C15H15NO4, Mr=273.28, monoclinic, C2/c, a=13.5059(9), b=9.3899(6), 
c=21.6502(17) Å, β=105.593 o, T=100 K, Z=8, R=0.0783 for 1726 data with F0>2σ(F), wR2=0.2634 
for 3031 unique data, GOF=1.132.  
 
 
Figure 29 X-Ray Structure of 247 
X-Ray Crystallographic Data 
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Crystal data for 258: C22H31NO5Si, Mr=417.57, orthorhombic, P212121, a=10.7398(3), b=8.2057(2), 
c=25.4880(9) Å, β=90 o, T=150 K, Z=4, R=0.0391 for 2907 data with F0>2σ(F), wR2=0.0919 for 
3524 unique data, GOF=1.060. CCDC813670 contains the supplementary crystallographic data 
for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 28 X-Ray Structure of 258 
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